1	ARTICLES	NNS	O	article	_	0	SENT_1	[p1l92t81r246b102],

1	Response	NN	O	response	_	0	SENT_2	[p1l92t173r377b231],
2	to	TO	O	to	dep	4	SENT_2	[p1l399t174r459b220],
3	antiretroviral	JJ	O	antiretroviral	amod	4	SENT_2	[p1l482t172r859b220],
4	treatment	NN	O	treatment	dep	15	SENT_2	[p1l882t174r1178b220],
5	in	IN	O	in	_	0	SENT_2	[p1l1203t172r1250b219],
6	HIV-1-infected	JJ	O	hiv-1-infected	amod	7	SENT_2	[p1l1277t172r1688b220],
7	individuals	NNS	O	individual	prep_in	4	SENT_2	[p1l1715t172r2024b220],
8	with	IN	O	with	_	0	SENT_2	[p1l89t256r213b304],
9	allelic	JJ	O	allelic	amod	10	SENT_2	[p1l238t256r412b304],
10	variants	NNS	O	variant	prep_with	7	SENT_2	[p1l434t256r670b304],
11	of	IN	O	of	_	0	SENT_2	[p1l694t256r750b304],
12	the	DT	O	the	det	14	SENT_2	[p1l768t257r864b304],
13	multidrug	JJ	O	multidrug	amod	14	SENT_2	[p1l889t256r1170b315],
14	resistance	NN	O	resistance	prep_of	10	SENT_2	[p1l1193t256r1500b304],
15	transporter	NN	O	transporter	dep	1	SENT_2	[p1l1522t258r1857b315],
16	1	CD	NUMBER	1	num	15	SENT_2	[p1l1879t257r1933b303],
17	:	:	O	:	_	0	SENT_2	[p1l1879t257r1933b303],
18	a	DT	O	a	det	19	SENT_2	[p1l1959t268r1991b304],
19	pharmacogenetics	NNS	O	pharmacogenetic	dep	1	SENT_2	[p1l92t341r638b400],
20	study	NN	O	study	dep	19	SENT_2	[p1l661t342r822b400],

1	Jacques	NNP	PERSON	Jacques	nn	2	SENT_3	[p1l87t475r216b508],
2	Fellay	NNP	PERSON	Fellay	_	0	SENT_3	[p1l230t475r326b508],
3	,	,	O	,	_	0	SENT_3	[p1l230t475r326b508],
4	Catia	NNP	PERSON	Catia	nn	5	SENT_3	[p1l342t475r420b502],
5	Marzolini	NNP	PERSON	Marzolini	appos	2	SENT_3	[p1l434t475r584b507],
6	,	,	O	,	_	0	SENT_3	[p1l434t475r584b507],
7	Emma	NNP	PERSON	Emma	nn	9	SENT_3	[p1l599t475r698b502],
8	R	NNP	PERSON	R	nn	9	SENT_3	[p1l713t475r734b501],
9	Meaden	NNP	PERSON	Meaden	appos	2	SENT_3	[p1l747t475r882b507],
10	,	,	O	,	_	0	SENT_3	[p1l747t475r882b507],
11	David	NNP	PERSON	David	nn	12	SENT_3	[p1l898t475r986b502],
12	J	NNP	PERSON	J	appos	2	SENT_3	[p1l995t475r1011b502],
13	Back	RB	PERSON	back	advmod	12	SENT_3	[p1l1023t475r1107b507],
14	,	,	O	,	_	0	SENT_3	[p1l1023t475r1107b507],
15	Thieriy	NNP	O	Thieriy	nn	16	SENT_3	[p1l1124t475r1231b508],
16	Buclin	NNP	O	Buclin	appos	2	SENT_3	[p1l1242t475r1345b507],
17	,	,	O	,	_	0	SENT_3	[p1l1242t475r1345b507],
18	Jean-Philippe	NNP	PERSON	Jean-Philippe	nn	19	SENT_3	[p1l1358t475r1567b508],
19	Chave	NNP	PERSON	Chave	appos	16	SENT_3	[p1l1581t475r1684b507],
20	,	,	O	,	_	0	SENT_3	[p1l1581t475r1684b507],
21	Laurent	NNP	PERSON	Laurent	nn	23	SENT_3	[p1l1699t475r1822b502],
22	A	NNP	PERSON	A	nn	23	SENT_3	[p1l1831t475r1852b501],
23	Decosterd	NNP	PERSON	Decosterd	appos	16	SENT_3	[p1l1866t475r2033b507],
24	,	,	O	,	_	0	SENT_3	[p1l1866t475r2033b507],
25	Hansjakob	NNP	PERSON	Hansjakob	nn	26	SENT_3	[p1l90t525r257b558],
26	Furrer	NNP	PERSON	Furrer	appos	16	SENT_3	[p1l270t525r372b557],
27	,	,	O	,	_	0	SENT_3	[p1l270t525r372b557],
28	Milos	NNP	PERSON	Milos	nn	29	SENT_3	[p1l387t525r469b552],
29	Opravil	NNP	PERSON	Opravil	appos	16	SENT_3	[p1l483t525r598b558],
30	,	,	O	,	_	0	SENT_3	[p1l483t525r598b558],
31	Giuseppe	NNP	PERSON	Giuseppe	nn	32	SENT_3	[p1l614t525r761b558],
32	Pantaleo	NNP	PERSON	Pantaleo	appos	16	SENT_3	[p1l775t525r920b557],
33	,	,	O	,	_	0	SENT_3	[p1l775t525r920b557],
34	Dorota	NNP	PERSON	Dorota	nn	35	SENT_3	[p1l936t525r1040b552],
35	Retelska	NNP	PERSON	Retelska	appos	16	SENT_3	[p1l1054t525r1197b557],
36	,	,	O	,	_	0	SENT_3	[p1l1054t525r1197b557],
37	Lidia	NNP	PERSON	Lidia	nn	38	SENT_3	[p1l1213t525r1286b552],
38	Ruiz	NNP	PERSON	Ruiz	appos	16	SENT_3	[p1l1300t525r1373b557],
39	,	,	O	,	_	0	SENT_3	[p1l1300t525r1373b557],
40	Alfred	NNP	PERSON	Alfred	nn	42	SENT_3	[p1l1387t525r1481b552],
41	H	NNP	PERSON	H	nn	42	SENT_3	[p1l1493t525r1516b551],
42	Schinkel	NNP	PERSON	Schinkel	appos	16	SENT_3	[p1l1527t525r1669b557],
43	,	,	O	,	_	0	SENT_3	[p1l1527t525r1669b557],
44	Pietro	NNP	LOCATION	Pietro	nn	45	SENT_3	[p1l1684t525r1774b552],
45	Vernazza	NNP	LOCATION	Vernazza	appos	16	SENT_3	[p1l1789t525r1937b557],
46	,	,	O	,	_	0	SENT_3	[p1l1789t525r1937b557],
47	Chin	NNP	O	Chin	nn	49	SENT_3	[p1l101t575r168b602],
48	B	NNP	O	B	nn	49	SENT_3	[p1l183t575r203b601],
49	Eap	NNP	O	Eap	appos	16	SENT_3	[p1l217t575r282b608],
50	,	,	O	,	_	0	SENT_3	[p1l217t575r282b608],
51	Amalio	NNP	PERSON	Amalio	nn	52	SENT_3	[p1l295t575r404b602],
52	Telenti	NNP	PERSON	Telenti	appos	16	SENT_3	[p1l418t575r529b607],
53	,	,	O	,	_	0	SENT_3	[p1l418t575r529b607],
54	for	IN	O	for	_	0	SENT_3	[p1l544t575r588b602],
55	the	DT	O	the	det	58	SENT_3	[p1l599t575r648b602],
56	Swiss	JJ	MISC	swiss	amod	58	SENT_3	[p1l660t575r748b602],
57	HIV	NN	O	hiv	nn	58	SENT_3	[p1l762t575r816b601],
58	Cohort	NN	O	cohort	prep_for	16	SENT_3	[p1l827t575r931b602],
59	Study	NN	O	study	nn	60	SENT_3	[p1l941t575r1049b608],
60	*	NN	O	*	dep	2	SENT_3	[p1l941t575r1049b608],

1	Summary	NN	O	summary	_	0	SENT_4	[p1l7t690r429b773],

1	Background	NN	O	background	nn	2	SENT_5	[p1l10t889r433b958],
2	HIV-1	NN	O	hiv-1	nsubj	6	SENT_5	[p1l501t888r973b945],
3	—	RB	O	—	advmod	5	SENT_5	[p1l501t888r973b945],
4	infected	JJ	O	infected	amod	5	SENT_5	[p1l501t888r973b945],
5	patients	NNS	O	patient	rcmod	2	SENT_5	[p1l1042t889r1319b958],
6	vary	VBP	O	vary	_	0	SENT_5	[p1l1380t902r1519b959],
7	considerably	RB	O	considerably	advmod	6	SENT_5	[p1l1579t889r2016b959],
8	by	IN	O	by	_	0	SENT_5	[p1l2078t889r2151b959],
9	their	PRP$	O	they	poss	10	SENT_5	[p1l6t982r164b1038],
10	response	NN	O	response	prep_by	6	SENT_5	[p1l251t995r568b1051],
11	to	TO	O	to	_	0	SENT_5	[p1l653t985r720b1038],
12	antiretroviral	JJ	O	antiretroviral	amod	13	SENT_5	[p1l807t982r1237b1038],
13	treatment	NN	O	treatment	prep_to	10	SENT_5	[p1l1325t985r1685b1048],
14	,	,	O	,	_	0	SENT_5	[p1l1325t985r1685b1048],
15	drug	NN	O	drug	nn	16	SENT_5	[p1l1776t982r1926b1053],
16	concentrations	NNS	O	concentration	conj_and	10	SENT_5	[p1l2010t995r2151b1038, p1l8t1075r397b1132],
17	in	IN	O	in	_	0	SENT_5	[p1l452t1075r503b1131],
18	plasma	NN	O	plasma	prep_in	16	SENT_5	[p1l561t1075r830b1144],
19	,	,	O	,	_	0	SENT_5	[p1l561t1075r830b1144],
20	toxic	JJ	O	toxic	amod	21	SENT_5	[p1l882t1075r1042b1132],
21	events	NNS	O	event	appos	18	SENT_5	[p1l1094t1078r1342b1141],
22	,	,	O	,	_	0	SENT_5	[p1l1094t1078r1342b1141],
23	and	CC	O	and	_	0	SENT_5	[p1l1397t1075r1520b1132],
24	rate	NN	O	rate	conj_and	10	SENT_5	[p1l1577t1078r1706b1132],
25	of	IN	O	of	_	0	SENT_5	[p1l1759t1075r1826b1132],
26	immune	JJ	O	immune	amod	27	SENT_5	[p1l1875t1075r2148b1132],
27	recovery	NN	O	recovery	prep_of	24	SENT_5	[p1l11t1181r312b1238],
28	.	.	O	.	_	0	SENT_5	[p1l11t1181r312b1238],

1	This	DT	O	this	det	2	SENT_6	[p1l343t1168r485b1224],
2	variability	NN	O	variability	nsubj	4	SENT_6	[p1l511t1168r839b1238],
3	could	MD	O	could	aux	4	SENT_6	[p1l865t1168r1046b1224],
4	have	VB	O	have	_	0	SENT_6	[p1l1079t1168r1236b1224],
5	a	DT	O	a	det	7	SENT_6	[p1l1266t1181r1302b1224],
6	genetic	JJ	O	genetic	amod	7	SENT_6	[p1l1331t1168r1582b1238],
7	basis	NN	O	basis	dobj	4	SENT_6	[p1l1612t1168r1815b1224],
8	.	.	O	.	_	0	SENT_6	[p1l1612t1168r1815b1224],

1	We	PRP	O	we	nsubj	2	SENT_7	[p1l1845t1168r1951b1224],
2	did	VBD	O	do	_	0	SENT_7	[p1l1980t1168r2079b1224],
3	a	DT	O	a	det	5	SENT_7	[p1l2111t1181r2146b1224],
4	pharmacogenetics	NNS	O	pharmacogenetic	nn	5	SENT_7	[p1l12t1261r646b1332],
5	study	NN	O	study	dobj	2	SENT_7	[p1l680t1261r865b1331],
6	to	TO	O	to	aux	7	SENT_7	[p1l892t1264r958b1317],
7	analyse	VB	O	analyse	xcomp	2	SENT_7	[p1l991t1261r1253b1331],
8	the	DT	O	the	det	9	SENT_7	[p1l1284t1261r1394b1317],
9	association	NN	O	association	dobj	7	SENT_7	[p1l1427t1261r1823b1317],
10	between	IN	O	between	_	0	SENT_7	[p1l1860t1261r2146b1317],
11	response	NN	O	response	prep_between	9	SENT_7	[p1l11t1367r329b1423],
12	to	TO	O	to	_	0	SENT_7	[p1l373t1357r440b1411],
13	antiretroviral	JJ	O	antiretroviral	amod	14	SENT_7	[p1l487t1354r917b1411],
14	treatment	NN	O	treatment	prep_to	7	SENT_7	[p1l964t1357r1307b1411],
15	and	CC	O	and	_	0	SENT_7	[p1l1351t1354r1473b1411],
16	allelic	JJ	O	allelic	amod	17	SENT_7	[p1l1523t1354r1720b1411],
17	variants	NNS	O	variant	prep_to	7	SENT_7	[p1l1764t1354r2039b1411],
18	of	IN	O	of	_	0	SENT_7	[p1l2087t1354r2153b1411],
19	several	JJ	O	several	amod	20	SENT_7	[p1l9t1447r252b1503],
20	genes	NNS	O	gene	prep_of	14	SENT_7	[p1l283t1455r512b1517],
21	.	.	O	.	_	0	SENT_7	[p1l283t1455r512b1517],

1	Methods	NNS	O	method	npadvmod	7	SENT_8	[p1l10t1635r319b1692],
2	In	IN	O	in	_	0	SENT_8	[p1l358t1635r410b1691],
3	123	CD	NUMBER	123	num	4	SENT_8	[p1l452t1635r587b1692],
4	patients	NNS	O	patient	prep_in	7	SENT_8	[p1l627t1635r924b1704],
5	,	,	O	,	_	0	SENT_8	[p1l627t1635r924b1704],
6	we	PRP	O	we	nsubj	7	SENT_8	[p1l962t1648r1055b1692],
7	did	VBD	O	do	_	0	SENT_8	[p1l1091t1635r1189b1692],
8	PCR	NN	O	pcr	nn	9	SENT_8	[p1l1229t1635r1366b1692],
9	analyses	NNS	O	analysis	dobj	7	SENT_8	[p1l1402t1635r1706b1705],
10	of	IN	O	of	_	0	SENT_8	[p1l1743t1635r1810b1692],
11	the	DT	O	the	det	12	SENT_8	[p1l1837t1635r1947b1692],
12	gene	NN	O	gene	prep_of	9	SENT_8	[p1l1981t1643r2147b1706],
13	for	IN	O	for	_	0	SENT_8	[p1l6t1727r99b1784],
14	the	DT	O	the	det	19	SENT_8	[p1l123t1728r232b1784],
15	multidrug-resistance	JJ	O	multidrug-resistance	amod	19	SENT_8	[p1l265t1728r967b1798],
16	transporter	NN	O	transporter	nn	19	SENT_8	[p1l995t1731r1383b1797],
17	(	CD	NUMBER	(	num	19	SENT_8	[p1l1410t1728r1687b1797],
18	MDR1	NN	O	mdr1	nn	19	SENT_8	[p1l1410t1728r1687b1797],
19	)	NN	O	)	prep_for	7	SENT_8	[p1l1410t1728r1687b1797],
20	,	,	O	,	_	0	SENT_8	[p1l1410t1728r1687b1797],
21	which	WDT	O	which	nsubj	22	SENT_8	[p1l1718t1728r1910b1784],
22	codes	VBZ	O	code	rcmod	19	SENT_8	[p1l1942t1728r2147b1784],
23	for	IN	O	for	_	0	SENT_8	[p1l6t1820r99b1878],
24	P	NN	O	p	nn	26	SENT_8	[p1l170t1821r666b1893],
25	—	CD	NUMBER	—	num	26	SENT_8	[p1l170t1821r666b1893],
26	glycoprotein	NN	O	glycoprotein	prep_for	22	SENT_8	[p1l170t1821r666b1893],
27	,	,	O	,	_	0	SENT_8	[p1l170t1821r666b1893],
28	of	IN	O	of	_	0	SENT_8	[p1l742t1820r809b1878],
29	genes	NNS	O	gene	prep_of	26	SENT_8	[p1l874t1829r1082b1893],
30	coding	VBG	O	code	partmod	29	SENT_8	[p1l1154t1821r1380b1893],
31	for	IN	O	for	_	0	SENT_8	[p1l1447t1820r1540b1878],
32	isoenzymes	NNS	O	isoenzyme	prep_for	30	SENT_8	[p1l1613t1821r2014b1892],
33	of	IN	O	of	_	0	SENT_8	[p1l2086t1820r2153b1878],
34	cytochrome	NN	O	cytochrome	nn	35	SENT_8	[p1l8t1915r404b1985],
35	P450	NN	O	p450	prep_of	32	SENT_8	[p1l507t1915r710b1981],
36	,	,	O	,	_	0	SENT_8	[p1l507t1915r710b1981],
37	CYP3A4	NN	O	cyp3a4	nn	41	SENT_8	[p1l815t1915r1110b1981],
38	,	,	O	,	_	0	SENT_8	[p1l815t1915r1110b1981],
39	CYP3A5	NN	O	cyp3a5	dep	41	SENT_8	[p1l1215t1915r1511b1981],
40	,	,	O	,	_	0	SENT_8	[p1l1215t1915r1511b1981],
41	CYP2D6	NN	O	cyp2d6	prep_of	32	SENT_8	[p1l1615t1915r1919b1981],
42	,	,	O	,	_	0	SENT_8	[p1l1615t1915r1919b1981],
43	and	CC	O	and	_	0	SENT_8	[p1l2023t1915r2146b1972],
44	CYP2C19	NN	O	cyp2c19	conj_and	41	SENT_8	[p1l9t2007r358b2074],
45	,	,	O	,	_	0	SENT_8	[p1l9t2007r358b2074],
46	and	CC	O	and	_	0	SENT_8	[p1l390t2008r512b2064],
47	of	IN	O	of	prep_of	32	SENT_8	[p1l544t2007r611b2064],
48	the	DT	O	the	det	49	SENT_8	[p1l631t2008r740b2064],
49	gene	NN	O	gene	pobj	47	SENT_8	[p1l767t2016r934b2078],
50	for	IN	O	for	_	0	SENT_8	[p1l961t2007r1054b2064],
51	the	DT	O	the	det	54	SENT_8	[p1l1077t2008r1186b2064],
52	chemokine	NN	O	chemokine	nn	54	SENT_8	[p1l1215t2008r1590b2064],
53	receptor	NN	O	receptor	nn	54	SENT_8	[p1l1622t2011r1907b2077],
54	CCR5	NN	O	ccr5	prep_for	35	SENT_8	[p1l1932t2007r2144b2064],
55	.	.	O	.	_	0	SENT_8	[p1l1932t2007r2144b2064],

1	We	PRP	O	we	nsubj	20	SENT_9	[p1l6t2101r112b2158],
2	measured	VBD	O	measure	_	0	SENT_9	[p1l153t2101r493b2158],
3	concentrations	NNS	O	concentration	dobj	2	SENT_9	[p1l533t2101r1047b2158],
4	in	IN	O	in	_	0	SENT_9	[p1l1088t2101r1140b2157],
5	plasma	NN	O	plasma	prep_in	2	SENT_9	[p1l1183t2101r1430b2170],
6	of	IN	O	of	_	0	SENT_9	[p1l1470t2100r1537b2158],
7	the	DT	O	the	det	10	SENT_9	[p1l1567t2101r1676b2158],
8	antiretroviral	JJ	O	antiretroviral	amod	10	SENT_9	[p1l1715t2101r2145b2158],
9	agents	NNS	O	agent	nn	10	SENT_9	[p1l8t2197r241b2265],
10	efavirenz	NN	O	efavirenz	prep_of	5	SENT_9	[p1l290t2194r598b2251],
11	and	CC	O	and	_	0	SENT_9	[p1l646t2194r768b2251],
12	nelfinavir	NN	O	nelfinavir	prep_of	5	SENT_9	[p1l822t2194r1134b2251],
13	by	IN	O	by	_	0	SENT_9	[p1l1181t2194r1254b2264],
14	high	JJ	O	high	amod	17	SENT_9	[p1l1303t2194r1898b2265],
15	—	NN	O	—	nn	17	SENT_9	[p1l1303t2194r1898b2265],
16	performance	NN	O	performance	nn	17	SENT_9	[p1l1303t2194r1898b2265],
17	liquidchromatography	NN	O	liquidchromatography	prep_by	2	SENT_9	[p1l1951t2194r2151b2263, p1l8t2287r583b2357],
18	,	,	O	,	_	0	SENT_9	[p1l1951t2194r2151b2263, p1l8t2287r583b2357],
19	and	CC	O	and	_	0	SENT_9	[p1l658t2287r780b2343],
20	measured	VBN	O	measure	conj_and	2	SENT_9	[p1l856t2287r1197b2343],
21	levels	NNS	O	level	dobj	20	SENT_9	[p1l1273t2287r1467b2343],
22	of	IN	O	of	_	0	SENT_9	[p1l1539t2286r1605b2343],
23	P	NN	O	p	nn	26	SENT_9	[p1l1673t2287r2145b2357],
24	—	CD	NUMBER	—	num	26	SENT_9	[p1l1673t2287r2145b2357],
25	glycoprotein	NN	O	glycoprotein	nn	26	SENT_9	[p1l1673t2287r2145b2357],
26	expression	NN	O	expression	prep_of	21	SENT_9	[p1l8t2380r404b2449],
27	,	,	O	,	_	0	SENT_9	[p1l8t2380r404b2449],
28	CD4	NN	O	cd4	nn	31	SENT_9	[p1l438t2380r718b2437],
29	—	NN	O	—	nn	31	SENT_9	[p1l438t2380r718b2437],
30	cell	NN	O	cell	nn	31	SENT_9	[p1l438t2380r718b2437],
31	count	NN	O	count	prep_of	21	SENT_9	[p1l751t2383r961b2446],
32	,	,	O	,	_	0	SENT_9	[p1l751t2383r961b2446],
33	and	CC	O	and	_	0	SENT_9	[p1l994t2380r1117b2437],
34	HIV-1	NN	O	hiv-1	nn	35	SENT_9	[p1l1152t2380r1327b2436],
35	viraemia	NN	O	viraemia	prep_of	21	SENT_9	[p1l1354t2380r1668b2437],
36	.	.	O	.	_	0	SENT_9	[p1l1354t2380r1668b2437],

1	Findings	NNS	O	finding	nsubj	18	SENT_10	[p1l10t2568r304b2638],
2	Median	JJ	MISC	median	amod	4	SENT_10	[p1l357t2569r604b2625],
3	drug	NN	O	drug	nn	4	SENT_10	[p1l657t2569r807b2639],
4	concentrations	NNS	O	concentration	npadvmod	1	SENT_10	[p1l854t2569r1367b2625],
5	in	IN	O	in	_	0	SENT_10	[p1l1421t2569r1472b2624],
6	patients	NNS	O	patient	prep_in	1	SENT_10	[p1l1528t2569r1805b2638],
7	with	IN	O	with	_	0	SENT_10	[p1l1853t2569r1989b2625],
8	the	DT	O	the	det	11	SENT_10	[p1l2038t2569r2148b2625],
9	MDR1	NN	O	mdr1	nn	11	SENT_10	[p1l9t2662r218b2718],
10	3435	CD	NUMBER	3435	num	11	SENT_10	[p1l263t2662r450b2719],
11	TT	NN	O	tt	prep_with	6	SENT_10	[p1l494t2662r591b2729],
12	,	,	O	,	_	0	SENT_10	[p1l494t2662r591b2729],
13	CT	NN	O	ct	conj_and	11	SENT_10	[p1l639t2662r744b2729],
14	,	,	O	,	_	0	SENT_10	[p1l639t2662r744b2729],
15	and	CC	O	and	_	0	SENT_10	[p1l793t2662r915b2719],
16	CC	NN	O	cc	nn	17	SENT_10	[p1l962t2662r1056b2719],
17	genotypes	NNS	O	genotype	prep_with	6	SENT_10	[p1l1099t2665r1454b2734],
18	were	VBD	O	be	_	0	SENT_10	[p1l1497t2676r1658b2719],
19	at	IN	O	at	_	0	SENT_10	[p1l1704t2665r1770b2719],
20	the	DT	O	the	det	21	SENT_10	[p1l1809t2662r1918b2719],
21	30th	JJ	ORDINAL	30th	prep_at	18	SENT_10	[p1l1964t2662r2144b2729],
22	,	,	O	,	_	0	SENT_10	[p1l1964t2662r2144b2729],
23	50th	JJ	ORDINAL	50th	conj_and	21	SENT_10	[p1l9t2756r189b2822],
24	,	,	O	,	_	0	SENT_10	[p1l9t2756r189b2822],
25	and	CC	ORDINAL	and	_	0	SENT_10	[p1l255t2756r377b2813],
26	75th	JJ	ORDINAL	75th	amod	27	SENT_10	[p1l445t2756r600b2813],
27	percentiles	NNS	O	percentile	prep_at	18	SENT_10	[p1l668t2756r1067b2825],
28	,	,	O	,	_	0	SENT_10	[p1l668t2756r1067b2825],
29	respectively	RB	O	respectively	advmod	21	SENT_10	[p1l1136t2756r1544b2826],
30	(	CD	NUMBER	(	num	31	SENT_10	[p1l1604t2756r2022b2826],
31	p	NN	O	p	dep	21	SENT_10	[p1l1604t2756r2022b2826],
32	=	JJ	O	=	amod	34	SENT_10	[p1l1604t2756r2022b2826],
33	O-OOO1	NN	O	o-ooo1	nn	34	SENT_10	[p1l1604t2756r2022b2826],
34	)	NN	O	)	dep	31	SENT_10	[p1l1604t2756r2022b2826],
35	.	.	O	.	_	0	SENT_10	[p1l1604t2756r2022b2826],

1	In	IN	O	in	_	0	SENT_11	[p1l2093t2756r2145b2812],
2	patients	NNS	O	patient	prep_in	13	SENT_11	[p1l12t2849r289b2918],
3	with	IN	O	with	_	0	SENT_11	[p1l379t2849r515b2905],
4	CYP2D6	NN	O	cyp2d6	nn	5	SENT_11	[p1l610t2849r885b2906],
5	extensive-metaboliser	NN	O	extensive-metaboliser	prep_with	2	SENT_11	[p1l974t2849r1735b2905],
6	or	CC	O	or	_	0	SENT_11	[p1l1825t2862r1891b2905],
7	poormetaboliser	NN	O	poormetaboliser	nn	8	SENT_11	[p1l1983t2862r2151b2918, p1l11t2942r421b2998],
8	alleles	NNS	O	allele	conj_or	5	SENT_11	[p1l475t2942r720b3008],
9	,	,	O	,	_	0	SENT_11	[p1l475t2942r720b3008],
10	median	JJ	O	median	amod	12	SENT_11	[p1l783t2942r1032b2998],
11	drug	NN	O	drug	nn	12	SENT_11	[p1l1092t2942r1242b3013],
12	concentrations	NNS	O	concentration	nsubj	13	SENT_11	[p1l1296t2942r1809b2998],
13	were	VBD	O	be	_	0	SENT_11	[p1l1865t2955r2027b2998],
14	at	IN	O	at	_	0	SENT_11	[p1l2085t2945r2151b2998],
15	percentiles	NNS	O	percentile	prep_at	13	SENT_11	[p1l12t3035r390b3104],
16	45	CD	NUMBER	45	num	15	SENT_11	[p1l419t3035r509b3092],
17	and	CC	O	and	_	0	SENT_11	[p1l539t3035r661b3092],
18	62-5	CD	NUMBER	62-5	prep_at	13	SENT_11	[p1l693t3035r876b3101],
19	,	,	O	,	_	0	SENT_11	[p1l693t3035r876b3101],
20	respectively	RB	O	respectively	advmod	15	SENT_11	[p1l911t3035r1319b3105],
21	(	CD	NUMBER	(	num	22	SENT_11	[p1l1346t3035r1668b3105],
22	p	NN	O	p	dep	15	SENT_11	[p1l1346t3035r1668b3105],
23	=	JJ	O	=	amod	25	SENT_11	[p1l1346t3035r1668b3105],
24	O-O4	NN	O	o-o4	nn	25	SENT_11	[p1l1346t3035r1668b3105],
25	)	NN	O	)	dep	22	SENT_11	[p1l1346t3035r1668b3105],
26	.	.	O	.	_	0	SENT_11	[p1l1346t3035r1668b3105],

1	Patients	NNS	O	patient	nsubj	12	SENT_12	[p1l1703t3035r1983b3092],
2	with	IN	O	with	_	0	SENT_12	[p1l2010t3035r2145b3092],
3	the	DT	O	the	det	6	SENT_12	[p1l6t3128r115b3184],
4	MDR1	NN	O	mdr1	nn	6	SENT_12	[p1l145t3128r353b3183],
5	TT	NN	O	tt	nn	6	SENT_12	[p1l380t3128r460b3183],
6	genotype	NN	O	genotype	prep_with	1	SENT_12	[p1l484t3131r797b3198],
7	6	CD	DURATION	6	num	8	SENT_12	[p1l826t3127r868b3184],
8	months	NNS	NUMBER	month	npadvmod	12	SENT_12	[p1l900t3128r1155b3184],
9	after	IN	O	after	_	0	SENT_12	[p1l1184t3127r1344b3184],
10	starting	VBG	O	start	prepc_after	12	SENT_12	[p1l1370t3128r1632b3198],
11	treatment	NN	O	treatment	dobj	10	SENT_12	[p1l1655t3131r1998b3184],
12	had	VBD	O	have	_	0	SENT_12	[p1l2026t3128r2146b3184],
13	a	DT	O	a	det	15	SENT_12	[p1l8t3234r45b3277],
14	greater	JJR	O	greater	amod	15	SENT_12	[p1l77t3223r325b3292],
15	rise	NN	O	rise	dobj	12	SENT_12	[p1l356t3220r478b3277],
16	in	IN	O	in	_	0	SENT_12	[p1l514t3220r566b3276],
17	CD4	NN	O	cd4	nn	21	SENT_12	[p1l602t3220r882b3277],
18	—	NN	O	—	nn	21	SENT_12	[p1l602t3220r882b3277],
19	cell	NN	O	cell	nn	21	SENT_12	[p1l602t3220r882b3277],
20	count	NN	O	count	nn	21	SENT_12	[p1l917t3224r1109b3277],
21	(	NN	O	(	prep_in	15	SENT_12	[p1l1140t3220r1300b3290],
22	257	CD	NUMBER	257	num	23	SENT_12	[p1l1140t3220r1300b3290],
23	CGHS/p	NN	O	cghs/p	dep	21	SENT_12	[p1l1335t3220r1650b3293],
24	.	.	O	.	_	0	SENT_12	[p1l1335t3220r1650b3293],

1	L	NN	O	l	nn	2	SENT_13	[p1l1335t3220r1650b3293],
2	)	NN	O	)	_	0	SENT_13	[p1l1335t3220r1650b3293],
3	than	IN	O	than	_	0	SENT_13	[p1l1681t3220r1832b3277],
4	patients	NNS	O	patient	prep_than	2	SENT_13	[p1l1870t3220r2147b3290],
5	with	IN	O	with	_	0	SENT_13	[p1l6t3314r142b3370],
6	the	DT	O	the	det	8	SENT_13	[p1l177t3314r287b3370],
7	CT	NN	O	ct	nn	8	SENT_13	[p1l324t3313r410b3370],
8	(	NN	O	(	prep_with	2	SENT_13	[p1l445t3313r606b3384],
9	165	CD	NUMBER	165	num	10	SENT_13	[p1l445t3313r606b3384],
10	cells/p	NNS	O	cells/p	dep	8	SENT_13	[p1l642t3314r958b3386],
11	.	.	O	.	_	0	SENT_13	[p1l642t3314r958b3386],

1	L	NN	O	l	nn	2	SENT_14	[p1l642t3314r958b3386],
2	)	NN	O	)	_	0	SENT_14	[p1l642t3314r958b3386],
3	and	CC	O	and	_	0	SENT_14	[p1l994t3314r1117b3370],
4	CC	NN	O	cc	nn	5	SENT_14	[p1l1155t3313r1249b3370],
5	(	NN	O	(	conj_and	2	SENT_14	[p1l1286t3313r1448b3384],
6	121	CD	NUMBER	121	num	7	SENT_14	[p1l1286t3313r1448b3384],
7	cells/p	NNS	O	cells/p	dep	2	SENT_14	[p1l1484t3314r1799b3386],
8	.	.	O	.	_	0	SENT_14	[p1l1484t3314r1799b3386],

1	L	NN	O	l	nn	4	SENT_15	[p1l1484t3314r1799b3386],
2	)	CD	NUMBER	)	num	4	SENT_15	[p1l1484t3314r1799b3386],
3	genotype	NN	O	genotype	nn	4	SENT_15	[p1l1834t3317r2147b3385],
4	(	NN	O	(	_	0	SENT_15	[p1l9t3407r428b3478],
5	p	NN	O	p	dep	4	SENT_15	[p1l9t3407r428b3478],
6	=	JJ	O	=	amod	8	SENT_15	[p1l9t3407r428b3478],
7	O-0048	NN	O	o-0048	nn	8	SENT_15	[p1l9t3407r428b3478],
8	)	NN	O	)	dep	5	SENT_15	[p1l9t3407r428b3478],
9	,	,	O	,	_	0	SENT_15	[p1l9t3407r428b3478],
10	and	CC	O	and	_	0	SENT_15	[p1l462t3408r584b3465],
11	the	DT	O	the	det	13	SENT_15	[p1l613t3408r722b3465],
12	best	JJS	O	best	amod	13	SENT_15	[p1l755t3408r904b3465],
13	recovery	NN	O	recovery	conj_and	5	SENT_15	[p1l934t3421r1218b3479],
14	of	IN	O	of	_	0	SENT_15	[p1l1245t3407r1312b3465],
15	naive	JJ	O	naive	amod	21	SENT_15	[p1l1339t3406r1515b3465],
16	CD4	NN	O	cd4	dep	15	SENT_15	[p1l1546t3407r1891b3465],
17	—	CD	NUMBER	—	num	16	SENT_15	[p1l1546t3407r1891b3465],
18	ce	NN	O	ce	nn	21	SENT_15	[p1l1546t3407r1891b3465],
19	|	NN	O	|	nn	21	SENT_15	[p1l1546t3407r1891b3465],
20	|	CD	NUMBER	|	num	21	SENT_15	[p1l1546t3407r1891b3465],
21	s.	NN	O	s.	prep_of	13	SENT_15	[p1l1546t3407r1891b3465],

1	Interpretation	NN	O	interpretation	nsubj	7	SENT_16	[p1l10t3597r497b3667],
2	The	DT	O	the	det	3	SENT_16	[p1l537t3598r660b3654],
3	polymorphism	NN	O	polymorphism	dep	1	SENT_16	[p1l706t3598r1183b3667],
4	MDR1	NN	O	mdr1	nn	6	SENT_16	[p1l1227t3598r1435b3653],
5	3435	CD	NUMBER	3435	num	6	SENT_16	[p1l1476t3597r1663b3654],
6	C/T	NNP	O	C/T	dep	1	SENT_16	[p1l1706t3597r1834b3667],
7	predicts	VBZ	O	predict	_	0	SENT_16	[p1l1875t3598r2147b3666],
8	immune	JJ	O	immune	amod	9	SENT_16	[p1l12t3691r284b3747],
9	recovery	NN	O	recovery	dobj	7	SENT_16	[p1l332t3704r617b3761],
10	after	IN	O	after	_	0	SENT_16	[p1l658t3690r819b3747],
11	initiation	NN	O	initiation	prep_after	7	SENT_16	[p1l863t3691r1155b3747],
12	of	IN	O	of	_	0	SENT_16	[p1l1202t3690r1269b3747],
13	antiretroviral	JJ	O	antiretroviral	amod	14	SENT_16	[p1l1309t3691r1739b3747],
14	treatment	NN	O	treatment	prep_of	11	SENT_16	[p1l1784t3694r2144b3747],
15	.	.	O	.	_	0	SENT_16	[p1l1784t3694r2144b3747],

1	This	DT	O	this	det	2	SENT_17	[p2l6t19r147b76],
2	finding	NN	O	finding	nsubj	3	SENT_17	[p2l191t18r424b91],
3	suggests	VBZ	O	suggest	_	0	SENT_17	[p2l466t23r778b91],
4	that	IN	O	that	complm	10	SENT_17	[p2l821t19r958b76],
5	P	NN	O	p	nn	8	SENT_17	[p2l1003t19r1476b91],
6	—	CD	NUMBER	—	num	8	SENT_17	[p2l1003t19r1476b91],
7	g	NN	O	g	nn	8	SENT_17	[p2l1003t19r1476b91],
8	|	NN	O	|	nsubj	10	SENT_17	[p2l1003t19r1476b91],
9	ycoprotein	NN	O	ycoprotein	dep	8	SENT_17	[p2l1003t19r1476b91],
10	has	VBZ	O	have	ccomp	3	SENT_17	[p2l1525t19r1646b76],
11	an	DT	O	a	det	13	SENT_17	[p2l1691t33r1770b76],
12	important	JJ	O	important	amod	13	SENT_17	[p2l1820t19r2151b89],
13	role	NN	O	role	dobj	10	SENT_17	[p2l11t113r134b169],
14	in	IN	O	in	_	0	SENT_17	[p2l209t113r260b168],
15	admittance	NN	O	admittance	prep_in	13	SENT_17	[p2l333t113r719b169],
16	of	IN	O	of	_	0	SENT_17	[p2l791t112r858b169],
17	antiretroviral	JJ	O	antiretroviral	amod	18	SENT_17	[p2l923t113r1353b169],
18	drugs	NNS	O	drug	prep_of	15	SENT_17	[p2l1427t113r1615b183],
19	to	TO	O	to	_	0	SENT_17	[p2l1684t116r1750b169],
20	restricted	JJ	O	restricted	amod	21	SENT_17	[p2l1824t113r2146b169],
21	compartments	NNS	O	compartment	prep_to	10	SENT_17	[p2l8t209r509b275],
22	in	FW	O	in	prep	21	SENT_17	[p2l542t206r594b261],
23	vivo	FW	O	vivo	pobj	22	SENT_17	[p2l623t206r774b262],
24	.	.	O	.	_	0	SENT_17	[p2l623t206r774b262],

1	Lancet	NNP	O	Lancet	_	0	SENT_18	[p2l9t358r239b413],
2	2002	CD	DATE	2002	num	1	SENT_18	[p2l265t356r472b422],
3	;	:	O	;	_	0	SENT_18	[p2l265t356r472b422],
4	359	CD	NUMBER	359	num	6	SENT_18	[p2l504t356r667b413],
5	:	:	O	:	_	0	SENT_18	[p2l504t356r667b413],
6	30-36	CD	NUMBER	30-36	dep	1	SENT_18	[p2l698t355r925b413],

1	*	NN	O	*	nn	2	SENT_19	[p2l13t515r333b565],
2	Members	NNS	O	member	nsubj	12	SENT_19	[p2l13t515r333b565],
3	listed	VBN	O	list	partmod	2	SENT_19	[p2l362t515r520b565],
4	at	IN	O	at	_	0	SENT_19	[p2l547t517r605b565],
5	end	NN	O	end	prep_at	3	SENT_19	[p2l628t515r736b565],
6	of	IN	O	of	_	0	SENT_19	[p2l763t514r822b565],
7	paper	NN	O	paper	nn	8	SENT_19	[p2l845t526r1015b575],
8	Division	NN	O	division	prep_of	5	SENT_19	[p2l9t610r248b661],
9	of	IN	O	of	_	0	SENT_19	[p2l273t610r332b661],
10	Infectious	JJ	O	infectious	amod	11	SENT_19	[p2l355t610r660b661],
11	Diseases	NNS	O	disease	prep_of	8	SENT_19	[p2l686t610r964b661],
12	(	VBP	O	(	_	0	SENT_19	[p2l990t611r1030b673],
13	J	NNP	O	J	nn	15	SENT_19	[p2l990t611r1030b673],
14	Fellay	NNP	O	Fellay	nn	15	SENT_19	[p2l1061t611r1228b673],
15	MD	NNP	O	MD	dobj	12	SENT_19	[p2l1252t627r1334b670],
16	,	,	O	,	_	0	SENT_19	[p2l1252t627r1334b670],
17	J	NNP	O	J	appos	15	SENT_19	[p2l1361t611r1441b661],
18	.	.	O	.	_	0	SENT_19	[p2l1361t611r1441b661],

1	—	NN	O	—	_	0	SENT_20	[p2l1361t611r1441b661],
2	.	.	O	.	_	0	SENT_20	[p2l1361t611r1441b661],

1	P	NN	O	p	dep	100	SENT_21	[p2l1361t611r1441b661],
2	Chave	NNP	O	Chave	dep	100	SENT_21	[p2l1465t610r1648b661],
3	MD	NNP	O	MD	dep	100	SENT_21	[p2l1675t627r1757b670],
4	,	,	O	,	_	0	SENT_21	[p2l1675t627r1757b670],
5	D	NNP	O	D	dep	100	SENT_21	[p2l11t700r50b750],
6	Retelska	NNP	O	Retelska	dep	100	SENT_21	[p2l78t700r337b751],
7	PhD	NNP	O	PhD	dep	100	SENT_21	[p2l364t716r459b759],
8	,	,	O	,	_	0	SENT_21	[p2l364t716r459b759],
9	A	NNP	O	A	dep	100	SENT_21	[p2l486t700r525b750],
10	Telenti	NNP	O	Telenti	dep	100	SENT_21	[p2l546t700r745b751],
11	MD	NNP	O	MD	dep	100	SENT_21	[p2l774t700r877b762],
12	)	NNP	O	)	dep	100	SENT_21	[p2l774t700r877b762],
13	,	,	O	,	_	0	SENT_21	[p2l774t700r877b762],
14	Division	NNP	O	Division	dep	100	SENT_21	[p2l906t699r1144b751],
15	of	IN	O	of	dep	100	SENT_21	[p2l1169t699r1229b751],
16	Clinical	JJ	O	clinical	dep	100	SENT_21	[p2l1249t699r1476b751],
17	Pharmacology	NN	O	pharmacology	dep	100	SENT_21	[p2l1504t700r1943b763],
18	(	NN	O	(	dep	100	SENT_21	[p2l9t787r68b848],
19	C	NN	O	c	dep	100	SENT_21	[p2l9t787r68b848],
20	Marzolini	NNP	PERSON	Marzolini	dep	100	SENT_21	[p2l97t787r359b837],
21	PharmD	NNP	O	PharmD	dep	100	SENT_21	[p2l387t800r577b846],
22	,	,	O	,	_	0	SENT_21	[p2l387t800r577b846],
23	T	NN	O	t	dep	100	SENT_21	[p2l604t787r638b837],
24	Buclin	NN	O	buclin	dep	100	SENT_21	[p2l664t787r841b837],
25	MD	NN	O	md	dep	100	SENT_21	[p2l869t804r951b846],
26	,	,	O	,	_	0	SENT_21	[p2l869t804r951b846],
27	L	NN	O	l	dep	100	SENT_21	[p2l983t787r1012b837],
28	A	NN	O	a	dep	100	SENT_21	[p2l1034t787r1072b837],
29	Decosterd	JJ	O	decosterd	dep	100	SENT_21	[p2l1099t787r1402b837],
30	PhD	NN	O	phd	dep	100	SENT_21	[p2l1429t787r1546b848],
31	)	NN	O	)	dep	100	SENT_21	[p2l1429t787r1546b848],
32	,	,	O	,	_	0	SENT_21	[p2l1429t787r1546b848],
33	and	CC	O	and	dep	100	SENT_21	[p2l1573t787r1682b837],
34	Division	NN	O	division	dep	100	SENT_21	[p2l1709t787r1948b837],
35	of	IN	O	of	dep	100	SENT_21	[p2l1973t787r2032b837],
36	Immunology	NN	O	immunology	dep	100	SENT_21	[p2l10t876r384b938],
37	(	CD	NUMBER	(	dep	100	SENT_21	[p2l409t876r549b938],
38	Prof	NNP	PERSON	Prof	dep	100	SENT_21	[p2l409t876r549b938],
39	G	NNP	PERSON	G	dep	100	SENT_21	[p2l570t876r610b926],
40	Pantaleo	NNP	PERSON	Pantaleo	dep	100	SENT_21	[p2l639t876r899b926],
41	MD	NNP	O	MD	dep	100	SENT_21	[p2l926t877r1030b938],
42	)	NNP	O	)	dep	100	SENT_21	[p2l926t877r1030b938],
43	,	,	O	,	_	0	SENT_21	[p2l926t877r1030b938],
44	University	NNP	ORGANIZATION	University	dep	100	SENT_21	[p2l1058t876r1365b938],
45	Hospital	NNP	ORGANIZATION	Hospital	dep	100	SENT_21	[p2l1390t876r1640b938],
46	of	IN	O	of	dep	100	SENT_21	[p2l1666t876r1725b926],
47	Lausanne	NNP	LOCATION	Lausanne	dep	100	SENT_21	[p2l1748t876r2058b937],
48	,	,	O	,	_	0	SENT_21	[p2l1748t876r2058b937],
49	Switzerland	NNP	LOCATION	Switzerland	dep	100	SENT_21	[p2l6t964r383b1025],
50	;	:	O	;	_	0	SENT_21	[p2l6t964r383b1025],
51	Unit	NN	O	unit	dep	100	SENT_21	[p2l412t964r536b1014],
52	of	IN	O	of	dep	100	SENT_21	[p2l560t964r619b1014],
53	Biochemistry	NNP	O	Biochemistry	dep	100	SENT_21	[p2l642t964r1048b1026],
54	and	CC	O	and	dep	100	SENT_21	[p2l1070t965r1180b1014],
55	Clinical	JJ	ORGANIZATION	clinical	dep	100	SENT_21	[p2l1205t964r1432b1014],
56	Psychopharmacology	NN	ORGANIZATION	psychopharmacology	dep	100	SENT_21	[p2l1460t964r2136b1026],
57	,	,	O	,	_	0	SENT_21	[p2l1460t964r2136b1026],
58	University	NNP	ORGANIZATION	University	dep	100	SENT_21	[p2l9t1052r316b1114],
59	Hospital	NNP	ORGANIZATION	Hospital	dep	100	SENT_21	[p2l341t1052r591b1114],
60	of	IN	ORGANIZATION	of	dep	100	SENT_21	[p2l617t1052r676b1102],
61	Lausanne	NNP	ORGANIZATION	Lausanne	dep	100	SENT_21	[p2l699t1053r991b1103],
62	(	CD	NUMBER	(	dep	100	SENT_21	[p2l1017t1052r1075b1114],
63	C	NN	O	c	dep	100	SENT_21	[p2l1017t1052r1075b1114],
64	B	NN	O	b	dep	100	SENT_21	[p2l1104t1053r1139b1102],
65	Eap	NN	O	eap	dep	100	SENT_21	[p2l1168t1053r1276b1113],
66	PhD	NN	O	phd	dep	100	SENT_21	[p2l1301t1053r1418b1114],
67	)	NN	O	)	dep	100	SENT_21	[p2l1301t1053r1418b1114],
68	;	:	O	;	_	0	SENT_21	[p2l1301t1053r1418b1114],
69	University	NNP	ORGANIZATION	University	dep	100	SENT_21	[p2l1447t1052r1754b1114],
70	Hospital	NNP	ORGANIZATION	Hospital	dep	100	SENT_21	[p2l1779t1052r2029b1114],
71	of	IN	ORGANIZATION	of	dep	100	SENT_21	[p2l2055t1052r2114b1102],
72	Bern	NNP	ORGANIZATION	Bern	dep	100	SENT_21	[p2l10t1141r168b1201],
73	,	,	O	,	_	0	SENT_21	[p2l10t1141r168b1201],
74	Bern	NNP	LOCATION	Bern	dep	100	SENT_21	[p2l198t1141r336b1191],
75	(	CD	NUMBER	(	dep	100	SENT_21	[p2l363t1141r422b1202],
76	H	NN	O	h	dep	100	SENT_21	[p2l363t1141r422b1202],
77	Furrer	NNP	O	Furrer	dep	100	SENT_21	[p2l453t1141r625b1191],
78	MD	NNP	O	MD	dep	100	SENT_21	[p2l648t1141r752b1202],
79	)	NN	O	)	dep	100	SENT_21	[p2l648t1141r752b1202],
80	;	:	O	;	_	0	SENT_21	[p2l648t1141r752b1202],
81	University	NNP	ORGANIZATION	University	dep	100	SENT_21	[p2l780t1140r1087b1202],
82	Hospital	NNP	ORGANIZATION	Hospital	dep	100	SENT_21	[p2l1112t1140r1362b1202],
83	of	IN	ORGANIZATION	of	dep	100	SENT_21	[p2l1388t1140r1447b1191],
84	Zurich	NNP	ORGANIZATION	Zurich	dep	100	SENT_21	[p2l1471t1140r1684b1201],
85	,	,	O	,	_	0	SENT_21	[p2l1471t1140r1684b1201],
86	Zurich	NNP	LOCATION	Zurich	dep	100	SENT_21	[p2l1714t1140r1908b1191],
87	(	CD	NUMBER	(	dep	100	SENT_21	[p2l9t1229r80b1290],
88	M	NN	O	m	dep	100	SENT_21	[p2l9t1229r80b1290],
89	Opravil	NN	O	opravil	dep	100	SENT_21	[p2l108t1229r309b1290],
90	Mo	NN	DURATION	mo	dep	100	SENT_21	[p2l338t1229r441b1290],
91	)	NN	O	)	dep	100	SENT_21	[p2l338t1229r441b1290],
92	;	:	O	;	_	0	SENT_21	[p2l338t1229r441b1290],
93	Hospital	NN	O	hospital	dep	100	SENT_21	[p2l470t1228r720b1290],
94	of	IN	O	of	dep	100	SENT_21	[p2l746t1228r805b1279],
95	La	NNP	O	La	dep	100	SENT_21	[p2l828t1229r895b1279],
96	Source	NNP	O	Source	dep	100	SENT_21	[p2l918t1229r1151b1289],
97	,	,	O	,	_	0	SENT_21	[p2l918t1229r1151b1289],
98	Lausanne	NNP	LOCATION	Lausanne	dep	100	SENT_21	[p2l1180t1229r1472b1279],
99	(	CD	NUMBER	(	dep	100	SENT_21	[p2l1498t1229r1597b1290],
100	J	NNP	O	J	_	0	SENT_21	[p2l1498t1229r1597b1290],
101	.	.	O	.	_	0	SENT_21	[p2l1498t1229r1597b1290],

1	—	NN	O	—	_	0	SENT_22	[p2l1498t1229r1597b1290],
2	.	.	O	.	_	0	SENT_22	[p2l1498t1229r1597b1290],

1	P	NN	O	p	dep	120	SENT_23	[p2l1498t1229r1597b1290],
2	Chave	NNP	O	Chave	dep	120	SENT_23	[p2l1622t1229r1844b1290],
3	)	CD	NUMBER	)	dep	120	SENT_23	[p2l1622t1229r1844b1290],
4	;	:	O	;	_	0	SENT_23	[p2l1622t1229r1844b1290],
5	Hospital	NN	O	hospital	dep	120	SENT_23	[p2l1873t1228r2124b1290],
6	of	IN	O	of	dep	120	SENT_23	[p2l7t1316r66b1366],
7	St-Gallen	NNP	O	St-Gallen	dep	120	SENT_23	[p2l85t1316r383b1377],
8	,	,	O	,	_	0	SENT_23	[p2l85t1316r383b1377],
9	St-Gallen	NNP	O	St-Gallen	dep	120	SENT_23	[p2l408t1316r687b1366],
10	(	CD	NUMBER	(	dep	120	SENT_23	[p2l714t1316r769b1377],
11	P	NN	O	p	dep	120	SENT_23	[p2l714t1316r769b1377],
12	Vernazza	NNP	LOCATION	Vernazza	dep	120	SENT_23	[p2l792t1316r1059b1366],
13	MD	NNP	O	MD	dep	120	SENT_23	[p2l1087t1316r1191b1377],
14	)	NN	O	)	dep	120	SENT_23	[p2l1087t1316r1191b1377],
15	;	:	O	;	_	0	SENT_23	[p2l1087t1316r1191b1377],
16	Department	NNP	ORGANIZATION	Department	dep	120	SENT_23	[p2l1220t1316r1585b1377],
17	of	IN	ORGANIZATION	of	dep	120	SENT_23	[p2l1608t1316r1667b1366],
18	Pharmacology	NNP	ORGANIZATION	Pharmacology	dep	120	SENT_23	[p2l1690t1316r2129b1378],
19	and	CC	ORGANIZATION	and	dep	120	SENT_23	[p2l8t1404r116b1454],
20	Therapeutics	NNP	ORGANIZATION	Therapeutics	dep	120	SENT_23	[p2l141t1404r563b1466],
21	,	,	O	,	_	0	SENT_23	[p2l141t1404r563b1466],
22	University	NNP	ORGANIZATION	University	dep	120	SENT_23	[p2l591t1404r898b1466],
23	of	IN	ORGANIZATION	of	dep	120	SENT_23	[p2l921t1404r980b1454],
24	Liverpool	NNP	ORGANIZATION	Liverpool	dep	120	SENT_23	[p2l1003t1404r1295b1466],
25	,	,	O	,	_	0	SENT_23	[p2l1003t1404r1295b1466],
26	Liverpool	NNP	ORGANIZATION	Liverpool	dep	120	SENT_23	[p2l1324t1404r1616b1466],
27	,	,	O	,	_	0	SENT_23	[p2l1324t1404r1616b1466],
28	UK	NNP	LOCATION	UK	dep	120	SENT_23	[p2l1645t1405r1732b1454],
29	(	NNP	O	(	dep	120	SENT_23	[p2l9t1492r149b1554],
30	Prof	NNP	O	Prof	dep	120	SENT_23	[p2l9t1492r149b1554],
31	D	NNP	O	D	dep	120	SENT_23	[p2l174t1492r212b1542],
32	J	NNP	O	J	dep	120	SENT_23	[p2l236t1492r258b1542],
33	Back	NNP	O	Back	dep	120	SENT_23	[p2l289t1493r433b1542],
34	PhD	NNP	O	PhD	dep	120	SENT_23	[p2l457t1509r552b1551],
35	,	,	O	,	_	0	SENT_23	[p2l457t1509r552b1551],
36	E	NNP	O	E	dep	120	SENT_23	[p2l584t1492r617b1542],
37	R	NNP	O	R	dep	120	SENT_23	[p2l644t1492r679b1542],
38	Meaden	NNP	PERSON	Meaden	dep	120	SENT_23	[p2l708t1492r946b1542],
39	Bsc	NNP	O	Bsc	dep	120	SENT_23	[p2l975t1493r1089b1554],
40	)	NN	O	)	dep	120	SENT_23	[p2l975t1493r1089b1554],
41	;	:	O	;	_	0	SENT_23	[p2l975t1493r1089b1554],
42	Retrovirology	NNP	ORGANIZATION	Retrovirology	dep	120	SENT_23	[p2l1118t1492r1528b1554],
43	Laboratory	NNP	ORGANIZATION	Laboratory	dep	120	SENT_23	[p2l1553t1492r1897b1554],
44	,	,	O	,	_	0	SENT_23	[p2l1553t1492r1897b1554],
45	University	NNP	ORGANIZATION	University	dep	120	SENT_23	[p2l9t1580r316b1642],
46	Hospital	NNP	ORGANIZATION	Hospital	dep	120	SENT_23	[p2l341t1580r591b1642],
47	Germans	NNPS	ORGANIZATION	Germans	dep	120	SENT_23	[p2l617t1580r890b1631],
48	Trias	NNP	ORGANIZATION	Trias	dep	120	SENT_23	[p2l913t1580r1064b1631],
49	i	FW	O	i	dep	120	SENT_23	[p2l1089t1580r1100b1630],
50	Pujol	NNP	PERSON	Pujol	dep	120	SENT_23	[p2l1129t1580r1296b1642],
51	,	,	O	,	_	0	SENT_23	[p2l1129t1580r1296b1642],
52	Barcelona	NNP	ORGANIZATION	Barcelona	dep	120	SENT_23	[p2l1326t1581r1654b1641],
53	,	,	O	,	_	0	SENT_23	[p2l1326t1581r1654b1641],
54	Spain	NNP	LOCATION	Spain	dep	120	SENT_23	[p2l1679t1580r1849b1642],
55	(	CD	NUMBER	(	dep	120	SENT_23	[p2l9t1669r62b1730],
56	L	NN	PERSON	l	dep	120	SENT_23	[p2l9t1669r62b1730],
57	Ruiz	NN	PERSON	ruiz	dep	120	SENT_23	[p2l88t1669r209b1719],
58	PhD	NN	O	phd	dep	120	SENT_23	[p2l233t1669r350b1730],
59	)	NN	O	)	dep	120	SENT_23	[p2l233t1669r350b1730],
60	;	:	O	;	_	0	SENT_23	[p2l233t1669r350b1730],
61	and	CC	O	and	dep	120	SENT_23	[p2l377t1669r486b1719],
62	Division	NNP	O	Division	dep	120	SENT_23	[p2l514t1668r752b1719],
63	of	IN	O	of	dep	120	SENT_23	[p2l777t1668r837b1719],
64	Experimental	JJ	O	experimental	dep	120	SENT_23	[p2l859t1668r1264b1730],
65	Therapy	NN	O	therapy	dep	120	SENT_23	[p2l1288t1669r1551b1730],
66	,	,	O	,	_	0	SENT_23	[p2l1288t1669r1551b1730],
67	Netherlands	NNP	ORGANIZATION	Netherlands	dep	120	SENT_23	[p2l1580t1669r1951b1719],
68	Cancer	NNP	ORGANIZATION	Cancer	dep	120	SENT_23	[p2l8t1757r228b1807],
69	Institute	NNP	ORGANIZATION	Institute	dep	120	SENT_23	[p2l252t1756r532b1817],
70	,	,	O	,	_	0	SENT_23	[p2l252t1756r532b1817],
71	Amsterdam	NNP	LOCATION	Amsterdam	dep	120	SENT_23	[p2l557t1757r932b1817],
72	,	,	O	,	_	0	SENT_23	[p2l557t1757r932b1817],
73	Netherlands	NNP	LOCATION	Netherlands	dep	120	SENT_23	[p2l961t1757r1333b1807],
74	(	CD	NUMBER	(	dep	120	SENT_23	[p2l1358t1757r1415b1818],
75	A	DT	O	a	dep	120	SENT_23	[p2l1358t1757r1415b1818],
76	H	NN	O	h	dep	120	SENT_23	[p2l1442t1757r1477b1806],
77	Schinkel	NNP	PERSON	Schinkel	dep	120	SENT_23	[p2l1506t1757r1757b1807],
78	Pho	NNP	O	Pho	dep	120	SENT_23	[p2l1786t1757r1884b1818],
79	)	NNP	O	)	dep	120	SENT_23	[p2l1786t1757r1884b1818],
80	Correspondence	NNP	O	Correspondence	dep	120	SENT_23	[p2l8t1850r512b1911],
81	to	TO	O	to	dep	120	SENT_23	[p2l534t1852r615b1900],
82	:	:	O	:	_	0	SENT_23	[p2l534t1852r615b1900],
83	Dr	NNP	O	Dr	dep	120	SENT_23	[p2l646t1850r710b1900],
84	Amalio	NNP	PERSON	Amalio	dep	120	SENT_23	[p2l730t1850r933b1900],
85	Telenti	NNP	PERSON	Telenti	dep	120	SENT_23	[p2l957t1850r1176b1909],
86	,	,	O	,	_	0	SENT_23	[p2l957t1850r1176b1909],
87	Division	NNP	O	Division	dep	120	SENT_23	[p2l1208t1850r1437b1900],
88	of	IN	O	of	dep	120	SENT_23	[p2l1465t1850r1523b1900],
89	Infectious	JJ	O	infectious	dep	120	SENT_23	[p2l1547t1850r1839b1900],
90	Diseases	NNS	O	disease	dep	120	SENT_23	[p2l11t1940r307b1998],
91	,	,	O	,	_	0	SENT_23	[p2l11t1940r307b1998],
92	CHUV-1011	NN	O	chuv-1011	dep	120	SENT_23	[p2l336t1939r689b1989],
93	Lausanne	NNP	LOCATION	Lausanne	dep	120	SENT_23	[p2l717t1940r1026b1998],
94	,	,	O	,	_	0	SENT_23	[p2l717t1940r1026b1998],
95	Switzerland	NNP	LOCATION	Switzerland	dep	120	SENT_23	[p2l1055t1939r1396b1989],
96	(	CD	NUMBER	(	dep	120	SENT_23	[p2l9t2028r224b2090],
97	e-mail	VB	O	e-mail	dep	120	SENT_23	[p2l9t2028r224b2090],
98	:	:	O	:	_	0	SENT_23	[p2l9t2028r224b2090],
99	amalio.telenti@chuv.hospvd.ch	NN	O	amalio.telenti@chuv.hospvd.ch	dep	120	SENT_23	[p2l252t2028r1213b2090],
100	)	CD	NUMBER	)	dep	120	SENT_23	[p2l252t2028r1213b2090],
101	Introduction	NN	O	introduction	dep	120	SENT_23	[p2l14t2104r559b2171],
102	The	DT	O	the	dep	120	SENT_23	[p2l10t2204r158b2264],
103	multidrug-resistance	JJ	O	multidrug-resistance	dep	120	SENT_23	[p2l261t2204r1014b2280],
104	transporter	NN	O	transporter	dep	120	SENT_23	[p2l1117t2218r1524b2280],
105	gene	NN	O	gene	dep	120	SENT_23	[p2l1624t2223r1790b2280],
106	MDRI	NN	O	mdrus	dep	120	SENT_23	[p2l1890t2205r2138b2263],
107	(	CD	NUMBER	(	dep	120	SENT_23	[p2l17t2296r320b2371],
108	HUGO	NNP	O	HUGO	dep	120	SENT_23	[p2l17t2296r320b2371],
109	nomenclature	NN	O	nomenclature	dep	120	SENT_23	[p2l351t2296r876b2357],
110	:	:	O	:	_	0	SENT_23	[p2l351t2296r876b2357],
111	ATP-binding	JJ	O	atp-binding	dep	120	SENT_23	[p2l909t2296r1401b2372],
112	cassette	NN	O	cassette	dep	120	SENT_23	[p2l1431t2310r1708b2357],
113	transporter	NN	O	transporter	dep	120	SENT_23	[p2l1738t2310r2145b2372],
114	gene	NN	O	gene	dep	120	SENT_23	[p2l10t2409r199b2465],
115	,	,	O	,	_	0	SENT_23	[p2l10t2409r199b2465],
116	ABCBI	NNP	ORGANIZATION	ABCBI	dep	120	SENT_23	[p2l226t2390r541b2465],
117	)	CD	NUMBER	)	dep	120	SENT_23	[p2l226t2390r541b2465],
118	codes	NNS	O	code	dep	120	SENT_23	[p2l579t2389r780b2450],
119	for	IN	O	for	dep	120	SENT_23	[p2l812t2389r915b2450],
120	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_23	[p2l944t2389r1501b2465],
121	.	.	O	.	_	0	SENT_23	[p2l944t2389r1501b2465],

1	This	DT	O	this	det	2	SENT_24	[p2l1536t2389r1700b2450],
2	protein	NN	O	protein	nsubj	3	SENT_24	[p2l1731t2390r1995b2465],
3	has	VBZ	O	have	_	0	SENT_24	[p2l2024t2389r2142b2450],
4	an	DT	O	a	det	6	SENT_24	[p2l12t2503r97b2543],
5	important	JJ	O	important	amod	6	SENT_24	[p2l151t2483r516b2559],
6	role	NN	O	role	dobj	3	SENT_24	[p2l569t2483r705b2543],
7	in	IN	O	in	_	0	SENT_24	[p2l761t2483r829b2542],
8	transportation	NN	O	transportation	prep_in	6	SENT_24	[p2l883t2483r1403b2559],
9	of	IN	O	of	_	0	SENT_24	[p2l1458t2483r1536b2543],
10	many	JJ	O	many	amod	12	SENT_24	[p2l1580t2502r1781b2559],
11	different	JJ	O	different	amod	12	SENT_24	[p2l1835t2483r2144b2543],
12	substrates	NNS	O	substrate	prep_of	8	SENT_24	[p2l12t2575r804b2651],
13	—	VBP	O	—	rcmod	6	SENT_24	[p2l12t2575r804b2651],
14	including	VBG	O	include	_	0	SENT_24	[p2l12t2575r804b2651],
15	some	DT	O	some	det	17	SENT_24	[p2l912t2595r1099b2636],
16	antiretroviral	JJ	O	antiretroviral	amod	17	SENT_24	[p2l1208t2575r1680b2636],
17	drugs	NNS	O	drug	prep_including	13	SENT_24	[p2l1789t2575r2144b2651],
18	—	VBP	O	—	rcmod	17	SENT_24	[p2l1789t2575r2144b2651],
19	at	IN	O	at	_	0	SENT_24	[p2l1789t2575r2144b2651],
20	compartmental	JJ	O	compartmental	amod	23	SENT_24	[p2l12t2668r568b2744],
21	and	CC	O	and	_	0	SENT_24	[p2l641t2668r774b2729],
22	cellular	JJ	O	cellular	conj_and	20	SENT_24	[p2l847t2668r1114b2729],
23	levels	NNS	O	level	prep_at	18	SENT_24	[p2l1184t2668r1399b2729],
24	.	.	O	.	_	0	SENT_24	[p2l1184t2668r1399b2729],

1	In	IN	O	in	_	0	SENT_25	[p2l1476t2669r1554b2728],
2	the	DT	O	the	det	3	SENT_25	[p2l1625t2668r1736b2729],
3	intestine	NN	O	intestine	prep_in	6	SENT_25	[p2l1809t2669r2140b2741],
4	,	,	O	,	_	0	SENT_25	[p2l1809t2669r2140b2741],
5	P-glycoprotein	NN	O	p-glycoprotein	nsubj	6	SENT_25	[p2l11t2762r549b2838],
6	restricts	VBZ	O	restrict	_	0	SENT_25	[p2l596t2762r881b2822],
7	drug	NN	O	drug	nn	8	SENT_25	[p2l931t2762r1099b2838],
8	entry	NN	O	entry	dobj	6	SENT_25	[p2l1146t2776r1332b2838],
9	into	IN	O	into	_	0	SENT_25	[p2l1378t2762r1518b2822],
10	the	DT	O	the	det	11	SENT_25	[p2l1567t2762r1678b2822],
11	body	NN	O	body	prep_into	6	SENT_25	[p2l1725t2762r1925b2838],
12	.	.	O	.	_	0	SENT_25	[p2l1725t2762r1925b2838],

1	This	DT	O	this	det	2	SENT_26	[p2l1977t2762r2142b2822],
2	protein	NN	O	protein	nsubj	5	SENT_26	[p2l9t2854r273b2930],
3	is	VBZ	O	be	cop	5	SENT_26	[p2l303t2854r354b2915],
4	also	RB	O	also	advmod	5	SENT_26	[p2l389t2854r525b2915],
5	abundant	JJ	O	abundant	_	0	SENT_26	[p2l560t2854r907b2915],
6	in	IN	O	in	_	0	SENT_26	[p2l937t2854r1005b2914],
7	the	DT	O	the	det	9	SENT_26	[p2l1035t2854r1147b2915],
8	apical	JJ	O	apical	amod	9	SENT_26	[p2l1181t2854r1389b2930],
9	membrane	NN	O	membrane	prep_in	5	SENT_26	[p2l1421t2854r1812b2915],
10	of	IN	O	of	_	0	SENT_26	[p2l1845t2854r1923b2915],
11	many	JJ	O	many	amod	14	SENT_26	[p2l1943t2874r2145b2930],
12	other	JJ	O	other	amod	14	SENT_26	[p2l12t2947r203b3008],
13	epithelial	JJ	O	epithelial	amod	14	SENT_26	[p2l240t2947r570b3023],
14	barriers	NNS	O	barrier	prep_of	9	SENT_26	[p2l607t2947r907b3020],
15	,	,	O	,	_	0	SENT_26	[p2l607t2947r907b3020],
16	such	JJ	O	such	_	0	SENT_26	[p2l949t2947r1115b3008],
17	as	IN	O	as	_	0	SENT_26	[p2l1154t2967r1222b3008],
18	the	DT	O	the	det	21	SENT_26	[p2l1261t2947r1372b3008],
19	blood	NN	O	blood	nn	21	SENT_26	[p2l1410t2947r1864b3020],
20	—	NN	O	—	nn	21	SENT_26	[p2l1410t2947r1864b3020],
21	brain	NN	O	brain	prep_such_as	9	SENT_26	[p2l1410t2947r1864b3020],
22	,	,	O	,	_	0	SENT_26	[p2l1410t2947r1864b3020],
23	bloodnerve	NN	O	bloodnerve	conj_and	21	SENT_26	[p2l1903t2947r2143b3008, p2l10t3060r229b3113],
24	,	,	O	,	_	0	SENT_26	[p2l1903t2947r2143b3008, p2l10t3060r229b3113],
25	blood-testis	NN	O	blood-testis	conj_and	21	SENT_26	[p2l359t3041r807b3113],
26	,	,	O	,	_	0	SENT_26	[p2l359t3041r807b3113],
27	and	CC	O	and	_	0	SENT_26	[p2l941t3041r1074b3101],
28	maternal-fetal	JJ	O	maternal-fetal	amod	29	SENT_26	[p2l1202t3041r1713b3101],
29	barriers	NNS	O	barrier	conj_and	21	SENT_26	[p2l1841t3041r2138b3101],
30	.	.	O	.	_	0	SENT_26	[p2l1841t3041r2138b3101],

1	Furthermore	RB	O	furthermore	advmod	5	SENT_27	[p2l11t3132r503b3205],
2	,	,	O	,	_	0	SENT_27	[p2l11t3132r503b3205],
3	it	PRP	O	it	nsubjpass	5	SENT_27	[p2l546t3132r595b3193],
4	is	VBZ	O	be	auxpass	5	SENT_27	[p2l635t3132r686b3193],
5	expressed	VBN	O	express	_	0	SENT_27	[p2l729t3132r1082b3208],
6	in	IN	O	in	_	0	SENT_27	[p2l1122t3132r1190b3192],
7	haemopoietic	JJ	O	haemopoietic	amod	9	SENT_27	[p2l1229t3132r1720b3208],
8	progenitor	NN	O	progenitor	nn	9	SENT_27	[p2l1760t3132r2145b3208],
9	cells	NNS	O	cell	prep_in	5	SENT_27	[p2l12t3225r188b3298],
10	,	,	O	,	_	0	SENT_27	[p2l12t3225r188b3298],
11	lymphocytes	NNS	O	lymphocyte	prep_in	5	SENT_27	[p2l233t3225r710b3301],
12	,	,	O	,	_	0	SENT_27	[p2l233t3225r710b3301],
13	and	CC	O	and	_	0	SENT_27	[p2l757t3225r890b3286],
14	macrophages	NNS	O	macrophage	prep_in	5	SENT_27	[p2l931t3225r1409b3301],
15	in	IN	O	in	_	0	SENT_27	[p2l1452t3226r1520b3285],
16	a	DT	O	a	det	17	SENT_27	[p2l1563t3245r1598b3286],
17	developmentspeciﬁc	NN	O	developmentspeciﬁc	prep_in	5	SENT_27	[p2l1642t3225r2143b3301, p2l12t3319r279b3395],
18	and	CC	O	and	_	0	SENT_27	[p2l309t3319r441b3379],
19	differentiation-speciﬁc	JJ	O	differentiation-speciﬁc	amod	20	SENT_27	[p2l469t3319r1289b3395],
20	manner	NN	O	manner	conj_and	17	SENT_27	[p2l1317t3320r1679b3379],
21	.	.	O	.	_	0	SENT_27	[p2l1317t3320r1679b3379],

1	”	NN	O	”	_	0	SENT_28	[p2l1317t3320r1679b3379],

1	We	PRP	O	we	nsubj	4	SENT_29	[p2l93t3412r216b3472],
2	do	VBP	O	do	aux	4	SENT_29	[p2l267t3411r354b3472],
3	not	RB	O	not	neg	4	SENT_29	[p2l404t3425r525b3472],
4	know	VB	O	know	_	0	SENT_29	[p2l573t3411r770b3472],
5	whether	IN	O	whether	complm	12	SENT_29	[p2l816t3411r1112b3472],
6	Variation	NN	O	variation	nsubj	12	SENT_29	[p2l1157t3411r1478b3472],
7	in	IN	O	in	_	0	SENT_29	[p2l1527t3411r1595b3471],
8	expression	NN	O	expression	prep_in	6	SENT_29	[p2l1644t3411r2026b3487],
9	of	IN	O	of	_	0	SENT_29	[p2l2076t3411r2153b3472],
10	MDR1	NN	O	mdr1	prep_of	8	SENT_29	[p2l7t3505r255b3564],
11	will	MD	O	will	aux	12	SENT_29	[p2l296t3504r425b3565],
12	lead	VB	O	lead	ccomp	4	SENT_29	[p2l464t3504r612b3565],
13	to	TO	O	to	_	0	SENT_29	[p2l650t3519r720b3565],
14	in-Vivo	JJ	MISC	in-vivo	amod	15	SENT_29	[p2l760t3505r1007b3565],
15	differences	NNS	O	difference	prep_to	12	SENT_29	[p2l1049t3504r1440b3565],
16	in	IN	O	in	_	0	SENT_29	[p2l1479t3505r1548b3564],
17	drug	NN	O	drug	nn	18	SENT_29	[p2l1588t3504r1755b3580],
18	exposure	NN	O	exposure	prep_in	12	SENT_29	[p2l1794t3524r2140b3580],
19	,	,	O	,	_	0	SENT_29	[p2l1794t3524r2140b3580],
20	which	WDT	O	which	nsubj	22	SENT_29	[p2l9t3598r228b3658],
21	could	MD	O	could	aux	22	SENT_29	[p2l320t3598r521b3658],
22	affect	VB	O	affect	rcmod	18	SENT_29	[p2l615t3598r812b3658],
23	Virological	JJ	MISC	virological	amod	26	SENT_29	[p2l901t3598r1277b3674],
24	and	CC	O	and	_	0	SENT_29	[p2l1372t3598r1504b3658],
25	immunological	JJ	O	immunological	conj_and	23	SENT_29	[p2l1596t3598r2143b3674],
26	response	NN	O	response	dobj	22	SENT_29	[p2l10t3710r327b3766],
27	to	TO	O	to	_	0	SENT_29	[p2l353t3704r422b3751],
28	antiretroviral	JJ	O	antiretroviral	amod	29	SENT_29	[p2l450t3690r921b3751],
29	treatment	NN	O	treatment	prep_to	22	SENT_29	[p2l946t3704r1321b3751],
30	.	.	O	.	_	0	SENT_29	[p2l946t3704r1321b3751],

1	In	IN	O	in	_	0	SENT_30	[p2l1352t3691r1429b3750],
2	the	DT	O	the	det	4	SENT_30	[p2l1453t3690r1565b3751],
3	mdrl-knockout	JJ	O	mdrl-knockout	amod	4	SENT_30	[p2l1592t3690r2144b3751],
4	mouse	NN	O	mouse	prep_in	24	SENT_30	[p3l10t35r248b76],
5	in	IN	O	in	_	0	SENT_30	[p3l293t15r361b75],
6	which	WDT	O	which	rel	11	SENT_30	[p3l403t15r622b76],
7	expression	NN	O	expression	nsubj	11	SENT_30	[p3l667t16r1048b91],
8	of	IN	O	of	_	0	SENT_30	[p3l1093t15r1170b76],
9	P-glycoprotein	NN	O	p-glycoprotein	prep_of	7	SENT_30	[p3l1205t15r1743b91],
10	is	VBZ	O	be	cop	11	SENT_30	[p3l1786t15r1838b76],
11	absent	JJ	O	absent	rcmod	4	SENT_30	[p3l1885t15r2140b88],
12	,	,	O	,	_	0	SENT_30	[p3l1885t15r2140b88],
13	concentrations	NNS	O	concentration	nsubj	24	SENT_30	[p3l12t109r548b169],
14	in	IN	O	in	_	0	SENT_30	[p3l574t109r643b168],
15	brain	NN	O	brain	nn	16	SENT_30	[p3l666t109r856b169],
16	tissue	NN	O	tissue	prep_in	13	SENT_30	[p3l880t109r1083b169],
17	of	IN	O	of	_	0	SENT_30	[p3l1110t109r1188b169],
18	HIV-1	NN	O	hiv-1	nn	20	SENT_30	[p3l1203t110r1431b169],
19	protease	NN	O	protease	nn	20	SENT_30	[p3l1465t123r1769b185],
20	inhibitors	NNS	O	inhibitor	prep_of	16	SENT_30	[p3l1795t109r2142b169],
21	are	VBP	O	be	cop	24	SENT_30	[p3l12t221r118b262],
22	many	JJ	O	many	quantmod	23	SENT_30	[p3l167t221r369b277],
23	times	NNS	O	time	npadvmod	24	SENT_30	[p3l414t201r607b262],
24	higher	JJR	O	higher	_	0	SENT_30	[p3l656t201r888b277],
25	than	IN	O	than	prep	24	SENT_30	[p3l933t201r1095b262],
26	in	IN	O	in	pcomp	25	SENT_30	[p3l1143t201r1211b261],
27	syngeneic	JJ	O	syngeneic	amod	28	SENT_30	[p3l1260t201r1611b277],
28	animals	NNS	O	animal	pobj	26	SENT_30	[p3l1660t201r1936b262],
29	with	IN	O	with	_	0	SENT_30	[p3l1984t201r2144b262],
30	wild	JJ	O	wild	amod	33	SENT_30	[p3l9t294r350b370],
31	—	NN	O	—	nn	33	SENT_30	[p3l9t294r350b370],
32	type	NN	O	type	nn	33	SENT_30	[p3l9t294r350b370],
33	genes	NNS	O	gene	prep_with	24	SENT_30	[p3l455t296r702b370],
34	?	.	O	?	_	0	SENT_30	[p3l455t296r702b370],

1	‘	NN	O	‘	npadvmod	8	SENT_31	[p3l455t296r702b370],
2	By	IN	O	by	_	0	SENT_31	[p3l808t296r905b371],
3	contrast	NN	O	contrast	prep_by	8	SENT_31	[p3l1009t309r1322b367],
4	,	,	O	,	_	0	SENT_31	[p3l1009t309r1322b367],
5	overexpression	NN	O	overexpression	nsubj	8	SENT_31	[p3l1431t295r1970b371],
6	of	IN	O	of	_	0	SENT_31	[p3l2076t294r2153b355],
7	P-glycoprotein	NN	O	p-glycoprotein	prep_of	5	SENT_31	[p3l11t388r549b464],
8	lowers	VBZ	O	lower	ccomp	24	SENT_31	[p3l627t388r858b448],
9	intracellular	JJ	O	intracellular	amod	10	SENT_31	[p3l939t388r1379b448],
10	concentrations	NNS	O	concentration	dobj	8	SENT_31	[p3l1458t388r1994b448],
11	of	IN	O	of	_	0	SENT_31	[p3l2076t388r2153b448],
12	protease	NN	O	protease	nn	13	SENT_31	[p3l9t494r313b556],
13	inhibitors	NNS	O	inhibitor	prep_of	10	SENT_31	[p3l339t480r736b541],
14	.4	CD	NUMBER	.4	npadvmod	15	SENT_31	[p3l339t480r736b541],
15	Thus	RB	O	thus	advmod	8	SENT_31	[p3l760t480r973b553],
16	,	,	O	,	_	0	SENT_31	[p3l760t480r973b553],
17	differences	NNS	O	difference	nsubj	24	SENT_31	[p3l1002t480r1394b541],
18	in	IN	O	in	_	0	SENT_31	[p3l1420t480r1489b540],
19	expression	NN	O	expression	prep_in	17	SENT_31	[p3l1514t480r1896b556],
20	of	IN	O	of	_	0	SENT_31	[p3l1922t480r1999b541],
21	this	DT	O	this	det	22	SENT_31	[p3l2014t480r2141b541],
22	protein	NN	O	protein	prep_of	19	SENT_31	[p3l9t574r272b649],
23	should	MD	O	should	aux	24	SENT_31	[p3l300t573r542b634],
24	lead	VB	O	lead	_	0	SENT_31	[p3l569t573r874b634],
25	—	RB	O	—	advmod	24	SENT_31	[p3l569t573r874b634],
26	in	IN	O	in	_	0	SENT_31	[p3l569t573r874b634],
27	various	JJ	O	various	amod	28	SENT_31	[p3l899t573r1159b634],
28	compartments	NNS	O	compartment	prep_in	24	SENT_31	[p3l1189t588r1713b649],
29	and	CC	O	and	_	0	SENT_31	[p3l1744t573r1876b634],
30	cells	NNS	O	cell	conj_and	28	SENT_31	[p3l1904t573r2145b634],
31	—	CD	NUMBER	—	tmod	24	SENT_31	[p3l1904t573r2145b634],
32	to	TO	O	to	_	0	SENT_31	[p3l10t680r80b727],
33	modiﬁcations	NNS	O	modiﬁcations	prep_to	31	SENT_31	[p3l106t667r601b727],
34	in	IN	O	in	_	0	SENT_31	[p3l627t667r696b726],
35	accumulation	NN	O	accumulation	prep_in	33	SENT_31	[p3l722t667r1217b727],
36	of	IN	O	of	_	0	SENT_31	[p3l1243t667r1321b727],
37	different	JJ	O	different	amod	39	SENT_31	[p3l1337t667r1646b727],
38	antiretroviral	JJ	O	antiretroviral	amod	39	SENT_31	[p3l1671t667r2143b727],
39	drugs	NNS	O	drug	prep_of	35	SENT_31	[p3l12t759r231b835],
40	.	.	O	.	_	0	SENT_31	[p3l12t759r231b835],

1	We	PRP	O	we	nsubj	2	SENT_32	[p3l93t853r216b913],
2	aimed	VBD	O	aim	_	0	SENT_32	[p3l259t852r479b913],
3	to	TO	O	to	aux	4	SENT_32	[p3l519t867r589b913],
4	investigate	VB	O	investigate	xcomp	2	SENT_32	[p3l631t852r1015b928],
5	the	DT	O	the	det	6	SENT_32	[p3l1056t852r1168b913],
6	role	NN	O	role	dobj	4	SENT_32	[p3l1209t852r1345b913],
7	of	IN	O	of	_	0	SENT_32	[p3l1388t852r1466b913],
8	P-glycoprotein	NN	O	p-glycoprotein	prep_of	6	SENT_32	[p3l1497t852r2035b928],
9	in	IN	O	in	_	0	SENT_32	[p3l2075t853r2143b912],
10	response	NN	O	response	prep_in	8	SENT_32	[p3l10t965r327b1022],
11	to	TO	O	to	_	0	SENT_32	[p3l354t960r423b1006],
12	antiretroviral	JJ	O	antiretroviral	amod	13	SENT_32	[p3l453t946r924b1006],
13	treatment	NN	O	treatment	prep_to	4	SENT_32	[p3l951t960r1307b1006],
14	in	IN	O	in	prep	13	SENT_32	[p3l1333t946r1402b1005],
15	a	DT	O	a	det	16	SENT_32	[p3l1429t966r1464b1006],
16	well	RB	O	well	pobj	14	SENT_32	[p3l1490t946r1635b1006],
17	characterised	VBN	O	characterise	partmod	16	SENT_32	[p3l1663t946r2143b1006],
18	population	NN	O	population	dobj	17	SENT_32	[p3l9t1038r406b1114],
19	of	IN	O	of	_	0	SENT_32	[p3l468t1038r546b1099],
20	HIV-1	NN	O	hiv-1	prep_of	18	SENT_32	[p3l597t1038r1160b1099],
21	—	CD	NUMBER	—	num	23	SENT_32	[p3l597t1038r1160b1099],
22	infected	JJ	O	infected	amod	23	SENT_32	[p3l597t1038r1160b1099],
23	patients	NNS	O	patient	dep	20	SENT_32	[p3l1219t1038r1526b1114],
24	.	.	O	.	_	0	SENT_32	[p3l1219t1038r1526b1114],

1	To	TO	O	to	aux	2	SENT_33	[p3l1590t1039r1697b1099],
2	investigate	VB	O	investigate	purpcl	11	SENT_33	[p3l1759t1038r2142b1114],
3	possible	JJ	O	possible	amod	4	SENT_33	[p3l9t1131r300b1207],
4	compensatory	JJ	O	compensatory	amod	5	SENT_33	[p3l405t1146r917b1207],
5	mechanisms	NNS	O	mechanism	dobj	2	SENT_33	[p3l1016t1131r1465b1192],
6	of	IN	O	of	_	0	SENT_33	[p3l1570t1131r1647b1192],
7	transporter	NN	O	transporter	nn	8	SENT_33	[p3l1738t1146r2145b1207],
8	function	NN	O	function	prep_of	5	SENT_33	[p3l10t1225r338b1298],
9	,	,	O	,	_	0	SENT_33	[p3l10t1225r338b1298],
10	we	PRP	O	we	nsubj	11	SENT_33	[p3l387t1245r486b1285],
11	looked	VBD	O	look	_	0	SENT_33	[p3l535t1225r777b1285],
12	at	IN	O	at	_	0	SENT_33	[p3l826t1239r891b1285],
13	the	DT	O	the	det	14	SENT_33	[p3l937t1225r1049b1285],
14	genes	NNS	O	gene	prep_at	11	SENT_33	[p3l1097t1244r1297b1301],
15	coding	VBG	O	code	partmod	14	SENT_33	[p3l1347t1225r1592b1301],
16	for	IN	O	for	_	0	SENT_33	[p3l1638t1225r1741b1285],
17	CYP3A4	NN	O	cyp3a4	prep_for	15	SENT_33	[p3l1789t1225r2140b1298],
18	,	,	O	,	_	0	SENT_33	[p3l1789t1225r2140b1298],
19	CYP3A5	NN	O	cyp3a5	appos	17	SENT_33	[p3l14t1317r364b1390],
20	,	,	O	,	_	0	SENT_33	[p3l14t1317r364b1390],
21	CYP2D6	NN	O	cyp2d6	conj_and	19	SENT_33	[p3l398t1317r759b1390],
22	,	,	O	,	_	0	SENT_33	[p3l398t1317r759b1390],
23	and	CC	O	and	_	0	SENT_33	[p3l791t1317r924b1378],
24	CYP2C19	NN	O	cyp2c19	conj_and	19	SENT_33	[p3l954t1317r1354b1378],
25	.	.	O	.	_	0	SENT_33	[p3l954t1317r1354b1378],

1	These	DT	O	these	det	2	SENT_34	[p3l1386t1317r1607b1378],
2	isoenzymes	NNS	O	isoenzyme	nsubjpass	8	SENT_34	[p3l1635t1317r2046b1393],
3	of	IN	O	of	_	0	SENT_34	[p3l2076t1317r2153b1378],
4	cytochrome	NN	O	cytochrome	nn	5	SENT_34	[p3l12t1410r439b1486],
5	P450	NN	O	p450	prep_of	2	SENT_34	[p3l506t1411r694b1471],
6	have	VBP	O	have	aux	8	SENT_34	[p3l761t1410r927b1471],
7	been	VBN	O	be	auxpass	8	SENT_34	[p3l992t1410r1166b1471],
8	identiﬁed	VBN	O	identiﬁed	_	0	SENT_34	[p3l1232t1410r1577b1471],
9	as	RB	O	as	advmod	10	SENT_34	[p3l1644t1430r1712b1471],
10	important	JJ	O	important	amod	11	SENT_34	[p3l1780t1411r2144b1486],
11	factors	NNS	O	factor	dobj	8	SENT_34	[p3l10t1504r252b1564],
12	in	IN	O	in	_	0	SENT_34	[p3l300t1504r369b1563],
13	the	DT	O	the	det	14	SENT_34	[p3l414t1504r526b1564],
14	metabolism	NN	O	metabolism	prep_in	8	SENT_34	[p3l573t1504r998b1564],
15	of	IN	O	of	_	0	SENT_34	[p3l1046t1504r1123b1564],
16	HIV-1	NN	MISC	hiv-1	nn	18	SENT_34	[p3l1160t1505r1388b1564],
17	protease	NN	O	protease	nn	18	SENT_34	[p3l1443t1518r1747b1580],
18	inhibitors	NNS	O	inhibitor	prep_of	14	SENT_34	[p3l1795t1504r2142b1564],
19	and	CC	O	and	_	0	SENT_34	[p3l12t1596r145b1657],
20	non	JJ	O	non	amod	24	SENT_34	[p3l241t1596r802b1657],
21	—	NN	O	—	nn	24	SENT_34	[p3l241t1596r802b1657],
22	nucleoside	NN	O	nucleoside	nn	24	SENT_34	[p3l241t1596r802b1657],
23	reverse-transcriptase	NN	O	reverse-transcriptase	nn	24	SENT_34	[p3l898t1596r1649b1672],
24	inhibitors	NNS	O	inhibitor	prep_of	14	SENT_34	[p3l1746t1596r2141b1657],
25	?	.	O	?	_	0	SENT_34	[p3l1746t1596r2141b1657],

1	Function	NN	O	function	nsubjpass	11	SENT_35	[p3l11t1690r346b1750],
2	of	IN	O	of	_	0	SENT_35	[p3l387t1689r464b1750],
3	CYPZD6	NN	O	cypzd6	prep_of	1	SENT_35	[p3l496t1690r858b1762],
4	,	,	O	,	_	0	SENT_35	[p3l496t1690r858b1762],
5	CYPZCI9	NN	O	cypzci9	prep_of	1	SENT_35	[p3l904t1690r1306b1762],
6	,	,	O	,	_	0	SENT_35	[p3l904t1690r1306b1762],
7	and	CC	O	and	_	0	SENT_35	[p3l1350t1690r1483b1750],
8	CYP3A5	NN	O	cyp3a5	prep_of	1	SENT_35	[p3l1526t1690r1850b1750],
9	can	MD	O	can	aux	11	SENT_35	[p3l1896t1709r2020b1750],
10	be	VB	O	be	auxpass	11	SENT_35	[p3l2058t1690r2142b1750],
11	predicted	VBN	O	predict	_	0	SENT_35	[p3l9t1782r354b1858],
12	from	IN	O	from	_	0	SENT_35	[p3l381t1782r555b1842],
13	genotypef	NN	O	genotypef	prep_from	11	SENT_35	[p3l582t1783r959b1858],

1	Patients	NNS	O	patient	_	0	SENT_36	[p3l13t1964r391b2031],
2	and	CC	O	and	_	0	SENT_36	[p3l421t1965r580b2031],
3	methods	NNS	O	method	conj_and	1	SENT_36	[p3l615t1965r1003b2031],

1	Patients	NNS	O	patient	nsubjpass	7	SENT_37	[p3l12t2066r299b2124],
2	Three	CD	NUMBER	three	num	3	SENT_37	[p3l10t2156r230b2217],
3	populations	NNS	O	population	dep	1	SENT_37	[p3l259t2156r688b2232],
4	of	IN	O	of	_	0	SENT_37	[p3l721t2156r799b2217],
5	patients	NNS	O	patient	prep_of	1	SENT_37	[p3l818t2156r1103b2232],
6	were	VBD	O	be	auxpass	7	SENT_37	[p3l1134t2176r1304b2217],
7	included	VBN	O	include	_	0	SENT_37	[p3l1335t2156r1651b2217],
8	in	IN	O	in	_	0	SENT_37	[p3l1682t2156r1750b2216],
9	the	DT	O	the	det	10	SENT_37	[p3l1779t2156r1891b2217],
10	study	NN	O	study	prep_in	7	SENT_37	[p3l1923t2156r2138b2232],
11	.	.	O	.	_	0	SENT_37	[p3l1923t2156r2138b2232],

1	The	DT	O	the	det	3	SENT_38	[p3l10t2249r158b2310],
2	first	JJ	ORDINAL	first	amod	3	SENT_38	[p3l211t2249r352b2310],
3	group	NN	O	group	nsubj	4	SENT_38	[p3l404t2269r614b2325],
4	included	VBD	O	include	_	0	SENT_38	[p3l669t2249r986b2310],
5	67	CD	NUMBER	67	num	7	SENT_38	[p3l1041t2252r1125b2310],
6	white	JJ	O	white	amod	7	SENT_38	[p3l1180t2249r1377b2310],
7	patients	NNS	O	patient	dobj	4	SENT_38	[p3l1429t2250r1715b2325],
8	who	WP	O	who	nsubjpass	10	SENT_38	[p3l1767t2249r1919b2310],
9	were	VBD	O	be	auxpass	10	SENT_38	[p3l1972t2269r2142b2310],
10	selected	VBN	O	select	rcmod	7	SENT_38	[p3l12t2343r300b2403],
11	on	IN	O	on	_	0	SENT_38	[p3l358t2362r448b2403],
12	the	DT	O	the	det	13	SENT_38	[p3l505t2343r616b2403],
13	basis	NN	O	basis	prep_on	10	SENT_38	[p3l673t2343r848b2403],
14	of	IN	O	of	_	0	SENT_38	[p3l908t2343r995b2403],
15	:	:	O	:	_	0	SENT_38	[p3l908t2343r995b2403],
16	long-term	JJ	O	long-term	amod	18	SENT_38	[p3l1058t2343r1419b2419],
17	viral	JJ	O	viral	amod	18	SENT_38	[p3l1474t2343r1631b2403],
18	suppression	NN	O	suppression	prep_of	13	SENT_38	[p3l1690t2343r2140b2419],
19	;	:	O	;	_	0	SENT_38	[p3l1690t2343r2140b2419],
20	treatment	NN	O	treatment	dep	18	SENT_38	[p3l10t2449r367b2496],
21	with	IN	O	with	_	0	SENT_38	[p3l433t2435r592b2496],
22	nelﬁnavir	NN	O	nelﬁnavir	prep_with	20	SENT_38	[p3l660t2435r1004b2496],
23	(	CD	NUMBER	(	number	24	SENT_38	[p3l1077t2436r1285b2510],
24	1250	CD	DATE	1250	num	25	SENT_38	[p3l1077t2436r1285b2510],
25	mg	NN	O	mg	npadvmod	26	SENT_38	[p3l1356t2455r1470b2511],
26	twice	RB	O	twice	advmod	28	SENT_38	[p3l1537t2435r1725b2496],
27	daily	JJ	SET	daily	amod	28	SENT_38	[p3l1797t2435r1994b2511],
28	)	NN	O	)	rcmod	22	SENT_38	[p3l1797t2435r1994b2511],
29	or	CC	O	or	_	0	SENT_38	[p3l2070t2455r2145b2496],
30	efavirenz	NN	O	efavirenz	nn	31	SENT_38	[p3l12t2528r335b2589],
31	(	NN	O	(	rcmod	22	SENT_38	[p3l377t2529r539b2604],
32	600	CD	NUMBER	600	num	33	SENT_38	[p3l377t2529r539b2604],
33	mg	NN	O	mg	dep	28	SENT_38	[p3l578t2548r692b2604],
34	per	IN	O	per	_	0	SENT_38	[p3l726t2548r845b2604],
35	day	NN	DURATION	day	prep_per	33	SENT_38	[p3l881t2528r1032b2604],
36	)	CD	NUMBER	)	number	37	SENT_38	[p3l881t2528r1032b2604],
37	3	CD	NUMBER	3	num	39	SENT_38	[p3l1042t2548r1060b2601],
38	antiretroviral	JJ	O	antiretroviral	amod	39	SENT_38	[p3l1102t2528r1573b2589],
39	treatment	NN	O	treatment	dobj	10	SENT_38	[p3l1610t2543r1966b2589],
40	that	WDT	O	that	nsubj	41	SENT_38	[p3l2001t2528r2144b2589],
41	suppressed	VBD	O	suppress	ccomp	39	SENT_38	[p3l12t2622r412b2698],
42	viral	JJ	O	viral	amod	43	SENT_38	[p3l451t2622r608b2682],
43	load	NN	O	load	dobj	41	SENT_38	[p3l650t2622r805b2682],
44	to	TO	O	to	_	0	SENT_38	[p3l845t2636r915b2682],
45	less	JJR	O	less	mwe	46	SENT_38	[p3l958t2622r1083b2682],
46	than	IN	O	than	quantmod	47	SENT_38	[p3l1125t2622r1288b2682],
47	400	CD	NUMBER	400	num	49	SENT_38	[p3l1329t2624r1463b2682],
48	RNA	NN	O	rna	nn	49	SENT_38	[p3l1508t2623r1698b2682],
49	copies/mL	NN	O	copies/ml	prep_to	41	SENT_38	[p3l1739t2622r2140b2698],
50	;	:	O	;	_	0	SENT_38	[p3l1739t2622r2140b2698],
51	stable	JJ	O	stable	amod	54	SENT_38	[p3l12t2714r219b2775],
52	plasma	NN	O	plasma	nn	54	SENT_38	[p3l308t2714r563b2790],
53	drug	NN	O	drug	nn	54	SENT_38	[p3l654t2714r823b2790],
54	concentrations	NNS	O	concentration	nsubj	55	SENT_38	[p3l912t2714r1447b2775],
55	(	VBP	O	(	parataxis	4	SENT_38	[p3l1544t2715r1701b2789],
56	two	CD	NUMBER	two	num	59	SENT_38	[p3l1544t2715r1701b2789],
57	or	CC	O	or	_	0	SENT_38	[p3l1794t2734r1868b2775],
58	more	JJR	O	more	num	59	SENT_38	[p3l1955t2734r2142b2775],
59	measurements	NNS	O	measurement	dobj	55	SENT_38	[p3l10t2821r536b2868],
60	with	IN	O	with	_	0	SENT_38	[p3l570t2807r729b2868],
61	<	JJR	O	<	amod	64	SENT_38	[p3l766t2808r982b2869],
62	25	CD	PERCENT	25	num	63	SENT_38	[p3l766t2808r982b2869],
63	%	NN	PERCENT	%	dep	61	SENT_38	[p3l766t2808r982b2869],
64	variation	NN	O	variation	prep_with	55	SENT_38	[p3l1018t2808r1340b2868],
65	obtained	VBN	O	obtain	partmod	64	SENT_38	[p3l1375t2807r1692b2868],
66	at	IN	O	at	_	0	SENT_38	[p3l1728t2821r1792b2868],
67	3-month	JJ	DURATION	3-month	amod	68	SENT_38	[p3l1827t2807r2144b2868],
68	intervals	NNS	O	interval	prep_at	65	SENT_38	[p3l10t2901r315b2961],
69	during	IN	O	during	_	0	SENT_38	[p3l347t2901r587b2977],
70	follow-up	JJ	O	follow-up	amod	71	SENT_38	[p3l615t2901r1020b2977],
71	)	NN	O	)	prep_during	65	SENT_38	[p3l615t2901r1020b2977],
72	,	,	O	,	_	0	SENT_38	[p3l615t2901r1020b2977],
73	and	CC	O	and	_	0	SENT_38	[p3l1054t2901r1187b2961],
74	no	DT	O	no	det	79	SENT_38	[p3l1216t2921r1306b2961],
75	potentially	RB	O	potentially	amod	79	SENT_38	[p3l1337t2901r1725b2977],
76	interacting	VBG	O	interact	dep	75	SENT_38	[p3l1753t2901r2145b2977],
77	co	NN	O	co	dobj	76	SENT_38	[p3l12t2993r587b3054],
78	—	NN	O	—	nn	79	SENT_38	[p3l12t2993r587b3054],
79	medications	NNS	O	medication	prep_with	55	SENT_38	[p3l12t2993r587b3054],
80	.	.	O	.	_	0	SENT_38	[p3l12t2993r587b3054],

1	These	DT	O	these	det	2	SENT_39	[p3l617t2993r839b3054],
2	factors	NNS	O	factor	nsubj	3	SENT_39	[p3l865t2993r1107b3054],
3	indicated	VBD	O	indicate	_	0	SENT_39	[p3l1133t2993r1470b3054],
4	that	IN	O	that	complm	8	SENT_39	[p3l1495t2993r1638b3054],
5	patients	NNS	O	patient	nsubj	8	SENT_39	[p3l1661t2993r1946b3069],
6	were	VBD	O	be	cop	8	SENT_39	[p3l1972t3013r2142b3054],
7	fully	RB	O	fully	advmod	8	SENT_39	[p3l10t3086r171b3162],
8	adherent	JJ	O	adherent	ccomp	3	SENT_39	[p3l252t3086r572b3147],
9	to	TO	O	to	_	0	SENT_39	[p3l653t3101r723b3147],
10	treatment	NN	O	treatment	prep_to	8	SENT_39	[p3l806t3101r1286b3147],
11	—	VBD	O	—	rcmod	10	SENT_39	[p3l806t3101r1286b3147],
12	a	DT	O	a	det	13	SENT_39	[p3l806t3101r1286b3147],
13	prerequisite	NN	O	prerequisite	dobj	11	SENT_39	[p3l1367t3087r1798b3162],
14	in	IN	O	in	_	0	SENT_39	[p3l1881t3087r1950b3146],
15	the	DT	O	the	det	16	SENT_39	[p3l2031t3086r2142b3147],
16	assessment	NN	O	assessment	prep_in	11	SENT_39	[p3l12t3194r413b3240],
17	of	IN	O	of	_	0	SENT_39	[p3l475t3180r552b3240],
18	the	DT	O	the	det	19	SENT_39	[p3l603t3180r715b3240],
19	contribution	NN	O	contribution	prep_of	16	SENT_39	[p3l779t3180r1233b3240],
20	of	IN	O	of	_	0	SENT_39	[p3l1296t3180r1373b3240],
21	various	JJ	O	various	amod	22	SENT_39	[p3l1423t3180r1684b3240],
22	genes	NNS	O	gene	prep_of	19	SENT_39	[p3l1747t3199r1945b3256],
23	and	CC	O	and	_	0	SENT_39	[p3l2010t3180r2143b3240],
24	genetic	JJ	O	genetic	amod	25	SENT_39	[p3l11t3272r268b3348],
25	variants	NNS	O	variant	prep_of	19	SENT_39	[p3l294t3272r578b3333],
26	to	TO	O	to	_	0	SENT_39	[p3l606t3286r675b3333],
27	treatment	NN	O	treatment	nn	28	SENT_39	[p3l703t3286r1060b3333],
28	response	NN	O	response	prep_to	11	SENT_39	[p3l1085t3292r1422b3348],
29	.	.	O	.	_	0	SENT_39	[p3l1085t3292r1422b3348],

1	The	DT	O	the	det	4	SENT_40	[p3l95t3365r243b3426],
2	second	JJ	ORDINAL	second	amod	4	SENT_40	[p3l295t3365r546b3426],
3	study	NN	O	study	nn	4	SENT_40	[p3l597t3365r794b3441],
4	group	NN	O	group	nsubj	5	SENT_40	[p3l842t3385r1053b3441],
5	included	VBD	O	include	_	0	SENT_40	[p3l1104t3365r1421b3426],
6	56	CD	NUMBER	56	num	8	SENT_40	[p3l1474t3368r1558b3426],
7	white	JJ	O	white	amod	8	SENT_40	[p3l1609t3365r1806b3426],
8	patients	NNS	O	patient	dobj	5	SENT_40	[p3l1856t3366r2142b3441],
9	who	WP	O	who	nsubjpass	12	SENT_40	[p3l9t3459r161b3519],
10	were	VBD	O	be	auxpass	12	SENT_40	[p3l199t3478r369b3519],
11	prospectively	RB	O	prospectively	advmod	12	SENT_40	[p3l407t3459r888b3535],
12	recruited	VBN	O	recruit	rcmod	8	SENT_40	[p3l923t3459r1252b3519],
13	between	IN	O	between	_	0	SENT_40	[p3l1288t3459r1592b3519],
14	March	NNP	DATE	March	prep_between	12	SENT_40	[p3l1630t3459r1893b3532],
15	,	,	DATE	,	_	0	SENT_40	[p3l1630t3459r1893b3532],
16	2000	CD	DATE	2000	appos	14	SENT_40	[p3l1937t3461r2140b3532],
17	,	,	O	,	_	0	SENT_40	[p3l1937t3461r2140b3532],

1	30	CD	NUMBER	30	_	0	SENT_41	[p3l93t3631r131b3657],
2	THE	DT	O	the	det	3	SENT_41	[p3l1226t3636r1292b3656],
3	LANCET	NN	O	lancet	dep	1	SENT_41	[p3l1302t3636r1431b3657],
4	-	:	O	-	_	0	SENT_41	[p3l1441t3643r1448b3650],
5	Vol	NN	O	vol	dep	1	SENT_41	[p3l1458t3636r1502b3657],
6	359	CD	NUMBER	359	num	5	SENT_41	[p3l1512t3636r1557b3657],
7	-	:	O	-	_	0	SENT_41	[p3l1568t3643r1576b3650],
8	January	NNP	DATE	January	dep	5	SENT_41	[p3l1584t3636r1682b3662],
9	5	CD	DATE	5	num	8	SENT_41	[p3l1691t3637r1713b3661],
10	,	,	DATE	,	_	0	SENT_41	[p3l1691t3637r1713b3661],
11	2002	CD	DATE	2002	num	8	SENT_41	[p3l1724t3637r1786b3657],
12	-	:	O	-	_	0	SENT_41	[p3l1796t3643r1804b3650],
13	www.the1ancet.com	CD	NUMBER	www.the1ancet.com	num	14	SENT_41	[p3l1813t3636r2064b3657],
14	ARTICLES	NNS	O	article	dep	8	SENT_41	[p3l1913t3679r2067b3700],

1	and	CC	O	and	dep	2	SENT_42	[p4l12t97r145b158],
2	February	NNP	DATE	February	_	0	SENT_42	[p4l173t97r527b173],
3	,	,	DATE	,	_	0	SENT_42	[p4l173t97r527b173],
4	2001	CD	DATE	2001	appos	2	SENT_42	[p4l561t100r762b158],
5	.	.	O	.	_	0	SENT_42	[p4l561t100r762b158],

1	This	DT	O	this	det	2	SENT_43	[p4l794t97r959b158],
2	group	NN	O	group	nsubj	3	SENT_43	[p4l989t117r1199b173],
3	received	VBD	O	receive	_	0	SENT_43	[p4l1229t97r1529b158],
4	nelﬁnavir	JJ	O	nelﬁnavir	acomp	3	SENT_43	[p4l1556t97r1901b158],
5	(	CD	NUMBER	(	number	6	SENT_43	[p4l1933t97r2141b173],
6	1250	CD	DATE	1250	num	7	SENT_43	[p4l1933t97r2141b173],
7	mg	NN	O	mg	dep	4	SENT_43	[p4l10t210r125b266],
8	twice	RB	O	twice	advmod	3	SENT_43	[p4l161t191r350b251],
9	daily	JJ	SET	daily	amod	10	SENT_43	[p4l390t190r588b266],
10	)	NN	O	)	pobj	8	SENT_43	[p4l390t190r588b266],
11	or	CC	O	or	_	0	SENT_43	[p4l634t210r709b251],
12	efavirenz	NN	O	efavirenz	nn	13	SENT_43	[p4l746t190r1069b251],
13	(	NN	O	(	conj_or	10	SENT_43	[p4l1113t191r1275b266],
14	600	CD	NUMBER	600	num	15	SENT_43	[p4l1113t191r1275b266],
15	mg	NN	O	mg	dep	13	SENT_43	[p4l1315t210r1429b266],
16	per	IN	O	per	_	0	SENT_43	[p4l1465t210r1584b266],
17	day	NN	DURATION	day	prep_per	3	SENT_43	[p4l1622t190r1798b266],
18	)	CD	NUMBER	)	num	17	SENT_43	[p4l1622t190r1798b266],
19	.	.	O	.	_	0	SENT_43	[p4l1622t190r1798b266],

1	In	IN	O	in	_	0	SENT_44	[p4l1842t191r1919b250],
2	these	DT	O	these	det	3	SENT_44	[p4l1957t190r2143b251],
3	patients	NNS	O	patient	prep_in	6	SENT_44	[p4l9t284r318b360],
4	,	,	O	,	_	0	SENT_44	[p4l9t284r318b360],
5	we	PRP	O	we	nsubj	6	SENT_44	[p4l357t304r456b344],
6	analysed	VBD	O	analyse	_	0	SENT_44	[p4l495t284r805b360],
7	the	DT	O	the	det	8	SENT_44	[p4l842t284r954b344],
8	activity	NN	O	activity	nsubj	12	SENT_44	[p4l993t284r1254b360],
9	of	IN	O	of	_	0	SENT_44	[p4l1290t284r1368b344],
10	CYP3A	NN	O	cyp3a	prep_of	8	SENT_44	[p4l1398t284r1682b344],
11	(	CD	NUMBER	(	num	10	SENT_44	[p4l1723t284r1858b359],
12	see	VBP	O	see	conj_and	12	SENT_44	[p4l1723t284r1858b359],
13	below	IN	O	below	_	0	SENT_44	[p4l1894t284r2137b359],
14	)	NN	O	)	prep_below	12	SENT_44	[p4l1894t284r2137b359],
15	before	IN	O	before	_	0	SENT_44	[p4l9t376r238b437],
16	initiation	NN	O	initiation	prep_before	12	SENT_44	[p4l302t376r631b437],
17	of	IN	O	of	_	0	SENT_44	[p4l695t376r773b437],
18	antiretroviral	JJ	O	antiretroviral	amod	19	SENT_44	[p4l828t376r1300b437],
19	treatment	NN	O	treatment	prep_of	16	SENT_44	[p4l1363t390r1719b437],
20	and	CC	O	and	_	0	SENT_44	[p4l1783t376r1916b437],
21	after	IN	O	after	_	0	SENT_44	[p4l1981t376r2145b437],
22	1	CD	DURATION	1	num	23	SENT_44	[p4l20t472r44b529],
23	month	NN	NUMBER	month	prep_after	12	SENT_44	[p4l125t469r367b530],
24	of	IN	O	of	_	0	SENT_44	[p4l440t469r517b530],
25	treatment	NN	O	treatment	prep_of	23	SENT_44	[p4l579t484r953b530],
26	.	.	O	.	_	0	SENT_44	[p4l579t484r953b530],

1	We	PRP	O	we	nsubj	2	SENT_45	[p4l1028t470r1151b530],
2	measured	VBD	O	measure	_	0	SENT_45	[p4l1223t469r1576b530],
3	plasma	NN	O	plasma	nn	5	SENT_45	[p4l1647t469r1903b545],
4	drug	NN	O	drug	nn	5	SENT_45	[p4l1976t469r2145b545],
5	concentrations	NNS	O	concentration	dobj	2	SENT_45	[p4l12t563r548b623],
6	at	IN	O	at	_	0	SENT_45	[p4l594t577r659b623],
7	1	CD	DURATION	1	prep_at	2	SENT_45	[p4l710t565r735b622],
8	month	NN	NUMBER	month	tmod	2	SENT_45	[p4l788t563r1047b623],
9	.	.	O	.	_	0	SENT_45	[p4l788t563r1047b623],

1	CD4-cell	JJ	O	cd4-cell	amod	2	SENT_46	[p4l1099t563r1433b623],
2	count	NN	O	count	nsubjpass	7	SENT_46	[p4l1478t577r1685b623],
3	and	CC	O	and	_	0	SENT_46	[p4l1729t563r1862b623],
4	HIV-1	NN	O	hiv-1	nn	5	SENT_46	[p4l1905t564r2134b623],
5	viraemia	NN	O	viraemia	conj_and	2	SENT_46	[p4l9t654r319b715],
6	were	VBD	O	be	auxpass	7	SENT_46	[p4l360t674r530b715],
7	measured	VBN	O	measure	conj_and	7	SENT_46	[p4l573t654r925b715],
8	at	IN	O	at	_	0	SENT_46	[p4l969t668r1033b715],
9	baseline	NN	O	baseline	prep_at	7	SENT_46	[p4l1073t654r1366b715],
10	and	CC	O	and	_	0	SENT_46	[p4l1410t654r1543b715],
11	after	IN	O	after	_	0	SENT_46	[p4l1586t654r1750b715],
12	1	CD	NUMBER	1	prep_after	7	SENT_46	[p4l1798t657r1854b726],
13	,	,	O	,	_	0	SENT_46	[p4l1798t657r1854b726],
14	3	CD	NUMBER	3	conj_and	12	SENT_46	[p4l1901t657r1964b726],
15	,	,	O	,	_	0	SENT_46	[p4l1901t657r1964b726],
16	and	CC	DURATION	and	_	0	SENT_46	[p4l2010t654r2143b715],
17	6	CD	DURATION	6	num	18	SENT_46	[p4l14t750r51b808],
18	months	NNS	NUMBER	month	conj_and	12	SENT_46	[p4l80t747r353b808],
19	of	IN	O	of	_	0	SENT_46	[p4l383t747r460b808],
20	treatment	NN	O	treatment	prep_of	18	SENT_46	[p4l477t761r852b808],
21	.	.	O	.	_	0	SENT_46	[p4l477t761r852b808],

1	107	CD	PERCENT	107	nsubj	13	SENT_47	[p4l104t843r229b901],
2	(	CD	PERCENT	(	num	4	SENT_47	[p4l280t841r500b916],
3	87	CD	PERCENT	87	num	4	SENT_47	[p4l280t841r500b916],
4	%	NN	PERCENT	%	dep	1	SENT_47	[p4l280t841r500b916],
5	)	CD	NUMBER	)	num	6	SENT_47	[p4l280t841r500b916],
6	patients	NNS	O	patient	dep	1	SENT_47	[p4l547t841r832b917],
7	from	IN	O	from	_	0	SENT_47	[p4l875t841r1050b901],
8	the	DT	O	the	det	12	SENT_47	[p4l1091t841r1203b901],
9	first	JJ	ORDINAL	first	amod	12	SENT_47	[p4l1245t841r1386b901],
10	and	CC	ORDINAL	and	_	0	SENT_47	[p4l1428t841r1561b901],
11	second	JJ	ORDINAL	second	amod	12	SENT_47	[p4l1604t841r1855b901],
12	groups	NNS	O	group	prep_from	6	SENT_47	[p4l1897t860r2142b917],
13	received	VBD	O	receive	_	0	SENT_47	[p4l10t933r310b994],
14	two	CD	NUMBER	two	num	19	SENT_47	[p4l377t947r508b994],
15	nucleoside	JJ	O	nucleoside	amod	19	SENT_47	[p4l576t933r1324b1009],
16	—	NN	O	—	nn	19	SENT_47	[p4l576t933r1324b1009],
17	analogue	NN	O	analogue	nn	19	SENT_47	[p4l576t933r1324b1009],
18	reverse-transcriptase	NN	O	reverse-transcriptase	nn	19	SENT_47	[p4l1391t933r2142b1009],
19	inhibitors	NNS	O	inhibitor	dobj	13	SENT_47	[p4l10t1026r358b1087],
20	in	IN	O	in	_	0	SENT_47	[p4l392t1027r461b1086],
21	addition	NN	O	addition	prep_in	13	SENT_47	[p4l496t1026r797b1087],
22	to	TO	O	to	_	0	SENT_47	[p4l830t1040r900b1087],
23	efavirenz	NN	O	efavirenz	prep_to	13	SENT_47	[p4l936t1026r1259b1087],
24	or	CC	O	or	_	0	SENT_47	[p4l1293t1046r1368b1087],
25	nelﬁnavir	NN	O	nelﬁnavir	prep_to	13	SENT_47	[p4l1399t1026r1761b1087],
26	.	.	O	.	_	0	SENT_47	[p4l1399t1026r1761b1087],

1	A	DT	DURATION	a	det	6	SENT_48	[p4l1798t1027r1859b1086],
2	second	JJ	DURATION	second	amod	6	SENT_48	[p4l1892t1026r2143b1087],
3	protease	NN	O	protease	nn	6	SENT_48	[p4l9t1134r313b1196],
4	inhibitor	NN	O	inhibitor	nn	6	SENT_48	[p4l367t1120r685b1180],
5	(	NN	O	(	nn	6	SENT_48	[p4l741t1120r1145b1196],
6	saquinavir	NN	O	saquinavir	nsubj	35	SENT_48	[p4l741t1120r1145b1196],
7	[	CD	NUMBER	[	num	8	SENT_48	[p4l1206t1120r1430b1195],
8	n	NN	O	n	dep	6	SENT_48	[p4l1206t1120r1430b1195],
9	=	JJ	O	=	amod	11	SENT_48	[p4l1206t1120r1430b1195],
10	7	CD	NUMBER	7	tmod	9	SENT_48	[p4l1206t1120r1430b1195],
11	]	NN	O	]	dep	8	SENT_48	[p4l1206t1120r1430b1195],
12	,	,	O	,	_	0	SENT_48	[p4l1206t1120r1430b1195],
13	lopinavir/ritonavir	JJ	O	lopinavir/ritonavir	amod	14	SENT_48	[p4l1486t1120r2145b1196],
14	[	NN	O	[	nsubj	35	SENT_48	[p4l20t1212r139b1288],
15	4	CD	NUMBER	4	num	16	SENT_48	[p4l20t1212r139b1288],
16	]	NN	O	]	dep	14	SENT_48	[p4l20t1212r139b1288],
17	,	,	O	,	_	0	SENT_48	[p4l20t1212r139b1288],
18	amprenavir	NN	O	amprenavir	nn	19	SENT_48	[p4l180t1212r595b1288],
19	[	NN	O	[	nsubj	35	SENT_48	[p4l638t1212r757b1288],
20	3	CD	NUMBER	3	num	21	SENT_48	[p4l638t1212r757b1288],
21	]	NN	O	]	dep	19	SENT_48	[p4l638t1212r757b1288],
22	,	,	O	,	_	0	SENT_48	[p4l638t1212r757b1288],
23	ritonavir	NN	O	ritonavir	nn	24	SENT_48	[p4l796t1212r1108b1273],
24	[	NN	O	[	nsubj	35	SENT_48	[p4l1152t1212r1270b1288],
25	1	CD	NUMBER	1	num	26	SENT_48	[p4l1152t1212r1270b1288],
26	]	NN	O	]	dep	24	SENT_48	[p4l1152t1212r1270b1288],
27	,	,	O	,	_	0	SENT_48	[p4l1152t1212r1270b1288],
28	or	CC	O	or	_	0	SENT_48	[p4l1311t1232r1386b1273],
29	nevirapine	NN	O	nevirapine	nn	31	SENT_48	[p4l1419t1212r1798b1288],
30	[	NN	O	[	nn	31	SENT_48	[p4l1845t1212r1969b1288],
31	l	NN	O	l	nsubj	35	SENT_48	[p4l1845t1212r1969b1288],
32	]	CD	NUMBER	]	num	33	SENT_48	[p4l1845t1212r1969b1288],
33	)	NN	O	)	dep	31	SENT_48	[p4l1845t1212r1969b1288],
34	was	VBD	O	be	cop	35	SENT_48	[p4l2009t1232r2142b1273],
35	part	NN	O	part	_	0	SENT_48	[p4l9t1320r156b1381],
36	of	IN	O	of	_	0	SENT_48	[p4l226t1305r304b1366],
37	antiretroviral	JJ	O	antiretroviral	amod	38	SENT_48	[p4l365t1305r836b1366],
38	treatment	NN	O	treatment	prep_of	35	SENT_48	[p4l905t1320r1262b1366],
39	taken	VBN	O	take	partmod	38	SENT_48	[p4l1330t1305r1528b1366],
40	by	IN	O	by	_	0	SENT_48	[p4l1596t1305r1684b1381],
41	16	CD	PERCENT	16	number	42	SENT_48	[p4l1761t1308r1839b1366],
42	(	CD	PERCENT	(	amod	46	SENT_48	[p4l1917t1306r2137b1381],
43	13	CD	PERCENT	13	num	44	SENT_48	[p4l1917t1306r2137b1381],
44	%	NN	PERCENT	%	dep	42	SENT_48	[p4l1917t1306r2137b1381],
45	)	NN	O	)	nn	46	SENT_48	[p4l1917t1306r2137b1381],
46	participants	NNS	O	participant	agent	39	SENT_48	[p4l9t1399r459b1475],
47	.	.	O	.	_	0	SENT_48	[p4l9t1399r459b1475],

1	In	IN	O	in	_	0	SENT_49	[p4l95t1492r173b1551],
2	a	DT	O	a	det	5	SENT_49	[p4l243t1511r278b1552],
3	third	JJ	ORDINAL	third	amod	5	SENT_49	[p4l346t1491r523b1552],
4	study	NN	O	study	nn	5	SENT_49	[p4l592t1491r789b1567],
5	group	NN	O	group	prep_in	13	SENT_49	[p4l856t1511r1090b1567],
6	,	,	O	,	_	0	SENT_49	[p4l856t1511r1090b1567],
7	80	CD	NUMBER	80	num	8	SENT_49	[p4l1165t1494r1250b1552],
8	patients	NNS	O	patient	nsubj	13	SENT_49	[p4l1320t1491r1605b1567],
9	who	WP	O	who	nsubj	10	SENT_49	[p4l1674t1491r1825b1552],
10	started	VBD	O	start	rcmod	8	SENT_49	[p4l1897t1491r2143b1552],
11	antiretroviral	JJ	O	antiretroviral	amod	12	SENT_49	[p4l12t1584r484b1645],
12	treatment	NN	O	treatment	dobj	10	SENT_49	[p4l549t1598r906b1645],
13	contributed	VBD	O	contribute	_	0	SENT_49	[p4l972t1584r1397b1645],
14	data	NNS	O	datum	dobj	13	SENT_49	[p4l1464t1584r1617b1645],
15	on	IN	O	on	_	0	SENT_49	[p4l1685t1604r1775b1645],
16	immune	JJ	O	immune	amod	18	SENT_49	[p4l1840t1585r2142b1645],
17	recovery	NN	O	recovery	nn	18	SENT_49	[p4l10t1697r319b1754],
18	(	NN	O	(	prep_on	13	SENT_49	[p4l374t1678r589b1753],
19	naive	JJ	O	naive	amod	23	SENT_49	[p4l374t1678r589b1753],
20	T-cell	NN	MISC	t-cell	nn	23	SENT_49	[p4l641t1678r858b1738],
21	subset	NN	O	subset	nn	23	SENT_49	[p4l912t1678r1139b1738],
22	data	NNS	O	datum	nn	23	SENT_49	[p4l1191t1678r1396b1753],
23	)	NN	O	)	dep	13	SENT_49	[p4l1191t1678r1396b1753],
24	.	.	O	.	_	0	SENT_49	[p4l1191t1678r1396b1753],

1	We	PRP	O	we	nsubj	3	SENT_50	[p4l1451t1679r1573b1738],
2	only	RB	O	only	advmod	3	SENT_50	[p4l1627t1678r1782b1754],
3	analysed	VBD	O	analyse	_	0	SENT_50	[p4l1833t1678r2143b1754],
4	MDR1	NN	O	mdr1	nn	5	SENT_50	[p4l7t1771r255b1830],
5	genotype	NN	O	genotype	dobj	3	SENT_50	[p4l287t1784r615b1846],
6	in	IN	O	in	_	0	SENT_50	[p4l643t1770r711b1830],
7	these	DT	O	these	det	8	SENT_50	[p4l737t1770r923b1831],
8	participants	NNS	O	participant	prep_in	3	SENT_50	[p4l949t1770r1399b1846],
9	.	.	O	.	_	0	SENT_50	[p4l949t1770r1399b1846],

1	Written	VBN	O	write	csubjpass	5	SENT_51	[p4l93t1864r377b1924],
2	informed	JJ	O	informed	amod	3	SENT_51	[p4l450t1863r784b1924],
3	consent	NN	O	consent	dobj	1	SENT_51	[p4l860t1877r1140b1924],
4	was	VBD	O	be	auxpass	5	SENT_51	[p4l1211t1883r1344b1924],
5	obtained	VBN	O	obtain	_	0	SENT_51	[p4l1421t1863r1738b1924],
6	from	IN	O	from	_	0	SENT_51	[p4l1812t1863r1986b1924],
7	all	DT	O	all	det	8	SENT_51	[p4l2061t1863r2143b1924],
8	patients	NNS	O	patient	prep_from	5	SENT_51	[p4l9t1957r295b2033],
9	in	IN	O	in	_	0	SENT_51	[p4l326t1957r395b2016],
10	accordance	NN	O	accordance	prep_in	8	SENT_51	[p4l425t1957r834b2017],
11	with	IN	O	with	_	0	SENT_51	[p4l863t1957r1023b2017],
12	the	DT	O	the	det	14	SENT_51	[p4l1051t1957r1163b2017],
13	Helsinki	NNP	LOCATION	Helsinki	nn	14	SENT_51	[p4l1193t1957r1496b2017],
14	Declaration	NNP	O	Declaration	prep_with	5	SENT_51	[p4l1526t1957r1976b2030],
15	,	,	O	,	_	0	SENT_51	[p4l1526t1957r1976b2030],
16	and	CC	O	and	_	0	SENT_51	[p4l2010t1957r2143b2017],
17	the	DT	O	the	det	18	SENT_51	[p4l10t2049r122b2110],
18	study	NN	O	study	nsubjpass	20	SENT_51	[p4l151t2049r347b2125],
19	was	VBD	O	be	auxpass	20	SENT_51	[p4l371t2069r503b2110],
20	approved	VBN	O	approve	conj_and	5	SENT_51	[p4l534t2049r871b2125],
21	by	IN	O	by	_	0	SENT_51	[p4l896t2049r985b2125],
22	the	DT	O	the	det	25	SENT_51	[p4l1009t2049r1121b2110],
23	local	JJ	O	local	amod	25	SENT_51	[p4l1149t2049r1317b2110],
24	ethics	NNS	O	ethic	nn	25	SENT_51	[p4l1346t2049r1552b2110],
25	committee	NN	O	committee	agent	20	SENT_51	[p4l1582t2049r1987b2110],
26	.	.	O	.	_	0	SENT_51	[p4l1582t2049r1987b2110],

1	Procedures	NNS	O	procedure	nsubj	3	SENT_52	[p4l12t2240r413b2299],
2	We	PRP	O	we	nsubj	3	SENT_52	[p4l8t2331r131b2391],
3	analysed	VBD	O	analyse	_	0	SENT_52	[p4l194t2330r526b2406],
4	,	,	O	,	_	0	SENT_52	[p4l194t2330r526b2406],
5	by	IN	O	by	_	0	SENT_52	[p4l589t2330r677b2406],
6	PCR	NN	O	pcr	nn	7	SENT_52	[p4l737t2330r918b2391],
7	ampliﬁcation	NN	O	ampliﬁcation	prep_by	3	SENT_52	[p4l976t2330r1455b2406],
8	and	CC	O	and	_	0	SENT_52	[p4l1517t2330r1649b2391],
9	sequencing	NN	O	sequencing	conj_and	7	SENT_52	[p4l1712t2330r2140b2406],
10	,	,	O	,	_	0	SENT_52	[p4l1712t2330r2140b2406],
11	MDR1	NN	O	mdr1	nn	12	SENT_52	[p4l7t2424r255b2483],
12	exon	NN	O	exon	dobj	3	SENT_52	[p4l301t2443r473b2484],
13	26	CD	NUMBER	26	dep	12	SENT_52	[p4l514t2426r599b2484],
14	and	CC	O	and	_	0	SENT_52	[p4l643t2423r776b2484],
15	its	PRP$	O	its	poss	19	SENT_52	[p4l815t2424r895b2484],
16	5	CD	NUMBER	5	num	19	SENT_52	[p4l939t2422r1002b2484],
17	’	NN	O	’	nn	19	SENT_52	[p4l939t2422r1002b2484],
18	ﬂanking	NN	O	ﬂanking	nn	19	SENT_52	[p4l1047t2423r1341b2499],
19	region	NN	O	region	dobj	3	SENT_52	[p4l1379t2424r1629b2499],
20	,	,	O	,	_	0	SENT_52	[p4l1379t2424r1629b2499],
21	the	DT	O	the	det	23	SENT_52	[p4l1671t2423r1783b2484],
22	CYP3A4	NN	O	cyp3a4	nn	23	SENT_52	[p4l1825t2424r2145b2484],
23	promoter	NN	O	promoter	conj_and	12	SENT_52	[p4l9t2531r354b2593],
24	and	CC	O	and	_	0	SENT_52	[p4l405t2517r538b2577],
25	exon	NN	O	exon	conj_and	12	SENT_52	[p4l591t2536r763b2577],
26	7	CD	NUMBER	7	num	25	SENT_52	[p4l817t2519r880b2590],
27	,	,	O	,	_	0	SENT_52	[p4l817t2519r880b2590],
28	and	CC	O	and	_	0	SENT_52	[p4l936t2517r1069b2577],
29	CYPZCI9	NN	O	cypzci9	nn	30	SENT_52	[p4l1123t2517r1485b2577],
30	exons	NNS	O	exon	conj_and	12	SENT_52	[p4l1536t2536r1740b2577],
31	4	CD	NUMBER	4	dep	30	SENT_52	[p4l1794t2519r1835b2576],
32	and	CC	O	and	_	0	SENT_52	[p4l1890t2517r2023b2577],
33	5	CD	NUMBER	5	dep	30	SENT_52	[p4l2078t2519r2137b2577],
34	.	.	O	.	_	0	SENT_52	[p4l2078t2519r2137b2577],

1	Analysis	NN	O	analysis	nsubjpass	5	SENT_53	[p4l9t2609r309b2685],
2	of	IN	O	of	_	0	SENT_53	[p4l349t2609r426b2670],
3	CYPZD6	NN	O	cypzd6	prep_of	1	SENT_53	[p4l454t2609r780b2670],
4	was	VBD	O	be	auxpass	5	SENT_53	[p4l811t2629r944b2670],
5	done	VBN	O	do	_	0	SENT_53	[p4l982t2609r1160b2670],
6	by	IN	O	by	_	0	SENT_53	[p4l1196t2609r1284b2685],
7	an	DT	O	a	det	10	SENT_53	[p4l1320t2629r1404b2670],
8	allele-speciﬁc	JJ	O	allele-speciﬁc	amod	10	SENT_53	[p4l1442t2609r1928b2685],
9	PCR	NN	O	pcr	nn	10	SENT_53	[p4l1966t2609r2147b2670],
10	strategy	NN	O	strategy	agent	5	SENT_53	[p4l12t2717r294b2778],
11	that	WDT	O	that	nsubj	12	SENT_53	[p4l318t2702r460b2763],
12	identiﬁes	VBZ	O	identiﬁes	rcmod	10	SENT_53	[p4l486t2702r815b2763],
13	alleles	NNS	O	allele	dobj	12	SENT_53	[p4l844t2702r1060b2763],
14	*	CD	NUMBER	*	number	15	SENT_53	[p4l1094t2703r1201b2775],
15	3	CD	NUMBER	3	dep	13	SENT_53	[p4l1094t2703r1201b2775],
16	,	,	O	,	_	0	SENT_53	[p4l1094t2703r1201b2775],
17	*	CD	NUMBER	*	number	18	SENT_53	[p4l1237t2703r1343b2775],
18	4	CD	NUMBER	4	appos	13	SENT_53	[p4l1237t2703r1343b2775],
19	,	,	O	,	_	0	SENT_53	[p4l1237t2703r1343b2775],
20	and	CC	O	and	_	0	SENT_53	[p4l1374t2702r1507b2763],
21	*	NN	O	*	appos	13	SENT_53	[p4l1540t2703r1644b2763],
22	6	CD	NUMBER	6	dep	21	SENT_53	[p4l1540t2703r1644b2763],
23	.	.	O	.	_	0	SENT_53	[p4l1540t2703r1644b2763],

1	These	DT	O	these	det	2	SENT_54	[p4l1675t2702r1897b2763],
2	alleles	NNS	O	allele	nsubj	5	SENT_54	[p4l1925t2702r2141b2763],
3	are	VBP	O	be	cop	5	SENT_54	[p4l12t2815r118b2856],
4	the	DT	O	the	det	5	SENT_54	[p4l174t2796r286b2856],
5	three	CD	NUMBER	three	_	0	SENT_54	[p4l341t2796r525b2856],
6	most	RBS	O	most	advmod	7	SENT_54	[p4l580t2810r759b2856],
7	frequent	JJ	O	frequent	amod	9	SENT_54	[p4l813t2796r1121b2872],
8	inactivating	VBG	O	inactivate	amod	9	SENT_54	[p4l1175t2796r1600b2872],
9	mutations	NNS	O	mutation	nsubj	31	SENT_54	[p4l1653t2796r2019b2856],
10	in	IN	O	in	_	0	SENT_54	[p4l2075t2796r2143b2855],
11	white	JJ	O	white	amod	12	SENT_54	[p4l9t2888r207b2949],
12	people	NNS	O	people	prep_in	9	SENT_54	[p4l293t2888r556b2964],
13	,	,	O	,	_	0	SENT_54	[p4l293t2888r556b2964],
14	which	WDT	O	which	nsubj	15	SENT_54	[p4l645t2888r864b2949],
15	result	VBP	O	result	rcmod	12	SENT_54	[p4l949t2888r1152b2949],
16	in	IN	O	in	_	0	SENT_54	[p4l1239t2888r1307b2948],
17	a	DT	O	a	det	19	SENT_54	[p4l1395t2908r1430b2949],
18	poor-metaboliser	NN	O	poor-metaboliser	nn	19	SENT_54	[p4l1517t2888r2145b2964],
19	phenotype	NN	O	phenotype	prep_in	15	SENT_54	[p4l9t2981r440b3057],
20	.7	CD	NUMBER	.7	num	21	SENT_54	[p4l9t2981r440b3057],
21	Analysis	NN	O	analysis	dobj	15	SENT_54	[p4l473t2982r774b3057],
22	of	IN	O	of	_	0	SENT_54	[p4l811t2981r889b3042],
23	CYPZD6	NN	O	cypzd6	nn	25	SENT_54	[p4l915t2982r1241b3042],
24	gene	NN	O	gene	nn	25	SENT_54	[p4l1271t3001r1438b3058],
25	ampliﬁcation	NN	O	ampliﬁcation	prep_of	21	SENT_54	[p4l1475t2981r1953b3058],
26	by	IN	O	by	_	0	SENT_54	[p4l1985t2982r2073b3058],
27	a	DT	O	a	det	30	SENT_54	[p4l2108t3001r2143b3042],
28	long-range	JJ	O	long-range	amod	30	SENT_54	[p4l11t3075r400b3151],
29	PCR	NN	O	pcr	nn	30	SENT_54	[p4l477t3075r657b3135],
30	strategy	NN	O	strategy	prep_by	15	SENT_54	[p4l730t3088r1012b3151],
31	allowed	VBD	O	allow	rcmod	5	SENT_54	[p4l1087t3075r1364b3135],
32	prediction	NN	O	prediction	dobj	31	SENT_54	[p4l1438t3075r1813b3151],
33	of	IN	O	of	_	0	SENT_54	[p4l1888t3075r1966b3135],
34	the	DT	O	the	det	38	SENT_54	[p4l2031t3075r2142b3135],
35	ultrarapid	JJ	O	ultrarapid	amod	38	SENT_54	[p4l10t3167r830b3243],
36	—	NN	O	—	nn	38	SENT_54	[p4l10t3167r830b3243],
37	metaboliser	NN	O	metaboliser	nn	38	SENT_54	[p4l10t3167r830b3243],
38	phenotype	NN	O	phenotype	prep_of	32	SENT_54	[p4l860t3167r1291b3243],
39	?	.	O	?	_	0	SENT_54	[p4l860t3167r1291b3243],

1	We	PRP	O	we	nsubj	2	SENT_55	[p4l1322t3168r1445b3228],
2	analysed	VBD	O	analyse	_	0	SENT_55	[p4l1480t3167r1790b3243],
3	CYP3A5	NN	O	cyp3a5	nn	4	SENT_55	[p4l1825t3167r2145b3228],
4	intron	NN	O	intron	dobj	2	SENT_55	[p4l10t3261r233b3321],
5	3	CD	NUMBER	3	dep	4	SENT_55	[p4l272t3263r310b3321],
6	and	CC	O	and	_	0	SENT_55	[p4l353t3261r486b3321],
7	heterozygosity	NN	O	heterozygosity	conj_and	4	SENT_55	[p4l522t3261r1046b3336],
8	for	IN	O	for	_	0	SENT_55	[p4l1081t3260r1184b3321],
9	the	DT	O	the	det	12	SENT_55	[p4l1219t3261r1331b3321],
10	CCR5	NN	MISC	ccr5	nn	12	SENT_55	[p4l1371t3261r1591b3321],
11	A32	NN	MISC	a32	nn	12	SENT_55	[p4l1626t3258r1770b3321],
12	mutation	NN	O	mutation	prep_for	7	SENT_55	[p4l1809t3261r2143b3321],
13	by	IN	O	by	_	0	SENT_55	[p4l9t3354r97b3430],
14	real-time	JJ	O	real-time	amod	15	SENT_55	[p4l147t3354r473b3414],
15	PCR	NN	O	pcr	prep_by	2	SENT_55	[p4l527t3354r708b3414],
16	with	IN	O	with	_	0	SENT_55	[p4l754t3354r913b3414],
17	TaqMan	NNP	O	TaqMan	nn	20	SENT_55	[p4l964t3355r1289b3430],
18	(	NNP	O	(	nn	20	SENT_55	[p4l1346t3354r1660b3430],
19	Applied	NNP	O	Applied	nn	20	SENT_55	[p4l1346t3354r1660b3430],
20	Biosystems	NNP	O	Biosystems	prep_with	2	SENT_55	[p4l1713t3354r2140b3430],
21	,	,	O	,	_	0	SENT_55	[p4l1713t3354r2140b3430],
22	Foster	NNP	LOCATION	Foster	nn	27	SENT_55	[p4l11t3447r244b3507],
23	City	NNP	LOCATION	City	nn	27	SENT_55	[p4l283t3446r456b3522],
24	,	,	O	,	_	0	SENT_55	[p4l283t3446r456b3522],
25	CA	NNP	LOCATION	CA	appos	27	SENT_55	[p4l500t3446r642b3519],
26	,	,	O	,	_	0	SENT_55	[p4l500t3446r642b3519],
27	USA	NNP	LOCATION	USA	appos	20	SENT_55	[p4l682t3446r913b3521],
28	)	CD	NUMBER	)	num	27	SENT_55	[p4l682t3446r913b3521],
29	.	.	O	.	_	0	SENT_55	[p4l682t3446r913b3521],

1	With	IN	O	with	_	0	SENT_56	[p4l954t3446r1137b3507],
2	the	DT	O	the	det	3	SENT_56	[p4l1173t3446r1285b3507],
3	exception	NN	O	exception	prep_with	12	SENT_56	[p4l1325t3446r1675b3522],
4	of	IN	O	of	_	0	SENT_56	[p4l1714t3446r1792b3507],
5	CYPZD6	NN	O	cypzd6	nn	6	SENT_56	[p4l1821t3446r2146b3507],
6	analysis	NN	O	analysis	prep_of	3	SENT_56	[p4l12t3539r312b3615],
7	,	,	O	,	_	0	SENT_56	[p4l12t3539r312b3615],
8	all	DT	O	all	det	10	SENT_56	[p4l351t3539r432b3600],
9	genotyping	VBG	O	genotype	amod	10	SENT_56	[p4l467t3540r872b3615],
10	strategies	NNS	O	strategy	nsubjpass	12	SENT_56	[p4l906t3540r1241b3615],
11	were	VBD	O	be	auxpass	12	SENT_56	[p4l1275t3559r1446b3600],
12	developed	VBN	O	develop	_	0	SENT_56	[p4l1482t3539r1851b3615],
13	for	IN	O	for	_	0	SENT_56	[p4l1885t3539r1988b3600],
14	our	PRP$	O	we	poss	15	SENT_56	[p4l2022t3559r2145b3600],
15	study	NN	O	study	prep_for	12	SENT_56	[p4l12t3633r229b3709],
16	,	,	O	,	_	0	SENT_56	[p4l12t3633r229b3709],
17	and	CC	O	and	_	0	SENT_56	[p4l261t3633r394b3693],
18	we	PRP	O	we	nsubj	19	SENT_56	[p4l421t3653r519b3693],
19	validated	VBD	O	validate	conj_and	12	SENT_56	[p4l547t3633r878b3693],
20	the	DT	O	the	det	21	SENT_56	[p4l905t3633r1017b3693],
21	methods	NNS	O	method	dobj	19	SENT_56	[p4l1046t3633r1359b3693],
22	by	IN	O	by	_	0	SENT_56	[p4l1387t3633r1475b3709],
23	sequence	NN	O	sequence	nn	24	SENT_56	[p4l1503t3653r1834b3709],
24	analysis	NN	O	analysis	prep_by	19	SENT_56	[p4l1865t3633r2142b3709],
25	and	CC	O	and	_	0	SENT_56	[p4l12t3725r145b3786],
26	creation	NN	O	creation	prep_by	19	SENT_56	[p4l184t3725r477b3786],
27	of	IN	O	of	_	0	SENT_56	[p4l515t3725r593b3786],
28	a	DT	O	a	det	29	SENT_56	[p4l622t3745r657b3786],
29	panel	NN	O	panel	prep_of	24	SENT_56	[p4l694t3725r891b3801],
30	of	IN	O	of	_	0	SENT_56	[p4l930t3725r1007b3786],
31	reference	NN	O	reference	nn	32	SENT_56	[p4l1034t3725r1368b3786],
32	alleles	NNS	O	allele	prep_of	29	SENT_56	[p4l1408t3725r1645b3786],
33	.	.	O	.	_	0	SENT_56	[p4l1408t3725r1645b3786],

1	Primers	NNS	O	primer	nsubj	8	SENT_57	[p4l1688t3725r1970b3786],
2	and	CC	O	and	_	0	SENT_57	[p4l2010t3725r2143b3786],
3	conditions	NNS	O	condition	conj_and	1	SENT_57	[p5l12t15r390b76],
4	for	IN	O	for	_	0	SENT_57	[p5l422t15r525b76],
5	PCR	NN	O	pcr	nn	6	SENT_57	[p5l553t16r734b76],
6	analysis	NN	O	analysis	prep_for	1	SENT_57	[p5l761t15r1038b91],
7	are	VBP	O	be	cop	8	SENT_57	[p5l1071t35r1177b76],
8	available	JJ	O	available	_	0	SENT_57	[p5l1209t15r1522b76],
9	on	IN	O	on	_	0	SENT_57	[p5l1554t35r1645b76],
10	request	NN	O	request	prep_on	8	SENT_57	[p5l1673t30r1940b91],
11	from	IN	O	from	_	0	SENT_57	[p5l1969t15r2143b76],
12	the	DT	O	the	det	13	SENT_57	[p5l10t109r122b169],
13	authors	NNS	O	author	prep_from	8	SENT_57	[p5l151t109r442b169],
14	.	.	O	.	_	0	SENT_57	[p5l151t109r442b169],

1	Plasma	NN	O	plasma	nn	3	SENT_58	[p5l96t201r356b262],
2	drug	NN	O	drug	nn	3	SENT_58	[p5l406t201r574b277],
3	concentrations	NNS	O	concentration	nsubjpass	5	SENT_58	[p5l621t201r1157b262],
4	were	VBD	O	be	auxpass	5	SENT_58	[p5l1204t221r1375b262],
5	measured	VBN	O	measure	ccomp	28	SENT_58	[p5l1423t201r1776b262],
6	by	IN	O	by	_	0	SENT_58	[p5l1821t201r1909b277],
7	highperformance	NN	O	highperformance	nn	8	SENT_58	[p5l1954t201r2143b277, p5l9t294r472b370],
8	liquid-chromatography	NN	O	liquid-chromatography	agent	5	SENT_58	[p5l593t294r1459b370],
9	,	,	O	,	_	0	SENT_58	[p5l593t294r1459b370],
10	which	WDT	O	which	nsubj	11	SENT_58	[p5l1581t294r1799b355],
11	allows	VBZ	O	allow	rcmod	8	SENT_58	[p5l1920t294r2142b355],
12	simultaneous	JJ	O	simultaneous	amod	13	SENT_58	[p5l12t388r492b448],
13	separation	NN	O	separation	dep	11	SENT_58	[p5l539t388r915b464],
14	and	CC	O	and	_	0	SENT_58	[p5l959t388r1092b448],
15	quantiﬁcation	NN	O	quantiﬁcation	dep	11	SENT_58	[p5l1138t388r1645b464],
16	of	IN	O	of	_	0	SENT_58	[p5l1690t388r1768b448],
17	nelﬁnavir	NN	O	nelﬁnavir	nn	20	SENT_58	[p5l1800t388r2145b448],
18	and	CC	O	and	_	0	SENT_58	[p5l12t480r145b541],
19	efavirenzf	NN	O	efavirenzf	nn	20	SENT_58	[p5l198t480r567b541],
20	’	NN	O	’	prep_of	13	SENT_58	[p5l198t480r567b541],
21	For	IN	O	for	dep	13	SENT_58	[p5l619t481r751b541],
22	comparison	NN	O	comparison	pobj	21	SENT_58	[p5l802t480r1227b556],
23	between	IN	O	between	_	0	SENT_58	[p5l1276t480r1580b541],
24	drugs	NNS	O	drug	prep_between	22	SENT_58	[p5l1632t480r1854b556],
25	,	,	O	,	_	0	SENT_58	[p5l1632t480r1854b556],
26	results	NNS	O	result	nsubjpass	28	SENT_58	[p5l1908t480r2141b541],
27	were	VBD	O	be	auxpass	28	SENT_58	[p5l9t593r180b634],
28	expressed	VBN	O	express	_	0	SENT_58	[p5l220t573r572b649],
29	as	IN	O	as	_	0	SENT_58	[p5l612t593r680b634],
30	percentile	JJ	O	percentile	amod	31	SENT_58	[p5l719t573r1076b649],
31	distribution	NN	O	distribution	prep_as	28	SENT_58	[p5l1117t573r1543b634],
32	on	IN	O	on	_	0	SENT_58	[p5l1582t593r1672b634],
33	the	DT	O	the	det	34	SENT_58	[p5l1710t573r1822b634],
34	basis	NN	O	basis	prep_on	28	SENT_58	[p5l1859t573r2034b634],
35	of	IN	O	of	_	0	SENT_58	[p5l2076t573r2153b634],
36	our	PRP$	O	we	poss	37	SENT_58	[p5l12t686r136b727],
37	database	NN	O	database	prep_of	34	SENT_58	[p5l164t667r501b739],
38	,	,	O	,	_	0	SENT_58	[p5l164t667r501b739],
39	which	WDT	O	which	nsubj	40	SENT_58	[p5l532t667r750b727],
40	includes	VBZ	O	include	rcmod	37	SENT_58	[p5l779t667r1079b727],
41	measurements	NNS	O	measurement	dobj	40	SENT_58	[p5l1109t680r1635b727],
42	of	IN	O	of	_	0	SENT_58	[p5l1668t667r1745b727],
43	more	JJR	O	more	mwe	44	SENT_58	[p5l1764t686r1951b727],
44	than	IN	O	than	quantmod	45	SENT_58	[p5l1981t667r2143b727],
45	4000	CD	NUMBER	4000	num	47	SENT_58	[p5l11t761r192b819],
46	drug	NN	O	drug	nn	47	SENT_58	[p5l223t758r391b834],
47	concentrations	NNS	O	concentration	prep_of	41	SENT_58	[p5l418t758r974b819],
48	.	.	O	.	_	0	SENT_58	[p5l418t758r974b819],

1	For	IN	O	for	_	0	SENT_59	[p5l95t852r227b912],
2	quantiﬁcation	NN	O	quantiﬁcation	prep_for	15	SENT_59	[p5l285t851r791b927],
3	of	IN	O	of	_	0	SENT_59	[p5l850t851r927b912],
4	MDR1	NN	O	mdr1	nn	6	SENT_59	[p5l971t852r1245b924],
5	,	,	O	,	_	0	SENT_59	[p5l971t852r1245b924],
6	ABCC1	NN	O	abcc1	prep_of	2	SENT_59	[p5l1299t852r1609b924],
7	,	,	O	,	_	0	SENT_59	[p5l1299t852r1609b924],
8	and	CC	O	and	_	0	SENT_59	[p5l1671t851r1804b912],
9	ABCC2	NN	O	abcc2	nn	10	SENT_59	[p5l1855t852r2144b912],
10	transcripts	NNS	O	transcript	conj_and	6	SENT_59	[p5l10t945r415b1021],
11	,	,	O	,	_	0	SENT_59	[p5l10t945r415b1021],
12	total	JJ	O	total	amod	13	SENT_59	[p5l495t945r658b1005],
13	RNA	NN	MISC	rna	nsubjpass	15	SENT_59	[p5l737t946r927b1005],
14	was	VBD	O	be	auxpass	15	SENT_59	[p5l1001t964r1134b1005],
15	extracted	VBN	O	extract	_	0	SENT_59	[p5l1214t945r1548b1005],
16	with	IN	O	with	_	0	SENT_59	[p5l1624t945r1783b1005],
17	RNeasy	NN	O	rneasy	nn	18	SENT_59	[p5l1860t946r2145b1021],
18	MiniKit	NN	O	minikit	prep_with	15	SENT_59	[p5l10t1037r307b1098],
19	(	CD	NUMBER	(	num	18	SENT_59	[p5l409t1037r717b1113],
20	Qiagen	NNP	ORGANIZATION	Qiagen	nn	24	SENT_59	[p5l409t1037r717b1113],
21	,	,	O	,	_	0	SENT_59	[p5l409t1037r717b1113],
22	Hilden	NNP	PERSON	Hilden	appos	24	SENT_59	[p5l817t1037r1091b1110],
23	,	,	O	,	_	0	SENT_59	[p5l817t1037r1091b1110],
24	Germany	NNP	LOCATION	Germany	dobj	15	SENT_59	[p5l1192t1037r1559b1113],
25	)	CD	NUMBER	)	num	24	SENT_59	[p5l1192t1037r1559b1113],
26	from	IN	O	from	_	0	SENT_59	[p5l1661t1037r1836b1098],
27	viable	JJ	O	viable	amod	30	SENT_59	[p5l1930t1037r2142b1098],
28	peripheral-blood	JJ	O	peripheral-blood	amod	30	SENT_59	[p5l9t1130r621b1206],
29	mononuclear	JJ	O	mononuclear	amod	30	SENT_59	[p5l669t1130r1154b1191],
30	cells	NNS	O	cell	prep_from	24	SENT_59	[p5l1201t1130r1354b1191],
31	conserved	VBN	O	conserve	partmod	30	SENT_59	[p5l1405t1130r1769b1191],
32	in	IN	O	in	_	0	SENT_59	[p5l1816t1131r1885b1190],
33	liquid	JJ	O	liquid	amod	34	SENT_59	[p5l1933t1130r2143b1206],
34	nitrogen	NN	O	nitrogen	prep_in	31	SENT_59	[p5l10t1224r335b1300],
35	.	.	O	.	_	0	SENT_59	[p5l10t1224r335b1300],

1	We	PRP	O	we	nsubj	2	SENT_60	[p5l427t1225r549b1284],
2	quantiﬁed	VBD	O	quantiﬁed	_	0	SENT_60	[p5l641t1224r1010b1300],
3	RNA	NN	O	rna	dobj	2	SENT_60	[p5l1099t1225r1290b1284],
4	by	IN	O	by	_	0	SENT_60	[p5l1375t1224r1464b1300],
5	optical	JJ	O	optical	amod	7	SENT_60	[p5l1552t1224r1795b1300],
6	density	NN	O	density	nn	7	SENT_60	[p5l1885t1224r2145b1300],
7	measurements	NNS	O	measurement	prep_by	2	SENT_60	[p5l10t1330r557b1377],
8	.	.	O	.	_	0	SENT_60	[p5l10t1330r557b1377],

1	Real-time	JJ	O	real-time	amod	2	SENT_61	[p5l600t1316r955b1377],
2	PCR	NN	O	pcr	nsubjpass	13	SENT_61	[p5l993t1316r1174b1377],
3	with	IN	O	with	_	0	SENT_61	[p5l1205t1316r1364b1377],
4	primers	NNS	O	primer	prep_with	2	SENT_61	[p5l1399t1316r1676b1392],
5	designed	VBN	O	design	partmod	4	SENT_61	[p5l1716t1316r2036b1392],
6	to	TO	O	to	aux	7	SENT_61	[p5l2072t1330r2141b1377],
7	avoid	VB	O	avoid	xcomp	5	SENT_61	[p5l12t1409r206b1470],
8	ampliﬁcation	NN	O	ampliﬁcation	dobj	7	SENT_61	[p5l234t1409r711b1485],
9	of	IN	O	of	_	0	SENT_61	[p5l739t1409r816b1470],
10	genomic	JJ	O	genomic	amod	11	SENT_61	[p5l833t1409r1141b1485],
11	DNA	NN	MISC	dna	prep_of	8	SENT_61	[p5l1168t1410r1370b1470],
12	was	VBD	O	be	auxpass	13	SENT_61	[p5l1393t1429r1526b1470],
13	used	VBN	O	use	_	0	SENT_61	[p5l1553t1409r1720b1470],
14	to	TO	O	to	aux	15	SENT_61	[p5l1746t1424r1815b1470],
15	quantify	VB	O	quantify	xcomp	13	SENT_61	[p5l1845t1409r2145b1485],
16	transcripts	NNS	O	transcript	dobj	15	SENT_61	[p5l10t1503r392b1579],
17	(	CD	NUMBER	(	num	18	SENT_61	[p5l450t1503r606b1578],
18	one	CD	NUMBER	one	nsubjpass	24	SENT_61	[p5l450t1503r606b1578],
19	of	IN	O	of	_	0	SENT_61	[p5l659t1503r736b1563],
20	the	DT	O	the	det	22	SENT_61	[p5l775t1503r887b1563],
21	two	CD	NUMBER	two	num	22	SENT_61	[p5l937t1517r1068b1563],
22	primers	NNS	O	primer	prep_of	18	SENT_61	[p5l1119t1503r1396b1579],
23	was	VBD	O	be	auxpass	24	SENT_61	[p5l1446t1523r1579b1563],
24	placed	VBN	O	place	rcmod	16	SENT_61	[p5l1629t1503r1866b1579],
25	at	IN	O	at	_	0	SENT_61	[p5l1918t1517r1982b1563],
26	the	DT	O	the	det	27	SENT_61	[p5l2031t1503r2142b1563],
27	junction	NN	O	junction	prep_at	24	SENT_61	[p5l10t1595r312b1671],
28	between	IN	O	between	_	0	SENT_61	[p5l381t1595r685b1656],
29	two	CD	NUMBER	two	num	30	SENT_61	[p5l755t1609r886b1656],
30	exons	NNS	O	exon	prep_between	27	SENT_61	[p5l961t1595r1218b1671],
31	)	CD	NUMBER	)	dep	30	SENT_61	[p5l961t1595r1218b1671],
32	.	.	O	.	_	0	SENT_61	[p5l961t1595r1218b1671],

1	For	IN	O	for	_	0	SENT_62	[p5l1294t1596r1426b1656],
2	quantiﬁcation	NN	O	quantiﬁcation	prep_for	7	SENT_62	[p5l1496t1595r2004b1671],
3	of	IN	O	of	_	0	SENT_62	[p5l2076t1595r2153b1656],
4	MDR1	NN	O	mdr1	prep_of	2	SENT_62	[p5l7t1689r282b1761],
5	,	,	O	,	_	0	SENT_62	[p5l7t1689r282b1761],
6	we	PRP	O	we	nsubj	7	SENT_62	[p5l330t1708r429b1749],
7	used	VBD	O	use	_	0	SENT_62	[p5l476t1688r644b1749],
8	the	DT	O	the	det	13	SENT_62	[p5l690t1688r802b1749],
9	LLC-PK	NN	O	llc-pk	nn	13	SENT_62	[p5l850t1689r1217b1749],
10	]	NN	O	]	nn	13	SENT_62	[p5l850t1689r1217b1749],
11	cell	NN	O	cell	nn	13	SENT_62	[p5l1276t1688r1396b1749],
12	line	NN	O	line	nn	13	SENT_62	[p5l1443t1688r1573b1749],
13	(	NN	O	(	dobj	7	SENT_62	[p5l1626t1688r1922b1764],
14	derived	VBN	O	derive	partmod	13	SENT_62	[p5l1626t1688r1922b1764],
15	from	IN	O	from	_	0	SENT_62	[p5l1969t1688r2143b1749],
16	porcine	NN	O	porcine	nn	17	SENT_62	[p5l9t1782r283b1858],
17	kidney	NN	O	kidney	prep_from	14	SENT_62	[p5l322t1782r584b1858],
18	,	,	O	,	_	0	SENT_62	[p5l322t1782r584b1858],
19	very	RB	O	very	advmod	20	SENT_62	[p5l624t1801r777b1858],
20	low	JJ	O	low	advmod	17	SENT_62	[p5l814t1782r942b1842],
21	P-glycoprotein	NN	O	p-glycoprotein	nn	23	SENT_62	[p5l980t1782r1517b1858],
22	expression	NN	O	expression	nn	23	SENT_62	[p5l1557t1782r1964b1858],
23	)	NN	O	)	dep	17	SENT_62	[p5l1557t1782r1964b1858],
24	and	CC	O	and	_	0	SENT_62	[p5l2010t1782r2143b1842],
25	the	DT	O	the	det	26	SENT_62	[p5l10t1874r122b1935],
26	L	NN	O	l	dep	17	SENT_62	[p5l150t1875r491b1934],
27	.	.	O	.	_	0	SENT_62	[p5l150t1875r491b1934],

1	—	NN	O	—	_	0	SENT_63	[p5l150t1875r491b1934],
2	.	.	O	.	_	0	SENT_63	[p5l150t1875r491b1934],

1	MDR1	NN	O	mdr1	nn	2	SENT_64	[p5l150t1875r491b1934],
2	cell	NN	O	cell	nsubj	4	SENT_64	[p5l530t1874r650b1935],
3	line	NN	O	line	nn	4	SENT_64	[p5l678t1874r808b1935],
4	(	NN	O	(	_	0	SENT_64	[p5l842t1874r1086b1949],
5	which	WDT	O	which	nsubjpass	7	SENT_64	[p5l842t1874r1086b1949],
6	was	VBD	O	be	auxpass	7	SENT_64	[p5l1112t1894r1244b1935],
7	transfected	VBN	O	transfect	rcmod	4	SENT_64	[p5l1273t1874r1675b1935],
8	with	IN	O	with	_	0	SENT_64	[p5l1702t1874r1861b1935],
9	human	JJ	O	human	amod	10	SENT_64	[p5l1886t1874r2144b1935],
10	MDR1	NN	O	mdr1	prep_with	7	SENT_64	[p5l7t1968r281b2040],
11	,	,	O	,	_	0	SENT_64	[p5l7t1968r281b2040],
12	very	RB	O	very	advmod	13	SENT_64	[p5l359t1987r512b2043],
13	high	JJ	O	high	amod	14	SENT_64	[p5l585t1967r745b2043],
14	expression	NN	O	expression	dobj	4	SENT_64	[p5l822t1968r1204b2043],
15	of	IN	O	of	_	0	SENT_64	[p5l1281t1967r1359b2028],
16	P-glycoprotein	NN	O	p-glycoprotein	prep_of	14	SENT_64	[p5l1426t1967r1989b2043],
17	)	CD	NUMBER	)	num	16	SENT_64	[p5l1426t1967r1989b2043],
18	as	IN	O	as	_	0	SENT_64	[p5l2074t1987r2142b2028],
19	negative	JJ	O	negative	amod	22	SENT_64	[p5l10t2061r309b2137],
20	and	CC	O	and	_	0	SENT_64	[p5l352t2061r484b2121],
21	positive	JJ	O	positive	conj_and	19	SENT_64	[p5l523t2061r802b2137],
22	controls	NNS	O	control	prep_as	14	SENT_64	[p5l844t2061r1158b2134],
23	,	,	O	,	_	0	SENT_64	[p5l844t2061r1158b2134],
24	respectively	RB	O	respectively	advmod	14	SENT_64	[p5l1200t2061r1696b2137],
25	.	.	O	.	_	0	SENT_64	[p5l1200t2061r1696b2137],

1	”	NN	O	”	nsubj	11	SENT_65	[p5l1200t2061r1696b2137],
2	To	TO	O	to	aux	3	SENT_65	[p5l1735t2062r1841b2121],
3	control	VB	O	control	infmod	1	SENT_65	[p5l1885t2061r2142b2121],
4	for	IN	O	for	_	0	SENT_65	[p5l10t2153r113b2214],
5	differences	NNS	O	difference	prep_for	3	SENT_65	[p5l184t2153r575b2214],
6	in	IN	O	in	_	0	SENT_65	[p5l649t2153r717b2213],
7	amount	NN	O	amount	prep_in	5	SENT_65	[p5l790t2167r1071b2214],
8	of	IN	O	of	_	0	SENT_65	[p5l1143t2153r1221b2214],
9	total	JJ	O	total	amod	10	SENT_65	[p5l1282t2153r1444b2214],
10	RNA	NN	O	rna	prep_of	7	SENT_65	[p5l1517t2154r1708b2213],
11	added	VBD	O	add	ccomp	22	SENT_65	[p5l1780t2153r2001b2214],
12	to	TO	O	to	_	0	SENT_65	[p5l2072t2167r2141b2214],
13	reactions	NNS	O	reaction	prep_to	11	SENT_65	[p5l10t2247r360b2319],
14	,	,	O	,	_	0	SENT_65	[p5l10t2247r360b2319],
15	quantiﬁcation	NN	O	quantiﬁcation	nn	16	SENT_65	[p5l409t2246r917b2322],
16	results	NNS	O	result	nsubjpass	22	SENT_65	[p5l960t2246r1194b2307],
17	of	IN	O	of	_	0	SENT_65	[p5l1241t2246r1319b2307],
18	the	DT	O	the	det	20	SENT_65	[p5l1353t2246r1465b2307],
19	target	NN	O	target	nn	20	SENT_65	[p5l1510t2261r1718b2322],
20	gene	NN	O	gene	prep_of	16	SENT_65	[p5l1762t2266r1928b2322],
21	were	VBD	O	be	auxpass	22	SENT_65	[p5l1972t2266r2143b2307],
22	normalised	VBN	O	normalise	_	0	SENT_65	[p5l10t2340r415b2400],
23	to	TO	O	to	_	0	SENT_65	[p5l454t2354r524b2400],
24	B-actin	NN	O	b-actin	prep_to	22	SENT_65	[p5l570t2340r844b2417],
25	.	.	O	.	_	0	SENT_65	[p5l570t2340r844b2417],

1	Expression	NN	O	expression	nn	2	SENT_66	[p5l889t2340r1290b2416],
2	levels	NNS	O	level	nsubjpass	4	SENT_66	[p5l1329t2340r1524b2400],
3	were	VBD	O	be	auxpass	4	SENT_66	[p5l1564t2360r1734b2400],
4	calculated	VBN	O	calculate	dep	25	SENT_66	[p5l1776t2340r2143b2400],
5	by	IN	O	by	_	0	SENT_66	[p5l9t2432r97b2508],
6	division	NN	O	division	agent	4	SENT_66	[p5l145t2432r427b2493],
7	of	IN	O	of	_	0	SENT_66	[p5l476t2432r554b2493],
8	the	DT	O	the	det	11	SENT_66	[p5l591t2432r703b2493],
9	ampliﬁcation	NN	O	ampliﬁcation	nn	11	SENT_66	[p5l754t2432r1232b2508],
10	threshold	NN	O	threshold	nn	11	SENT_66	[p5l1279t2432r1622b2493],
11	cycle	NN	O	cycle	prep_of	6	SENT_66	[p5l1672t2432r1849b2508],
12	by	IN	O	by	_	0	SENT_66	[p5l1896t2432r1985b2508],
13	the	DT	O	the	det	14	SENT_66	[p5l2031t2432r2142b2493],
14	value	NN	O	value	agent	4	SENT_66	[p5l9t2525r199b2586],
15	for	IN	O	for	_	0	SENT_66	[p5l231t2525r334b2586],
16	the	DT	O	the	det	17	SENT_66	[p5l363t2525r475b2586],
17	sample	NN	O	sample	prep_for	14	SENT_66	[p5l508t2525r760b2601],
18	with	IN	O	with	_	0	SENT_66	[p5l791t2525r950b2586],
19	the	DT	O	the	det	21	SENT_66	[p5l980t2525r1092b2586],
20	lowest	JJS	O	lowest	amod	21	SENT_66	[p5l1124t2525r1354b2586],
21	expression	NN	O	expression	prep_with	17	SENT_66	[p5l1386t2526r1767b2601],
22	(	CD	NUMBER	(	num	24	SENT_66	[p5l1804t2525r2145b2601],
23	arbitrary	JJ	O	arbitrary	amod	24	SENT_66	[p5l1804t2525r2145b2601],
24	units	NNS	O	unit	nsubj	25	SENT_66	[p5l10t2619r241b2692],
25	)	VBP	O	)	_	0	SENT_66	[p5l10t2619r241b2692],
26	.	.	O	.	_	0	SENT_66	[p5l10t2619r241b2692],

1	For	IN	O	for	_	0	SENT_67	[p5l95t2711r227b2771],
2	analysis	NN	O	analysis	prep_for	9	SENT_67	[p5l252t2710r529b2786],
3	of	IN	O	of	_	0	SENT_67	[p5l557t2710r634b2771],
4	expression	NN	O	expression	prep_of	2	SENT_67	[p5l651t2710r1033b2786],
5	of	IN	O	of	_	0	SENT_67	[p5l1059t2710r1137b2771],
6	P-glycoprotein	NN	O	p-glycoprotein	prep_of	4	SENT_67	[p5l1153t2710r1711b2786],
7	,	,	O	,	_	0	SENT_67	[p5l1153t2710r1711b2786],
8	we	PRP	O	we	nsubj	14	SENT_67	[p5l1738t2730r1837b2771],
9	isolated	VBD	O	isolate	_	0	SENT_67	[p5l1864t2710r2143b2771],
10	peripheral-blood	JJ	O	peripheral-blood	amod	12	SENT_67	[p5l9t2803r621b2879],
11	mononuclear	JJ	O	mononuclear	amod	12	SENT_67	[p5l661t2803r1146b2864],
12	cells	NNS	O	cell	dobj	9	SENT_67	[p5l1186t2803r1338b2864],
13	and	CC	O	and	_	0	SENT_67	[p5l1382t2803r1515b2864],
14	incubated	VBN	O	incubate	conj_and	9	SENT_67	[p5l1556t2803r1917b2864],
15	them	PRP	O	they	dobj	14	SENT_67	[p5l1957t2803r2143b2864],
16	with	IN	O	with	prep	14	SENT_67	[p5l9t2897r168b2957],
17	either	CC	O	either	dep	16	SENT_67	[p5l222t2897r429b2957],
18	an	DT	O	a	det	19	SENT_67	[p5l481t2917r566b2957],
19	antibody	NN	O	antibody	conj	16	SENT_67	[p5l620t2897r940b2973],
20	against	IN	O	against	_	0	SENT_67	[p5l992t2897r1245b2973],
21	human	JJ	O	human	amod	24	SENT_67	[p5l1296t2897r1553b2957],
22	P-glycoprotein	NN	O	p-glycoprotein	nn	24	SENT_67	[p5l1606t2897r2143b2973],
23	(	CD	NUMBER	(	num	24	SENT_67	[p5l16t2989r276b3064],
24	UIC2	NN	O	uic2	prep_against	16	SENT_67	[p5l16t2989r276b3064],
25	;	:	O	;	_	0	SENT_67	[p5l16t2989r276b3064],
26	Immunotech	NNP	LOCATION	Immunotech	nn	30	SENT_67	[p5l309t2989r804b3062],
27	,	,	O	,	_	0	SENT_67	[p5l309t2989r804b3062],
28	Marseille	NNP	LOCATION	Marseille	appos	30	SENT_67	[p5l836t2989r1195b3062],
29	,	,	O	,	_	0	SENT_67	[p5l836t2989r1195b3062],
30	France	NNP	LOCATION	France	dep	43	SENT_67	[p5l1228t2990r1507b3064],
31	)	CD	NUMBER	)	num	30	SENT_67	[p5l1228t2990r1507b3064],
32	or	CC	O	or	_	0	SENT_67	[p5l1544t3009r1619b3050],
33	mouse	NN	O	mouse	nn	35	SENT_67	[p5l1647t3009r1884b3050],
34	IgG2a	NN	O	igg2a	nn	35	SENT_67	[p5l1914t2989r2142b3065],
35	isotype	NN	O	isotype	conj_or	30	SENT_67	[p5l10t3083r265b3158],
36	control	NN	O	control	dep	43	SENT_67	[p5l299t3082r557b3143],
37	(	CD	NUMBER	(	num	36	SENT_67	[p5l595t3083r916b3158],
38	Serotec	NNP	O	Serotec	nn	43	SENT_67	[p5l595t3083r916b3158],
39	,	,	O	,	_	0	SENT_67	[p5l595t3083r916b3158],
40	Oxford	NNP	LOCATION	Oxford	appos	43	SENT_67	[p5l953t3082r1233b3155],
41	,	,	O	,	_	0	SENT_67	[p5l953t3082r1233b3155],
42	UK	NNP	LOCATION	UK	appos	43	SENT_67	[p5l1267t3083r1430b3158],
43	)	NNP	O	)	dep	53	SENT_67	[p5l1267t3083r1430b3158],
44	for	IN	O	for	_	0	SENT_67	[p5l1467t3082r1570b3143],
45	30	CD	DURATION	30	num	46	SENT_67	[p5l1602t3085r1688b3143],
46	min	NN	DURATION	min	prep_for	43	SENT_67	[p5l1722t3083r1864b3142],
47	on	IN	O	on	_	0	SENT_67	[p5l1897t3102r1987b3143],
48	ice	NN	O	ice	prep_on	53	SENT_67	[p5l2019t3083r2140b3155],
49	,	,	O	,	_	0	SENT_67	[p5l2019t3083r2140b3155],
50	unstained	JJ	O	unstained	amod	51	SENT_67	[p5l10t3176r366b3236],
51	cells	NNS	O	cell	nsubjpass	53	SENT_67	[p5l394t3176r547b3236],
52	were	VBD	O	be	auxpass	53	SENT_67	[p5l574t3196r744b3236],
53	used	VBN	O	use	parataxis	9	SENT_67	[p5l771t3176r938b3236],
54	as	IN	O	as	_	0	SENT_67	[p5l967t3196r1035b3236],
55	a	DT	O	a	det	57	SENT_67	[p5l1065t3196r1100b3236],
56	negative	JJ	O	negative	amod	57	SENT_67	[p5l1127t3176r1426b3252],
57	control	NN	O	control	prep_as	53	SENT_67	[p5l1455t3176r1732b3236],
58	.	.	O	.	_	0	SENT_67	[p5l1455t3176r1732b3236],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_68	[p5l1768t3176r1945b3236],
2	were	VBD	O	be	auxpass	3	SENT_68	[p5l1972t3196r2142b3236],
3	washed	VBN	O	wash	_	0	SENT_68	[p5l9t3268r279b3329],
4	twice	RB	O	twice	advmod	3	SENT_68	[p5l362t3268r551b3329],
5	with	IN	O	with	_	0	SENT_68	[p5l634t3268r794b3329],
6	cold	JJ	O	cold	amod	8	SENT_68	[p5l878t3268r1031b3329],
7	phosphate	NN	O	phosphate	nn	8	SENT_68	[p5l1113t3268r1829b3344],
8	—	NN	O	—	prep_with	3	SENT_68	[p5l1113t3268r1829b3344],
9	buffered	VBN	O	buffer	dep	8	SENT_68	[p5l1113t3268r1829b3344],
10	saline	NN	O	saline	dobj	9	SENT_68	[p5l1914t3268r2140b3341],
11	,	,	O	,	_	0	SENT_68	[p5l1914t3268r2140b3341],
12	centrifuged	VBN	O	centrifuge	conj_and	9	SENT_68	[p5l12t3361r445b3437],
13	,	,	O	,	_	0	SENT_68	[p5l12t3361r445b3437],
14	and	CC	O	and	_	0	SENT_68	[p5l500t3361r633b3422],
15	then	RB	O	then	advmod	16	SENT_68	[p5l682t3361r843b3422],
16	incubated	VBN	O	incubate	conj_and	9	SENT_68	[p5l893t3361r1254b3422],
17	with	IN	O	with	_	0	SENT_68	[p5l1302t3361r1462b3422],
18	Rphycoerythrinbound	JJ	O	rphycoerythrinbound	amod	29	SENT_68	[p5l1512t3361r2142b3437, p5l9t3455r246b3515],
19	IgG	NN	O	igg	nn	29	SENT_68	[p5l327t3455r469b3531],
20	secondary	JJ	O	secondary	amod	29	SENT_68	[p5l550t3455r916b3531],
21	antibody	NN	O	antibody	nn	29	SENT_68	[p5l997t3455r1317b3531],
22	(	NN	O	(	nn	29	SENT_68	[p5l1401t3455r1654b3531],
23	Sigma	NNP	ORGANIZATION	Sigma	nn	29	SENT_68	[p5l1401t3455r1654b3531],
24	Chemicals	NNP	ORGANIZATION	Chemicals	nn	29	SENT_68	[p5l1738t3455r2140b3528],
25	,	,	O	,	_	0	SENT_68	[p5l1738t3455r2140b3528],
26	Dorset	NNP	LOCATION	Dorset	appos	29	SENT_68	[p5l10t3548r279b3620],
27	,	,	O	,	_	0	SENT_68	[p5l10t3548r279b3620],
28	UK	NNP	LOCATION	UK	appos	29	SENT_68	[p5l307t3547r469b3622],
29	)	NNP	O	)	prep_with	16	SENT_68	[p5l307t3547r469b3622],
30	for	IN	O	for	_	0	SENT_68	[p5l501t3547r604b3608],
31	30	CD	DURATION	30	num	32	SENT_68	[p5l628t3550r715b3608],
32	min	NN	DURATION	min	prep_for	16	SENT_68	[p5l741t3547r884b3607],
33	on	IN	O	on	_	0	SENT_68	[p5l910t3567r1000b3608],
34	ice	NN	O	ice	prep_on	32	SENT_68	[p5l1025t3547r1123b3608],
35	in	IN	O	in	_	0	SENT_68	[p5l1149t3547r1218b3607],
36	the	DT	O	the	det	37	SENT_68	[p5l1242t3547r1354b3608],
37	dark	NN	O	dark	prep_in	34	SENT_68	[p5l1381t3547r1560b3608],
38	.	.	O	.	_	0	SENT_68	[p5l1381t3547r1560b3608],

1	We	PRP	O	we	nsubj	2	SENT_69	[p5l1589t3548r1711b3608],
2	washed	VBD	O	wash	_	0	SENT_69	[p5l1736t3547r2005b3608],
3	the	DT	O	the	det	4	SENT_69	[p5l2030t3547r2142b3608],
4	cells	NNS	O	cell	dobj	2	SENT_69	[p5l12t3640r164b3701],
5	twice	RB	O	twice	advmod	2	SENT_69	[p5l201t3641r389b3701],
6	with	IN	O	with	_	0	SENT_69	[p5l424t3640r583b3701],
7	cold	JJ	O	cold	amod	9	SENT_69	[p5l619t3640r772b3701],
8	phosphate	NN	O	phosphate	nn	9	SENT_69	[p5l806t3640r1521b3716],
9	—	NN	O	—	prep_with	2	SENT_69	[p5l806t3640r1521b3716],
10	buffered	VBN	O	buffer	partmod	9	SENT_69	[p5l806t3640r1521b3716],
11	saline	NN	O	saline	dobj	10	SENT_69	[p5l1558t3640r1761b3701],
12	and	CC	O	and	_	0	SENT_69	[p5l1798t3640r1931b3701],
13	ﬁxed	VBD	O	ﬁxed	conj_and	2	SENT_69	[p5l1966t3640r2143b3701],
14	them	PRP	O	they	dobj	13	SENT_69	[p5l10t3734r196b3794],
15	in	IN	O	in	_	0	SENT_69	[p5l229t3734r298b3793],
16	paraformaldehyde	NN	O	paraformaldehyde	prep_in	13	SENT_69	[p5l329t3734r1013b3810],
17	.	.	O	.	_	0	SENT_69	[p5l329t3734r1013b3810],

1	All	DT	O	all	det	2	SENT_70	[p5l1050t3734r1154b3793],
2	samples	NNS	O	sample	nsubjpass	4	SENT_70	[p5l1190t3734r1475b3810],
3	were	VBD	O	be	auxpass	4	SENT_70	[p5l1508t3753r1679b3794],
4	analysed	VBN	O	analyse	_	0	SENT_70	[p5l1714t3734r2025b3810],
5	by	IN	O	by	prep	4	SENT_70	[p5l2057t3734r2145b3810],

1	ﬂow	NN	O	ﬂow	nn	2	SENT_71	[p6l10t15r165b76],
2	cytometry	NN	O	cytometry	_	0	SENT_71	[p6l202t29r587b91],
3	,	,	O	,	_	0	SENT_71	[p6l202t29r587b91],
4	on	IN	O	on	dep	2	SENT_71	[p6l629t35r719b76],
5	a	DT	O	a	det	8	SENT_71	[p6l757t35r792b76],
6	Coulter	NNP	O	Coulter	nn	8	SENT_71	[p6l833t15r1112b76],
7	Epics	NNPS	O	Epics	nn	8	SENT_71	[p6l1147t15r1343b91],
8	XL	NNP	O	XL	pobj	4	SENT_71	[p6l1380t15r1745b76],
9	.	.	O	.	_	0	SENT_71	[p6l1380t15r1745b76],

1	—	NN	O	—	_	0	SENT_72	[p6l1380t15r1745b76],
2	.	.	O	.	_	0	SENT_72	[p6l1380t15r1745b76],

1	MCL	NN	O	mcl	nn	2	SENT_73	[p6l1380t15r1745b76],
2	cytometer	NN	O	cytometer	_	0	SENT_73	[p6l1781t29r2145b91],
3	(	CD	NUMBER	(	dep	2	SENT_73	[p6l16t108r719b184],
4	Beckman-Coulter	NNP	O	Beckman-Coulter	nn	10	SENT_73	[p6l16t108r719b184],
5	,	,	O	,	_	0	SENT_73	[p6l16t108r719b184],
6	Fullerton	NNP	ORGANIZATION	Fullerton	appos	10	SENT_73	[p6l755t108r1118b181],
7	,	,	O	,	_	0	SENT_73	[p6l755t108r1118b181],
8	CA	NNP	O	CA	appos	10	SENT_73	[p6l1157t109r1300b181],
9	,	,	O	,	_	0	SENT_73	[p6l1157t109r1300b181],
10	USA	NNP	LOCATION	USA	dep	3	SENT_73	[p6l1335t109r1567b184],
11	)	CD	NUMBER	)	num	10	SENT_73	[p6l1335t109r1567b184],
12	.	.	O	.	_	0	SENT_73	[p6l1335t109r1567b184],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_74	[p6l1606t108r2143b184],
2	expression	NN	O	expression	nsubjpass	4	SENT_74	[p6l12t202r393b278],
3	was	VBD	O	be	auxpass	4	SENT_74	[p6l473t222r605b262],
4	deﬁned	VBN	O	deﬁned	dep	37	SENT_74	[p6l690t202r960b262],
5	as	IN	O	as	_	0	SENT_74	[p6l1043t222r1110b262],
6	a	DT	O	a	det	8	SENT_74	[p6l1195t222r1230b262],
7	one-fold	JJ	O	one-fold	amod	8	SENT_74	[p6l1314t202r1618b262],
8	increase	NN	O	increase	prep_as	4	SENT_74	[p6l1700t202r1992b262],
9	in	IN	O	in	_	0	SENT_74	[p6l2075t202r2143b261],
10	ﬂuorescence	NN	O	ﬂuorescence	prep_in	8	SENT_74	[p6l10t294r485b367],
11	,	,	O	,	_	0	SENT_74	[p6l10t294r485b367],
12	which	WDT	O	which	nsubjpass	14	SENT_74	[p6l511t294r730b355],
13	is	VBZ	O	be	auxpass	14	SENT_74	[p6l754t294r805b355],
14	calculated	VBN	O	calculate	rcmod	10	SENT_74	[p6l833t294r1200b355],
15	by	IN	O	by	_	0	SENT_74	[p6l1224t294r1311b370],
16	division	NN	O	division	agent	14	SENT_74	[p6l1336t294r1618b355],
17	of	IN	O	of	_	0	SENT_74	[p6l1643t294r1721b355],
18	the	DT	O	the	det	21	SENT_74	[p6l1735t294r1847b355],
19	median	JJ	O	median	amod	21	SENT_74	[p6l1872t294r2143b355],
20	ﬂuorescence	NN	O	ﬂuorescence	nn	21	SENT_74	[p6l10t387r463b448],
21	intensity	NN	O	intensity	prep_of	16	SENT_74	[p6l506t388r818b463],
22	seen	VBN	O	see	partmod	21	SENT_74	[p6l860t407r1017b448],
23	with	IN	O	with	_	0	SENT_74	[p6l1058t387r1216b448],
24	UIC2	NN	O	uic2	nn	25	SENT_74	[p6l1258t388r1468b448],
25	antibody	NN	O	antibody	prep_with	22	SENT_74	[p6l1514t387r1834b463],
26	by	IN	O	by	_	0	SENT_74	[p6l1873t387r1961b463],
27	that	DT	O	that	agent	22	SENT_74	[p6l2001t387r2144b448],
28	seen	VBN	O	see	partmod	27	SENT_74	[p6l12t500r169b541],
29	with	IN	O	with	_	0	SENT_74	[p6l194t481r353b541],
30	the	DT	O	the	det	33	SENT_74	[p6l379t481r491b541],
31	IgG2a	NN	O	igg2a	nn	33	SENT_74	[p6l519t481r747b557],
32	isotype	NN	O	isotype	nn	33	SENT_74	[p6l774t481r1029b557],
33	control	NN	O	control	prep_with	28	SENT_74	[p6l1058t481r1316b541],
34	(	CD	NUMBER	(	num	36	SENT_74	[p6l1349t481r1690b557],
35	arbitrary	JJ	O	arbitrary	amod	36	SENT_74	[p6l1349t481r1690b557],
36	units	NNS	O	unit	nsubj	37	SENT_74	[p6l1715t481r1946b556],
37	)	VBP	O	)	_	0	SENT_74	[p6l1715t481r1946b556],
38	.	.	O	.	_	0	SENT_74	[p6l1715t481r1946b556],

1	Midazolam	NNP	MISC	Midazolam	nsubj	5	SENT_75	[p6l95t573r509b634],
2	is	VBZ	O	be	cop	5	SENT_75	[p6l590t573r641b634],
3	a	DT	O	a	det	5	SENT_75	[p6l725t593r760b634],
4	short	JJ	O	short	amod	5	SENT_75	[p6l842t573r1280b649],
5	—	NN	O	—	_	0	SENT_75	[p6l842t573r1280b649],
6	acting	VBG	O	act	partmod	5	SENT_75	[p6l842t573r1280b649],
7	benzodiazepine	NN	O	benzodiazepine	dobj	6	SENT_75	[p6l1356t573r1920b649],
8	that	IN	O	that	nsubj	9	SENT_75	[p6l2001t573r2144b634],
9	undergoes	VBZ	O	undergo	rcmod	7	SENT_75	[p6l10t666r384b742],
10	oxidative	JJ	O	oxidative	amod	11	SENT_75	[p6l417t666r744b727],
11	metabolism	NN	O	metabolism	dobj	9	SENT_75	[p6l774t666r1199b727],
12	to	TO	O	to	_	0	SENT_75	[p6l1229t681r1299b727],
13	one	CD	NUMBER	one	num	15	SENT_75	[p6l1332t686r1461b727],
14	major	JJ	O	major	amod	15	SENT_75	[p6l1492t666r1704b742],
15	metabolite	NN	O	metabolite	prep_to	9	SENT_75	[p6l1732t666r2140b739],
16	,	,	O	,	_	0	SENT_75	[p6l1732t666r2140b739],
17	1	CD	NUMBER	1	dobj	9	SENT_75	[p6l19t759r835b836],
18	’	SYM	O	’	dep	20	SENT_75	[p6l19t759r835b836],
19	-	:	O	-	_	0	SENT_75	[p6l19t759r835b836],
20	hydroxymidazolam	NN	O	hydroxymidazolam	dep	17	SENT_75	[p6l19t759r835b836],
21	.	.	O	.	_	0	SENT_75	[p6l19t759r835b836],

1	This	DT	O	this	det	3	SENT_76	[p6l945t760r1110b820],
2	metabolic	JJ	O	metabolic	amod	3	SENT_76	[p6l1216t760r1574b820],
3	pathway	NN	O	pathway	nsubjpass	5	SENT_76	[p6l1679t760r1986b836],
4	is	VBZ	O	be	auxpass	5	SENT_76	[p6l2090t760r2141b820],
5	mediated	VBN	O	mediate	_	0	SENT_76	[p6l10t852r349b913],
6	almost	RB	O	almost	advmod	7	SENT_76	[p6l399t852r639b913],
7	exclusively	RB	O	exclusively	advmod	5	SENT_76	[p6l688t852r1079b928],
8	by	IN	O	by	_	0	SENT_76	[p6l1123t852r1212b928],
9	CYP3A	NN	O	cyp3a	nn	10	SENT_76	[p6l1261t852r1545b913],
10	isoforms	NNS	O	isoform	agent	5	SENT_76	[p6l1592t852r1969b913],
11	.	.	O	.	_	0	SENT_76	[p6l1592t852r1969b913],

1	“	NN	O	“	nsubj	3	SENT_77	[p6l1592t852r1969b913],
2	We	PRP	O	we	nsubj	3	SENT_77	[p6l2019t853r2142b913],
3	quantiﬁed	VBD	O	quantiﬁed	_	0	SENT_77	[p6l12t945r381b1021],
4	midazolam	NN	O	midazolam	dobj	3	SENT_77	[p6l521t946r923b1006],
5	and	CC	O	and	_	0	SENT_77	[p6l1065t945r1197b1006],
6	1	CD	NUMBER	1	dobj	3	SENT_77	[p6l1347t948r1371b1005],
7	'	''	O	'	_	0	SENT_77	[p6l1391t944r2143b1021],
8	-	:	O	-	_	0	SENT_77	[p6l1391t944r2143b1021],
9	hydroxymidazolam	NN	O	hydroxymidazolam	nn	10	SENT_77	[p6l1391t944r2143b1021],
10	concentrations	NNS	O	concentration	dep	16	SENT_77	[p6l12t1039r547b1099],
11	after	IN	O	after	_	0	SENT_77	[p6l620t1039r784b1099],
12	administration	NN	O	administration	prep_after	10	SENT_77	[p6l852t1039r1385b1099],
13	of	IN	O	of	_	0	SENT_77	[p6l1455t1039r1533b1099],
14	one	CD	NUMBER	one	num	15	SENT_77	[p6l1593t1039r2143b1099],
15	—	NN	O	—	prep_of	12	SENT_77	[p6l1593t1039r2143b1099],
16	hundredth	JJ	ORDINAL	hundredth	dep	4	SENT_77	[p6l1593t1039r2143b1099],
17	(	CD	NUMBER	(	number	18	SENT_77	[p6l16t1132r247b1206],
18	0075	CD	DATE	0075	num	20	SENT_77	[p6l16t1132r247b1206],
19	mg	NN	O	mg	nn	20	SENT_77	[p6l287t1132r426b1207],
20	)	NN	O	)	dep	4	SENT_77	[p6l287t1132r426b1207],
21	of	IN	O	of	_	0	SENT_77	[p6l469t1131r547b1192],
22	the	DT	O	the	det	24	SENT_77	[p6l572t1131r684b1192],
23	therapeutic	JJ	O	therapeutic	amod	24	SENT_77	[p6l720t1131r1131b1207],
24	dose	NN	O	dose	prep_of	4	SENT_77	[p6l1169t1131r1331b1192],
25	of	IN	O	of	_	0	SENT_77	[p6l1369t1131r1446b1192],
26	midazolam	NN	O	midazolam	prep_of	24	SENT_77	[p6l1471t1131r1874b1192],
27	by	IN	O	by	_	0	SENT_77	[p6l1908t1131r1996b1207],
28	gas	NN	O	gas	nn	29	SENT_77	[p6l2030t1151r2142b1207],
29	chromatography	NN	O	chromatography	prep_by	3	SENT_77	[p6l12t1224r632b1300],
30	,	,	O	,	_	0	SENT_77	[p6l12t1224r632b1300],
31	mass	NN	O	mass	nn	32	SENT_77	[p6l726t1244r902b1285],
32	spectrometry	NN	O	spectrometry	prep_by	3	SENT_77	[p6l996t1239r1493b1300],
33	,	,	O	,	_	0	SENT_77	[p6l996t1239r1493b1300],
34	and	CC	O	and	_	0	SENT_77	[p6l1589t1224r1722b1285],
35	negativechemical	JJ	O	negativechemical	amod	36	SENT_77	[p6l1812t1225r2142b1300, p6l12t1318r333b1378],
36	ionisation	NN	O	ionisation	prep_by	3	SENT_77	[p6l375t1318r752b1378],
37	.	.	O	.	_	0	SENT_77	[p6l375t1318r752b1378],

1	30	CD	DURATION	30	num	2	SENT_78	[p6l801t1320r886b1378],
2	min	NN	DURATION	min	npadvmod	11	SENT_78	[p6l930t1318r1073b1377],
3	after	IN	O	after	_	0	SENT_78	[p6l1116t1318r1280b1378],
4	oral	JJ	O	oral	amod	5	SENT_78	[p6l1320t1318r1457b1378],
5	administration	NN	O	administration	prep_after	11	SENT_78	[p6l1501t1318r2032b1378],
6	of	IN	O	of	_	0	SENT_78	[p6l2075t1318r2153b1378],
7	the	DT	O	the	det	8	SENT_78	[p6l10t1410r121b1471],
8	drug	NN	O	drug	prep_of	5	SENT_78	[p6l150t1410r338b1486],
9	,	,	O	,	_	0	SENT_78	[p6l150t1410r338b1486],
10	we	PRP	O	we	nsubj	11	SENT_78	[p6l366t1430r465b1471],
11	obtained	VBD	O	obtain	_	0	SENT_78	[p6l493t1410r811b1471],
12	9-mL	JJ	O	9-ml	amod	14	SENT_78	[p6l839t1411r1045b1471],
13	blood	NN	O	blood	nn	14	SENT_78	[p6l1067t1410r1276b1471],
14	samples	NNS	O	sample	dobj	11	SENT_78	[p6l1303t1410r1588b1486],
15	in	IN	O	in	_	0	SENT_78	[p6l1616t1410r1684b1470],
16	Monovettes	NNP	LOCATION	Monovettes	prep_in	11	SENT_78	[p6l1710t1411r2141b1471],
17	(	CD	NUMBER	(	num	16	SENT_78	[p6l16t1503r362b1579],
18	Sarstedt	NNP	PERSON	Sarstedt	nn	22	SENT_78	[p6l16t1503r362b1579],
19	,	,	O	,	_	0	SENT_78	[p6l16t1503r362b1579],
20	Niimbrecht	NNP	O	Niimbrecht	appos	22	SENT_78	[p6l440t1503r888b1576],
21	,	,	O	,	_	0	SENT_78	[p6l440t1503r888b1576],
22	Germany	NNP	LOCATION	Germany	dep	11	SENT_78	[p6l969t1504r1336b1579],
23	)	CD	NUMBER	)	num	22	SENT_78	[p6l969t1504r1336b1579],
24	containing	VBG	O	contain	partmod	22	SENT_78	[p6l1420t1504r1805b1579],
25	lithium	NN	O	lithium	nn	26	SENT_78	[p6l1880t1503r2143b1564],
26	heparinate	NN	O	heparinate	dobj	24	SENT_78	[p6l9t1597r414b1673],
27	.	.	O	.	_	0	SENT_78	[p6l9t1597r414b1673],

1	The	DT	O	the	det	2	SENT_79	[p6l463t1597r611b1657],
2	tubes	NNS	O	tube	nsubjpass	4	SENT_79	[p6l656t1597r849b1657],
3	were	VBD	O	be	auxpass	4	SENT_79	[p6l894t1616r1065b1657],
4	centrifuged	VBN	O	centrifuge	_	0	SENT_79	[p6l1112t1597r1524b1673],
5	within	IN	O	within	_	0	SENT_79	[p6l1567t1597r1797b1657],
6	30	CD	DURATION	30	num	7	SENT_79	[p6l1843t1599r1930b1657],
7	min	NN	DURATION	min	prep_within	4	SENT_79	[p6l1976t1597r2140b1670],
8	,	,	O	,	_	0	SENT_79	[p6l1976t1597r2140b1670],
9	and	CC	O	and	_	0	SENT_79	[p6l12t1689r145b1750],
10	the	DT	O	the	det	11	SENT_79	[p6l173t1689r285b1750],
11	plasma	NN	O	plasma	nsubjpass	13	SENT_79	[p6l314t1689r570b1765],
12	was	VBD	O	be	auxpass	13	SENT_79	[p6l599t1709r731b1750],
13	frozen	VBN	O	freeze	conj_and	4	SENT_79	[p6l762t1689r989b1750],
14	until	IN	O	until	_	0	SENT_79	[p6l1017t1689r1185b1750],
15	analysis	NN	O	analysis	prep_until	13	SENT_79	[p6l1217t1689r1515b1765],
16	.	.	O	.	_	0	SENT_79	[p6l1217t1689r1515b1765],

1	We	PRP	O	we	nsubj	2	SENT_80	[p6l1547t1690r1670b1750],
2	did	VBD	O	do	_	0	SENT_80	[p6l1701t1689r1817b1750],
3	analyses	NNS	O	analysis	dobj	2	SENT_80	[p6l1848t1689r2142b1765],
4	at	IN	O	at	_	0	SENT_80	[p6l12t1796r76b1843],
5	baseline	NN	O	baseline	prep_at	2	SENT_80	[p6l101t1782r394b1843],
6	and	CC	O	and	_	0	SENT_80	[p6l424t1782r556b1843],
7	1	CD	DURATION	1	num	8	SENT_80	[p6l592t1785r617b1842],
8	month	NN	NUMBER	month	prep_at	2	SENT_80	[p6l653t1782r894b1843],
9	after	IN	O	after	_	0	SENT_80	[p6l922t1782r1086b1843],
10	initiation	NN	O	initiation	prep_after	2	SENT_80	[p6l1111t1782r1440b1843],
11	of	IN	O	of	_	0	SENT_80	[p6l1468t1782r1545b1843],
12	treatment	NN	O	treatment	prep_of	10	SENT_80	[p6l1562t1796r1937b1843],
13	.	.	O	.	_	0	SENT_80	[p6l1562t1796r1937b1843],

1	Statistical	JJ	O	statistical	amod	4	SENT_81	[p6l9t1971r363b2031],
2	analysis	NN	O	analysis	nn	4	SENT_81	[p6l389t1972r675b2044],
3	Continuous	JJ	O	continuous	amod	4	SENT_81	[p6l14t2063r442b2123],
4	data	NNS	O	datum	nsubjpass	6	SENT_81	[p6l528t2062r681b2123],
5	were	VBD	O	be	auxpass	6	SENT_81	[p6l762t2082r932b2123],
6	analysed	VBN	O	analyse	_	0	SENT_81	[p6l1016t2062r1327b2138],
7	by	IN	O	by	_	0	SENT_81	[p6l1407t2062r1495b2138],
8	non-parametric	JJ	O	non-parametric	amod	10	SENT_81	[p6l1575t2063r2142b2138],
9	(	NN	O	(	nn	10	SENT_81	[p6l16t2156r613b2231],
10	Kruskal-Wallis	NN	O	kruskal-walli	agent	6	SENT_81	[p6l16t2156r613b2231],
11	)	CD	NUMBER	)	dep	10	SENT_81	[p6l16t2156r613b2231],
12	or	CC	O	or	_	0	SENT_81	[p6l654t2175r729b2216],
13	parametric	JJ	O	parametric	amod	14	SENT_81	[p6l759t2156r1152b2232],
14	(	NN	O	(	agent	6	SENT_81	[p6l1192t2156r1564b2231],
15	ANOVA	NNP	O	ANOVA	nn	17	SENT_81	[p6l1192t2156r1564b2231],
16	)	CD	NUMBER	)	num	17	SENT_81	[p6l1192t2156r1564b2231],
17	tests	NNS	O	test	dep	14	SENT_81	[p6l1603t2170r1783b2216],
18	.	.	O	.	_	0	SENT_81	[p6l1603t2170r1783b2216],

1	We	PRP	O	we	nsubj	2	SENT_82	[p6l1819t2157r1942b2216],
2	used	VBD	O	use	_	0	SENT_82	[p6l1975t2156r2143b2216],
3	logistic	JJ	O	logistic	amod	4	SENT_82	[p6l10t2248r265b2324],
4	regression	NN	O	regression	dobj	2	SENT_82	[p6l321t2248r688b2324],
5	to	TO	O	to	aux	6	SENT_82	[p6l743t2262r812b2309],
6	analyse	VB	O	analyse	xcomp	2	SENT_82	[p6l871t2248r1132b2324],
7	variables	NNS	O	variable	dobj	6	SENT_82	[p6l1186t2248r1503b2309],
8	associated	VBN	O	associate	partmod	7	SENT_82	[p6l1562t2248r1930b2309],
9	with	IN	O	with	_	0	SENT_82	[p6l1984t2248r2143b2309],
10	drug	NN	O	drug	nn	11	SENT_82	[p6l11t2341r180b2417],
11	concentrations	NNS	O	concentration	prep_with	8	SENT_82	[p6l213t2342r748b2402],
12	in	IN	O	in	_	0	SENT_82	[p6l783t2342r851b2401],
13	plasma	NN	O	plasma	prep_in	11	SENT_82	[p6l883t2341r1139b2417],
14	or	CC	O	or	_	0	SENT_82	[p6l1174t2361r1249b2402],
15	with	IN	O	with	_	0	SENT_82	[p6l1278t2341r1438b2402],
16	increases	NNS	O	increase	conj_or	11	SENT_82	[p6l1470t2342r1795b2402],
17	in	IN	O	in	_	0	SENT_82	[p6l1830t2342r1898b2401],
18	CD4cell	NN	O	cd4cell	nn	19	SENT_82	[p6l1934t2342r2142b2402, p6l12t2435r132b2495],
19	count	NN	O	count	prep_in	16	SENT_82	[p6l180t2449r405b2495],
20	.	.	O	.	_	0	SENT_82	[p6l180t2449r405b2495],

1	Stata	NNP	PERSON	Stata	nn	3	SENT_83	[p6l459t2435r640b2495],
2	software	NN	O	software	nn	3	SENT_83	[p6l687t2435r990b2495],
3	version	NN	O	version	nsubjpass	14	SENT_83	[p6l1034t2435r1297b2495],
4	7.0	CD	NUMBER	7.0	dep	3	SENT_83	[p6l1344t2437r1454b2495],
5	(	NNP	O	(	nn	7	SENT_83	[p6l1508t2435r1810b2511],
6	College	NNP	O	College	nn	7	SENT_83	[p6l1508t2435r1810b2511],
7	Station	NNP	O	Station	dep	3	SENT_83	[p6l1859t2435r2140b2508],
8	,	,	O	,	_	0	SENT_83	[p6l1859t2435r2140b2508],
9	TX	NNP	LOCATION	TX	nn	11	SENT_83	[p6l9t2528r159b2600],
10	,	,	O	,	_	0	SENT_83	[p6l9t2528r159b2600],
11	USA	NNP	LOCATION	USA	appos	7	SENT_83	[p6l189t2527r394b2602],
12	)	CD	NUMBER	)	num	11	SENT_83	[p6l189t2527r394b2602],
13	was	VBD	O	be	auxpass	14	SENT_83	[p6l426t2547r559b2588],
14	used	VBN	O	use	_	0	SENT_83	[p6l586t2527r754b2588],
15	for	IN	O	for	_	0	SENT_83	[p6l781t2527r884b2588],
16	statistical	JJ	O	statistical	amod	17	SENT_83	[p6l910t2527r1247b2588],
17	analyses	NNS	O	analysis	prep_for	14	SENT_83	[p6l1275t2527r1590b2603],
18	.	.	O	.	_	0	SENT_83	[p6l1275t2527r1590b2603],

1	Role	NN	O	role	nsubj	11	SENT_84	[p6l12t2718r167b2777],
2	of	IN	O	of	_	0	SENT_84	[p6l197t2717r271b2777],
3	the	DT	O	the	det	5	SENT_84	[p6l292t2718r402b2776],
4	funding	NN	O	funding	nn	5	SENT_84	[p6l432t2717r704b2792],
5	source	NN	O	source	prep_of	1	SENT_84	[p6l726t2731r965b2777],
6	The	DT	O	the	det	7	SENT_84	[p6l9t2809r158b2870],
7	sponsors	NNS	O	sponsor	dep	5	SENT_84	[p6l201t2829r515b2885],
8	of	IN	O	of	_	0	SENT_84	[p6l558t2809r636b2870],
9	the	DT	O	the	det	10	SENT_84	[p6l666t2809r778b2870],
10	study	NN	O	study	prep_of	7	SENT_84	[p6l821t2809r1017b2885],
11	had	VBD	O	have	_	0	SENT_84	[p6l1055t2809r1190b2870],
12	no	DT	O	no	det	13	SENT_84	[p6l1230t2829r1320b2870],
13	role	NN	O	role	dobj	11	SENT_84	[p6l1362t2809r1499b2870],
14	in	IN	O	in	_	0	SENT_84	[p6l1540t2809r1608b2869],
15	study	NN	O	study	nn	16	SENT_84	[p6l1650t2809r1847b2885],
16	design	NN	O	design	prep_in	13	SENT_84	[p6l1887t2809r2140b2885],
17	,	,	O	,	_	0	SENT_84	[p6l1887t2809r2140b2885],
18	data	NNS	O	datum	nn	19	SENT_84	[p6l11t2902r164b2963],
19	collection	NN	O	collection	prep_in	13	SENT_84	[p6l231t2902r604b2975],
20	,	,	O	,	_	0	SENT_84	[p6l231t2902r604b2975],
21	data	NN	O	datum	nn	22	SENT_84	[p6l673t2902r825b2963],
22	analysis	NN	O	analysis	prep_in	13	SENT_84	[p6l892t2902r1192b2978],
23	,	,	O	,	_	0	SENT_84	[p6l892t2902r1192b2978],
24	data	NNS	O	datum	nn	25	SENT_84	[p6l1260t2902r1413b2963],
25	interpretation	NN	O	interpretation	prep_in	13	SENT_84	[p6l1478t2902r2001b2978],
26	,	,	O	,	_	0	SENT_84	[p6l1478t2902r2001b2978],
27	or	CC	O	or	_	0	SENT_84	[p6l2070t2922r2145b2963],
28	writing	NN	O	writing	prep_in	13	SENT_84	[p6l9t2996r267b3072],
29	of	IN	O	of	_	0	SENT_84	[p6l294t2996r372b3056],
30	the	DT	O	the	det	31	SENT_84	[p6l388t2996r500b3056],
31	report	NN	O	report	prep_of	28	SENT_84	[p6l527t3010r769b3072],
32	.	.	O	.	_	0	SENT_84	[p6l527t3010r769b3072],

1	Results	NNS	O	result	_	0	SENT_85	[p6l13t3179r353b3245],

1	On	IN	O	on	_	0	SENT_86	[p7l13t23r125b83],
2	the	DT	O	the	det	3	SENT_86	[p7l213t23r325b83],
3	basis	NN	O	basis	prep_on	15	SENT_86	[p7l412t23r587b83],
4	of	IN	O	of	_	0	SENT_86	[p7l679t23r756b83],
5	previous	JJ	O	previous	amod	6	SENT_86	[p7l833t23r1141b99],
6	analyses	NNS	O	analysis	prep_of	3	SENT_86	[p7l1232t23r1526b99],
7	of	IN	O	of	_	0	SENT_86	[p7l1618t23r1695b83],
8	functional	JJ	O	functional	amod	9	SENT_86	[p7l1773t23r2142b83],
9	polymorphisms	NNS	O	polymorphism	prep_of	6	SENT_86	[p7l9t115r572b191],
10	in	IN	O	in	_	0	SENT_86	[p7l612t115r681b175],
11	MDR1	NN	O	mdr1	prep_in	9	SENT_86	[p7l715t116r1039b188],
12	,	,	O	,	_	0	SENT_86	[p7l715t116r1039b188],
13	”	CD	NUMBER	”	appos	11	SENT_86	[p7l715t116r1039b188],
14	we	PRP	O	we	nsubj	15	SENT_86	[p7l1076t135r1175b176],
15	ascertained	VBD	O	ascertain	_	0	SENT_86	[p7l1215t115r1624b176],
16	the	DT	O	the	det	17	SENT_86	[p7l1662t115r1774b176],
17	genotype	NN	O	genotype	dobj	15	SENT_86	[p7l1814t129r2142b191],
18	of	IN	O	of	_	0	SENT_86	[p7l12t208r90b269],
19	the	DT	O	the	det	20	SENT_86	[p7l124t208r235b269],
20	5	CD	NUMBER	5	prep_of	17	SENT_86	[p7l285t207r346b269],
21	'	''	O	'	_	0	SENT_86	[p7l285t207r346b269],
22	ﬂanking	JJ	O	ﬂanking	amod	23	SENT_86	[p7l398t208r692b284],
23	region	NN	O	region	dobj	15	SENT_86	[p7l736t209r964b284],
24	and	CC	O	and	_	0	SENT_86	[p7l1010t208r1143b269],
25	exon	NN	O	exon	dobj	15	SENT_86	[p7l1190t228r1362b269],
26	26	CD	NUMBER	26	num	25	SENT_86	[p7l1408t211r1494b269],
27	of	IN	O	of	_	0	SENT_86	[p7l1544t208r1621b269],
28	this	DT	O	this	det	29	SENT_86	[p7l1655t208r1783b269],
29	gene	NN	O	gene	prep_of	25	SENT_86	[p7l1830t228r1996b284],
30	for	IN	O	for	_	0	SENT_86	[p7l2042t208r2145b269],
31	123	CD	NUMBER	123	num	32	SENT_86	[p7l19t304r144b362],
32	patients	NNS	O	patient	prep_for	15	SENT_86	[p7l184t302r470b378],
33	receiving	VBG	O	receive	partmod	32	SENT_86	[p7l509t302r837b378],
34	antiretroviral	JJ	O	antiretroviral	amod	35	SENT_86	[p7l875t302r1346b362],
35	treatment	NN	O	treatment	dobj	33	SENT_86	[p7l1384t316r1759b362],
36	.	.	O	.	_	0	SENT_86	[p7l1384t316r1759b362],

1	Although	IN	O	although	mark	5	SENT_87	[p7l1800t302r2144b378],
2	we	PRP	O	we	nsubj	5	SENT_87	[p7l9t414r108b455],
3	did	VBD	O	do	aux	5	SENT_87	[p7l137t394r252b455],
4	not	RB	O	not	neg	5	SENT_87	[p7l278t409r399b455],
5	identify	VB	O	identify	advcl	27	SENT_87	[p7l425t394r701b470],
6	any	DT	O	any	det	7	SENT_87	[p7l728t414r854b470],
7	mutation	NN	O	mutation	dobj	5	SENT_87	[p7l879t394r1213b455],
8	in	IN	O	in	_	0	SENT_87	[p7l1239t394r1308b454],
9	the	DT	O	the	det	13	SENT_87	[p7l1333t394r1445b455],
10	5	CD	NUMBER	5	num	13	SENT_87	[p7l1476t393r1537b455],
11	’	NN	O	’	nn	13	SENT_87	[p7l1476t393r1537b455],
12	ﬂanking	NN	O	ﬂanking	nn	13	SENT_87	[p7l1571t394r1865b470],
13	region	NN	O	region	prep_in	7	SENT_87	[p7l1890t394r2140b470],
14	,	,	O	,	_	0	SENT_87	[p7l1890t394r2140b470],
15	a	DT	O	a	det	17	SENT_87	[p7l12t507r47b548],
16	particular	JJ	O	particular	amod	17	SENT_87	[p7l87t487r442b563],
17	polymorphism	NN	O	polymorphism	nsubjpass	27	SENT_87	[p7l480t487r1012b563],
18	at	IN	O	at	_	0	SENT_87	[p7l1054t502r1119b548],
19	exon	NN	O	exon	prep_at	17	SENT_87	[p7l1161t507r1333b548],
20	26	CD	NUMBER	26	number	21	SENT_87	[p7l1376t490r1462b548],
21	(	CD	NUMBER	(	num	22	SENT_87	[p7l1512t488r1962b563],
22	3435C	NN	O	3435c	dep	19	SENT_87	[p7l1512t488r1962b563],
23	+	CC	O	+	_	0	SENT_87	[p7l1512t488r1962b563],
24	T	NN	O	t	nn	25	SENT_87	[p7l1512t488r1962b563],
25	)	NN	O	)	dep	19	SENT_87	[p7l1512t488r1962b563],
26	was	VBD	O	be	auxpass	27	SENT_87	[p7l2008t507r2141b548],
27	associated	VBN	O	associate	_	0	SENT_87	[p7l12t581r380b641],
28	with	IN	O	with	_	0	SENT_87	[p7l405t581r564b641],
29	differences	NNS	O	difference	prep_with	27	SENT_87	[p7l591t581r982b641],
30	in	IN	O	in	_	0	SENT_87	[p7l1009t581r1078b640],
31	plasma	NN	O	plasma	nn	33	SENT_87	[p7l1103t581r1359b657],
32	drug	NN	O	drug	nn	33	SENT_87	[p7l1387t581r1555b657],
33	concentrations	NNS	O	concentration	prep_in	29	SENT_87	[p7l1581t581r2137b641],
34	.	.	O	.	_	0	SENT_87	[p7l1581t581r2137b641],

1	Patients	NNS	O	patient	nsubj	6	SENT_88	[p7l11t673r301b734],
2	with	IN	O	with	_	0	SENT_88	[p7l379t673r538b734],
3	the	DT	O	the	det	5	SENT_88	[p7l615t673r727b734],
4	TT	NN	O	tt	nn	5	SENT_88	[p7l805t674r932b733],
5	genotype	NN	O	genotype	prep_with	1	SENT_88	[p7l1008t687r1337b749],
6	had	VBD	O	have	_	0	SENT_88	[p7l1415t673r1549b734],
7	median	JJ	O	median	amod	9	SENT_88	[p7l1626t673r1898b734],
8	drug	NN	O	drug	nn	9	SENT_88	[p7l1976t673r2144b749],
9	concentrations	NNS	O	concentration	dobj	6	SENT_88	[p7l12t767r547b827],
10	at	IN	O	at	_	0	SENT_88	[p7l597t781r661b827],
11	the	DT	O	the	det	17	SENT_88	[p7l706t766r818b827],
12	30th	JJ	ORDINAL	30th	amod	17	SENT_88	[p7l867t766r1031b827],
13	percentile	NN	O	percentile	nn	17	SENT_88	[p7l1076t766r1434b842],
14	(	NN	O	(	nn	17	SENT_88	[p7l1487t767r1675b842],
15	IQR	NN	O	iqr	nn	17	SENT_88	[p7l1487t767r1675b842],
16	15-50	CD	NUMBER	15-50	num	17	SENT_88	[p7l1727t767r1996b841],
17	)	NN	O	)	prep_at	9	SENT_88	[p7l1727t767r1996b841],
18	.	.	O	.	_	0	SENT_88	[p7l1727t767r1996b841],

1	By	IN	O	by	_	0	SENT_89	[p7l2048t767r2145b842],
2	contrast	NN	O	contrast	prep_by	9	SENT_89	[p7l12t874r325b933],
3	,	,	O	,	_	0	SENT_89	[p7l12t874r325b933],
4	patients	NNS	O	patient	nsubj	9	SENT_89	[p7l356t860r642b936],
5	with	IN	O	with	_	0	SENT_89	[p7l671t860r830b920],
6	the	DT	O	the	det	8	SENT_89	[p7l858t860r969b920],
7	CT	NNP	O	CT	nn	8	SENT_89	[p7l1002t860r1127b920],
8	genotype	NN	O	genotype	prep_with	4	SENT_89	[p7l1155t874r1484b936],
9	had	VBD	O	have	dep	26	SENT_89	[p7l1512t860r1647b920],
10	median	JJ	O	median	amod	12	SENT_89	[p7l1675t860r1946b920],
11	drug	NN	O	drug	nn	12	SENT_89	[p7l1976t860r2144b936],
12	concentrations	NNS	O	concentration	dobj	9	SENT_89	[p7l12t952r547b1013],
13	at	IN	O	at	_	0	SENT_89	[p7l590t966r655b1013],
14	the	DT	O	the	det	16	SENT_89	[p7l693t952r804b1013],
15	50th	JJ	ORDINAL	50th	amod	16	SENT_89	[p7l848t952r1011b1013],
16	percentile	NN	O	percentile	prep_at	12	SENT_89	[p7l1049t952r1407b1028],
17	(	CD	NUMBER	(	num	19	SENT_89	[p7l1453t953r1732b1027],
18	25-75	CD	NUMBER	25-75	num	19	SENT_89	[p7l1453t953r1732b1027],
19	)	NN	O	)	dep	16	SENT_89	[p7l1453t953r1732b1027],
20	and	CC	O	and	_	0	SENT_89	[p7l1779t952r1912b1013],
21	those	DT	O	those	prep_at	12	SENT_89	[p7l1951t952r2142b1013],
22	with	IN	O	with	_	0	SENT_89	[p7l9t1045r168b1106],
23	the	DT	O	the	det	25	SENT_89	[p7l216t1045r328b1106],
24	CC	NN	O	cc	nn	25	SENT_89	[p7l380t1046r503b1106],
25	genotype	NN	O	genotype	prep_with	21	SENT_89	[p7l555t1060r883b1121],
26	had	VBD	O	have	_	0	SENT_89	[p7l931t1045r1066b1106],
27	concentrations	NNS	O	concentration	dobj	26	SENT_89	[p7l1116t1046r1652b1106],
28	at	IN	O	at	_	0	SENT_89	[p7l1704t1060r1769b1106],
29	the	DT	O	the	det	32	SENT_89	[p7l1816t1045r1927b1106],
30	75th	JJ	ORDINAL	75th	amod	32	SENT_89	[p7l1979t1045r2143b1106],
31	percentile	NN	O	percentile	nn	32	SENT_89	[p7l9t1139r367b1215],
32	(	NN	O	(	prep_at	27	SENT_89	[p7l409t1139r684b1214],
33	60-85	CD	NUMBER	60-85	nsubj	26	SENT_89	[p7l409t1139r684b1214],
34	;	:	O	;	_	0	SENT_89	[p7l409t1139r684b1214],
35	p	NN	O	p	nn	37	SENT_89	[p7l721t1141r1103b1215],
36	=	JJ	O	=	amod	37	SENT_89	[p7l721t1141r1103b1215],
37	O-0001	NN	O	o-0001	dep	33	SENT_89	[p7l721t1141r1103b1215],
38	,	,	O	,	_	0	SENT_89	[p7l721t1141r1103b1215],
39	ﬁgure	NN	O	ﬁgure	nn	41	SENT_89	[p7l1141t1139r1349b1215],
40	1	CD	NUMBER	1	num	41	SENT_89	[p7l1394t1139r1481b1214],
41	)	NN	O	)	appos	37	SENT_89	[p7l1394t1139r1481b1214],
42	.	.	O	.	_	0	SENT_89	[p7l1394t1139r1481b1214],

1	For	IN	O	for	_	0	SENT_90	[p7l1521t1140r1653b1199],
2	the	DT	O	the	det	5	SENT_90	[p7l1686t1139r1798b1199],
3	different	JJ	O	different	amod	5	SENT_90	[p7l1835t1139r2144b1199],
4	MDR1	NN	O	mdr1	nn	5	SENT_90	[p7l7t1232r254b1291],
5	genotypes	NNS	O	genotype	prep_for	26	SENT_90	[p7l319t1245r704b1307],
6	,	,	O	,	_	0	SENT_90	[p7l319t1245r704b1307],
7	the	DT	O	the	det	9	SENT_90	[p7l766t1231r878b1292],
8	69	CD	NUMBER	69	num	9	SENT_90	[p7l942t1234r1025b1292],
9	patients	NNS	O	patient	nsubj	26	SENT_90	[p7l1087t1231r1372b1307],
10	receiving	VBG	O	receive	partmod	9	SENT_90	[p7l1434t1231r1761b1307],
11	efavirenz	NN	O	efavirenz	nn	13	SENT_90	[p7l1821t1231r2143b1292],
12	(	NN	O	(	nn	13	SENT_90	[p7l16t1325r363b1400],
13	p	NN	O	p	nsubj	16	SENT_90	[p7l16t1325r363b1400],
14	=	JJ	O	=	amod	16	SENT_90	[p7l16t1325r363b1400],
15	0-O2	NN	O	0-o2	nn	16	SENT_90	[p7l16t1325r363b1400],
16	)	NN	O	)	xcomp	10	SENT_90	[p7l16t1325r363b1400],
17	,	,	O	,	_	0	SENT_90	[p7l16t1325r363b1400],
18	which	WDT	O	which	nsubj	22	SENT_90	[p7l397t1324r615b1385],
19	is	VBZ	O	be	cop	22	SENT_90	[p7l647t1325r698b1385],
20	not	RB	O	not	neg	22	SENT_90	[p7l731t1339r852b1385],
21	a	DT	O	a	det	22	SENT_90	[p7l885t1344r920b1385],
22	substrate	NN	O	substrate	rcmod	16	SENT_90	[p7l954t1324r1281b1385],
23	of	IN	O	of	_	0	SENT_90	[p7l1315t1324r1393b1385],
24	P-glycoprotein	NN	O	p-glycoprotein	prep_of	22	SENT_90	[p7l1415t1324r1974b1400],
25	,	,	O	,	_	0	SENT_90	[p7l1415t1324r1974b1400],
26	had	VBD	O	have	_	0	SENT_90	[p7l2008t1324r2143b1385],
27	an	DT	O	a	det	30	SENT_90	[p7l12t1437r96b1478],
28	in-vivo	JJ	O	in-vivo	amod	30	SENT_90	[p7l155t1418r403b1478],
29	distribution	NN	O	distribution	nn	30	SENT_90	[p7l465t1418r890b1478],
30	pattern	NN	O	pattern	nsubj	38	SENT_90	[p7l947t1432r1211b1494],
31	similar	JJ	O	similar	dep	38	SENT_90	[p7l1270t1418r1516b1478],
32	to	TO	O	to	_	0	SENT_90	[p7l1572t1432r1642b1478],
33	that	DT	O	that	prep_to	31	SENT_90	[p7l1702t1418r1845b1478],
34	of	IN	O	of	_	0	SENT_90	[p7l1904t1418r1982b1478],
35	the	DT	O	the	det	37	SENT_90	[p7l2030t1418r2142b1478],
36	54	CD	NUMBER	54	num	37	SENT_90	[p7l13t1513r99b1571],
37	patients	NNS	O	patient	prep_of	33	SENT_90	[p7l135t1510r420b1586],
38	receiving	VBG	O	receive	xcomp	26	SENT_90	[p7l457t1510r784b1586],
39	nelﬁnavir	JJ	O	nelﬁnavir	amod	41	SENT_90	[p7l817t1510r1162b1571],
40	(	NN	O	(	nn	41	SENT_90	[p7l1201t1511r1548b1586],
41	p	NN	O	p	dobj	38	SENT_90	[p7l1201t1511r1548b1586],
42	=	JJ	O	=	amod	44	SENT_90	[p7l1201t1511r1548b1586],
43	O-O3	NN	O	o-o3	nn	44	SENT_90	[p7l1201t1511r1548b1586],
44	)	NN	O	)	tmod	38	SENT_90	[p7l1201t1511r1548b1586],
45	,	,	O	,	_	0	SENT_90	[p7l1201t1511r1548b1586],
46	which	WDT	O	which	nsubj	51	SENT_90	[p7l1585t1510r1803b1571],
47	is	VBZ	O	be	cop	51	SENT_90	[p7l1838t1510r1889b1571],
48	a	DT	O	a	det	51	SENT_90	[p7l1928t1530r1963b1571],
49	well	RB	O	well	advmod	50	SENT_90	[p7l1997t1510r2143b1571],
50	deﬁned	JJ	O	deﬁned	amod	51	SENT_90	[p7l11t1603r282b1664],
51	substrate	NN	O	substrate	rcmod	44	SENT_90	[p7l344t1603r670b1664],
52	of	IN	O	of	_	0	SENT_90	[p7l734t1603r812b1664],
53	P-glycoprotein	NN	O	p-glycoprotein	prep_of	51	SENT_90	[p7l864t1603r1471b1679],
54	.	.	O	.	_	0	SENT_90	[p7l864t1603r1471b1679],

1	”	NN	O	”	nsubj	27	SENT_91	[p7l864t1603r1471b1679],
2	The	DT	O	the	det	3	SENT_91	[p7l1532t1604r1681b1664],
3	association	NN	O	association	nsubjpass	17	SENT_91	[p7l1745t1604r2143b1664],
4	between	IN	O	between	_	0	SENT_91	[p7l9t1697r313b1757],
5	MDR1	NN	O	mdr1	nn	8	SENT_91	[p7l372t1698r620b1756],
6	3435	CD	NUMBER	3435	num	8	SENT_91	[p7l689t1699r867b1757],
7	TT	NN	O	tt	nn	8	SENT_91	[p7l933t1698r1060b1756],
8	genotype	NN	O	genotype	prep_between	3	SENT_91	[p7l1123t1711r1451b1773],
9	and	CC	O	and	_	0	SENT_91	[p7l1517t1697r1650b1757],
10	lower	JJR	O	lower	amod	12	SENT_91	[p7l1713t1697r1914b1757],
11	drug	NN	O	drug	nn	12	SENT_91	[p7l1976t1697r2144b1773],
12	concentrations	NNS	O	concentration	conj_and	3	SENT_91	[p7l12t1789r547b1850],
13	in	IN	O	in	_	0	SENT_91	[p7l642t1789r710b1849],
14	plasma	NN	O	plasma	prep_in	12	SENT_91	[p7l801t1789r1057b1865],
15	was	VBD	O	be	auxpass	17	SENT_91	[p7l1149t1809r1282b1850],
16	also	RB	O	also	advmod	17	SENT_91	[p7l1378t1789r1514b1850],
17	conﬁrmed	VBN	O	conﬁrmed	rcmod	1	SENT_91	[p7l1610t1789r1982b1850],
18	in	IN	O	in	_	0	SENT_91	[p7l2075t1789r2143b1849],
19	107	CD	NUMBER	107	num	20	SENT_91	[p7l19t1885r144b1943],
20	patients	NNS	O	patient	prep_in	17	SENT_91	[p7l181t1883r467b1958],
21	who	WP	O	who	nsubj	24	SENT_91	[p7l502t1882r654b1943],
22	did	VBD	O	do	aux	24	SENT_91	[p7l692t1882r807b1943],
23	not	RB	O	not	neg	24	SENT_91	[p7l841t1897r962b1943],
24	receive	VB	O	receive	rcmod	20	SENT_91	[p7l996t1883r1247b1943],
25	additional	JJ	O	additional	amod	26	SENT_91	[p7l1284t1882r1648b1943],
26	drugs	NNS	O	drug	dobj	24	SENT_91	[p7l1685t1882r1884b1958],
27	(	VBP	O	(	_	0	SENT_91	[p7l1927t1882r2145b1958],
28	other	JJ	O	other	dobj	27	SENT_91	[p7l1927t1882r2145b1958],
29	than	IN	O	than	_	0	SENT_91	[p7l10t1976r172b2036],
30	nelﬁnavir	NN	O	nelﬁnavir	nn	33	SENT_91	[p7l232t1976r576b2036],
31	or	CC	O	or	_	0	SENT_91	[p7l635t1995r710b2036],
32	efavirenz	NN	O	efavirenz	conj_or	30	SENT_91	[p7l770t1976r1119b2049],
33	)	NN	O	)	prep_than	28	SENT_91	[p7l770t1976r1119b2049],
34	that	WDT	O	that	nsubj	36	SENT_91	[p7l1185t1976r1327b2036],
35	could	MD	O	could	aux	36	SENT_91	[p7l1388t1976r1589b2036],
36	interact	VB	O	interact	rcmod	28	SENT_91	[p7l1649t1976r1926b2036],
37	with	IN	O	with	prep	36	SENT_91	[p7l1984t1976r2143b2036],

1	THE	DT	O	the	det	2	SENT_92	[p7l92t2150r158b2170],
2	LANCET	NN	O	lancet	_	0	SENT_92	[p7l167t2150r297b2171],
3	-	:	O	-	_	0	SENT_92	[p7l306t2157r314b2164],
4	Vol	NN	O	vol	dep	2	SENT_92	[p7l323t2150r367b2171],
5	359	CD	NUMBER	359	num	4	SENT_92	[p7l377t2151r422b2171],
6	-	:	O	-	_	0	SENT_92	[p7l433t2157r441b2164],
7	January	NNP	DATE	January	dep	4	SENT_92	[p7l449t2150r547b2176],
8	5	CD	DATE	5	num	7	SENT_92	[p7l557t2151r578b2175],
9	,	,	DATE	,	_	0	SENT_92	[p7l557t2151r578b2175],
10	2002	CD	DATE	2002	num	7	SENT_92	[p7l589t2151r651b2171],
11	-	:	O	-	_	0	SENT_92	[p7l662t2157r669b2164],
12	www.thelancet.com	NNP	O	www.thelancet.com	nn	14	SENT_92	[p7l679t2150r929b2171],
13	31	CD	NUMBER	31	num	14	SENT_92	[p7l2025t2145r2060b2171],
14	ARTICLES	NNS	O	article	dep	2	SENT_92	[p7l91t2193r244b2214],

1	Nelfinavir	NNP	O	Nelfinavir	nn	2	SENT_93	[p7l597t2355r824b2395],
2	Efavirenz	NNP	O	Efavirenz	_	0	SENT_93	[p7l1647t2355r1864b2395],

1	MDR1	NN	O	mdr1	nn	2	SENT_94	[p7l35t2466r184b2504],
2	3435C	NN	O	3435c	_	0	SENT_94	[p7l202t2465r401b2513],
3	/	:	O	/	punct	4	SENT_94	[p7l202t2465r401b2513],
4	T	NN	O	t	dep	2	SENT_94	[p7l403t2466r431b2504],

1	Drug	NN	O	drug	nn	2	SENT_95	[p7l19t2988r68b3094],
2	concentration	NN	O	concentration	_	0	SENT_95	[p7l22t2648r58b2970],
3	in	IN	O	in	_	0	SENT_95	[p7l84t3093r123b3128],
4	plasma	NN	O	plasma	nn	7	SENT_95	[p7l84t2900r132b3069],
5	(	CD	NUMBER	(	num	7	SENT_95	[p7l84t2614r132b2878],
6	percentile	NN	O	percentile	nn	7	SENT_95	[p7l84t2614r132b2878],
7	)	NN	O	)	prep_in	2	SENT_95	[p7l84t2614r132b2878],

1	M	NN	O	m	nn	4	SENT_96	[p7l176t3010r204b3049],
2	01	CD	NUMBER	01	num	4	SENT_96	[p7l177t2851r205b2889],
3	\	NN	O	\	nn	4	SENT_96	[p7l178t2687r204b2726],
4	l	NN	O	l	_	0	SENT_96	[p7l178t2687r204b2726],
5	on	IN	O	on	_	0	SENT_96	[p7l210t3010r238b3049],
6	o	NN	O	o	prep_on	4	SENT_96	[p7l209t2850r238b2889],
7	on	IN	O	on	prep	4	SENT_96	[p7l210t2687r238b2726],

1	I	PRP	O	I	_	0	SENT_97	[p7l496t3024r514b3042],

1	I	PRP	O	I	_	0	SENT_98	[p7l697t2864r715b2882],
2	I	PRP	O	I	dep	1	SENT_98	[p7l683t2703r701b2720],
3	:	:	O	:	_	0	SENT_98	[p7l719t3022r765b3040],
4	g	NN	O	g	nn	6	SENT_98	[p7l721t2864r787b2882],
5	o	NN	O	o	nn	6	SENT_98	[p7l707t2703r797b2720],
6	冤	NN	O	冤	dep	2	SENT_98	[p7l707t2703r797b2720],
7	+	CC	O	+	rcmod	6	SENT_98	[p7l707t2703r797b2720],

1	I	PRP	O	I	nsubj	2	SENT_99	[p7l972t3021r990b3038],
2	I	PRP	O	I	_	0	SENT_99	[p7l972t2864r990b2882],
3	I	PRP	O	I	dep	2	SENT_99	[p7l972t2766r990b2784],
4	I	PRP	O	I	nsubj	5	SENT_99	[p7l972t2735r990b2753],
5	é	VBP	O	é	rcmod	2	SENT_99	[p7l905t2704r1057b2722],
6	:	:	O	:	_	0	SENT_99	[p7l950t2670r992b2688],
7	I	PRP	O	I	dep	12	SENT_99	[p7l972t2636r990b2653],
8	I	PRP	O	I	dep	7	SENT_99	[p7l972t2606r990b2624],
9	I	PRP	O	I	dep	7	SENT_99	[p7l972t2575r990b2593],
10	I	PRP	O	I	dep	9	SENT_99	[p7l998t2670r1016b2688],
11	I	PRP	O	I	dep	9	SENT_99	[p7l1521t2608r1539b2626],
12	I	PRP	O	I	parataxis	2	SENT_99	[p7l1521t2575r1539b2593],

1	I	PRP	O	I	_	0	SENT_100	[p7l1742t2704r1783b2722],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_101	[p8l36t47r230b85],
2	genotype	NN	O	genotype	_	0	SENT_101	[p8l246t48r472b95],

1	P	NN	O	p	nn	2	SENT_102	[p8l145t105r238b144],
2	*	NN	O	*	_	0	SENT_102	[p8l145t105r238b144],
3	II	CD	NUMBER	ii	dep	2	SENT_102	[p8l718t149r763b167],
4	II	NNP	O	II	nn	5	SENT_102	[p8l1507t150r1550b168],
5	II	NNP	O	II	dep	2	SENT_102	[p8l1742t150r1785b168],

1	c	NN	O	c	nsubj	7	SENT_103	[p8l28t223r58b245],
2	if	IN	O	if	prep	1	SENT_103	[p8l84t188r132b254],
3	:	:	O	:	_	0	SENT_103	[p8l467t181r536b264],
4	'	''	O	'	_	0	SENT_103	[p8l467t181r536b264],
5	:	:	O	:	_	0	SENT_103	[p8l467t181r536b264],
6	'	''	O	'	_	0	SENT_103	[p8l467t181r536b264],
7	:	:	O	:	_	0	SENT_103	[p8l467t181r536b264],
8	.	.	O	.	_	0	SENT_103	[p8l732t246r750b264],
9	'	''	O	'	_	0	SENT_103	[p8l975t181r993b199],

1	$	$	MONEY	$	_	0	SENT_104	[p8l1480t181r1574b264],
2	*	CD	MONEY	*	num	1	SENT_104	[p8l1480t181r1574b264],
3	*	CD	MONEY	*	num	1	SENT_104	[p8l1742t178r1785b264],
4	"	``	O	"	punct	5	SENT_104	[p8l1981t182r2024b199],
5	S	NN	O	s	dep	1	SENT_104	[p8l22t251r58b309],
6	E	NN	O	e	rcmod	5	SENT_104	[p8l87t258r123b302],
7	*	CD	NUMBER	*	num	6	SENT_104	[p8l178t261r238b300],
8	I	PRP	O	I	dep	6	SENT_104	[p8l440t276r560b326],
9	:	:	O	:	_	0	SENT_104	[p8l440t276r560b326],
10	III	CD	NUMBER	iii	dep	6	SENT_104	[p8l440t276r560b326],
11	:	:	O	:	_	0	SENT_104	[p8l732t277r750b326],
12	:	:	O	:	_	0	SENT_104	[p8l975t278r993b325],
13	II	CD	NUMBER	ii	num	14	SENT_104	[p8l1742t275r1785b293],
14	g	NN	O	g	dep	5	SENT_104	[p8l22t312r58b374],
15	g	NN	O	g	dep	14	SENT_104	[p8l94t308r123b375],
16	:	:	O	:	_	0	SENT_104	[p8l493t309r536b358],
17	l	NN	O	l	dep	5	SENT_104	[p8l493t309r536b358],
18	I	PRP	O	I	dep	17	SENT_104	[p8l1519t340r1537b357],
19	I	PRP	O	I	dep	1	SENT_104	[p8l1757t309r1774b327],
20	I	PRP	O	I	dep	19	SENT_104	[p8l1994t309r2012b327],
21	C	NN	O	c	nn	23	SENT_104	[p8l28t378r58b400],
22	(	NN	O	(	nn	23	SENT_104	[p8l94t381r123b407],
23	D	NN	O	d	dep	1	SENT_104	[p8l94t381r123b407],
24	II	CD	NUMBER	ii	num	25	SENT_104	[p8l718t373r763b390],
25	IIII	NN	O	iiii	dep	23	SENT_104	[p8l1480t371r1574b389],
26	.	.	O	.	_	0	SENT_104	[p8l1716t372r1814b389],

1	—	NN	O	—	_	0	SENT_105	[p8l1716t372r1814b389],
2	.	.	O	.	_	0	SENT_105	[p8l1716t372r1814b389],

1	I-I	NN	O	i-i	_	0	SENT_106	[p8l1716t372r1814b389],
2	8	CD	NUMBER	8	num	3	SENT_106	[p8l28t406r58b458],
3	3	CD	NUMBER	3	dep	1	SENT_106	[p8l85t410r132b452],
4	,	,	O	,	_	0	SENT_106	[p8l177t424r238b463],
5	*	CD	NUMBER	*	appos	3	SENT_106	[p8l177t424r238b463],
6	.	.	O	.	_	0	SENT_106	[p8l419t404r583b455],

1	—	NN	O	—	_	0	SENT_107	[p8l419t404r583b455],
2	.	.	O	.	_	0	SENT_107	[p8l419t404r583b455],

1	I-I-I-I	NN	O	i-i-i-i	nn	3	SENT_108	[p8l419t404r583b455],
2	I	NN	O	i	nn	3	SENT_108	[p8l732t435r750b453],
3	I	NN	O	i	_	0	SENT_108	[p8l975t404r993b422],
4	II	CD	NUMBER	ii	dep	3	SENT_108	[p8l1470t405r1587b454],
5	:	:	O	:	_	0	SENT_108	[p8l1470t405r1587b454],
6	II	CD	NUMBER	ii	num	7	SENT_108	[p8l1470t405r1587b454],
7	II	CD	NUMBER	ii	dep	3	SENT_108	[p8l1742t436r1785b454],
8	8	CD	NUMBER	8	num	9	SENT_108	[p8l28t463r58b517],
9	‘	NN	O	‘	dep	7	SENT_108	[p8l94t474r123b499],
10	-5	CD	NUMBER	-5	dep	7	SENT_108	[p8l94t474r123b499],
11	.	.	O	.	_	0	SENT_108	[p8l1443t468r1610b486],

1	—	NN	O	—	_	0	SENT_109	[p8l1443t468r1610b486],
2	.	.	O	.	_	0	SENT_109	[p8l1443t468r1610b486],

1	I-I-I-I	NN	O	i-i-i-i	nn	4	SENT_110	[p8l1443t468r1610b486],
2	I	CD	NUMBER	i	num	4	SENT_110	[p8l1757t468r1774b486],
3	o	NN	O	o	nn	4	SENT_110	[p8l28t521r58b544],
4	E	NN	O	e	_	0	SENT_110	[p8l94t504r123b572],
5	:	:	O	:	_	0	SENT_110	[p8l493t500r511b550],
6	;	:	O	;	_	0	SENT_110	[p8l1507t500r1550b549],
7	*	CD	NUMBER	*	dep	21	SENT_110	[p8l1507t500r1550b549],
8	I	PRP	O	I	dep	7	SENT_110	[p8l1757t532r1774b550],
9	3	CD	PERCENT	3	num	10	SENT_110	[p8l25t562r132b643],
10	%	NN	PERCENT	%	dep	8	SENT_110	[p8l25t562r132b643],
11	25	CD	NUMBER	25	number	12	SENT_110	[p8l176t584r238b623],
12	III	CD	NUMBER	iii	num	10	SENT_110	[p8l456t562r549b612],
13	:	:	O	:	_	0	SENT_110	[p8l456t562r549b612],
14	III	CD	NUMBER	iii	dep	8	SENT_110	[p8l1480t564r1574b614],
15	:	:	O	:	_	0	SENT_110	[p8l1480t564r1574b614],
16	"	``	O	"	punct	19	SENT_110	[p8l1732t564r1799b582],
17	'	''	O	'	_	0	SENT_110	[p8l1732t564r1799b582],
18	Q	NNP	O	Q	nn	19	SENT_110	[p8l19t638r58b668],
19	C	NNP	O	C	dep	14	SENT_110	[p8l94t667r123b690],
20	I-I-I	NNP	O	I-I-I	nn	21	SENT_110	[p8l467t629r536b677],
21	I-I-I	NNP	O	I-I-I	dep	4	SENT_110	[p8l1495t627r1562b678],
22	I	PRP	O	I	dep	21	SENT_110	[p8l1757t628r1774b646],

1	O	NN	O	o	_	0	SENT_111	[p8l209t742r238b781],
2	I	CD	NUMBER	i	dep	1	SENT_111	[p8l493t724r511b742],
3	I	PRP	O	I	dep	1	SENT_111	[p8l1519t723r1537b741],

1	wt/wt	NN	O	wt/wt	nn	2	SENT_112	[p8l432t818r568b866],
2	wt/mut	NN	O	wt/mut	_	0	SENT_112	[p8l651t818r826b866],
3	mut/mut	JJ	O	mut/mut	amod	4	SENT_112	[p8l874t818r1084b866],
4	wt/wt	NN	O	wt/wt	dep	2	SENT_112	[p8l1440t818r1576b866],
5	wt/mut	NN	O	wt/mut	nn	6	SENT_112	[p8l1659t818r1834b866],
6	mut/mut	NN	O	mut/mut	dep	2	SENT_112	[p8l1882t818r2092b866],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_113	[p8l36t946r260b985],
2	genotype	NN	O	genotype	_	0	SENT_113	[p8l277t947r502b994],

1	-	:	O	-	_	0	SENT_114	[p8l145t1004r238b1043],
2	*	NN	O	*	nsubj	18	SENT_114	[p8l145t1004r238b1043],
3	I	PRP	O	I	dep	2	SENT_114	[p8l495t1049r513b1067],
4	I	PRP	O	I	dep	2	SENT_114	[p8l734t1048r752b1066],
5	III	CD	NUMBER	iii	rcmod	4	SENT_114	[p8l1493t1048r1560b1065],
6	I	PRP	O	I	dep	5	SENT_114	[p8l1758t1049r1775b1067],
7	c	SYM	O	c	dep	5	SENT_114	[p8l28t1106r58b1129],
8	-	:	O	-	_	0	SENT_114	[p8l85t1071r132b1138],
9	*	NN	O	*	nn	10	SENT_114	[p8l85t1071r132b1138],
10	I	NN	O	i	dep	5	SENT_114	[p8l480t1081r525b1130],
11	:	:	O	:	_	0	SENT_114	[p8l480t1081r525b1130],
12	I	PRP	O	I	dep	5	SENT_114	[p8l734t1081r752b1129],
13	'	''	O	'	_	0	SENT_114	[p8l1467t1081r1585b1130],
14	I	PRP	O	I	dep	5	SENT_114	[p8l1467t1081r1585b1130],
15	:	:	O	:	_	0	SENT_114	[p8l1467t1081r1585b1130],
16	:	:	O	:	_	0	SENT_114	[p8l1467t1081r1585b1130],
17	'	''	O	'	_	0	SENT_114	[p8l1467t1081r1585b1130],
18	I	PRP	O	I	_	0	SENT_114	[p8l1758t1081r1775b1133],
19	/	:	PERCENT	/	punct	20	SENT_114	[p8l19t1134r58b1171],
20	%	NN	PERCENT	%	dep	18	SENT_114	[p8l19t1134r58b1171],
21	*	SYM	O	*	dep	24	SENT_114	[p8l19t1134r58b1171],
22	-	:	O	-	_	0	SENT_114	[p8l87t1142r123b1185],
23	IE	JJ	O	ie	amod	24	SENT_114	[p8l87t1142r123b1185],
24	w	NN	O	w	dep	18	SENT_114	[p8l178t1161r238b1200],
25	-	:	O	-	_	0	SENT_114	[p8l178t1161r238b1200],
26	*	CD	NUMBER	*	num	27	SENT_114	[p8l178t1161r238b1200],
27	III	CD	NUMBER	iii	dep	30	SENT_114	[p8l470t1144r539b1162],
28	I	PRP	O	I	dep	27	SENT_114	[p8l974t1145r992b1163],
29	II	CD	NUMBER	ii	dep	30	SENT_114	[p8l1505t1145r1548b1163],
30	I	PRP	O	I	dep	35	SENT_114	[p8l1758t1145r1775b1163],
31	E	NN	O	e	nn	34	SENT_114	[p8l22t1175r58b1236],
32	8	CD	NUMBER	8	num	34	SENT_114	[p8l94t1191r123b1243],
33	II-I-IIII	NN	O	ii-i-iiii	nn	34	SENT_114	[p8l433t1175r577b1225],
34	I	NN	O	i	dep	30	SENT_114	[p8l734t1204r752b1222],
35	II	CD	NUMBER	ii	dep	24	SENT_114	[p8l1505t1175r1548b1226],
36	.	.	O	.	_	0	SENT_114	[p8l1505t1175r1548b1226],

1	I	PRP	O	I	nsubj	2	SENT_115	[p8l1758t1176r1775b1194],
2	ég	VBP	O	ég	_	0	SENT_115	[p8l28t1261r132b1341],
3	7	CD	NUMBER	7	number	4	SENT_115	[p8l177t1324r238b1363],
4	*	CD	NUMBER	*	dobj	2	SENT_115	[p8l177t1324r238b1363],
5	.	.	O	.	_	0	SENT_115	[p8l446t1272r557b1320],

1	—	NN	O	—	_	0	SENT_116	[p8l446t1272r557b1320],
2	.	.	O	.	_	0	SENT_116	[p8l446t1272r557b1320],

1	I-I	NN	O	i-i	_	0	SENT_117	[p8l446t1272r557b1320],
2	.	.	O	.	_	0	SENT_117	[p8l446t1272r557b1320],

1	—	NN	O	—	_	0	SENT_118	[p8l446t1272r557b1320],
2	.	.	O	.	_	0	SENT_118	[p8l446t1272r557b1320],

1	-	:	O	-	_	0	SENT_119	[p8l446t1272r557b1320],
2	I	PRP	O	I	_	0	SENT_119	[p8l446t1272r557b1320],
3	.	.	O	.	_	0	SENT_119	[p8l691t1272r790b1321],

1	—	NN	O	—	_	0	SENT_120	[p8l691t1272r790b1321],
2	.	.	O	.	_	0	SENT_120	[p8l691t1272r790b1321],

1	I	PRP	O	I	_	0	SENT_121	[p8l691t1272r790b1321],
2	.	.	O	.	_	0	SENT_121	[p8l691t1272r790b1321],

1	—	NN	O	—	_	0	SENT_122	[p8l691t1272r790b1321],
2	.	.	O	.	_	0	SENT_122	[p8l691t1272r790b1321],

1	-	:	O	-	_	0	SENT_123	[p8l691t1272r790b1321],
2	III	CD	NUMBER	iii	_	0	SENT_123	[p8l1493t1272r1560b1290],
3	.	.	O	.	_	0	SENT_123	[p8l1711t1271r1813b1289],

1	—	NN	O	—	_	0	SENT_124	[p8l1711t1271r1813b1289],
2	.	.	O	.	_	0	SENT_124	[p8l1711t1271r1813b1289],

1	I-I	NN	O	i-i	nn	3	SENT_125	[p8l1711t1271r1813b1289],
2	I	NN	O	i	nn	3	SENT_125	[p8l1994t1272r2012b1290],
3	C	NN	O	c	dep	7	SENT_125	[p8l28t1347r58b1369],
4	III	CD	NUMBER	iii	dep	3	SENT_125	[p8l470t1335r539b1353],
5	II	CD	NUMBER	ii	num	6	SENT_125	[p8l721t1337r766b1355],
6	IIII	NN	O	iiii	dep	7	SENT_125	[p8l1480t1335r1573b1353],
7	I	PRP	O	I	dep	16	SENT_125	[p8l1758t1335r1775b1353],
8	I	PRP	O	I	dep	7	SENT_125	[p8l1995t1367r2012b1385],
9	8	CD	PERCENT	8	number	10	SENT_125	[p8l28t1375r58b1427],
10	%	NN	PERCENT	%	amod	8	SENT_125	[p8l94t1358r123b1456],
11	:	:	O	:	_	0	SENT_125	[p8l495t1399r513b1449],
12	I-I-I	NN	O	i-i-i	dep	8	SENT_125	[p8l1493t1400r1560b1450],
13	no	DT	O	no	det	14	SENT_125	[p8l25t1445r68b1472],
14	(	NN	O	(	dep	12	SENT_125	[p8l94t1461r123b1486],
15	5	CD	NUMBER	5	num	16	SENT_125	[p8l94t1461r123b1486],
16	III	CD	NUMBER	iii	_	0	SENT_125	[p8l470t1464r539b1482],
17	I	PRP	O	I	nsubj	18	SENT_125	[p8l974t1463r992b1481],
18	IIII	VBP	O	iiii	rcmod	16	SENT_125	[p8l1480t1463r1573b1481],
19	III	CD	NUMBER	iii	num	22	SENT_125	[p8l1733t1463r1800b1481],
20	E	NN	O	e	nn	22	SENT_125	[p8l28t1477r58b1516],
21	—	NN	O	—	nn	22	SENT_125	[p8l85t1492r123b1497],
22	C	NN	O	c	nsubj	24	SENT_125	[p8l176t1483r238b1523],
23	*	CD	NUMBER	*	number	24	SENT_125	[p8l176t1483r238b1523],
24	III	CD	NUMBER	iii	xcomp	18	SENT_125	[p8l470t1495r539b1513],
25	I	PRP	O	I	nsubj	26	SENT_125	[p8l734t1495r752b1513],
26	IIII	VBP	O	iiii	rcmod	24	SENT_125	[p8l1480t1495r1573b1513],
27	Q	NNP	O	Q	dobj	26	SENT_125	[p8l19t1522r58b1552],
28	2	LS	NUMBER	2	dep	27	SENT_125	[p8l94t1503r132b1573],
29	-	:	O	-	_	0	SENT_125	[p8l94t1503r132b1573],
30	I	PRP	O	I	dobj	26	SENT_125	[p8l470t1528r539b1577],
31	:	:	O	:	_	0	SENT_125	[p8l470t1528r539b1577],
32	l	NN	O	l	nn	33	SENT_125	[p8l470t1528r539b1577],
33	I	NN	O	i	dep	16	SENT_125	[p8l734t1527r752b1545],
34	II	CD	NUMBER	ii	num	36	SENT_125	[p8l1467t1528r1585b1576],
35	:	:	O	:	_	0	SENT_125	[p8l1467t1528r1585b1576],
36	II	CD	NUMBER	ii	dep	33	SENT_125	[p8l1467t1528r1585b1576],

1	O	NN	O	o	_	0	SENT_126	[p8l209t1641r238b1681],
2	I	CD	NUMBER	i	dep	1	SENT_126	[p8l495t1622r513b1640],
3	I	PRP	O	I	dep	1	SENT_126	[p8l1517t1623r1535b1641],

1	wt/wt	NN	O	wt/wt	nn	2	SENT_127	[p8l432t1718r568b1765],
2	wt/mut	NN	O	wt/mut	_	0	SENT_127	[p8l651t1718r826b1765],
3	mut/mut	JJ	O	mut/mut	amod	4	SENT_127	[p8l874t1718r1084b1765],
4	wt/wt	NN	O	wt/wt	dep	2	SENT_127	[p8l1440t1718r1576b1765],
5	wt/mut	NN	O	wt/mut	nn	6	SENT_127	[p8l1659t1718r1834b1765],
6	mut/mut	NN	O	mut/mut	dep	2	SENT_127	[p8l1882t1718r2092b1765],

1	CYP3A4/3A5	NN	O	cyp3a4/3a5	nn	2	SENT_128	[p8l36t1843r351b1891],
2	genotype	NN	O	genotype	_	0	SENT_128	[p8l367t1844r592b1891],

1	100	CD	NUMBER	100	_	0	SENT_129	[p8l145t1901r238b1940],
2	I	PRP	O	I	dep	1	SENT_129	[p8l495t1946r513b1963],
3	I	PRP	O	I	dep	1	SENT_129	[p8l734t1945r752b1962],
4	"	``	O	"	punct	3	SENT_129	[p8l1493t1941r1560b1959],
5	I	PRP	O	I	dep	3	SENT_129	[p8l1493t1941r1560b1959],

1	C	NN	O	c	_	0	SENT_130	[p8l28t2002r58b2025],
2	*	CD	NUMBER	*	num	1	SENT_130	[p8l85t1968r132b2034],
3	I	PRP	O	I	nsubj	4	SENT_130	[p8l734t2008r752b2026],
4	II-I-II	VBP	O	ii-i-ii	rcmod	1	SENT_130	[p8l1467t1973r1585b2023],
5	I	PRP	O	I	nsubj	6	SENT_130	[p8l1758t2004r1775b2022],
6	_	VBP	O	_	ccomp	4	SENT_130	[p8l19t2031r58b2068],
7	Q	NNP	O	Q	dobj	6	SENT_130	[p8l19t2031r58b2068],
8	-	:	O	-	_	0	SENT_130	[p8l87t2038r123b2082],
9	E	NN	O	e	dep	1	SENT_130	[p8l87t2038r123b2082],
10	’	CD	NUMBER	’	num	9	SENT_130	[p8l87t2038r123b2082],
11	*	NN	O	*	dep	9	SENT_130	[p8l178t2058r238b2096],
12	II	CD	NUMBER	ii	num	11	SENT_130	[p8l480t2042r525b2060],
13	I	PRP	O	I	dep	9	SENT_130	[p8l734t2042r752b2060],
14	II	CD	NUMBER	ii	dep	13	SENT_130	[p8l1505t2035r1548b2085],
15	.	.	O	.	_	0	SENT_130	[p8l1505t2035r1548b2085],

1	I	PRP	O	I	nsubj	2	SENT_131	[p8l1758t2036r1775b2054],
2	E	NN	O	e	_	0	SENT_131	[p8l22t2072r58b2133],
3	8	CD	NUMBER	8	num	4	SENT_131	[p8l94t2088r123b2140],
4	IIIIIIIII	NN	O	iiiiiiiii	dobj	2	SENT_131	[p8l433t2072r577b2122],
5	.	.	O	.	_	0	SENT_131	[p8l685t2072r796b2090],

1	—	NN	O	—	_	0	SENT_132	[p8l685t2072r796b2090],
2	.	.	O	.	_	0	SENT_132	[p8l685t2072r796b2090],

1	I-I	NN	O	i-i	_	0	SENT_133	[p8l685t2072r796b2090],
2	I	CD	NUMBER	i	num	3	SENT_133	[p8l1517t2101r1535b2119],
3	ég	NN	O	ég	dep	1	SENT_133	[p8l28t2157r132b2238],
4	;	:	O	;	_	0	SENT_133	[p8l28t2157r132b2238],
5	l6	NN	O	l6	dep	3	SENT_133	[p8l177t2220r238b2260],
6	*	CD	NUMBER	*	num	7	SENT_133	[p8l177t2220r238b2260],
7	_	NN	O	_	dep	5	SENT_133	[p8l446t2168r557b2217],
8	...	:	O	...	_	0	SENT_133	[p8l446t2168r557b2217],
9	_	SYM	O	_	dep	11	SENT_133	[p8l446t2168r557b2217],
10	-	:	O	-	_	0	SENT_133	[p8l446t2168r557b2217],
11	I	PRP	O	I	dep	5	SENT_133	[p8l446t2168r557b2217],
12	III	CD	NUMBER	iii	num	13	SENT_133	[p8l1493t2165r1560b2182],
13	II	CD	NUMBER	ii	dep	3	SENT_133	[p8l1743t2165r1786b2182],
14	E	NN	O	e	prep	13	SENT_133	[p8l28t2243r58b2324],
15	E	NN	O	e	dep	14	SENT_133	[p8l94t2255r123b2352],
16	:	:	O	:	_	0	SENT_133	[p8l495t2296r513b2346],
17	I-I	NN	O	i-i	dep	14	SENT_133	[p8l1505t2294r1548b2342],
18	:	:	O	:	_	0	SENT_133	[p8l1758t2260r1775b2343],
19	'	''	O	'	_	0	SENT_133	[p8l25t2342r68b2369],
20	oo	NN	O	oo	nn	21	SENT_133	[p8l25t2342r68b2369],
21	(	NN	O	(	dep	1	SENT_133	[p8l94t2358r123b2383],
22	5	CD	NUMBER	5	num	23	SENT_133	[p8l94t2358r123b2383],
23	I.	NN	O	i.	dep	21	SENT_133	[p8l456t2360r549b2378],
24	.	.	O	.	_	0	SENT_133	[p8l456t2360r549b2378],

1	.	.	O	.	_	0	SENT_134	[p8l456t2360r549b2378],

1	IIIIII	CD	NUMBER	iiiiii	number	2	SENT_135	[p8l1458t2356r1601b2374],
2	3	CD	NUMBER	3	nsubj	6	SENT_135	[p8l29t2373r58b2396],
3	—	NN	O	—	dep	2	SENT_135	[p8l85t2388r123b2393],
4	III	CD	NUMBER	iii	num	3	SENT_135	[p8l470t2391r539b2409],
5	I	PRP	O	I	dep	2	SENT_135	[p8l734t2391r752b2409],
6	IIII	VBP	O	iiii	_	0	SENT_135	[p8l1480t2391r1573b2409],
7	5	CD	NUMBER	5	num	8	SENT_135	[p8l19t2399r58b2449],
8	p	NN	O	p	dobj	6	SENT_135	[p8l84t2399r132b2483],
9	5	CD	NUMBER	5	number	10	SENT_135	[p8l84t2399r132b2483],
10	*	CD	NUMBER	*	num	12	SENT_135	[p8l84t2399r132b2483],
11	*	NN	O	*	nn	12	SENT_135	[p8l176t2380r238b2419],
12	I	NN	O	i	dep	8	SENT_135	[p8l470t2425r539b2473],
13	:	:	O	:	_	0	SENT_135	[p8l470t2425r539b2473],
14	I	PRP	O	I	dep	8	SENT_135	[p8l470t2425r539b2473],
15	I	PRP	O	I	dep	14	SENT_135	[p8l974t2424r992b2442],
16	@	SYM	O	@	dep	18	SENT_135	[p8l1505t2419r1548b2470],
17	5	CD	NUMBER	5	num	18	SENT_135	[p8l1505t2419r1548b2470],
18	*	NN	O	*	dep	19	SENT_135	[p8l1505t2419r1548b2470],
19	II	CD	NUMBER	ii	dep	6	SENT_135	[p8l1743t2452r1786b2470],

1	o	NN	O	o	_	0	SENT_136	[p8l209t2538r238b2577],
2	I	CD	NUMBER	i	dep	1	SENT_136	[p8l495t2518r513b2536],
3	I	PRP	O	I	dep	1	SENT_136	[p8l1517t2520r1535b2538],

1	wt	JJ	O	wt	amod	3	SENT_137	[p8l473t2617r526b2653],
2	het	NN	O	het	nn	3	SENT_137	[p8l704t2614r777b2653],
3	hom	NN	O	hom	_	0	SENT_137	[p8l929t2614r1026b2653],
4	wt	JJ	O	wt	amod	6	SENT_137	[p8l1481t2617r1534b2653],
5	het	NN	O	het	nn	6	SENT_137	[p8l1711t2614r1785b2653],
6	hom	NN	O	hom	dep	3	SENT_137	[p8l1937t2614r2034b2653],

1	Figure	NNP	O	Figure	_	0	SENT_138	[p8l12t2743r150b2792],
2	1	CD	NUMBER	1	num	1	SENT_138	[p8l172t2744r213b2781],
3	:	:	O	:	_	0	SENT_138	[p8l172t2744r213b2781],
4	Concentrations	NNS	O	concentration	dep	1	SENT_138	[p8l236t2743r609b2782],
5	of	IN	O	of	_	0	SENT_138	[p8l628t2743r674b2782],
6	nelfinavir	NN	O	nelfinavir	prep_of	4	SENT_138	[p8l692t2743r913b2782],
7	and	CC	O	and	_	0	SENT_138	[p8l931t2743r1016b2782],
8	efavirenz	NN	O	efavirenz	prep_of	4	SENT_138	[p8l1036t2743r1252b2782],
9	in	IN	O	in	_	0	SENT_138	[p8l1272t2743r1311b2781],
10	plasma	NN	O	plasma	prep_in	4	SENT_138	[p8l1333t2743r1504b2791],
11	according	VBG	O	accord	_	0	SENT_138	[p8l1524t2743r1765b2791],
12	to	TO	O	to	prepc_according_to	10	SENT_138	[p8l1781t2744r1830b2782],
13	allelic	JJ	O	allelic	amod	14	SENT_138	[p8l1849t2743r1992b2782],
14	variations	NNS	O	variation	pobj	10	SENT_138	[p8l8t2811r247b2851],
15	in	IN	O	in	_	0	SENT_138	[p8l268t2811r307b2850],
16	MDR1	NN	O	mdr1	nn	20	SENT_138	[p8l327t2812r490b2859],
17	,	,	O	,	_	0	SENT_138	[p8l327t2812r490b2859],
18	CYP2D6	NN	O	cyp2d6	dep	20	SENT_138	[p8l513t2812r720b2859],
19	,	,	O	,	_	0	SENT_138	[p8l513t2812r720b2859],
20	CYP2C19	NN	O	cyp2c19	prep_in	14	SENT_138	[p8l742t2812r980b2859],
21	,	,	O	,	_	0	SENT_138	[p8l742t2812r980b2859],
22	and	CC	O	and	_	0	SENT_138	[p8l1002t2812r1087b2851],
23	CYP3A4/3A5	NN	O	cyp3a4/3a5	nn	24	SENT_138	[p8l1108t2812r1423b2860],
24	mut	NN	O	mut	conj_and	20	SENT_138	[p8l11t2877r355b2920],
25	=	JJ	O	=	dep	4	SENT_138	[p8l11t2877r355b2920],
26	inactivating	VBG	O	inactivate	partmod	25	SENT_138	[p8l11t2877r355b2920],
27	alleles	NNS	O	allele	dobj	26	SENT_138	[p8l371t2877r505b2911],
28	*	CD	NUMBER	*	number	29	SENT_138	[p8l527t2877r589b2917],
29	3	CD	NUMBER	3	dep	27	SENT_138	[p8l527t2877r589b2917],
30	,	,	O	,	_	0	SENT_138	[p8l527t2877r589b2917],
31	*	CD	NUMBER	*	number	32	SENT_138	[p8l612t2877r675b2917],
32	4	CD	NUMBER	4	dobj	26	SENT_138	[p8l612t2877r675b2917],
33	,	,	O	,	_	0	SENT_138	[p8l612t2877r675b2917],
34	or	CC	O	or	_	0	SENT_138	[p8l695t2885r735b2911],
35	*	NN	O	*	nn	38	SENT_138	[p8l754t2877r806b2912],
36	6	CD	NUMBER	6	num	38	SENT_138	[p8l754t2877r806b2912],
37	(	NN	O	(	nn	38	SENT_138	[p8l822t2877r1026b2919],
38	CYP2D6	NN	O	cyp2d6	conj_or	27	SENT_138	[p8l822t2877r1026b2919],
39	)	NN	O	)	dep	38	SENT_138	[p8l822t2877r1026b2919],
40	,	,	O	,	_	0	SENT_138	[p8l822t2877r1026b2919],
41	or	CC	O	or	_	0	SENT_138	[p8l1046t2885r1086b2911],
42	*	NN	O	*	conj_or	27	SENT_138	[p8l1105t2877r1156b2911],
43	2	CD	NUMBER	2	number	44	SENT_138	[p8l1105t2877r1156b2911],
44	(	CD	NUMBER	(	num	46	SENT_138	[p8l1174t2877r1403b2919],
45	CYP2C19	NN	O	cyp2c19	nn	46	SENT_138	[p8l1174t2877r1403b2919],
46	)	NN	O	)	dep	42	SENT_138	[p8l1174t2877r1403b2919],
47	.	.	O	.	_	0	SENT_138	[p8l1174t2877r1403b2919],

1	het	NN	O	het	_	0	SENT_139	[p8l1424t2877r1768b2920],
2	=	JJ	O	=	amod	3	SENT_139	[p8l1424t2877r1768b2920],
3	heterozyous	NNS	O	heterozyous	dep	1	SENT_139	[p8l1424t2877r1768b2920],
4	at	IN	O	at	prep	3	SENT_139	[p8l1786t2879r1825b2911],
5	either	CC	O	either	dep	12	SENT_139	[p8l1841t2877r1960b2911],
6	CYP3A4	NN	O	cyp3a4	nn	8	SENT_139	[p8l10t2931r256b2966],
7	*	CD	NUMBER	*	num	8	SENT_139	[p8l10t2931r256b2966],
8	1B	NN	O	1b	dep	5	SENT_139	[p8l10t2931r256b2966],
9	or	CC	O	or	_	0	SENT_139	[p8l273t2939r313b2965],
10	CYP3A5	NN	O	cyp3a5	nn	11	SENT_139	[p8l328t2931r556b2971],
11	*	NN	O	*	dep	5	SENT_139	[p8l328t2931r556b2971],
12	1	CD	NUMBER	1	dep	4	SENT_139	[p8l328t2931r556b2971],
13	;	:	O	;	_	0	SENT_139	[p8l328t2931r556b2971],
14	hom	NN	O	hom	dep	12	SENT_139	[p8l578t2931r952b2974],
15	=	JJ	O	=	amod	16	SENT_139	[p8l578t2931r952b2974],
16	homozygous	JJ	O	homozygous	amod	14	SENT_139	[p8l578t2931r952b2974],
17	at	IN	O	at	prep	4	SENT_139	[p8l970t2933r1010b2965],
18	either	CC	O	either	dep	17	SENT_139	[p8l1026t2931r1145b2965],
19	CYP3A4	NN	O	cyp3a4	nn	21	SENT_139	[p8l1161t2931r1406b2966],
20	*	CD	NUMBER	*	num	21	SENT_139	[p8l1161t2931r1406b2966],
21	1B	NN	O	1b	conj	17	SENT_139	[p8l1161t2931r1406b2966],
22	or	CC	O	or	_	0	SENT_139	[p8l1423t2939r1463b2965],
23	CYP3A5	NN	O	cyp3a5	nn	24	SENT_139	[p8l1479t2931r1707b2966],
24	*	NN	O	*	conj_or	21	SENT_139	[p8l1479t2931r1707b2966],
25	1	CD	NUMBER	1	dep	3	SENT_139	[p8l1479t2931r1707b2966],
26	.	.	O	.	_	0	SENT_139	[p8l1479t2931r1707b2966],

1	Results	NNS	O	result	nsubjpass	21	SENT_140	[p8l1729t2931r1882b2965],
2	from	IN	O	from	_	0	SENT_140	[p8l1899t2931r1991b2965],
3	one	CD	NUMBER	one	num	4	SENT_140	[p8l2010t2939r2084b2965],
4	patient	NN	O	patient	prep_from	1	SENT_140	[p8l11t2987r154b3029],
5	with	IN	O	with	_	0	SENT_140	[p8l169t2987r250b3021],
6	the	DT	O	the	det	14	SENT_140	[p8l267t2987r333b3021],
7	CYP2D6	NN	O	cyp2d6	nn	14	SENT_140	[p8l352t2987r516b3021],
8	ultrarapid	NN	O	ultrarapid	nn	14	SENT_140	[p8l533t2987r727b3029],
9	metaboliser	NN	O	metaboliser	nn	14	SENT_140	[p8l747t2987r993b3021],
10	genotype	NN	O	genotype	nn	14	SENT_140	[p8l1007t2989r1194b3030],
11	(	CD	NUMBER	(	num	14	SENT_140	[p8l1213t2987r1377b3029],
12	plasma	NN	O	plasma	nn	14	SENT_140	[p8l1213t2987r1377b3029],
13	efavirenz	NN	O	efavirenz	nn	14	SENT_140	[p8l1395t2986r1580b3021],
14	concentration	NN	O	concentration	prep_with	4	SENT_140	[p8l1596t2987r1878b3021],
15	at	IN	O	at	_	0	SENT_140	[p8l1897t2989r1937b3021],
16	15th	JJ	ORDINAL	15th	amod	18	SENT_140	[p8l1954t2987r2047b3021],
17	percentile	NN	O	percentile	nn	18	SENT_140	[p8l11t3040r227b3082],
18	)	NN	O	)	prep_at	14	SENT_140	[p8l11t3040r227b3082],
19	are	VBP	O	be	auxpass	21	SENT_140	[p8l245t3048r309b3074],
20	not	RB	O	not	neg	21	SENT_140	[p8l328t3042r393b3074],
21	shown	VBN	O	show	_	0	SENT_140	[p8l409t3040r539b3074],
22	(	CD	NUMBER	(	num	24	SENT_140	[p8l558t3040r762b3082],
23	CYP2D6	NN	O	cyp2d6	nn	24	SENT_140	[p8l558t3040r762b3082],
24	)	NN	O	)	dobj	21	SENT_140	[p8l558t3040r762b3082],
25	.	.	O	.	_	0	SENT_140	[p8l558t3040r762b3082],

1	Plasma	NN	O	plasma	nn	3	SENT_141	[p8l783t3040r933b3074],
2	efavirenz	NN	O	efavirenz	nn	3	SENT_141	[p8l952t3040r1136b3074],
3	concentration	NN	O	concentration	nsubj	13	SENT_141	[p8l1152t3040r1434b3074],
4	at	IN	O	at	_	0	SENT_141	[p8l1453t3042r1493b3074],
5	10th	JJ	ORDINAL	10th	amod	6	SENT_141	[p8l1511t3040r1603b3074],
6	percentile	NN	O	percentile	prep_at	3	SENT_141	[p8l1624t3040r1838b3082],
7	,	,	O	,	_	0	SENT_141	[p8l1624t3040r1838b3082],
8	median	NN	O	median	prep_at	3	SENT_141	[p8l1860t3040r2022b3080],
9	,	,	O	,	_	0	SENT_141	[p8l1860t3040r2022b3080],
10	and	CC	O	and	_	0	SENT_141	[p8l2042t3040r2115b3074],
11	90th	JJ	ORDINAL	90th	amod	12	SENT_141	[p8l10t3094r104b3128],
12	percentile	NN	O	percentile	prep_at	3	SENT_141	[p8l125t3094r326b3136],
13	correspond	VBP	O	correspond	_	0	SENT_141	[p8l344t3094r575b3136],
14	to	TO	O	to	_	0	SENT_141	[p8l592t3096r632b3128],
15	1213	CD	DATE	1213	num	16	SENT_141	[p8l651t3094r761b3128],
16	ng/mL	NN	O	ng/ml	prep_to	13	SENT_141	[p8l781t3094r927b3137],
17	,	,	O	,	_	0	SENT_141	[p8l781t3094r927b3137],
18	2245	CD	DATE	2245	num	19	SENT_141	[p8l947t3094r1058b3128],
19	ng/mL	NN	O	ng/ml	prep_to	13	SENT_141	[p8l1078t3094r1224b3137],
20	,	,	O	,	_	0	SENT_141	[p8l1078t3094r1224b3137],
21	and	CC	O	and	_	0	SENT_141	[p8l1244t3094r1318b3128],
22	4491	CD	DATE	4491	num	23	SENT_141	[p8l1336t3094r1449b3128],
23	ng/mL	NN	O	ng/ml	prep_to	13	SENT_141	[p8l1468t3094r1603b3137],
24	(	CD	NUMBER	(	num	26	SENT_141	[p8l1620t3094r1723b3136],
25	14-h	JJ	O	14-h	amod	26	SENT_141	[p8l1620t3094r1723b3136],
26	post	NN	O	post	dep	23	SENT_141	[p8l1744t3096r1833b3136],
27	dose	NN	O	dose	nn	28	SENT_141	[p8l1850t3094r1976b3136],
28	)	NN	O	)	dep	26	SENT_141	[p8l1850t3094r1976b3136],
29	,	,	O	,	_	0	SENT_141	[p8l1850t3094r1976b3136],
30	respectively	RB	O	respectively	advmod	26	SENT_141	[p8l11t3150r266b3192],
31	.	.	O	.	_	0	SENT_141	[p8l11t3150r266b3192],

1	Plasma	NN	O	plasma	nn	4	SENT_142	[p8l287t3150r436b3184],
2	nelfinavir	NN	O	nelfinavir	nn	4	SENT_142	[p8l456t3149r643b3184],
3	trough	NN	O	trough	nn	4	SENT_142	[p8l657t3150r787b3193],
4	concentrations	NNS	O	concentration	nsubj	13	SENT_142	[p8l806t3150r1114b3184],
5	at	IN	O	at	_	0	SENT_142	[p8l1131t3152r1171b3184],
6	10th	JJ	ORDINAL	10th	prep_at	4	SENT_142	[p8l1189t3149r1295b3190],
7	,	,	O	,	_	0	SENT_142	[p8l1189t3149r1295b3190],
8	50th	JJ	ORDINAL	50th	prep_at	4	SENT_142	[p8l1316t3149r1423b3190],
9	,	,	O	,	_	0	SENT_142	[p8l1316t3149r1423b3190],
10	and	CC	ORDINAL	and	_	0	SENT_142	[p8l1443t3150r1517b3184],
11	90th	JJ	ORDINAL	90th	amod	12	SENT_142	[p8l1536t3149r1630b3184],
12	percentiles	NNS	O	percentile	prep_at	4	SENT_142	[p8l1651t3150r1878b3192],
13	correspond	VBP	O	correspond	_	0	SENT_142	[p8l1895t3150r2126b3192],
14	to	TO	O	to	_	0	SENT_142	[p8l8t3205r47b3237],
15	380	CD	NUMBER	380	num	16	SENT_142	[p8l65t3203r148b3237],
16	ng/mL	NN	O	ng/ml	prep_to	13	SENT_142	[p8l168t3203r314b3246],
17	,	,	O	,	_	0	SENT_142	[p8l168t3203r314b3246],
18	974	CD	NUMBER	974	num	19	SENT_142	[p8l334t3203r417b3237],
19	ng/mL	NN	O	ng/ml	prep_to	13	SENT_142	[p8l436t3203r582b3246],
20	,	,	O	,	_	0	SENT_142	[p8l436t3203r582b3246],
21	and	CC	O	and	_	0	SENT_142	[p8l602t3203r676b3237],
22	2318	CD	DATE	2318	num	23	SENT_142	[p8l695t3203r807b3237],
23	ng/mL	NN	O	ng/ml	prep_to	13	SENT_142	[p8l826t3203r972b3246],
24	,	,	O	,	_	0	SENT_142	[p8l826t3203r972b3246],
25	respectively	RB	O	respectively	advmod	16	SENT_142	[p8l994t3203r1248b3246],
26	.	.	O	.	_	0	SENT_142	[p8l994t3203r1248b3246],

1	Bar	NN	O	bar	nsubj	2	SENT_143	[p8l1270t3203r1338b3237],
2	represents	VBZ	O	represent	_	0	SENT_143	[p8l1356t3205r1577b3245],
3	the	DT	O	the	det	4	SENT_143	[p8l1593t3203r1658b3237],
4	median	NN	O	median	dobj	2	SENT_143	[p8l1678t3203r1840b3237],
5	.	.	O	.	_	0	SENT_143	[p8l1678t3203r1840b3237],

1	compared	VBN	O	compare	_	0	SENT_144	[p8l18t3502r566b3616],
2	with	IN	O	with	pcomp	1	SENT_144	[p8l641t3502r882b3594],
3	CT	NN	O	ct	nn	4	SENT_144	[p8l965t3502r1153b3594],
4	genotype	NN	O	genotype	pobj	2	SENT_144	[p8l1231t3524r1727b3616],
5	(	CD	NUMBER	(	num	6	SENT_144	[p8l1817t3503r2133b3615],
6	2-36	CD	NUMBER	2-36	dep	4	SENT_144	[p8l1817t3503r2133b3615],
7	,	,	O	,	_	0	SENT_144	[p8l1817t3503r2133b3615],
8	1-89-2-44	CD	NUMBER	1-89-2-44	num	9	SENT_144	[p8l30t3644r612b3757],
9	)	NN	O	)	appos	4	SENT_144	[p8l30t3644r612b3757],
10	and	CC	O	and	_	0	SENT_144	[p8l697t3643r897b3735],
11	CC	NN	O	cc	nn	12	SENT_144	[p8l975t3644r1160b3735],
12	genotype	NN	O	genotype	conj_and	9	SENT_144	[p8l1238t3665r1733b3757],
13	(	CD	NUMBER	(	num	14	SENT_144	[p8l1817t3644r2133b3757],
14	2-79	CD	NUMBER	2-79	dep	12	SENT_144	[p8l1817t3644r2133b3757],
15	,	,	O	,	_	0	SENT_144	[p8l1817t3644r2133b3757],

1	2-07-3-15	CD	DATE	2-07-3-15	_	0	SENT_145	[p9l18t24r605b130],
2	;	:	O	;	_	0	SENT_145	[p9l18t24r605b130],
3	p	NN	O	p	dep	1	SENT_145	[p9l671t21r1153b135],
4	=	JJ	O	=	amod	6	SENT_145	[p9l671t21r1153b135],
5	O-02	NN	O	o-02	nn	6	SENT_145	[p9l671t21r1153b135],
6	)	NN	O	)	dep	3	SENT_145	[p9l671t21r1153b135],
7	.	.	O	.	_	0	SENT_145	[p9l671t21r1153b135],

1	This	DT	O	this	det	2	SENT_146	[p9l1221t21r1470b111],
2	association	NN	O	association	nsubjpass	4	SENT_146	[p9l1538t21r2138b111],
3	was	VBD	O	be	auxpass	4	SENT_146	[p9l13t191r213b253],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_146	[p9l385t161r946b253],
5	by	IN	O	by	_	0	SENT_146	[p9l1110t161r1243b275],
6	ﬂuorescenceactivated	VBN	O	ﬂuorescenceactivated	agent	4	SENT_146	[p9l1407t161r2138b253, p9l18t302r508b394],
7	cell-sorter	NN	O	cell-sorter	nn	8	SENT_146	[p9l695t302r1245b394],
8	analysis	NN	O	analysis	dobj	6	SENT_146	[p9l1429t302r1847b416],
9	of	IN	O	of	_	0	SENT_146	[p9l2037t302r2153b394],
10	P	NN	O	p	nn	13	SENT_146	[p9l16t444r829b558],
11	—	CD	NUMBER	—	num	13	SENT_146	[p9l16t444r829b558],
12	glycoprotein	NN	O	glycoprotein	nn	13	SENT_146	[p9l16t444r829b558],
13	expression	NN	O	expression	prep_of	8	SENT_146	[p9l907t444r1482b558],
14	in	IN	O	in	_	0	SENT_146	[p9l1559t444r1662b533],
15	peripheral-blood	JJ	O	peripheral-blood	amod	17	SENT_146	[p9l1736t444r2138b558, p9l18t583r580b675],
16	mononuclear	JJ	O	mononuclear	amod	17	SENT_146	[p9l690t583r1423b675],
17	cells	NNS	O	cell	prep_in	6	SENT_146	[p9l1533t583r1795b675],
18	.	.	O	.	_	0	SENT_146	[p9l1533t583r1795b675],

1	The	DT	O	the	det	3	SENT_147	[p9l1912t583r2136b675],
2	correlation	NN	O	correlation	nn	3	SENT_147	[p9l18t724r612b816],
3	coefﬁcient	NN	O	coefﬁcient	nsubj	16	SENT_147	[p9l864t724r1433b816],
4	between	IN	O	between	_	0	SENT_147	[p9l1680t724r2138b816],
5	transcript	NN	O	transcript	nn	8	SENT_147	[p9l14t867r545b981],
6	and	CC	O	and	_	0	SENT_147	[p9l613t867r813b957],
7	protein	NN	O	protein	nn	8	SENT_147	[p9l878t867r1276b981],
8	expression	NN	O	expression	prep_between	3	SENT_147	[p9l1344t867r1919b981],
9	for	IN	O	for	_	0	SENT_147	[p9l1986t867r2141b957],
10	the	DT	O	the	det	12	SENT_147	[p9l15t1007r184b1099],
11	same	JJ	O	same	amod	12	SENT_147	[p9l255t1037r530b1099],
12	set	NN	O	set	prep_for	8	SENT_147	[p9l603t1029r750b1099],
13	of	IN	O	of	_	0	SENT_147	[p9l820t1007r938b1099],
14	samples	NNS	O	sample	prep_of	12	SENT_147	[p9l994t1007r1423b1121],
15	was	VBD	O	be	cop	16	SENT_147	[p9l1492t1037r1692b1099],
16	r	NN	O	r	_	0	SENT_147	[p9l1766t1012r2133b1099],
17	=	JJ	O	=	amod	20	SENT_147	[p9l1766t1012r2133b1099],
18	O-58	NN	O	o-58	nn	20	SENT_147	[p9l1766t1012r2133b1099],
19	(	NN	O	(	nn	20	SENT_147	[p9l25t1149r686b1262],
20	p	NN	O	p	dep	16	SENT_147	[p9l25t1149r686b1262],
21	=	JJ	O	=	amod	23	SENT_147	[p9l25t1149r686b1262],
22	O-0006	NN	O	o-0006	nn	23	SENT_147	[p9l25t1149r686b1262],
23	)	NN	O	)	dep	20	SENT_147	[p9l25t1149r686b1262],
24	.	.	O	.	_	0	SENT_147	[p9l25t1149r686b1262],

1	There	EX	O	there	expl	2	SENT_148	[p9l837t1148r1170b1240],
2	was	VBD	O	be	_	0	SENT_148	[p9l1315t1178r1515b1240],
3	a	DT	O	a	det	5	SENT_148	[p9l1665t1178r1718b1240],
4	weak	JJ	O	weak	amod	5	SENT_148	[p9l1861t1148r2141b1240],
5	correlation	NN	O	correlation	conj_and	5	SENT_148	[p9l18t1290r612b1380],
6	between	IN	O	between	_	0	SENT_148	[p9l648t1290r1107b1380],
7	MDR1	NN	O	mdr1	nn	8	SENT_148	[p9l1139t1291r1513b1379],
8	expression	NN	O	expression	prep_between	5	SENT_148	[p9l1562t1290r2138b1404],
9	and	CC	O	and	_	0	SENT_148	[p9l18t1430r218b1522],
10	drug	NN	O	drug	nn	11	SENT_148	[p9l311t1430r566b1544],
11	concentrations	NNS	O	concentration	prep_between	5	SENT_148	[p9l656t1430r1465b1522],
12	in	IN	O	in	_	0	SENT_148	[p9l1559t1430r1662b1520],
13	plasma	NN	O	plasma	nn	17	SENT_148	[p9l1750t1430r2138b1544],
14	(	NN	O	(	nn	17	SENT_148	[p9l25t1572r470b1685],
15	r	NN	O	r	nn	17	SENT_148	[p9l25t1572r470b1685],
16	=	JJ	O	=	amod	17	SENT_148	[p9l25t1572r470b1685],
17	O-22	NN	O	o-22	prep_in	5	SENT_148	[p9l25t1572r470b1685],
18	,	,	O	,	_	0	SENT_148	[p9l25t1572r470b1685],
19	p	NN	O	p	appos	17	SENT_148	[p9l658t1572r1102b1685],
20	=	JJ	O	=	amod	22	SENT_148	[p9l658t1572r1102b1685],
21	0-10	CD	NUMBER	0-10	tmod	20	SENT_148	[p9l658t1572r1102b1685],
22	)	NN	O	)	dep	19	SENT_148	[p9l658t1572r1102b1685],
23	and	CC	O	and	_	0	SENT_148	[p9l1298t1571r1498b1663],
24	between	IN	O	between	_	0	SENT_148	[p9l1680t1571r2138b1663],
25	P	NN	O	p	nn	28	SENT_148	[p9l16t1713r829b1827],
26	—	CD	NUMBER	—	num	28	SENT_148	[p9l16t1713r829b1827],
27	glycoprotein	NN	O	glycoprotein	nn	28	SENT_148	[p9l16t1713r829b1827],
28	expression	NN	O	expression	prep_between	5	SENT_148	[p9l922t1713r1498b1827],
29	and	CC	O	and	_	0	SENT_148	[p9l1591t1713r1793b1803],
30	drug	NN	O	drug	nn	31	SENT_148	[p9l1887t1713r2140b1827],
31	concentrations	NNS	O	concentration	conj_and	5	SENT_148	[p9l18t1853r827b1945],
32	in	IN	O	in	_	0	SENT_148	[p9l950t1853r1052b1943],
33	plasma	NN	O	plasma	nn	35	SENT_148	[p9l1170t1853r1557b1967],
34	(	NN	O	(	nn	35	SENT_148	[p9l1687t1854r2133b1966],
35	r	NN	O	r	prep_in	31	SENT_148	[p9l1687t1854r2133b1966],
36	=	JJ	O	=	amod	31	SENT_148	[p9l1687t1854r2133b1966],
37	O-25	CD	NUMBER	o-25	tmod	36	SENT_148	[p9l1687t1854r2133b1966],
38	,	,	O	,	_	0	SENT_148	[p9l1687t1854r2133b1966],
39	p	NN	O	p	nn	41	SENT_148	[p9l13t1996r496b2109],
40	=	JJ	O	=	amod	41	SENT_148	[p9l13t1996r496b2109],
41	O	NN	O	o	appos	31	SENT_148	[p9l13t1996r496b2109],
42	°	CD	NUMBER	°	num	44	SENT_148	[p9l13t1996r496b2109],
43	O6	NN	O	o6	nn	44	SENT_148	[p9l13t1996r496b2109],
44	)	NN	O	)	dep	41	SENT_148	[p9l13t1996r496b2109],
45	.	.	O	.	_	0	SENT_148	[p9l13t1996r496b2109],

1	Expression	NN	O	expression	nn	2	SENT_149	[p9l144t2137r748b2251],
2	levels	NNS	O	level	nsubjpass	13	SENT_149	[p9l873t2137r1167b2227],
3	of	IN	O	of	_	0	SENT_149	[p9l1298t2137r1414b2227],
4	two	CD	NUMBER	two	num	6	SENT_149	[p9l1525t2157r1723b2227],
5	other	JJ	O	other	amod	6	SENT_149	[p9l1854t2137r2141b2227],
6	transporters	NNS	O	transporter	prep_of	2	SENT_149	[p9l14t2299r709b2391],
7	,	,	O	,	_	0	SENT_149	[p9l14t2299r709b2391],
8	ABCCI	NN	O	abccus	appos	6	SENT_149	[p9l815t2277r1243b2369],
9	and	CC	O	and	_	0	SENT_149	[p9l1364t2277r1564b2369],
10	ABCC2	NN	O	abcc2	appos	6	SENT_149	[p9l1665t2277r2133b2386],
11	,	,	O	,	_	0	SENT_149	[p9l1665t2277r2133b2386],
12	were	VBD	O	be	auxpass	13	SENT_149	[p9l13t2448r271b2510],
13	measured	VBN	O	measure	_	0	SENT_149	[p9l374t2418r907b2510],
14	in	IN	O	in	_	0	SENT_149	[p9l1009t2419r1114b2508],
15	peripheral-blood	JJ	O	peripheral-blood	amod	17	SENT_149	[p9l1214t2418r2138b2532],
16	mononuclear	JJ	O	mononuclear	amod	17	SENT_149	[p9l15t2560r747b2650],
17	cells	NNS	O	cell	prep_in	13	SENT_149	[p9l859t2560r1088b2650],
18	from	IN	O	from	_	0	SENT_149	[p9l1204t2560r1467b2650],
19	the	DT	O	the	det	21	SENT_149	[p9l1578t2560r1747b2650],
20	same	JJ	O	same	amod	21	SENT_149	[p9l1863t2589r2136b2650],
21	subset	NN	O	subset	prep_from	13	SENT_149	[p9l18t2700r361b2792],
22	of	IN	O	of	_	0	SENT_149	[p9l446t2700r564b2792],
23	patients	NNS	O	patient	prep_of	21	SENT_149	[p9l631t2700r1062b2814],
24	in	IN	O	in	_	0	SENT_149	[p9l1149t2700r1252b2790],
25	whom	WP	O	whom	rel	29	SENT_149	[p9l1335t2700r1677b2792],
26	MDR1	NN	O	mdr1	nn	27	SENT_149	[p9l1757t2702r2131b2790],
27	expression	NN	O	expression	nsubjpass	29	SENT_149	[p9l18t2841r593b2955],
28	was	VBD	O	be	auxpass	29	SENT_149	[p9l666t2871r866b2933],
29	analysed	VBN	O	analyse	rcmod	23	SENT_149	[p9l948t2841r1445b2955],
30	.	.	O	.	_	0	SENT_149	[p9l948t2841r1445b2955],

1	There	EX	O	there	expl	2	SENT_150	[p9l1528t2841r1861b2933],
2	was	VBD	O	be	_	0	SENT_150	[p9l1936t2871r2136b2933],
3	no	DT	O	no	det	4	SENT_150	[p9l14t3012r150b3073],
4	relation	NN	O	relation	nsubj	2	SENT_150	[p9l286t2983r706b3073],
5	between	IN	O	between	_	0	SENT_150	[p9l835t2983r1294b3073],
6	MDR1	NN	O	mdr1	prep_between	4	SENT_150	[p9l1421t2984r1795b3072],
7	and	CC	O	and	advmod	2	SENT_150	[p9l1938t2983r2138b3073],

1	ABCC	NN	ORGANIZATION	abcc	nn	3	SENT_151	[p9l6t3123r433b3215],
2	]	NN	O	]	nn	3	SENT_151	[p9l6t3123r433b3215],
3	expression	NN	O	expression	_	0	SENT_151	[p9l523t3123r1100b3237],
4	(	CD	NUMBER	(	num	5	SENT_151	[p9l1189t3123r1635b3237],
5	r	NN	O	r	dep	3	SENT_151	[p9l1189t3123r1635b3237],
6	=	JJ	O	=	amod	7	SENT_151	[p9l1189t3123r1635b3237],
7	0-O3	NN	O	0-o3	dep	5	SENT_151	[p9l1189t3123r1635b3237],
8	,	,	O	,	_	0	SENT_151	[p9l1189t3123r1635b3237],
9	p	NN	O	p	appos	7	SENT_151	[p9l1718t3124r2133b3237],
10	=	JJ	O	=	amod	9	SENT_151	[p9l1718t3124r2133b3237],
11	0-2	CD	NUMBER	0-2	tmod	10	SENT_151	[p9l1718t3124r2133b3237],
12	)	NN	O	)	nn	17	SENT_151	[p9l1718t3124r2133b3237],
13	,	,	O	,	_	0	SENT_151	[p9l1718t3124r2133b3237],
14	MDR1	NN	O	mdr1	nn	17	SENT_151	[p9l11t3266r384b3354],
15	and	CC	O	and	_	0	SENT_151	[p9l574t3264r774b3356],
16	ABCC2	NN	O	abcc2	nn	17	SENT_151	[p9l945t3265r1382b3356],
17	expression	NN	O	expression	dep	3	SENT_151	[p9l1562t3264r2138b3378],
18	(	CD	NUMBER	(	num	19	SENT_151	[p9l25t3406r535b3518],
19	r	NN	O	r	npadvmod	20	SENT_151	[p9l25t3406r535b3518],
20	=	JJ	O	=	amod	17	SENT_151	[p9l25t3406r535b3518],
21	.	.	O	.	_	0	SENT_151	[p9l25t3406r535b3518],

1	—	NN	O	—	_	0	SENT_152	[p9l25t3406r535b3518],
2	.	.	O	.	_	0	SENT_152	[p9l25t3406r535b3518],

1	0-05	CD	NUMBER	0-05	_	0	SENT_153	[p9l25t3406r535b3518],
2	,	,	O	,	_	0	SENT_153	[p9l25t3406r535b3518],
3	p	NN	O	p	appos	1	SENT_153	[p9l670t3406r1085b3520],
4	=	JJ	O	=	amod	3	SENT_153	[p9l670t3406r1085b3520],
5	0-2	CD	NUMBER	0-2	num	6	SENT_153	[p9l670t3406r1085b3520],
6	)	NN	O	)	tmod	4	SENT_153	[p9l670t3406r1085b3520],
7	,	,	O	,	_	0	SENT_153	[p9l670t3406r1085b3520],
8	or	CC	O	or	_	0	SENT_153	[p9l1225t3435r1337b3496],
9	ABCC1	NN	O	abcc1	nn	12	SENT_153	[p9l1458t3406r1885b3496],
10	or	CC	O	or	_	0	SENT_153	[p9l2028t3435r2141b3496],
11	ABCC2	NN	O	abcc2	nn	12	SENT_153	[p9l6t3546r443b3638],
12	expression	NN	O	expression	tmod	4	SENT_153	[p9l664t3546r1240b3660],
13	and	CC	O	and	_	0	SENT_153	[p9l1463t3546r1663b3638],
14	drug	NN	O	drug	nn	15	SENT_153	[p9l1886t3546r2140b3660],
15	concentrations	NNS	O	concentration	conj_and	3	SENT_153	[p9l18t3687r827b3779],
16	in	IN	O	in	_	0	SENT_153	[p9l870t3688r974b3777],
17	plasma	NN	O	plasma	prep_in	15	SENT_153	[p9l1011t3687r1428b3801],
18	.	.	O	.	_	0	SENT_153	[p9l1011t3687r1428b3801],

1	Patients	NNS	O	patient	dep	16	SENT_154	[p10l144t21r583b111],
2	who	WP	O	who	nsubj	6	SENT_154	[p10l649t21r878b111],
3	were	VBD	O	be	cop	4	SENT_154	[p10l944t50r1201b111],
4	homozygous	JJ	O	homozygous	ccomp	1	SENT_154	[p10l1267t21r1957b135],
5	or	CC	O	or	_	0	SENT_154	[p10l2028t50r2141b111],
6	heterozygous	JJ	O	heterozygous	ccomp	1	SENT_154	[p10l13t161r735b275],
7	for	IN	O	for	_	0	SENT_154	[p10l842t161r998b253],
8	a	DT	O	a	det	10	SENT_154	[p10l1103t191r1156b253],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_154	[p10l1265t161r1757b253],
10	allele	NN	O	allele	prep_for	4	SENT_154	[p10l1860t161r2136b253],
11	associated	VBN	O	associate	partmod	10	SENT_154	[p10l18t302r574b394],
12	with	IN	O	with	_	0	SENT_154	[p10l680t302r921b394],
13	a	DT	O	a	det	15	SENT_154	[p10l1032t332r1085b394],
14	poor-metaboliser	NN	O	poor-metaboliser	nn	15	SENT_154	[p10l1192t302r2141b416],
15	phenotype	NN	O	phenotype	prep_with	11	SENT_154	[p10l14t444r591b558],
16	had	VBD	O	have	_	0	SENT_154	[p10l787t444r991b534],
17	higher	JJR	O	higher	amod	19	SENT_154	[p10l1185t444r1535b558],
18	median	JJ	O	median	amod	19	SENT_154	[p10l1729t444r2138b534],
19	concentrations	NNS	O	concentration	dobj	16	SENT_154	[p10l18t584r827b675],
20	in	IN	O	in	_	0	SENT_154	[p10l946t584r1049b674],
21	plasma	NN	O	plasma	prep_in	19	SENT_154	[p10l1163t584r1550b698],
22	of	IN	O	of	_	0	SENT_154	[p10l1670t584r1786b675],
23	both	DT	O	both	det	24	SENT_154	[p10l1885t584r2138b675],
24	nelﬁnavir	NN	O	nelﬁnavir	prep_of	21	SENT_154	[p10l14t725r535b817],
25	and	CC	O	and	_	0	SENT_154	[p10l642t725r842b817],
26	efavirenz	NN	O	efavirenz	prep_of	21	SENT_154	[p10l953t725r1441b817],
27	(	CD	NUMBER	(	num	26	SENT_154	[p10l1557t725r2136b839],
28	percentile	NN	O	percentile	nsubj	16	SENT_154	[p10l1557t725r2136b839],
29	62-5	CD	NUMBER	62-5	num	28	SENT_154	[p10l21t870r293b976],
30	,	,	O	,	_	0	SENT_154	[p10l21t870r293b976],
31	IQR	NN	O	iqr	nn	33	SENT_154	[p10l376t867r622b981],
32	47-5-77-5	CD	NUMBER	47-5-77-5	num	33	SENT_154	[p10l697t867r1293b979],
33	)	NN	O	)	appos	28	SENT_154	[p10l697t867r1293b979],
34	than	IN	O	than	_	0	SENT_154	[p10l1381t867r1627b957],
35	patients	NNS	O	patient	prep_than	33	SENT_154	[p10l1704t867r2136b981],
36	with	IN	O	with	_	0	SENT_154	[p10l13t1007r254b1097],
37	a	DT	O	a	det	40	SENT_154	[p10l304t1037r358b1097],
38	CYPZD6	NN	O	cypzd6	nn	40	SENT_154	[p10l410t1007r902b1097],
39	extensive-metaboliser	NN	O	extensive-metaboliser	nn	40	SENT_154	[p10l948t1007r2141b1097],
40	genotype	NN	O	genotype	prep_with	35	SENT_154	[p10l16t1170r511b1262],
41	(	CD	NUMBER	(	number	42	SENT_154	[p10l589t1149r798b1262],
42	45	CD	NUMBER	45	dep	40	SENT_154	[p10l589t1149r798b1262],
43	,	,	O	,	_	0	SENT_154	[p10l589t1149r798b1262],
44	25-75	CD	NUMBER	25-75	appos	40	SENT_154	[p10l873t1153r1245b1257],
45	;	:	O	;	_	0	SENT_154	[p10l873t1153r1245b1257],
46	p	NN	O	p	dep	33	SENT_154	[p10l1315t1153r1751b1262],
47	=	JJ	O	=	amod	48	SENT_154	[p10l1315t1153r1751b1262],
48	0-O4	NN	O	0-o4	dep	46	SENT_154	[p10l1315t1153r1751b1262],
49	;	:	O	;	_	0	SENT_154	[p10l1315t1153r1751b1262],
50	ﬁgure	NN	O	ﬁgure	dep	33	SENT_154	[p10l1823t1148r2136b1262],
51	1	CD	NUMBER	1	num	52	SENT_154	[p10l30t1290r160b1402],
52	)	NN	O	)	dep	50	SENT_154	[p10l30t1290r160b1402],
53	.	.	O	.	_	0	SENT_154	[p10l30t1290r160b1402],

1	By	IN	O	by	_	0	SENT_155	[p10l246t1291r392b1404],
2	contrast	NN	O	contrast	prep_by	7	SENT_155	[p10l470t1310r943b1399],
3	,	,	O	,	_	0	SENT_155	[p10l470t1310r943b1399],
4	we	PRP	O	we	nsubj	7	SENT_155	[p10l1023t1319r1172b1380],
5	did	VBD	O	do	aux	7	SENT_155	[p10l1253t1290r1428b1380],
6	not	RB	O	not	neg	7	SENT_155	[p10l1504t1310r1687b1380],
7	note	VB	O	note	_	0	SENT_155	[p10l1762t1310r2003b1380],
8	a	DT	O	a	det	9	SENT_155	[p10l2085t1319r2138b1380],
9	contribution	NN	O	contribution	dobj	7	SENT_155	[p10l18t1430r704b1521],
10	of	IN	O	of	_	0	SENT_155	[p10l750t1430r868b1521],
11	C	NN	O	c	nn	13	SENT_155	[p10l900t1430r989b1520],
12	YP2C19	NN	O	yp2c19	nn	13	SENT_155	[p10l999t1430r1448b1520],
13	genotype	NN	O	genotype	prep_of	9	SENT_155	[p10l1489t1451r1984b1544],
14	to	TO	O	to	_	0	SENT_155	[p10l2030t1451r2135b1521],
15	nelﬁnavir	NN	O	nelﬁnavir	nn	18	SENT_155	[p10l14t1570r535b1662],
16	or	CC	O	or	_	0	SENT_155	[p10l598t1601r711b1662],
17	efavirenz	NN	O	efavirenz	conj_or	15	SENT_155	[p10l774t1570r1261b1662],
18	concentrations	NNS	O	concentration	prep_to	7	SENT_155	[p10l1327t1570r2136b1662],
19	in	IN	O	in	_	0	SENT_155	[p10l16t1713r119b1802],
20	plasma	NN	O	plasma	prep_in	18	SENT_155	[p10l195t1713r616b1827],
21	,	,	O	,	_	0	SENT_155	[p10l195t1713r616b1827],
22	despite	IN	O	despite	_	0	SENT_155	[p10l702t1713r1087b1827],
23	the	DT	O	the	det	24	SENT_155	[p10l1168t1713r1336b1803],
24	fact	NN	O	fact	prep_despite	7	SENT_155	[p10l1417t1713r1617b1803],
25	that	IN	O	that	complm	28	SENT_155	[p10l1694t1713r1909b1803],
26	invitro	NN	O	invitro	nn	27	SENT_155	[p10l1989t1713r2138b1802, p10l13t1852r264b1943],
27	data	NNS	O	datum	nsubj	28	SENT_155	[p10l320t1852r551b1943],
28	identiﬁed	VBD	O	identiﬁed	dep	24	SENT_155	[p10l605t1852r1126b1943],
29	CYP2C19	NN	O	cyp2c19	dobj	28	SENT_155	[p10l1182t1852r1752b1944],
30	as	IN	O	as	_	0	SENT_155	[p10l1812t1882r1914b1943],
31	the	DT	O	the	det	33	SENT_155	[p10l1968t1852r2136b1943],
32	main	JJ	O	main	amod	33	SENT_155	[p10l14t1994r291b2086],
33	cytochrome	NN	O	cytochrome	prep_as	28	SENT_155	[p10l364t1994r1008b2108],
34	in	IN	O	in	_	0	SENT_155	[p10l1081t1994r1185b2084],
35	the	DT	O	the	det	36	SENT_155	[p10l1255t1994r1424b2086],
36	metabolism	NN	O	metabolism	prep_in	28	SENT_155	[p10l1496t1994r2138b2086],
37	of	IN	O	of	_	0	SENT_155	[p10l18t2136r134b2226],
38	nelﬁnavir	NN	O	nelﬁnavir	prep_of	36	SENT_155	[p10l235t2136r860b2226],
39	.	.	O	.	_	0	SENT_155	[p10l235t2136r860b2226],

1	”	NN	O	”	nn	2	SENT_156	[p10l235t2136r860b2226],
2	Patients	NNS	O	patient	nsubj	17	SENT_156	[p10l978t2136r1416b2226],
3	who	WP	O	who	nsubj	5	SENT_156	[p10l1533t2136r1762b2226],
4	were	VBD	O	be	cop	5	SENT_156	[p10l1880t2165r2136b2226],
5	homozygous	JJ	O	homozygous	rcmod	2	SENT_156	[p10l13t2276r704b2390],
6	or	CC	O	or	_	0	SENT_156	[p10l806t2306r919b2368],
7	heterozygous	JJ	O	heterozygous	conj_or	5	SENT_156	[p10l1011t2276r1732b2390],
8	for	IN	O	for	_	0	SENT_156	[p10l1832t2276r1988b2368],
9	a	DT	O	a	det	11	SENT_156	[p10l2085t2306r2138b2368],
10	CYPZCI9	NN	O	cypzci9	nn	11	SENT_156	[p10l19t2417r566b2508],
11	allele	NN	O	allele	prep_for	5	SENT_156	[p10l675t2416r952b2508],
12	associated	VBN	O	associate	partmod	11	SENT_156	[p10l1066t2416r1623b2508],
13	with	IN	O	with	_	0	SENT_156	[p10l1731t2416r1972b2508],
14	a	DT	O	a	det	16	SENT_156	[p10l2085t2447r2138b2508],
15	poor-metaboliser	NN	O	poor-metaboliser	nn	16	SENT_156	[p10l14t2559r962b2673],
16	phenotype	NN	O	phenotype	prep_with	12	SENT_156	[p10l1158t2559r1735b2673],
17	had	VBD	O	have	_	0	SENT_156	[p10l1934t2559r2138b2649],
18	median	JJ	O	median	amod	19	SENT_156	[p10l15t2698r424b2790],
19	concentrations	NNS	O	concentration	dobj	17	SENT_156	[p10l608t2698r1417b2790],
20	of	IN	O	of	_	0	SENT_156	[p10l1603t2698r1721b2790],
21	both	DT	O	both	preconj	22	SENT_156	[p10l1885t2698r2138b2790],
22	nelﬁnavir	NN	O	nelﬁnavir	prep_of	19	SENT_156	[p10l14t2840r535b2932],
23	and	CC	O	and	_	0	SENT_156	[p10l600t2840r800b2932],
24	efavirenz	NN	O	efavirenz	prep_of	19	SENT_156	[p10l868t2840r1355b2932],
25	in	IN	O	in	_	0	SENT_156	[p10l1419t2840r1523b2930],
26	plasma	NN	O	plasma	prep_in	22	SENT_156	[p10l1586t2840r1974b2954],
27	at	IN	O	at	_	0	SENT_156	[p10l2042t2862r2139b2932],
28	the	DT	O	the	det	34	SENT_156	[p10l15t2982r184b3072],
29	60th	JJ	ORDINAL	60th	amod	34	SENT_156	[p10l311t2982r557b3072],
30	percentile	NN	O	percentile	nn	34	SENT_156	[p10l675t2982r1216b3096],
31	(	NN	O	(	nn	34	SENT_156	[p10l1347t2982r1632b3096],
32	IQR	NN	O	iqr	nn	34	SENT_156	[p10l1347t2982r1632b3096],
33	30-75	CD	NUMBER	30-75	num	34	SENT_156	[p10l1750t2982r2129b3095],
34	)	NN	O	)	prep_at	17	SENT_156	[p10l1750t2982r2129b3095],
35	compared	VBN	O	compare	_	0	SENT_156	[p10l18t3122r566b3236],
36	with	IN	O	with	prepc_compared_with	17	SENT_156	[p10l603t3122r844b3214],
37	those	DT	O	those	dep	46	SENT_156	[p10l883t3122r1173b3214],
38	with	IN	O	with	_	0	SENT_156	[p10l1213t3122r1453b3214],
39	a	DT	O	a	det	42	SENT_156	[p10l1496t3152r1549b3214],
40	CYPZCI9	NN	O	cypzci9	nn	42	SENT_156	[p10l1595t3122r2141b3214],
41	extensive	JJ	O	extensive	amod	42	SENT_156	[p10l18t3263r516b3355],
42	metaboliser	NN	O	metaboliser	prep_with	37	SENT_156	[p10l578t3263r1221b3355],
43	genotype	NN	O	genotype	dep	46	SENT_156	[p10l1279t3285r1776b3377],
44	(	CD	NUMBER	(	num	43	SENT_156	[p10l1847t3263r2139b3377],
45	50th	JJ	ORDINAL	50th	amod	46	SENT_156	[p10l1847t3263r2139b3377],
46	percentile	NN	O	percentile	dep	56	SENT_156	[p10l14t3405r588b3519],
47	,	,	O	,	_	0	SENT_156	[p10l14t3405r588b3519],
48	25-75	CD	DATE	25-75	appos	46	SENT_156	[p10l637t3408r1008b3514],
49	,	,	O	,	_	0	SENT_156	[p10l637t3408r1008b3514],
50	p	NN	O	p	appos	46	SENT_156	[p10l1052t3408r1416b3519],
51	=	JJ	O	=	amod	50	SENT_156	[p10l1052t3408r1416b3519],
52	0-7	CD	NUMBER	0-7	tmod	51	SENT_156	[p10l1052t3408r1416b3519],
53	,	,	O	,	_	0	SENT_156	[p10l1052t3408r1416b3519],
54	ﬁgure	NN	O	ﬁgure	appos	46	SENT_156	[p10l1462t3405r1776b3519],
55	1	CD	NUMBER	1	num	56	SENT_156	[p10l1832t3405r1962b3517],
56	)	NN	O	)	dep	17	SENT_156	[p10l1832t3405r1962b3517],
57	.	.	O	.	_	0	SENT_156	[p10l1832t3405r1962b3517],

1	CYP3A4	NN	O	cyp3a4	nn	2	SENT_157	[p10l148t3544r639b3636],
2	function	NN	O	function	nsubjpass	6	SENT_157	[p10l822t3544r1279b3636],
3	can	MD	O	can	aux	6	SENT_157	[p10l1462t3566r1832b3636],
4	not	RB	O	not	neg	6	SENT_157	[p10l1462t3566r1832b3636],
5	be	VB	O	be	auxpass	6	SENT_157	[p10l2009t3544r2136b3636],
6	predicted	VBN	O	predict	_	0	SENT_157	[p10l13t3686r528b3800],
7	from	IN	O	from	_	0	SENT_157	[p10l644t3686r904b3778],
8	genotype	NN	O	genotype	prep_from	6	SENT_157	[p10l1020t3708r1541b3800],
9	.	.	O	.	_	0	SENT_157	[p10l1020t3708r1541b3800],

1	We	PRP	O	we	nsubj	4	SENT_158	[p10l1661t3688r1846b3778],
2	did	VBD	O	do	aux	4	SENT_158	[p10l1965t3686r2138b3778],
3	however	RB	O	however	advmod	4	SENT_158	[p11l13t21r472b111],
4	assess	VB	O	assess	_	0	SENT_158	[p11l663t50r974b111],
5	two	CD	NUMBER	two	dobj	4	SENT_158	[p11l1165t41r1363b111],
6	recognised	VBN	O	recognise	partmod	5	SENT_158	[p11l1555t21r2138b135],
7	polymorphic	JJ	O	polymorphic	amod	8	SENT_158	[p11l13t161r706b275],
8	regions	NNS	O	region	dobj	6	SENT_158	[p11l953t161r1373b275],
9	:	:	O	:	_	0	SENT_158	[p11l953t161r1373b275],
10	promoter	NN	O	promoter	nn	13	SENT_158	[p11l1626t183r2141b275],
11	(	NN	O	(	nn	13	SENT_158	[p11l25t303r155b416],
12	C	NN	O	c	nn	13	SENT_158	[p11l25t303r155b416],
13	YP3/l	NN	O	yp3/l	dep	4	SENT_158	[p11l165t303r472b394],
14	4	CD	NUMBER	4	number	15	SENT_158	[p11l487t304r609b394],
15	*	CD	NUMBER	*	dep	13	SENT_158	[p11l487t304r609b394],
16	I	PRP	O	I	dep	15	SENT_158	[p11l632t307r678b392],
17	B	NN	O	b	nn	18	SENT_158	[p11l687t303r813b416],
18	)	NN	O	)	dep	15	SENT_158	[p11l687t303r813b416],
19	and	CC	O	and	_	0	SENT_158	[p11l1088t302r1286b394],
20	exon	NN	O	exon	dep	13	SENT_158	[p11l1552t332r1810b394],
21	7	CD	NUMBER	7	number	22	SENT_158	[p11l2076t307r2132b392],
22	(	CD	NUMBER	(	num	26	SENT_158	[p11l25t444r758b556],
23	CYP3/14	NN	O	cyp3/14	nn	26	SENT_158	[p11l25t444r758b556],
24	*	NN	O	*	nn	26	SENT_158	[p11l25t444r758b556],
25	2	CD	NUMBER	2	num	26	SENT_158	[p11l25t444r758b556],
26	)	NN	O	)	dep	20	SENT_158	[p11l25t444r758b556],
27	.	.	O	.	_	0	SENT_158	[p11l25t444r758b556],

1	Exon	NN	O	exon	nsubjpass	4	SENT_159	[p11l820t445r1105b534],
2	7	CD	NUMBER	7	num	1	SENT_159	[p11l1154t447r1211b533],
3	is	VBZ	O	be	auxpass	4	SENT_159	[p11l1262t444r1339b534],
4	thought	VBN	O	think	_	0	SENT_159	[p11l1387t444r1815b558],
5	to	TO	O	to	aux	8	SENT_159	[p11l1859t464r1963b534],
6	be	VB	O	be	cop	8	SENT_159	[p11l2009t444r2136b534],
7	functionally	RB	O	functionally	advmod	8	SENT_159	[p11l15t584r663b698],
8	relevant	JJ	O	relevant	xcomp	4	SENT_159	[p11l777t584r1210b676],
9	because	IN	O	because	mark	12	SENT_159	[p11l1323t584r1752b676],
10	it	PRP	O	it	nsubjpass	12	SENT_159	[p11l1870t584r1943b676],
11	is	VBZ	O	be	auxpass	12	SENT_159	[p11l2059t584r2135b676],
12	associated	VBN	O	associate	advcl	8	SENT_159	[p11l18t724r568b816],
13	with	IN	O	with	_	0	SENT_159	[p11l699t724r936b816],
14	reduced	VBN	O	reduce	amod	15	SENT_159	[p11l1067t724r1508b816],
15	CYP3A4	NN	O	cyp3a4	prep_with	12	SENT_159	[p11l1644t725r2134b816],

1	function	NN	O	function	_	0	SENT_160	[p11l15t868r576b959],
2	.	.	O	.	_	0	SENT_160	[p11l15t868r576b959],

1	”	NN	O	”	nn	2	SENT_161	[p11l15t868r576b959],
2	Analysis	NN	O	analysis	nsubj	5	SENT_161	[p11l670t868r1119b981],
3	of	IN	O	of	_	0	SENT_161	[p11l1219t868r1336b959],
4	CYP3A	NN	O	cyp3a	prep_of	2	SENT_161	[p11l1421t868r1846b959],
5	was	VBD	O	be	_	0	SENT_161	[p11l1936t897r2135b959],

1	CYP450	NN	O	cyp450	nn	2	SENT_162	[p11l88t989r226b1016],
2	(	NN	O	(	nsubj	3	SENT_162	[p11l250t989r260b1023],
3	=	JJ	O	=	_	0	SENT_162	[p11l284t997r305b1009],
4	-01	CD	NUMBER	-01	num	5	SENT_162	[p11l331t989r403b1023],
5	)	NN	O	)	dobj	3	SENT_162	[p11l331t989r403b1023],
6	,	,	O	,	_	0	SENT_162	[p11l331t989r403b1023],
7	in	IN	O	in	_	0	SENT_162	[p11l424t989r455b1016],
8	56	CD	NUMBER	56	num	9	SENT_162	[p11l476t990r513b1016],
9	patients	NNS	O	patient	prep_in	5	SENT_162	[p11l533t989r660b1023],
10	starting	VBG	O	start	_	0	SENT_162	[p11l681t989r802b1023],
11	antiretroviral	JJ	O	antiretroviral	amod	14	SENT_162	[p11l822t989r1030b1016],
12	completed	VBN	O	complete	amod	14	SENT_162	[p11l1127t989r1294b1023],
13	b	NN	O	b	nn	14	SENT_162	[p11l1308t989r1327b1016],
14	sessment	NN	O	sessment	prep_starting	9	SENT_162	[p11l1393t995r1537b1016],
15	of	IN	O	of	_	0	SENT_162	[p11l1552t989r1586b1016],
16	the	DT	O	the	det	18	SENT_162	[p11l1596t989r1645b1016],
17	CYP3A5	NN	O	cyp3a5	nn	18	SENT_162	[p11l1661t989r1802b1016],
18	region	NN	O	region	prep_of	14	SENT_162	[p11l1815t989r1915b1023],
19	in	IN	O	in	_	0	SENT_162	[p11l1930t989r1960b1016],
20	which	WDT	O	which	det	21	SENT_162	[p11l1974t989r2070b1016],
21	treatment	NN	O	treatment	prep_in	18	SENT_162	[p11l87t1036r253b1063],
22	,	,	O	,	_	0	SENT_162	[p11l87t1036r253b1063],
23	in	IN	O	in	_	0	SENT_162	[p11l338t1030r368b1057],
24	67	CD	NUMBER	67	num	25	SENT_162	[p11l382t1031r418b1057],
25	patients	NNS	O	patient	prep_in	5	SENT_162	[p11l431t1030r558b1064],
26	on	IN	O	on	_	0	SENT_162	[p11l571t1039r611b1057],
27	stable	JJ	O	stable	amod	29	SENT_162	[p11l623t1030r715b1057],
28	chronic	JJ	O	chronic	amod	29	SENT_162	[p11l728t1030r848b1057],
29	treatment	NN	O	treatment	prep_on	5	SENT_162	[p11l860t1036r1026b1057],
30	.	.	O	.	_	0	SENT_162	[p11l860t1036r1026b1057],

1	mutation	NN	O	mutation	_	0	SENT_163	[p11l1126t1030r1272b1057],
2	le	DT	O	le	dep	1	SENT_163	[p11l1303t1030r1329b1057],
3	to	TO	O	to	_	0	SENT_163	[p11l1413t1036r1444b1057],
4	aberrant	JJ	O	aberrant	amod	5	SENT_163	[p11l1476t1030r1610b1057],
5	splicing	NN	O	splicing	prep_to	2	SENT_163	[p11l1641t1030r1762b1064],
6	and	CC	O	and	_	0	SENT_163	[p11l1793t1030r1851b1057],
7	chan	NN	O	chan	nn	8	SENT_163	[p11l1883t1030r1958b1057],
8	Quantiﬁcation	NN	O	quantiﬁcation	prep_to	2	SENT_163	[p11l125t1072r359b1106],
9	of	IN	O	of	_	0	SENT_163	[p11l371t1072r406b1099],
10	MDRI	NN	O	mdrus	nn	11	SENT_163	[p11l412t1072r522b1099],
11	transc	NN	O	transc	prep_of	5	SENT_163	[p11l536t1078r632b1099],
12	'	''	O	'	_	0	SENT_163	[p11l651t1072r655b1076],
13	in	IN	O	in	_	0	SENT_163	[p11l718t1072r748b1099],
14	peripheral-blood	JJ	O	peripheral-blood	amod	16	SENT_163	[p11l759t1072r1030b1106],
15	CYP3A5	NN	O	cyp3a5	nn	16	SENT_163	[p11l1127t1072r1270b1099],
16	expression	NN	O	expression	prep_in	11	SENT_163	[p11l1286t1072r1483b1106],
17	.	.	O	.	_	0	SENT_163	[p11l1286t1072r1483b1106],

1	”	NN	O	”	_	0	SENT_164	[p11l1286t1072r1483b1106],
2	We	PRP	O	we	nsubj	5	SENT_164	[p11l1496t1072r1550b1099],
3	did	VBD	O	do	aux	5	SENT_164	[p11l1564t1072r1615b1099],
4	not	RB	O	not	neg	5	SENT_164	[p11l1627t1078r1680b1099],
5	identify	VB	O	identify	rcmod	1	SENT_164	[p11l1693t1072r1814b1106],
6	any	DT	O	any	det	7	SENT_164	[p11l1827t1081r1883b1106],
7	assoc	JJ	O	assoc	dobj	5	SENT_164	[p11l1896t1072r1986b1099],
8	"	``	O	"	punct	7	SENT_164	[p11l1896t1072r1986b1099],
9	"	``	O	"	punct	16	SENT_164	[p11l2022t1072r2070b1099],
10	on	IN	O	on	_	0	SENT_164	[p11l2022t1072r2070b1099],
11	mononuclear	JJ	O	mononuclear	amod	12	SENT_164	[p11l87t1113r301b1140],
12	cells	NNS	O	cell	prep_on	16	SENT_164	[p11l313t1113r380b1140],
13	from	IN	O	from	_	0	SENT_164	[p11l392t1113r469b1140],
14	59	CD	NUMBER	59	prep_from	12	SENT_164	[p11l483t1114r520b1140],
15	patien	NN	O	patien	nsubj	16	SENT_164	[p11l532t1113r632b1147],
16	owed	VBD	O	owe	rcmod	7	SENT_164	[p11l708t1113r792b1140],
17	an	DT	O	a	det	18	SENT_164	[p11l805t1122r842b1140],
18	association	NN	O	association	iobj	16	SENT_164	[p11l854t1113r1030b1140],
19	between	IN	O	between	_	0	SENT_164	[p11l1125t1113r1259b1140],
20	allele	NN	O	allele	nn	21	SENT_164	[p11l1282t1113r1362b1140],
21	CYP3A4	NN	O	cyp3a4	prep_between	18	SENT_164	[p11l1386t1113r1544b1140],
22	*	CD	NUMBER	*	num	23	SENT_164	[p11l1386t1113r1544b1140],
23	IB	NNP	O	IB	dobj	16	SENT_164	[p11l1552t1113r1594b1140],
24	(	CD	NUMBER	(	num	23	SENT_164	[p11l1618t1113r1747b1147],
25	present	JJ	DATE	present	amod	23	SENT_164	[p11l1618t1113r1747b1147],
26	at	IN	O	at	_	0	SENT_164	[p11l1770t1119r1798b1140],
27	equency	NN	O	equency	prep_at	25	SENT_164	[p11l1885t1122r2017b1147],
28	of	IN	O	of	prep	27	SENT_164	[p11l2040t1113r2074b1140],
29	between	IN	O	between	pcomp	28	SENT_164	[p11l86t1154r221b1182],
30	MDR1	NN	O	mdr1	nn	33	SENT_164	[p11l235t1155r345b1181],
31	3435	CD	NUMBER	3435	num	33	SENT_164	[p11l365t1155r443b1181],
32	TT	NN	O	tt	nn	33	SENT_164	[p11l462t1155r518b1181],
33	genotype	NN	O	genotype	pobj	29	SENT_164	[p11l534t1160r680b1188],
34	and	CC	O	and	_	0	SENT_164	[p11l698t1154r756b1181],
35	a	DT	O	a	det	37	SENT_164	[p11l774t1163r789b1181],
36	lower	JJR	O	lower	amod	37	SENT_164	[p11l806t1154r895b1182],
37	level	NN	O	level	prep_at	25	SENT_164	[p11l911t1154r983b1182],
38	of	IN	O	of	_	0	SENT_164	[p11l1000t1154r1035b1181],
39	4-0	JJ	PERCENT	4-0	quantmod	40	SENT_164	[p11l1127t1154r1234b1188],
40	%	NN	PERCENT	%	num	41	SENT_164	[p11l1127t1154r1234b1188],
41	)	CD	NUMBER	)	prep_of	37	SENT_164	[p11l1127t1154r1234b1188],
42	,	,	O	,	_	0	SENT_164	[p11l1127t1154r1234b1188],
43	allele	NN	O	allele	nn	45	SENT_164	[p11l1261t1154r1341b1181],
44	CYP3A4	NN	O	cyp3a4	nn	45	SENT_164	[p11l1368t1154r1550b1181],
45	*	NN	O	*	prep_at	25	SENT_164	[p11l1368t1154r1550b1181],
46	2	CD	NUMBER	2	dep	45	SENT_164	[p11l1368t1154r1550b1181],
47	-	:	O	-	_	0	SENT_164	[p11l1611t1166r1616b1171],
48	%	NN	O	%	prep_at	25	SENT_164	[p11l1642t1154r1696b1188],
49	)	CD	NUMBER	)	num	48	SENT_164	[p11l1642t1154r1696b1188],
50	,	,	O	,	_	0	SENT_164	[p11l1642t1154r1696b1188],
51	or	CC	O	or	_	0	SENT_164	[p11l1724t1163r1757b1181],
52	all	DT	O	all	conj_or	27	SENT_164	[p11l1782t1154r1817b1181],
53	e	SYM	O	e	dep	54	SENT_164	[p11l1847t1163r1862b1181],
54	CYP3A5	CD	NUMBER	cyp3a5	dep	55	SENT_164	[p11l1888t1154r2067b1181],
55	*	NN	O	*	dep	23	SENT_164	[p11l1888t1154r2067b1181],
56	1	CD	NUMBER	1	num	55	SENT_164	[p11l1888t1154r2067b1181],
57	in	IN	O	in	prep	5	SENT_164	[p11l2039t1030r2070b1057],

1	MDR1	NN	O	mdr1	nn	2	SENT_165	[p11l85t1196r195b1223],
2	expression	NN	O	expression	_	0	SENT_165	[p11l238t1196r406b1230],
3	(	CD	NUMBER	(	num	5	SENT_165	[p11l449t1196r580b1229],
4	median	NN	O	median	nn	5	SENT_165	[p11l449t1196r580b1229],
5	1-s7	NN	O	1-s7	dep	2	SENT_165	[p11l624t1197r701b1228],
6	,	,	O	,	_	0	SENT_165	[p11l624t1197r701b1228],
7	IQR	NN	O	iqr	appos	5	SENT_165	[p11l742t1196r814b1230],
8	174-21	CD	NUMBER	174-21	num	7	SENT_165	[p11l856t1197r991b1223],
9	1	CD	NUMBER	1	num	10	SENT_165	[p11l1001t1196r1028b1230],
10	)	NN	O	)	dep	7	SENT_165	[p11l1001t1196r1028b1230],
11	(	CD	PERCENT	(	num	13	SENT_165	[p11l1129t1196r1257b1230],
12	11-3	CD	PERCENT	11-3	num	13	SENT_165	[p11l1129t1196r1257b1230],
13	%	NN	PERCENT	%	dep	2	SENT_165	[p11l1129t1196r1257b1230],
14	)	CD	NUMBER	)	nn	19	SENT_165	[p11l1129t1196r1257b1230],
15	and	CC	O	and	_	0	SENT_165	[p11l1281t1196r1340b1223],
16	drug	NN	O	drug	nn	19	SENT_165	[p11l1362t1196r1436b1230],
17	concen	NN	O	concen	nn	19	SENT_165	[p11l1457t1205r1570b1223],
18	'	''	O	'	_	0	SENT_165	[p11l1630t1196r1691b1223],
19	ons	NNS	O	on	dep	13	SENT_165	[p11l1630t1196r1691b1223],
20	in	IN	O	in	_	0	SENT_165	[p11l1714t1196r1744b1223],
21	plasma	NN	O	plasma	prep_in	19	SENT_165	[p11l1765t1196r1877b1230],
22	(	CD	NUMBER	(	num	23	SENT_165	[p11l1901t1196r2003b1230],
23	figure	NN	O	figure	dep	2	SENT_165	[p11l1901t1196r2003b1230],
24	1	CD	NUMBER	1	num	25	SENT_165	[p11l2029t1196r2067b1230],
25	)	NN	O	)	dep	23	SENT_165	[p11l2029t1196r2067b1230],
26	.	.	O	.	_	0	SENT_165	[p11l2029t1196r2067b1230],

1	32	CD	NUMBER	32	_	0	SENT_166	[p11l92t1326r130b1352],
2	THE	DT	O	the	det	3	SENT_166	[p11l1225t1331r1291b1351],
3	LANCET	NN	O	lancet	dep	1	SENT_166	[p11l1300t1331r1430b1352],
4	-	:	O	-	_	0	SENT_166	[p11l1439t1338r1447b1345],
5	Vol	NN	O	vol	dep	1	SENT_166	[p11l1456t1331r1500b1352],
6	359	CD	NUMBER	359	num	5	SENT_166	[p11l1510t1331r1555b1352],
7	-	:	O	-	_	0	SENT_166	[p11l1567t1338r1574b1345],
8	January	NNP	DATE	January	dep	5	SENT_166	[p11l1582t1331r1680b1357],
9	5	CD	DATE	5	num	8	SENT_166	[p11l1690t1331r1711b1356],
10	,	,	DATE	,	_	0	SENT_166	[p11l1690t1331r1711b1356],
11	2002	CD	DATE	2002	num	8	SENT_166	[p11l1722t1332r1784b1352],
12	-	:	O	-	_	0	SENT_166	[p11l1795t1338r1802b1345],
13	www.thelancet.com	NN	O	www.thelancet.com	dep	8	SENT_166	[p11l1812t1331r2062b1352],

1	MDR1	NN	O	mdr1	_	0	SENT_167	[p11l634t1586r801b1630],
2	(	CD	NUMBER	(	number	3	SENT_167	[p11l826t1585r994b1641],
3	3435	CD	NUMBER	3435	num	4	SENT_167	[p11l826t1585r994b1641],
4	C	NN	O	c	dep	1	SENT_167	[p11l1018t1585r1086b1641],
5	/	:	O	/	punct	6	SENT_167	[p11l1018t1585r1086b1641],
6	T	NN	O	t	dep	4	SENT_167	[p11l1090t1586r1138b1641],
7	)	CD	NUMBER	)	num	8	SENT_167	[p11l1090t1586r1138b1641],
8	CYP2D6	NN	O	cyp2d6	dep	6	SENT_167	[p11l1290t1585r1542b1642],
9	-	:	O	-	_	0	SENT_167	[p11l1290t1585r1542b1642],
10	|	SYM	O	|	dep	12	SENT_167	[p11l1290t1585r1542b1642],
11	-	:	O	-	_	0	SENT_167	[p11l1290t1585r1542b1642],
12	CYP2C19j	NN	O	cyp2c19j	dep	6	SENT_167	[p11l1754t1585r2037b1642],
13	:	:	O	:	_	0	SENT_167	[p11l1754t1585r2037b1642],

1	16	CD	NUMBER	16	dep	140	SENT_168	[p11l12t1700r82b1745],
2	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t1700r696b1745],
3	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t1703r1350b1745],
4	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t1703r1814b1745],
5	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t1776r43b1821],
6	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t1776r696b1821],
7	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t1779r1350b1821],
8	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t1779r1814b1821],
9	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t1852r43b1897],
10	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t1852r696b1897],
11	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t1855r1350b1897],
12	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t1855r1814b1897],
13	2	CD	NUMBER	2	dep	140	SENT_168	[p11l10t1928r42b1973],
14	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t1928r696b1973],
15	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t1931r1350b1973],
16	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t1928r1843b1984],
17	/	:	O	/	dep	140	SENT_168	[p11l1751t1928r1843b1984],
18	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t1939r1931b1984],
19	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t2004r43b2049],
20	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t2004r696b2049],
21	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2007r1350b2049],
22	pm	NN	O	pm	dep	140	SENT_168	[p11l1755t2015r1834b2059],
23	/	:	O	/	dep	140	SENT_168	[p11l1837t2004r1868b2060],
24	pm	NN	O	pm	dep	140	SENT_168	[p11l1876t2015r1955b2060],
25	2	CD	NUMBER	2	dep	140	SENT_168	[p11l10t2080r42b2125],
26	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t2080r696b2125],
27	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2080r1379b2136],
28	/	:	O	/	dep	140	SENT_168	[p11l1287t2080r1379b2136],
29	pm	NN	O	pm	dep	140	SENT_168	[p11l1388t2091r1467b2136],
30	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2083r1814b2125],
31	2	CD	NUMBER	2	dep	140	SENT_168	[p11l10t2156r42b2201],
32	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t2156r696b2201],
33	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2156r1379b2212],
34	/	:	O	/	dep	140	SENT_168	[p11l1287t2156r1379b2212],
35	pm	NN	O	pm	dep	140	SENT_168	[p11l1388t2167r1467b2212],
36	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2159r1814b2201],
37	2	CD	NUMBER	2	dep	140	SENT_168	[p11l10t2232r42b2277],
38	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t2232r696b2277],
39	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2232r1379b2288],
40	/	:	O	/	dep	140	SENT_168	[p11l1287t2232r1379b2288],
41	pm	NN	O	pm	dep	140	SENT_168	[p11l1388t2243r1467b2288],
42	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2232r1843b2288],
43	/	:	O	/	dep	140	SENT_168	[p11l1751t2232r1843b2288],
44	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t2243r1931b2288],
45	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t2308r43b2353],
46	TT	NN	ORGANIZATION	tt	dep	140	SENT_168	[p11l632t2308r696b2353],
47	pm	NN	O	pm	dep	140	SENT_168	[p11l1291t2319r1370b2363],
48	/	:	O	/	dep	140	SENT_168	[p11l1373t2308r1404b2364],
49	pm	NN	O	pm	dep	140	SENT_168	[p11l1412t2319r1491b2364],
50	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2311r1814b2353],
51	27	CD	NUMBER	27	dep	140	SENT_168	[p11l10t2384r80b2429],
52	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2384r703b2429],
53	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2387r1350b2429],
54	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2387r1814b2429],
55	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t2460r43b2505],
56	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2460r703b2505],
57	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2463r1350b2505],
58	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2463r1814b2505],
59	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t2536r43b2581],
60	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2536r703b2581],
61	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2539r1350b2581],
62	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2539r1814b2581],
63	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t2612r43b2657],
64	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2612r703b2657],
65	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2615r1350b2657],
66	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2615r1814b2657],
67	6	CD	NUMBER	6	dep	140	SENT_168	[p11l10t2688r43b2733],
68	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2688r703b2733],
69	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2691r1350b2733],
70	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2688r1843b2744],
71	/	:	O	/	dep	140	SENT_168	[p11l1751t2688r1843b2744],
72	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t2699r1931b2744],
73	2	CD	NUMBER	2	dep	140	SENT_168	[p11l10t2764r42b2809],
74	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2764r703b2809],
75	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2767r1350b2809],
76	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2764r1843b2820],
77	/	:	O	/	dep	140	SENT_168	[p11l1751t2764r1843b2820],
78	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t2775r1931b2820],
79	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t2840r43b2885],
80	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2840r703b2885],
81	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2843r1350b2885],
82	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2840r1843b2896],
83	/	:	O	/	dep	140	SENT_168	[p11l1751t2840r1843b2896],
84	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t2851r1931b2896],
85	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t2916r43b2961],
86	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2916r703b2961],
87	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2919r1350b2961],
88	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t2916r1843b2972],
89	/	:	O	/	dep	140	SENT_168	[p11l1751t2916r1843b2972],
90	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t2927r1931b2972],
91	2	CD	NUMBER	2	dep	140	SENT_168	[p11l10t2992r42b3037],
92	CT	NN	O	ct	dep	140	SENT_168	[p11l634t2992r703b3037],
93	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t2995r1350b3037],
94	pm	NN	O	pm	dep	140	SENT_168	[p11l1755t3003r1834b3047],
95	/	:	O	/	dep	140	SENT_168	[p11l1837t2992r1868b3048],
96	pm	NN	O	pm	dep	140	SENT_168	[p11l1876t3003r1955b3048],
97	8	CD	NUMBER	8	dep	140	SENT_168	[p11l9t3068r44b3113],
98	CT	NN	O	ct	dep	140	SENT_168	[p11l634t3068r703b3113],
99	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t3068r1379b3124],
100	/	:	O	/	dep	140	SENT_168	[p11l1287t3068r1379b3124],
101	pm	NN	O	pm	dep	140	SENT_168	[p11l1387t3079r1467b3124],
102	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t3071r1814b3113],
103	4	CD	NUMBER	4	dep	140	SENT_168	[p11l9t3144r44b3189],
104	CT	NN	O	ct	dep	140	SENT_168	[p11l634t3144r703b3189],
105	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t3144r1379b3200],
106	/	:	O	/	dep	140	SENT_168	[p11l1287t3144r1379b3200],
107	pm	NN	O	pm	dep	140	SENT_168	[p11l1387t3155r1467b3200],
108	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t3144r1843b3200],
109	/	:	O	/	dep	140	SENT_168	[p11l1751t3144r1843b3200],
110	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t3155r1931b3200],
111	3	CD	NUMBER	3	dep	140	SENT_168	[p11l9t3220r43b3265],
112	CT	NN	O	ct	dep	140	SENT_168	[p11l634t3220r703b3265],
113	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t3220r1379b3276],
114	/	:	O	/	dep	140	SENT_168	[p11l1287t3220r1379b3276],
115	pm	NN	O	pm	dep	140	SENT_168	[p11l1388t3231r1467b3276],
116	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t3220r1843b3276],
117	/	:	O	/	dep	140	SENT_168	[p11l1751t3220r1843b3276],
118	pm	NN	O	pm	dep	140	SENT_168	[p11l1852t3231r1931b3276],
119	2	CD	NUMBER	2	dep	140	SENT_168	[p11l10t3296r42b3341],
120	CT	NN	O	ct	dep	140	SENT_168	[p11l634t3296r703b3341],
121	pm	NN	O	pm	dep	140	SENT_168	[p11l1291t3307r1370b3351],
122	/	:	O	/	dep	140	SENT_168	[p11l1373t3296r1404b3352],
123	pm	NN	O	pm	dep	140	SENT_168	[p11l1412t3307r1491b3352],
124	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t3299r1814b3341],
125	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t3372r43b3417],
126	CT	NN	O	ct	dep	140	SENT_168	[p11l634t3372r703b3417],
127	um	NN	O	um	dep	140	SENT_168	[p11l1291t3383r1370b3417],
128	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t3375r1814b3417],
129	10	CD	NUMBER	10	dep	140	SENT_168	[p11l12t3448r82b3493],
130	CC	NN	O	cc	dep	140	SENT_168	[p11l634t3448r709b3493],
131	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t3451r1350b3493],
132	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t3451r1814b3493],
133	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t3524r43b3569],
134	CC	NN	ORGANIZATION	cc	dep	140	SENT_168	[p11l634t3524r709b3569],
135	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t3527r1350b3569],
136	wt	JJ	O	wt	dep	140	SENT_168	[p11l1751t3527r1814b3569],
137	1	CD	NUMBER	1	dep	140	SENT_168	[p11l12t3600r43b3645],
138	CC	NN	O	cc	dep	140	SENT_168	[p11l634t3600r709b3645],
139	wt	JJ	O	wt	dep	140	SENT_168	[p11l1287t3603r1350b3645],
140	wt	JJ	O	wt	_	0	SENT_168	[p11l1751t3603r1814b3645],

1	2	CD	NUMBER	2	num	4	SENT_169	[p12l10t22r42b67],
2	CC	NN	O	cc	nn	4	SENT_169	[p12l634t22r709b67],
3	mm	NN	O	mm	nn	4	SENT_169	[p12l1287t25r1350b67],
4	mm/mn	NN	O	mm/mn	dep	15	SENT_169	[p12l1751t22r1931b78],
5	1	CD	NUMBER	1	num	8	SENT_169	[p12l12t98r43b143],
6	CC	NN	O	cc	nn	8	SENT_169	[p12l634t98r709b143],
7	mm	NN	O	mm	nn	8	SENT_169	[p12l1287t101r1350b143],
8	pm/pm	NN	O	pm/pm	dep	4	SENT_169	[p12l1755t98r1952b154],
9	5	CD	NUMBER	5	num	11	SENT_169	[p12l10t174r43b219],
10	CC	NN	ORGANIZATION	cc	nn	11	SENT_169	[p12l634t174r709b219],
11	wvpni	NNS	O	wvpnus	dep	8	SENT_169	[p12l1287t174r1467b230],
12	mm	NN	O	mm	dep	15	SENT_169	[p12l1751t177r1814b219],
13	1	CD	NUMBER	1	num	12	SENT_169	[p12l12t250r43b295],
14	CC	NN	O	cc	nn	15	SENT_169	[p12l634t250r709b295],
15	wvpni	NNS	O	wvpnus	dep	20	SENT_169	[p12l1287t250r1467b306],
16	mm	NN	O	mm	nn	19	SENT_169	[p12l1751t253r1814b295],
17	1	CD	NUMBER	1	num	19	SENT_169	[p12l12t326r43b371],
18	CC	NN	ORGANIZATION	cc	nn	19	SENT_169	[p12l634t326r709b371],
19	wvpm	NN	O	wvpm	dep	15	SENT_169	[p12l1287t326r1467b382],
20	wvpm	NN	O	wvpm	dep	28	SENT_169	[p12l1751t326r1931b382],
21	1	CD	NUMBER	1	num	20	SENT_169	[p12l12t402r43b447],
22	CC	NN	O	cc	nn	28	SENT_169	[p12l634t402r709b447],
23	pm/mn	NN	O	pm/mn	nn	28	SENT_169	[p12l1291t402r1491b458],
24	WUMK	NN	O	wumk	nn	28	SENT_169	[p12l1751t402r1910b458],
25	1	CD	NUMBER	1	num	28	SENT_169	[p12l12t478r43b523],
26	CC	NN	O	cc	nn	28	SENT_169	[p12l634t478r709b523],
27	pm/mn	NN	O	pm/mn	nn	28	SENT_169	[p12l1291t478r1491b534],
28	wvpm	NN	O	wvpm	dep	33	SENT_169	[p12l1751t478r1931b534],
29	CYP3A4	NN	O	cyp3a4	nn	32	SENT_169	[p12l12t555r338b600],
30	*	CD	NUMBER	*	num	32	SENT_169	[p12l12t555r338b600],
31	1B	NN	O	1b	nn	32	SENT_169	[p12l12t555r338b600],
32	CYP3A5	NN	O	cyp3a5	dep	28	SENT_169	[p12l530t555r816b600],
33	*	NN	O	*	_	0	SENT_169	[p12l530t555r816b600],
34	1	CD	NUMBER	1	num	33	SENT_169	[p12l530t555r816b600],

1	AA	NN	O	aa	dep	128	SENT_170	[p12l9t711r80b756],
2	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t711r608b756],
3	22-5	CD	NUMBER	22-5	dep	128	SENT_170	[p12l1244t711r1372b756],
4	(	CD	NUMBER	(	dep	128	SENT_170	[p12l1397t711r1615b767],
5	10-50	CD	NUMBER	10-50	dep	128	SENT_170	[p12l1397t711r1615b767],
6	)	CD	NUMBER	)	dep	128	SENT_170	[p12l1397t711r1615b767],
7	AG	NNP	ORGANIZATION	AG	dep	128	SENT_170	[p12l9t787r84b832],
8	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t787r608b832],
9	15	CD	NUMBER	15	dep	128	SENT_170	[p12l1245t787r1315b832],
10	AA	NN	ORGANIZATION	aa	dep	128	SENT_170	[p12l9t863r80b908],
11	GA	NN	ORGANIZATION	ga	dep	128	SENT_170	[p12l530t863r605b908],
12	15	CD	NUMBER	15	dep	128	SENT_170	[p12l1245t863r1315b908],
13	AA	NN	O	aa	dep	128	SENT_170	[p12l9t939r80b984],
14	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t939r608b985],
15	25,50	CD	NUMBER	25,50	dep	128	SENT_170	[p12l1244t939r1431b992],
16	AA	NN	O	aa	dep	128	SENT_170	[p12l9t1015r80b1060],
17	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t1015r608b1060],
18	45	CD	NUMBER	45	dep	128	SENT_170	[p12l1243t1015r1315b1060],
19	AA	NN	O	aa	dep	128	SENT_170	[p12l9t1091r80b1136],
20	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t1091r608b1137],
21	30,60	CD	NUMBER	30,60	dep	128	SENT_170	[p12l1243t1091r1431b1144],
22	AA	NN	O	aa	dep	128	SENT_170	[p12l9t1167r80b1212],
23	GA	NN	O	ga	dep	128	SENT_170	[p12l530t1167r605b1213],
24	35,45	CD	NUMBER	35,45	dep	128	SENT_170	[p12l1243t1167r1430b1220],
25	AA	NN	O	aa	dep	128	SENT_170	[p12l9t1243r80b1288],
26	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t1243r608b1289],
27	30,30	CD	NUMBER	30,30	dep	128	SENT_170	[p12l1243t1243r1431b1296],
28	AA	NN	O	aa	dep	128	SENT_170	[p12l9t1319r80b1364],
29	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t1319r608b1364],
30	55	CD	NUMBER	55	dep	128	SENT_170	[p12l1244t1319r1315b1364],
31	AA	NN	O	aa	dep	128	SENT_170	[p12l9t1395r80b1440],
32	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t1395r608b1440],
33	40	CD	NUMBER	40	dep	128	SENT_170	[p12l1243t1395r1558b1451],
34	(	CD	NUMBER	(	dep	128	SENT_170	[p12l1243t1395r1558b1451],
35	25	CD	NUMBER	25	dep	128	SENT_170	[p12l1243t1395r1558b1451],
36	—	NN	O	—	dep	128	SENT_170	[p12l1243t1395r1558b1451],
37	66	CD	NUMBER	66	dep	128	SENT_170	[p12l1243t1395r1558b1451],
38	)	CD	NUMBER	)	dep	128	SENT_170	[p12l1243t1395r1558b1451],
39	AG	NNP	ORGANIZATION	AG	dep	128	SENT_170	[p12l9t1471r84b1516],
40	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t1471r608b1516],
41	75	CD	NUMBER	75	dep	128	SENT_170	[p12l1245t1471r1315b1516],
42	AA	NN	ORGANIZATION	aa	dep	128	SENT_170	[p12l9t1547r80b1592],
43	GA	NN	ORGANIZATION	ga	dep	128	SENT_170	[p12l530t1547r605b1592],
44	25	CD	NUMBER	25	dep	128	SENT_170	[p12l1244t1547r1315b1592],
45	AA	NN	ORGANIZATION	aa	dep	128	SENT_170	[p12l9t1623r80b1668],
46	AA	NN	ORGANIZATION	aa	dep	128	SENT_170	[p12l528t1623r598b1668],
47	50	CD	NUMBER	50	dep	128	SENT_170	[p12l1244t1623r1315b1668],
48	AA	NN	O	aa	dep	128	SENT_170	[p12l9t1699r80b1744],
49	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t1699r608b1744],
50	60	CD	NUMBER	60	dep	128	SENT_170	[p12l1244t1699r1558b1755],
51	(	CD	NUMBER	(	dep	128	SENT_170	[p12l1244t1699r1558b1755],
52	12	CD	NUMBER	12	dep	128	SENT_170	[p12l1244t1699r1558b1755],
53	—	NN	O	—	dep	128	SENT_170	[p12l1244t1699r1558b1755],
54	88	CD	NUMBER	88	dep	128	SENT_170	[p12l1244t1699r1558b1755],
55	)	CD	NUMBER	)	dep	128	SENT_170	[p12l1244t1699r1558b1755],
56	AA	NN	ORGANIZATION	aa	dep	128	SENT_170	[p12l9t1775r80b1820],
57	GA	NN	ORGANIZATION	ga	dep	128	SENT_170	[p12l530t1775r605b1821],
58	60,85	CD	ORGANIZATION	60,85	dep	128	SENT_170	[p12l1244t1775r1430b1828],
59	AG	NNP	ORGANIZATION	AG	dep	128	SENT_170	[p12l9t1851r84b1896],
60	GA	NNP	O	GA	dep	128	SENT_170	[p12l530t1851r605b1896],
61	50	CD	NUMBER	50	dep	128	SENT_170	[p12l1244t1851r1315b1896],
62	GG	NNS	O	gg	dep	128	SENT_170	[p12l12t1927r90b1972],
63	GA	NN	O	ga	dep	128	SENT_170	[p12l530t1927r605b1972],
64	20	CD	NUMBER	20	dep	128	SENT_170	[p12l1244t1927r1315b1972],
65	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2003r80b2048],
66	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2003r608b2049],
67	30,80	CD	NUMBER	30,80	dep	128	SENT_170	[p12l1243t2003r1431b2056],
68	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2079r80b2124],
69	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2079r608b2124],
70	55	CD	NUMBER	55	dep	128	SENT_170	[p12l1244t2079r1315b2124],
71	(	CD	NUMBER	(	dep	128	SENT_170	[p12l1339t2079r1673b2135],
72	23-5-76-5	CD	NUMBER	23-5-76-5	dep	128	SENT_170	[p12l1339t2079r1673b2135],
73	)	CD	NUMBER	)	dep	128	SENT_170	[p12l1339t2079r1673b2135],
74	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2155r80b2200],
75	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2155r608b2200],
76	60	CD	NUMBER	60	dep	128	SENT_170	[p12l1244t2155r1558b2211],
77	(	CD	NUMBER	(	dep	128	SENT_170	[p12l1244t2155r1558b2211],
78	50	CD	NUMBER	50	dep	128	SENT_170	[p12l1244t2155r1558b2211],
79	—	CD	NUMBER	—	dep	128	SENT_170	[p12l1244t2155r1558b2211],
80	75	CD	NUMBER	75	dep	128	SENT_170	[p12l1244t2155r1558b2211],
81	)	CD	NUMBER	)	dep	128	SENT_170	[p12l1244t2155r1558b2211],
82	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2231r80b2276],
83	GA	NN	O	ga	dep	128	SENT_170	[p12l530t2231r605b2277],
84	50,80,95	CD	NUMBER	50,80,95	dep	128	SENT_170	[p12l1244t2231r1545b2284],
85	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2307r80b2352],
86	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2307r608b2353],
87	70,90	CD	NUMBER	70,90	dep	128	SENT_170	[p12l1245t2307r1431b2360],
88	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2383r80b2428],
89	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2383r608b2428],
90	15	CD	NUMBER	15	dep	128	SENT_170	[p12l1245t2383r1315b2428],
91	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2459r80b2504],
92	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2459r608b2504],
93	75	CD	NUMBER	75	dep	128	SENT_170	[p12l1245t2459r1315b2504],
94	(	CD	NUMBER	(	dep	128	SENT_170	[p12l1339t2459r1615b2515],
95	31-5-83	CD	NUMBER	31-5-83	dep	128	SENT_170	[p12l1339t2459r1615b2515],
96	)	CD	NUMBER	)	dep	128	SENT_170	[p12l1339t2459r1615b2515],
97	AG	NNP	ORGANIZATION	AG	dep	128	SENT_170	[p12l9t2535r84b2580],
98	GA	NNP	O	GA	dep	128	SENT_170	[p12l530t2535r605b2580],
99	75	CD	NUMBER	75	dep	128	SENT_170	[p12l1245t2535r1315b2580],
100	GG	NNS	O	gg	dep	128	SENT_170	[p12l12t2611r90b2656],
101	GA	NN	O	ga	dep	128	SENT_170	[p12l530t2611r605b2656],
102	50	CD	NUMBER	50	dep	128	SENT_170	[p12l1244t2611r1315b2656],
103	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2687r80b2732],
104	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2687r608b2733],
105	50,90	CD	NUMBER	50,90	dep	128	SENT_170	[p12l1244t2687r1431b2740],
106	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2763r80b2808],
107	GA	NN	O	ga	dep	128	SENT_170	[p12l530t2763r605b2808],
108	60	CD	NUMBER	60	dep	128	SENT_170	[p12l1244t2763r1315b2808],
109	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2839r80b2884],
110	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t2839r608b2884],
111	70	CD	NUMBER	70	dep	128	SENT_170	[p12l1245t2839r1558b2895],
112	(	CD	NUMBER	(	dep	128	SENT_170	[p12l1245t2839r1558b2895],
113	20	CD	NUMBER	20	dep	128	SENT_170	[p12l1245t2839r1558b2895],
114	—	NN	O	—	dep	128	SENT_170	[p12l1245t2839r1558b2895],
115	95	CD	NUMBER	95	dep	128	SENT_170	[p12l1245t2839r1558b2895],
116	)	CD	NUMBER	)	dep	128	SENT_170	[p12l1245t2839r1558b2895],
117	AG	NNP	ORGANIZATION	AG	dep	128	SENT_170	[p12l9t2915r84b2960],
118	GA	NNP	O	GA	dep	128	SENT_170	[p12l530t2915r605b2960],
119	80	CD	NUMBER	80	dep	128	SENT_170	[p12l1243t2915r1315b2960],
120	AA	NN	O	aa	dep	128	SENT_170	[p12l9t2991r80b3036],
121	GA	NN	O	ga	dep	128	SENT_170	[p12l530t2991r605b3036],
122	10	CD	NUMBER	10	dep	128	SENT_170	[p12l1245t2991r1315b3036],
123	AA	NN	O	aa	dep	128	SENT_170	[p12l9t3067r80b3112],
124	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t3067r608b3112],
125	75	CD	NUMBER	75	dep	128	SENT_170	[p12l1245t3067r1315b3112],
126	AA	NN	O	aa	dep	128	SENT_170	[p12l9t3143r80b3188],
127	GG	NNS	O	gg	dep	128	SENT_170	[p12l530t3143r608b3188],
128	90	CD	NUMBER	90	_	0	SENT_170	[p12l1244t3143r1315b3188],

1	*	RB	O	*	advmod	6	SENT_171	[p12l94t3221r219b3244],
2	Complete	JJ	O	complete	amod	4	SENT_171	[p12l94t3221r219b3244],
3	genotype	NN	O	genotype	nn	4	SENT_171	[p12l228t3222r334b3245],
4	analysis	NN	O	analysis	nsubj	6	SENT_171	[p12l344t3221r438b3245],
5	was	VBD	O	be	cop	6	SENT_171	[p12l448t3226r493b3240],
6	unsuccessful	JJ	O	unsuccessful	_	0	SENT_171	[p12l504t3221r656b3240],
7	in	IN	O	in	_	0	SENT_171	[p12l668t3221r686b3240],
8	ten	CD	NUMBER	ten	num	9	SENT_171	[p12l695t3222r732b3240],
9	patients	NNS	O	patient	prep_in	6	SENT_171	[p12l743t3221r844b3244],
10	.	.	O	.	_	0	SENT_171	[p12l743t3221r844b3244],

1	1-wt	NN	O	1-wt	nsubj	14	SENT_172	[p12l854t3221r955b3245],
2	=	JJ	O	=	amod	13	SENT_172	[p12l854t3221r955b3245],
3	wi	NN	O	wus	nn	13	SENT_172	[p12l854t3221r955b3245],
4	|	NN	O	|	nn	13	SENT_172	[p12l854t3221r955b3245],
5	d	NN	O	d	nn	13	SENT_172	[p12l854t3221r955b3245],
6	type	NN	O	type	nn	13	SENT_172	[p12l964t3222r1020b3245],
7	,	,	O	,	_	0	SENT_172	[p12l964t3222r1020b3245],
8	pm	NN	O	pm	nn	13	SENT_172	[p12l1032t3226r1136b3244],
9	=	JJ	O	=	amod	13	SENT_172	[p12l1032t3226r1136b3244],
10	poor	JJ	O	poor	amod	13	SENT_172	[p12l1032t3226r1136b3244],
11	metaboliser	NN	O	metaboliser	nn	13	SENT_172	[p12l1145t3221r1284b3240],
12	(	NN	O	(	nn	13	SENT_172	[p12l1293t3221r1376b3244],
13	alleles	NNS	O	allele	dep	1	SENT_172	[p12l1293t3221r1376b3244],
14	2D6	VBP	O	2d6	_	0	SENT_172	[p12l1385t3221r1472b3243],
15	*	CD	NUMBER	*	number	16	SENT_172	[p12l1385t3221r1472b3243],
16	4	CD	NUMBER	4	dobj	14	SENT_172	[p12l1385t3221r1472b3243],
17	,	,	O	,	_	0	SENT_172	[p12l1385t3221r1472b3243],
18	*	CD	NUMBER	*	number	19	SENT_172	[p12l1485t3221r1521b3243],
19	3	CD	NUMBER	3	num	23	SENT_172	[p12l1485t3221r1521b3243],
20	,	,	O	,	_	0	SENT_172	[p12l1485t3221r1521b3243],
21	*	CD	NUMBER	*	number	22	SENT_172	[p12l1534t3221r1577b3244],
22	6	CD	NUMBER	6	num	23	SENT_172	[p12l1534t3221r1577b3244],
23	)	NN	O	)	appos	16	SENT_172	[p12l1534t3221r1577b3244],
24	,	,	O	,	_	0	SENT_172	[p12l1534t3221r1577b3244],
25	um	NN	O	um	appos	23	SENT_172	[p12l1589t3221r1757b3244],
26	=	JJ	O	=	amod	25	SENT_172	[p12l1589t3221r1757b3244],
27	u	FW	O	u	nn	30	SENT_172	[p12l1589t3221r1757b3244],
28	|	FW	O	|	nn	30	SENT_172	[p12l1589t3221r1757b3244],
29	tra-rapid	JJ	O	tra-rapid	amod	30	SENT_172	[p12l1589t3221r1757b3244],
30	metaboliser	NN	O	metaboliser	tmod	14	SENT_172	[p12l1768t3221r1907b3240],
31	(	NN	O	(	nn	34	SENT_172	[p12l1916t3221r1979b3245],
32	gene	NN	O	gene	nn	34	SENT_172	[p12l1916t3221r1979b3245],
33	duplication	NN	O	duplication	nn	34	SENT_172	[p12l92t3255r234b3278],
34	)	NN	O	)	dep	30	SENT_172	[p12l92t3255r234b3278],
35	.	.	O	.	_	0	SENT_172	[p12l92t3255r234b3278],

1	iwt	NN	O	iwt	_	0	SENT_173	[p12l245t3255r345b3279],
2	=	JJ	O	=	amod	6	SENT_173	[p12l245t3255r345b3279],
3	wi	NN	O	wus	nn	6	SENT_173	[p12l245t3255r345b3279],
4	|	NN	O	|	nn	6	SENT_173	[p12l245t3255r345b3279],
5	d	NN	O	d	nn	6	SENT_173	[p12l245t3255r345b3279],
6	type	NN	O	type	dep	1	SENT_173	[p12l354t3256r410b3279],
7	,	,	O	,	_	0	SENT_173	[p12l354t3256r410b3279],
8	pm	NN	O	pm	nn	12	SENT_173	[p12l422t3260r526b3278],
9	=	JJ	O	=	amod	12	SENT_173	[p12l422t3260r526b3278],
10	poor	JJ	O	poor	amod	12	SENT_173	[p12l422t3260r526b3278],
11	metaboliser	NN	O	metaboliser	nn	12	SENT_173	[p12l535t3255r674b3274],
12	(	NN	O	(	appos	6	SENT_173	[p12l683t3255r752b3278],
13	allele	NN	O	allele	nn	15	SENT_173	[p12l683t3255r752b3278],
14	2C19	NN	O	2c19	nn	15	SENT_173	[p12l761t3255r870b3278],
15	*	NN	O	*	dep	1	SENT_173	[p12l761t3255r870b3278],
16	2	CD	NUMBER	2	num	17	SENT_173	[p12l761t3255r870b3278],
17	)	NN	O	)	dep	15	SENT_173	[p12l761t3255r870b3278],
18	.	.	O	.	_	0	SENT_173	[p12l761t3255r870b3278],

1	§	NN	O	§	dep	13	SENT_174	[p12l882t3255r961b3279],
2	When	WRB	O	when	advmod	13	SENT_174	[p12l882t3255r961b3279],
3	more	JJR	O	more	mwe	4	SENT_174	[p12l973t3260r1030b3274],
4	than	IN	O	than	quantmod	5	SENT_174	[p12l1039t3255r1090b3274],
5	three	CD	NUMBER	three	num	6	SENT_174	[p12l1100t3255r1160b3274],
6	patients	NNS	O	patient	nsubj	13	SENT_174	[p12l1171t3255r1264b3278],
7	per	IN	O	per	_	0	SENT_174	[p12l1275t3260r1312b3278],
8	genotype	NN	O	genotype	prep_per	6	SENT_174	[p12l1320t3256r1432b3279],
9	,	,	O	,	_	0	SENT_174	[p12l1320t3256r1432b3279],
10	data	NNS	O	datum	appos	8	SENT_174	[p12l1443t3255r1493b3274],
11	are	VBP	O	be	cop	13	SENT_174	[p12l1504t3260r1540b3274],
12	median	JJ	O	median	amod	13	SENT_174	[p12l1551t3255r1635b3274],
13	value	NN	O	value	_	0	SENT_174	[p12l1644t3255r1706b3274],
14	(	CD	NUMBER	(	num	16	SENT_174	[p12l1716t3255r1779b3278],
15	IQR	NN	O	iqr	nn	16	SENT_174	[p12l1716t3255r1779b3278],
16	)	NN	O	)	attr	13	SENT_174	[p12l1716t3255r1779b3278],
17	.	.	O	.	_	0	SENT_174	[p12l1716t3255r1779b3278],

1	When	WRB	O	when	advmod	3	SENT_175	[p12l1789t3255r1854b3274],
2	three	CD	NUMBER	three	num	3	SENT_175	[p12l1863t3255r1923b3274],
3	patients	NNS	O	patient	advcl	10	SENT_175	[p12l1934t3255r2028b3278],
4	or	CC	O	or	_	0	SENT_175	[p12l2038t3260r2061b3274],
5	less	JJR	O	less	advcl	10	SENT_175	[p12l93t3289r146b3311],
6	,	,	O	,	_	0	SENT_175	[p12l93t3289r146b3311],
7	every	DT	O	every	det	8	SENT_175	[p12l157t3293r218b3312],
8	percentile	NN	O	percentile	nsubjpass	10	SENT_175	[p12l228t3289r341b3312],
9	is	VBZ	O	be	auxpass	10	SENT_175	[p12l352t3289r370b3308],
10	shown	VBN	O	show	_	0	SENT_175	[p12l380t3289r461b3308],
11	.	.	O	.	_	0	SENT_175	[p12l380t3289r461b3308],

1	Distribution	NN	O	distribution	nsubj	18	SENT_176	[p12l93t3338r263b3361],
2	of	IN	O	of	_	0	SENT_176	[p12l275t3338r303b3361],
3	MDR1	NN	O	mdr1	nn	9	SENT_176	[p12l313t3338r412b3366],
4	,	,	O	,	_	0	SENT_176	[p12l313t3338r412b3366],
5	CYP2D6	NN	O	cyp2d6	dep	9	SENT_176	[p12l426t3338r551b3366],
6	,	,	O	,	_	0	SENT_176	[p12l426t3338r551b3366],
7	CYP2C19	NN	O	cyp2c19	dep	9	SENT_176	[p12l565t3338r709b3366],
8	,	,	O	,	_	0	SENT_176	[p12l565t3338r709b3366],
9	CYP3A4	NN	O	cyp3a4	prep_of	1	SENT_176	[p12l723t3338r847b3366],
10	,	,	O	,	_	0	SENT_176	[p12l723t3338r847b3366],
11	and	CC	O	and	_	0	SENT_176	[p12l860t3338r912b3361],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_176	[p12l924t3338r1041b3362],
13	genotypes	NNS	O	genotype	prep_of	1	SENT_176	[p12l1051t3339r1204b3367],
14	in	IN	O	in	_	0	SENT_176	[p12l1217t3338r1240b3361],
15	113	CD	NUMBER	113	num	17	SENT_176	[p12l1253t3338r1310b3361],
16	study	NN	O	study	nn	17	SENT_176	[p12l1322t3338r1403b3367],
17	participants	NNS	O	participant	prep_in	1	SENT_176	[p12l1415t3338r1608b3367],
18	*	VBP	O	*	_	0	SENT_176	[p12l1415t3338r1608b3367],

1	However	RB	O	however	advmod	4	SENT_177	[p13l11t75r357b147],
2	,	,	O	,	_	0	SENT_177	[p13l11t75r357b147],
3	we	PRP	O	we	nsubj	4	SENT_177	[p13l417t94r515b135],
4	recorded	VBD	O	record	_	0	SENT_177	[p13l573t74r893b135],
5	linkage	NN	O	linkage	nn	6	SENT_177	[p13l950t74r1203b150],
6	disequilibrium	NN	O	disequilibrium	dep	16	SENT_177	[p13l1263t74r1786b150],
7	between	IN	O	between	_	0	SENT_177	[p13l1842t74r2143b135],
8	CYP3A4	NN	O	cyp3a4	nn	10	SENT_177	[p13l13t168r483b228],
9	*	CD	NUMBER	*	num	10	SENT_177	[p13l13t168r483b228],
10	1B	NN	O	1b	prep_between	6	SENT_177	[p13l13t168r483b228],
11	and	CC	O	and	_	0	SENT_177	[p13l563t167r695b228],
12	CYP3A5	NN	O	cyp3a5	nn	13	SENT_177	[p13l778t168r1182b228],
13	*	NN	O	*	conj_and	10	SENT_177	[p13l778t168r1182b228],
14	1	CD	NUMBER	1	num	15	SENT_177	[p13l778t168r1182b228],
15	(	NN	O	(	dep	16	SENT_177	[p13l1274t167r1690b243],
16	correlation	NN	O	correlation	dep	4	SENT_177	[p13l1274t167r1690b243],
17	coefﬁcient	NN	O	coefﬁcient	nn	18	SENT_177	[p13l1772t167r2144b228],
18	r	NN	O	r	dep	16	SENT_177	[p13l12t263r277b334],
19	=	JJ	O	=	amod	20	SENT_177	[p13l12t263r277b334],
20	O-37	NN	O	o-37	dobj	4	SENT_177	[p13l12t263r277b334],
21	,	,	O	,	_	0	SENT_177	[p13l12t263r277b334],
22	p	NN	O	p	appos	20	SENT_177	[p13l304t261r713b337],
23	=	JJ	O	=	amod	25	SENT_177	[p13l304t261r713b337],
24	0-0002	CD	NUMBER	0-0002	tmod	23	SENT_177	[p13l304t261r713b337],
25	)	NN	O	)	dep	22	SENT_177	[p13l304t261r713b337],
26	.	.	O	.	_	0	SENT_177	[p13l304t261r713b337],

1	To	TO	O	to	aux	3	SENT_178	[p13l95t354r200b414],
2	further	RB	O	further	advmod	3	SENT_178	[p13l251t353r504b414],
3	assess	VB	O	assess	purpcl	8	SENT_178	[p13l552t373r760b414],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_178	[p13l814t353r1098b414],
5	function	NN	O	function	dobj	3	SENT_178	[p13l1144t353r1472b426],
6	,	,	O	,	_	0	SENT_178	[p13l1144t353r1472b426],
7	we	PRP	O	we	nsubj	8	SENT_178	[p13l1522t373r1621b414],
8	analysed	VBD	O	analyse	_	0	SENT_178	[p13l1672t353r1982b429],
9	the	DT	O	the	det	10	SENT_178	[p13l2031t353r2142b414],
10	ratio	NN	O	ratio	dobj	8	SENT_178	[p13l10t447r175b507],
11	of	IN	O	of	_	0	SENT_178	[p13l236t446r313b507],
12	1	CD	NUMBER	1	prep_of	10	SENT_178	[p13l370t445r1166b522],
13	’	SYM	O	’	dep	10	SENT_178	[p13l370t445r1166b522],
14	-	:	O	-	_	0	SENT_178	[p13l370t445r1166b522],
15	hydroxymidazolam	NN	O	hydroxymidazolam	dep	10	SENT_178	[p13l370t445r1166b522],
16	to	TO	O	to	_	0	SENT_178	[p13l1222t461r1292b507],
17	midazolam	NN	O	midazolam	prep_to	15	SENT_178	[p13l1350t446r1753b507],
18	in	IN	O	in	_	0	SENT_178	[p13l1810t447r1879b506],
19	blood	NN	O	blood	nn	21	SENT_178	[p13l1934t446r2143b507],
20	30	CD	DURATION	30	num	21	SENT_178	[p13l12t542r99b600],
21	min	NN	DURATION	min	prep_in	17	SENT_178	[p13l130t540r272b599],
22	after	IN	O	after	_	0	SENT_178	[p13l303t540r466b600],
23	oral	JJ	O	oral	amod	24	SENT_178	[p13l495t540r631b600],
24	administration	NN	O	administration	prep_after	8	SENT_178	[p13l662t540r1195b600],
25	of	IN	O	of	_	0	SENT_178	[p13l1225t540r1303b600],
26	midazolam	NN	O	midazolam	prep_of	24	SENT_178	[p13l1322t540r1745b612],
27	,	,	O	,	_	0	SENT_178	[p13l1322t540r1745b612],
28	which	WDT	O	which	nsubj	31	SENT_178	[p13l1776t540r1995b600],
29	is	VBZ	O	be	cop	31	SENT_178	[p13l2024t540r2075b600],
30	a	DT	O	a	det	31	SENT_178	[p13l2108t559r2143b600],
31	probe	NN	O	probe	rcmod	26	SENT_178	[p13l9t631r219b707],
32	of	IN	O	of	_	0	SENT_178	[p13l251t631r329b692],
33	CYP3A	NN	O	cyp3a	nn	34	SENT_178	[p13l352t631r636b692],
34	activity	NN	O	activity	prep_of	31	SENT_178	[p13l666t631r992b707],
35	.	.	O	.	_	0	SENT_178	[p13l666t631r992b707],

1	“	NN	O	“	nsubj	3	SENT_179	[p13l666t631r992b707],
2	We	PRP	O	we	nsubj	3	SENT_179	[p13l1024t632r1146b692],
3	did	VBD	O	do	_	0	SENT_179	[p13l1178t631r1293b692],
4	this	DT	O	this	det	5	SENT_179	[p13l1323t631r1451b692],
5	test	NN	O	test	dobj	3	SENT_179	[p13l1482t645r1610b692],
6	in	IN	O	in	_	0	SENT_179	[p13l1639t631r1707b691],
7	50	CD	NUMBER	50	num	8	SENT_179	[p13l1739t634r1824b692],
8	patients	NNS	O	patient	prep_in	3	SENT_179	[p13l1856t631r2142b707],
9	at	IN	O	at	_	0	SENT_179	[p13l12t739r77b785],
10	baseline	NN	O	baseline	prep_at	3	SENT_179	[p13l112t724r405b785],
11	and	CC	O	and	_	0	SENT_179	[p13l446t724r578b785],
12	at	IN	O	at	_	0	SENT_179	[p13l618t739r683b785],
13	steady	JJ	O	steady	amod	15	SENT_179	[p13l721t724r1170b800],
14	—	JJ	O	—	amod	15	SENT_179	[p13l721t724r1170b800],
15	state	NN	O	state	conj_and	10	SENT_179	[p13l721t724r1170b800],
16	,	,	O	,	_	0	SENT_179	[p13l721t724r1170b800],
17	after	IN	O	after	_	0	SENT_179	[p13l1213t724r1377b785],
18	at	IN	DURATION	at	quantmod	20	SENT_179	[p13l1414t739r1479b785],
19	least	JJS	DURATION	least	mwe	18	SENT_179	[p13l1516t724r1678b785],
20	1	CD	DURATION	1	num	21	SENT_179	[p13l1724t727r1749b784],
21	month	NN	NUMBER	month	prep_after	3	SENT_179	[p13l1796t724r2037b785],
22	of	IN	O	of	_	0	SENT_179	[p13l2076t724r2153b785],
23	antiretroviral	JJ	O	antiretroviral	amod	24	SENT_179	[p13l12t818r484b878],
24	treatment	NN	O	treatment	prep_of	21	SENT_179	[p13l518t832r893b878],
25	.	.	O	.	_	0	SENT_179	[p13l518t832r893b878],

1	We	PRP	O	we	nsubj	4	SENT_180	[p13l931t819r1054b878],
2	did	VBD	O	do	aux	4	SENT_180	[p13l1091t818r1206b878],
3	not	RB	O	not	neg	4	SENT_180	[p13l1240t832r1361b878],
4	identify	VB	O	identify	_	0	SENT_180	[p13l1395t818r1672b894],
5	any	DT	O	any	det	6	SENT_180	[p13l1706t838r1832b894],
6	relation	NN	O	relation	nsubj	30	SENT_180	[p13l1866t818r2143b878],
7	between	IN	O	between	_	0	SENT_180	[p13l9t910r313b971],
8	baseline	NN	O	baseline	nn	10	SENT_180	[p13l382t910r675b971],
9	CYP3A	NN	O	cyp3a	nn	10	SENT_180	[p13l750t910r1033b971],
10	activity	NN	O	activity	prep_between	6	SENT_180	[p13l1104t910r1365b986],
11	and	CC	O	and	_	0	SENT_180	[p13l1436t910r1569b971],
12	MDR1	NN	O	mdr1	nn	15	SENT_180	[p13l1636t911r1883b970],
13	3435	CD	DATE	3435	num	15	SENT_180	[p13l1961t913r2138b971],
14	genotype	NN	O	genotype	nn	15	SENT_180	[p13l10t1018r339b1079],
15	(	NN	O	(	conj_and	10	SENT_180	[p13l371t1004r643b1079],
16	p	NN	O	p	nn	18	SENT_180	[p13l371t1004r643b1079],
17	=	JJ	O	=	amod	18	SENT_180	[p13l371t1004r643b1079],
18	O-9	NN	O	o-9	dep	10	SENT_180	[p13l371t1004r643b1079],
19	)	CD	NUMBER	)	dep	18	SENT_180	[p13l371t1004r643b1079],
20	or	CC	O	or	_	0	SENT_180	[p13l676t1023r751b1064],
21	drug	NN	O	drug	nn	22	SENT_180	[p13l775t1003r943b1079],
22	concentrations	NNS	O	concentration	prep_between	6	SENT_180	[p13l968t1004r1504b1064],
23	in	IN	O	in	_	0	SENT_180	[p13l1530t1004r1599b1063],
24	plasma	NN	O	plasma	prep_in	22	SENT_180	[p13l1622t1003r1878b1079],
25	during	IN	O	during	_	0	SENT_180	[p13l1905t1003r2145b1079],
26	subsequent	JJ	O	subsequent	amod	29	SENT_180	[p13l12t1097r424b1173],
27	treatment	NN	O	treatment	nn	29	SENT_180	[p13l522t1111r879b1157],
28	(	NN	O	(	nn	29	SENT_180	[p13l984t1097r1322b1172],
29	r	NN	O	r	prep_during	24	SENT_180	[p13l984t1097r1322b1172],
30	=	JJ	O	=	xcomp	4	SENT_180	[p13l984t1097r1322b1172],
31	.	.	O	.	_	0	SENT_180	[p13l984t1097r1322b1172],

1	—	NN	O	—	_	0	SENT_181	[p13l984t1097r1322b1172],
2	.	.	O	.	_	0	SENT_181	[p13l984t1097r1322b1172],

1	O-05	NNP	O	O-05	_	0	SENT_182	[p13l984t1097r1322b1172],
2	,	,	O	,	_	0	SENT_182	[p13l984t1097r1322b1172],
3	p	NN	O	p	appos	1	SENT_182	[p13l1424t1097r1696b1173],
4	=	JJ	O	=	amod	6	SENT_182	[p13l1424t1097r1696b1173],
5	O-9	NN	O	o-9	nn	6	SENT_182	[p13l1424t1097r1696b1173],
6	)	NN	O	)	dep	3	SENT_182	[p13l1424t1097r1696b1173],
7	.	.	O	.	_	0	SENT_182	[p13l1424t1097r1696b1173],

1	Efavirenz	NNP	O	Efavirenz	nsubj	2	SENT_183	[p13l1801t1097r2143b1157],
2	induced	VBD	O	induce	_	0	SENT_183	[p13l10t1188r304b1249],
3	CYP3A	NN	O	cyp3a	nn	4	SENT_183	[p13l374t1188r658b1249],
4	function	NN	O	function	dobj	2	SENT_183	[p13l723t1188r1050b1260],
5	,	,	O	,	_	0	SENT_183	[p13l723t1188r1050b1260],
6	whereas	IN	O	whereas	mark	9	SENT_183	[p13l1119t1188r1411b1249],
7	nelﬁnavir	NN	O	nelﬁnavir	nn	9	SENT_183	[p13l1478t1188r1823b1249],
8	limited	JJ	O	limited	amod	9	SENT_183	[p13l1888t1188r2143b1249],
9	conversion	NN	O	conversion	advcl	2	SENT_183	[p13l12t1282r405b1342],
10	of	IN	O	of	_	0	SENT_183	[p13l439t1281r516b1342],
11	midazolam	NN	O	midazolam	prep_of	9	SENT_183	[p13l538t1281r941b1342],
12	to	TO	O	to	dep	9	SENT_183	[p13l973t1295r1042b1342],
13	its	PRP$	O	its	poss	14	SENT_183	[p13l1077t1282r1156b1342],
14	metabolite	NN	O	metabolite	pobj	12	SENT_183	[p13l1191t1281r1596b1342],
15	.	.	O	.	_	0	SENT_183	[p13l1191t1281r1596b1342],

1	There	EX	O	there	expl	2	SENT_184	[p13l1633t1281r1854b1342],
2	was	VBD	O	be	_	0	SENT_184	[p13l1885t1301r2018b1342],
3	no	DT	O	no	det	4	SENT_184	[p13l2051t1301r2141b1342],
4	correlation	NN	O	correlation	nsubj	2	SENT_184	[p13l12t1375r406b1435],
5	between	IN	O	between	_	0	SENT_184	[p13l435t1375r739b1435],
6	efavirenz	NN	O	efavirenz	nn	9	SENT_184	[p13l772t1375r1094b1435],
7	or	CC	O	or	_	0	SENT_184	[p13l1127t1394r1202b1435],
8	nelﬁnavir	NN	O	nelﬁnavir	nn	9	SENT_184	[p13l1231t1375r1575b1435],
9	concentrations	NNS	O	concentration	prep_between	4	SENT_184	[p13l1606t1375r2142b1435],
10	in	IN	O	in	_	0	SENT_184	[p13l10t1467r79b1527],
11	plasma	NN	O	plasma	prep_in	9	SENT_184	[p13l126t1467r382b1543],
12	and	CC	O	and	_	0	SENT_184	[p13l432t1467r565b1528],
13	rate	NN	O	rate	conj_and	11	SENT_184	[p13l613t1481r749b1528],
14	of	IN	O	of	_	0	SENT_184	[p13l799t1467r877b1528],
15	midazolam	NN	O	midazolam	nn	16	SENT_184	[p13l915t1467r1317b1528],
16	metabolism	NN	O	metabolism	prep_of	4	SENT_184	[p13l1365t1467r1790b1528],
17	(	CD	NUMBER	(	num	16	SENT_184	[p13l1844t1467r2140b1542],
18	r	NN	O	r	nn	20	SENT_184	[p13l1844t1467r2140b1542],
19	=	JJ	O	=	amod	20	SENT_184	[p13l1844t1467r2140b1542],
20	O-12	NN	O	o-12	dep	4	SENT_184	[p13l1844t1467r2140b1542],
21	,	,	O	,	_	0	SENT_184	[p13l1844t1467r2140b1542],
22	p	NN	O	p	nn	24	SENT_184	[p13l9t1563r251b1636],
23	=	JJ	O	=	amod	24	SENT_184	[p13l9t1563r251b1636],
24	O-4	NN	O	o-4	nsubj	2	SENT_184	[p13l9t1563r251b1636],
25	;	:	O	;	_	0	SENT_184	[p13l9t1563r251b1636],
26	and	CC	O	and	_	0	SENT_184	[p13l297t1560r430b1621],
27	r	NN	O	r	conj_and	4	SENT_184	[p13l473t1563r783b1633],
28	=	JJ	O	=	amod	27	SENT_184	[p13l473t1563r783b1633],
29	.	.	O	.	_	0	SENT_184	[p13l473t1563r783b1633],

1	—	NN	O	—	_	0	SENT_185	[p13l473t1563r783b1633],
2	.	.	O	.	_	0	SENT_185	[p13l473t1563r783b1633],

1	O-17	NN	O	o-17	_	0	SENT_186	[p13l473t1563r783b1633],
2	,	,	O	,	_	0	SENT_186	[p13l473t1563r783b1633],
3	p	NN	O	p	appos	1	SENT_186	[p13l826t1563r1068b1636],
4	=	JJ	O	=	amod	3	SENT_186	[p13l826t1563r1068b1636],
5	0-8	CD	NUMBER	0-8	tmod	4	SENT_186	[p13l826t1563r1068b1636],
6	,	,	O	,	_	0	SENT_186	[p13l826t1563r1068b1636],
7	respectively	RB	O	respectively	advmod	8	SENT_186	[p13l1113t1560r1589b1636],
8	)	CD	NUMBER	)	appos	1	SENT_186	[p13l1113t1560r1589b1636],
9	.	.	O	.	_	0	SENT_186	[p13l1113t1560r1589b1636],

1	However	RB	O	however	advmod	17	SENT_187	[p13l1636t1561r1986b1633],
2	,	,	O	,	_	0	SENT_187	[p13l1636t1561r1986b1633],
3	the	DT	O	the	det	4	SENT_187	[p13l2031t1560r2142b1621],
4	fact	NN	O	fact	nsubj	17	SENT_187	[p13l10t1654r143b1714],
5	that	IN	O	that	complm	11	SENT_187	[p13l172t1654r315b1714],
6	midazolam	NN	O	midazolam	nn	7	SENT_187	[p13l344t1654r746b1714],
7	hydroxylation	NN	O	hydroxylation	nsubjpass	11	SENT_187	[p13l775t1654r1281b1730],
8	was	VBD	O	be	auxpass	11	SENT_187	[p13l1310t1674r1442b1714],
9	almost	RB	O	almost	advmod	10	SENT_187	[p13l1476t1654r1716b1714],
10	completely	RB	O	completely	advmod	11	SENT_187	[p13l1747t1654r2145b1730],
11	inhibited	VBN	O	inhibit	dep	4	SENT_187	[p13l10t1746r336b1807],
12	by	IN	O	by	_	0	SENT_187	[p13l387t1746r475b1822],
13	nelﬁnavir	NN	O	nelﬁnavir	agent	11	SENT_187	[p13l524t1746r868b1807],
14	does	VBZ	O	do	aux	17	SENT_187	[p13l920t1746r1081b1807],
15	not	RB	O	not	neg	17	SENT_187	[p13l1134t1760r1255b1807],
16	necessarily	RB	O	necessarily	advmod	17	SENT_187	[p13l1305t1746r1698b1822],
17	prove	VB	O	prove	_	0	SENT_187	[p13l1747t1766r1949b1822],
18	that	IN	O	that	complm	28	SENT_187	[p13l2001t1746r2144b1807],
19	metabolism	NN	O	metabolism	nsubjpass	28	SENT_187	[p13l10t1839r435b1900],
20	of	IN	O	of	_	0	SENT_187	[p13l505t1839r583b1900],
21	nelﬁnavir	NN	O	nelﬁnavir	prep_of	19	SENT_187	[p13l641t1839r985b1900],
22	by	IN	O	by	_	0	SENT_187	[p13l1050t1839r1138b1915],
23	CYP3A	NN	O	cyp3a	prep_by	21	SENT_187	[p13l1208t1840r1492b1900],
24	would	MD	O	would	aux	28	SENT_187	[p13l1556t1839r1783b1900],
25	also	RB	O	also	advmod	28	SENT_187	[p13l1853t1839r1989b1900],
26	be	VB	O	be	auxpass	28	SENT_187	[p13l2058t1839r2142b1900],
27	completely	RB	O	completely	advmod	28	SENT_187	[p13l12t1933r410b2009],
28	inhibited	VBN	O	inhibit	ccomp	17	SENT_187	[p13l435t1933r780b1993],
29	.	.	O	.	_	0	SENT_187	[p13l435t1933r780b1993],

1	Drug	NN	O	drug	nn	2	SENT_188	[p13l96t2026r288b2101],
2	concentrations	NNS	O	concentration	nsubjpass	7	SENT_188	[p13l320t2025r856b2086],
3	in	IN	O	in	_	0	SENT_188	[p13l889t2025r958b2085],
4	plasma	NN	O	plasma	prep_in	2	SENT_188	[p13l988t2025r1245b2101],
5	could	MD	O	could	aux	7	SENT_188	[p13l1278t2025r1479b2086],
6	be	VB	O	be	auxpass	7	SENT_188	[p13l1510t2025r1594b2086],
7	predicted	VBN	O	predict	_	0	SENT_188	[p13l1626t2025r1971b2101],
8	to	TO	O	to	_	0	SENT_188	[p13l2002t2039r2072b2086],
9	a	DT	O	a	det	11	SENT_188	[p13l2108t2045r2143b2086],
10	certain	JJ	O	certain	amod	11	SENT_188	[p13l12t2119r259b2179],
11	extent	NN	O	extent	prep_to	7	SENT_188	[p13l314t2132r537b2179],
12	by	IN	O	by	_	0	SENT_188	[p13l589t2118r677b2194],
13	the	DT	O	the	det	16	SENT_188	[p13l728t2118r840b2179],
14	noted	VBN	O	note	amod	16	SENT_188	[p13l894t2118r1102b2179],
15	genetic	JJ	O	genetic	amod	16	SENT_188	[p13l1156t2119r1414b2194],
16	variation	NN	O	variation	agent	7	SENT_188	[p13l1467t2118r1788b2179],
17	between	IN	O	between	_	0	SENT_188	[p13l1840t2118r2144b2179],
18	MDR1	NN	O	mdr1	prep_between	16	SENT_188	[p13l7t2213r255b2271],
19	and	CC	O	and	_	0	SENT_188	[p13l296t2212r429b2272],
20	CYPZD6	NN	O	cypzd6	nn	23	SENT_188	[p13l466t2212r791b2272],
21	(	CD	NUMBER	(	num	23	SENT_188	[p13l828t2212r1080b2287],
22	table	NN	O	table	nn	23	SENT_188	[p13l828t2212r1080b2287],
23	)	NN	O	)	conj_and	18	SENT_188	[p13l828t2212r1080b2287],
24	.	.	O	.	_	0	SENT_188	[p13l828t2212r1080b2287],

1	This	DT	O	this	det	2	SENT_189	[p13l1124t2212r1288b2272],
2	possibility	NN	O	possibility	nsubj	4	SENT_189	[p13l1323t2212r1692b2288],
3	was	VBD	O	be	cop	4	SENT_189	[p13l1723t2232r1856b2272],
4	further	JJ	O	further	_	0	SENT_189	[p13l1892t2212r2145b2272],
5	explored	VBN	O	explore	partmod	4	SENT_189	[p13l12t2304r326b2380],
6	by	IN	O	by	_	0	SENT_189	[p13l386t2304r475b2380],
7	logistic	JJ	O	logistic	amod	10	SENT_189	[p13l535t2304r1191b2380],
8	—	NN	O	—	nn	10	SENT_189	[p13l535t2304r1191b2380],
9	regression	NN	O	regression	nn	10	SENT_189	[p13l535t2304r1191b2380],
10	analysis	NN	O	analysis	agent	5	SENT_189	[p13l1255t2304r1531b2380],
11	including	VBG	O	include	_	0	SENT_189	[p13l1595t2304r1938b2380],
12	age	NN	O	age	prep_including	10	SENT_189	[p13l2000t2324r2140b2380],
13	,	,	O	,	_	0	SENT_189	[p13l2000t2324r2140b2380],
14	sex	NN	O	sex	conj_and	12	SENT_189	[p13l12t2417r145b2470],
15	,	,	O	,	_	0	SENT_189	[p13l12t2417r145b2470],
16	weight	NN	O	weight	conj_and	12	SENT_189	[p13l214t2397r476b2473],
17	,	,	O	,	_	0	SENT_189	[p13l214t2397r476b2473],
18	MDR1	NN	O	mdr1	conj_and	12	SENT_189	[p13l542t2398r790b2457],
19	3435	CD	NUMBER	3435	num	18	SENT_189	[p13l864t2400r1068b2470],
20	,	,	O	,	_	0	SENT_189	[p13l864t2400r1068b2470],
21	CYPZD6	NN	O	cypzd6	prep_including	10	SENT_189	[p13l1140t2398r1484b2470],
22	,	,	O	,	_	0	SENT_189	[p13l1140t2398r1484b2470],
23	CYPZCI9	NN	O	cypzci9	prep_including	10	SENT_189	[p13l1556t2398r1938b2470],
24	,	,	O	,	_	0	SENT_189	[p13l1556t2398r1938b2470],
25	and	CC	O	and	_	0	SENT_189	[p13l2010t2397r2143b2458],
26	CYP3A4	NN	O	cyp3a4	nn	28	SENT_189	[p13l13t2491r504b2551],
27	*	CD	NUMBER	*	num	28	SENT_189	[p13l13t2491r504b2551],
28	1B	NN	O	1b	conj_and	12	SENT_189	[p13l13t2491r504b2551],
29	.	.	O	.	_	0	SENT_189	[p13l13t2491r504b2551],

1	Drug	NN	O	drug	nn	2	SENT_190	[p13l553t2492r745b2567],
2	concentrations	NNS	O	concentration	nsubjpass	10	SENT_190	[p13l788t2491r1323b2551],
3	in	IN	O	in	_	0	SENT_190	[p13l1368t2491r1436b2550],
4	plasma	NN	O	plasma	prep_in	2	SENT_190	[p13l1477t2491r1734b2567],
5	above	IN	O	above	_	0	SENT_190	[p13l1779t2491r1987b2551],
6	the	DT	O	the	det	8	SENT_190	[p13l2031t2491r2142b2551],
7	50th	JJ	ORDINAL	50th	amod	8	SENT_190	[p13l14t2583r177b2644],
8	percentile	NN	O	percentile	prep_above	4	SENT_190	[p13l220t2583r578b2659],
9	were	VBD	O	be	auxpass	10	SENT_190	[p13l622t2603r793b2644],
10	associated	VBN	O	associate	_	0	SENT_190	[p13l840t2583r1208b2644],
11	with	IN	O	with	_	0	SENT_190	[p13l1251t2583r1411b2644],
12	both	DT	O	both	det	16	SENT_190	[p13l1453t2583r1621b2644],
13	MDR1	NN	O	mdr1	nn	16	SENT_190	[p13l1662t2584r1909b2643],
14	3435	CD	NUMBER	3435	num	16	SENT_190	[p13l1961t2586r2138b2644],
15	CC	NN	O	cc	nn	16	SENT_190	[p13l14t2677r136b2737],
16	genotype	NN	O	genotype	prep_with	10	SENT_190	[p13l191t2691r520b2752],
17	(	CD	NUMBER	(	num	18	SENT_190	[p13l578t2676r776b2752],
18	odds	NNS	O	odds	dep	16	SENT_190	[p13l578t2676r776b2752],
19	ratio	NN	O	ratio	dep	16	SENT_190	[p13l829t2677r994b2737],
20	7-9	CD	NUMBER	7-9	num	19	SENT_190	[p13l1049t2679r1183b2749],
21	,	,	O	,	_	0	SENT_190	[p13l1049t2679r1183b2749],
22	95	CD	PERCENT	95	number	23	SENT_190	[p13l1240t2676r1400b2739],
23	%	NN	PERCENT	%	amod	24	SENT_190	[p13l1240t2676r1400b2739],
24	CI	NN	O	ci	conj_and	16	SENT_190	[p13l1459t2677r1551b2737],
25	21-302	CD	NUMBER	21-302	num	26	SENT_190	[p13l1605t2677r1951b2751],
26	)	NN	O	)	dep	24	SENT_190	[p13l1605t2677r1951b2751],
27	and	CC	O	and	_	0	SENT_190	[p13l2010t2676r2143b2737],
28	CYPZD6	NN	O	cypzd6	nn	30	SENT_190	[p13l13t2770r338b2830],
29	poor-metaboliser	NN	O	poor-metaboliser	nn	30	SENT_190	[p13l360t2770r989b2846],
30	genotype	NN	O	genotype	conj_and	16	SENT_190	[p13l1014t2784r1342b2846],
31	(	CD	NUMBER	(	num	32	SENT_190	[p13l1376t2770r1539b2845],
32	4-5	CD	NUMBER	4-5	dep	30	SENT_190	[p13l1376t2770r1539b2845],
33	,	,	O	,	_	0	SENT_190	[p13l1376t2770r1539b2845],
34	1-5-13-8	CD	DATE	1-5-13-8	num	35	SENT_190	[p13l1579t2770r1944b2845],
35	)	NN	O	)	appos	32	SENT_190	[p13l1579t2770r1944b2845],
36	.	.	O	.	_	0	SENT_190	[p13l1579t2770r1944b2845],

1	To	TO	O	to	aux	2	SENT_191	[p13l95t2863r200b2923],
2	investigate	VB	O	investigate	purpcl	22	SENT_191	[p13l259t2862r642b2938],
3	whether	IN	O	whether	complm	8	SENT_191	[p13l698t2862r995b2923],
4	MDR1	NN	O	mdr1	nsubj	8	SENT_191	[p13l1045t2863r1293b2922],
5	3435	CD	NUMBER	3435	num	7	SENT_191	[p13l1356t2865r1534b2923],
6	allelic	JJ	O	allelic	amod	7	SENT_191	[p13l1596t2862r1802b2923],
7	variants	NNS	O	variant	dep	4	SENT_191	[p13l1858t2862r2141b2923],
8	predicted	VBD	O	predict	ccomp	2	SENT_191	[p13l9t2955r354b3031],
9	not	RB	O	not	neg	12	SENT_191	[p13l385t2970r507b3016],
10	only	RB	O	only	advmod	12	SENT_191	[p13l539t2955r694b3031],
11	drug	NN	O	drug	nn	12	SENT_191	[p13l726t2955r894b3031],
12	concentration	NN	O	concentration	dobj	8	SENT_191	[p13l927t2956r1431b3016],
13	in	IN	O	in	_	0	SENT_191	[p13l1462t2956r1531b3015],
14	plasma	NN	O	plasma	prep_in	12	SENT_191	[p13l1562t2955r1818b3031],
15	but	CC	O	but	_	0	SENT_191	[p13l1849t2955r1972b3016],
16	also	RB	O	also	advmod	12	SENT_191	[p13l2005t2955r2141b3016],
17	response	NN	O	response	dobj	8	SENT_191	[p13l10t3068r327b3125],
18	to	TO	O	to	_	0	SENT_191	[p13l368t3063r438b3109],
19	treatment	NN	O	treatment	prep_to	17	SENT_191	[p13l480t3063r858b3122],
20	,	,	O	,	_	0	SENT_191	[p13l480t3063r858b3122],
21	we	PRP	O	we	nsubj	22	SENT_191	[p13l901t3069r999b3109],
22	assessed	VBD	O	assess	_	0	SENT_191	[p13l1043t3049r1342b3109],
23	viraemia	NN	O	viraemia	dobj	22	SENT_191	[p13l1381t3049r1691b3109],
24	and	CC	O	and	_	0	SENT_191	[p13l1735t3049r1867b3109],
25	rise	NN	O	rise	conj_and	23	SENT_191	[p13l1909t3049r2033b3109],
26	in	IN	O	in	_	0	SENT_191	[p13l2075t3049r2143b3108],
27	CD4-cell	JJ	O	cd4-cell	amod	28	SENT_191	[p13l14t3141r347b3202],
28	count	NN	O	count	prep_in	22	SENT_191	[p13l379t3155r585b3202],
29	after	IN	O	after	_	0	SENT_191	[p13l615t3141r779b3202],
30	initiation	NN	O	initiation	prep_after	22	SENT_191	[p13l806t3141r1135b3202],
31	of	IN	O	of	_	0	SENT_191	[p13l1165t3141r1242b3202],
32	antiretroviral	JJ	O	antiretroviral	amod	33	SENT_191	[p13l1262t3141r1734b3202],
33	treatment	NN	O	treatment	prep_of	30	SENT_191	[p13l1763t3155r2137b3202],
34	.	.	O	.	_	0	SENT_191	[p13l1763t3155r2137b3202],

1	Patients	NNS	O	patient	nsubj	8	SENT_192	[p13l11t3235r301b3295],
2	with	IN	O	with	_	0	SENT_192	[p13l356t3234r515b3295],
3	the	DT	O	the	det	5	SENT_192	[p13l568t3234r680b3295],
4	various	JJ	O	various	amod	5	SENT_192	[p13l733t3235r994b3295],
5	MDR1	NN	O	mdr1	prep_with	1	SENT_192	[p13l1047t3235r1294b3294],
6	3435	CD	NUMBER	3435	num	7	SENT_192	[p13l1356t3237r1533b3295],
7	genotypes	NNS	O	genotype	dep	5	SENT_192	[p13l1592t3249r1953b3310],
8	had	VBD	O	have	_	0	SENT_192	[p13l2008t3234r2143b3295],
9	similar	JJ	O	similar	amod	10	SENT_192	[p13l12t3328r257b3388],
10	CD4-cell	JJ	O	cd4-cell	amod	11	SENT_192	[p13l309t3328r643b3388],
11	counts	NNS	O	count	dobj	8	SENT_192	[p13l695t3342r934b3388],
12	before	RB	O	before	prep	8	SENT_192	[p13l984t3328r1213b3388],
13	initiation	NN	O	initiation	pobj	12	SENT_192	[p13l1264t3328r1593b3388],
14	of	IN	O	of	_	0	SENT_192	[p13l1645t3328r1723b3388],
15	treatment	NN	O	treatment	prep_of	13	SENT_192	[p13l1763t3342r2137b3388],
16	.	.	O	.	_	0	SENT_192	[p13l1763t3342r2137b3388],

1	Mean	NN	O	mean	nsubj	11	SENT_193	[p14l10t24r222b84],
2	(	CD	NUMBER	(	num	3	SENT_193	[p14l281t23r452b98],
3	SD	NN	O	sd	dep	1	SENT_193	[p14l281t23r452b98],
4	)	CD	NUMBER	)	num	6	SENT_193	[p14l281t23r452b98],
5	CD4	NN	O	cd4	nn	6	SENT_193	[p14l515t23r692b84],
6	count	NN	O	count	dep	1	SENT_193	[p14l748t37r955b84],
7	at	IN	O	at	_	0	SENT_193	[p14l1010t37r1075b84],
8	baseline	NN	O	baseline	prep_at	6	SENT_193	[p14l1126t23r1419b84],
9	was	VBD	O	be	cop	11	SENT_193	[p14l1471t43r1604b84],
10	163	CD	NUMBER	163	num	11	SENT_193	[p14l1668t26r1793b84],
11	cells/p	NNS	O	cells/p	_	0	SENT_193	[p14l1851t23r2146b100],
12	.	.	O	.	_	0	SENT_193	[p14l1851t23r2146b100],

1	L	NN	O	l	_	0	SENT_194	[p14l1851t23r2146b100],
2	(	CD	NUMBER	(	number	3	SENT_194	[p14l16t117r206b192],
3	139	CD	NUMBER	139	num	4	SENT_194	[p14l16t117r206b192],
4	)	NN	O	)	dep	1	SENT_194	[p14l16t117r206b192],
5	in	IN	O	in	_	0	SENT_194	[p14l262t117r330b176],
6	patients	NNS	O	patient	prep_in	4	SENT_194	[p14l378t117r664b192],
7	with	IN	O	with	_	0	SENT_194	[p14l713t116r873b177],
8	the	DT	O	the	det	12	SENT_194	[p14l921t116r1032b177],
9	MDRI	NNP	O	MDRI	nn	12	SENT_194	[p14l1079t117r1327b176],
10	3435	CD	NUMBER	3435	num	12	SENT_194	[p14l1382t119r1560b177],
11	TT	NN	O	tt	nn	12	SENT_194	[p14l1613t117r1740b176],
12	genotype	NN	O	genotype	prep_with	6	SENT_194	[p14l1789t131r2140b192],
13	,	,	O	,	_	0	SENT_194	[p14l1789t131r2140b192],
14	194	CD	NUMBER	194	num	15	SENT_194	[p14l19t212r146b270],
15	cells/p	NNS	O	cells/p	appos	12	SENT_194	[p14l189t210r483b287],
16	.	.	O	.	_	0	SENT_194	[p14l189t210r483b287],

1	L	NN	O	l	_	0	SENT_195	[p14l189t210r483b287],
2	(	CD	NUMBER	(	number	3	SENT_195	[p14l525t210r716b285],
3	156	CD	NUMBER	156	num	4	SENT_195	[p14l525t210r716b285],
4	)	NN	O	)	dep	1	SENT_195	[p14l525t210r716b285],
5	in	IN	O	in	_	0	SENT_195	[p14l761t210r830b269],
6	those	DT	O	those	prep_in	4	SENT_195	[p14l868t210r1059b270],
7	with	IN	O	with	_	0	SENT_195	[p14l1098t210r1257b270],
8	the	DT	O	the	det	10	SENT_195	[p14l1296t210r1408b270],
9	CT	NNP	O	CT	nn	10	SENT_195	[p14l1451t210r1576b270],
10	genotype	NN	O	genotype	prep_with	6	SENT_195	[p14l1615t224r1966b286],
11	,	,	O	,	_	0	SENT_195	[p14l1615t224r1966b286],
12	and	CC	O	and	_	0	SENT_195	[p14l2010t210r2143b270],
13	175	CD	NUMBER	175	num	14	SENT_195	[p14l19t305r143b363],
14	cells/p	NNS	O	cells/p	dep	1	SENT_195	[p14l213t302r508b379],
15	.	.	O	.	_	0	SENT_195	[p14l213t302r508b379],

1	L	NN	O	l	_	0	SENT_196	[p14l213t302r508b379],
2	(	CD	NUMBER	(	num	1	SENT_196	[p14l574t302r764b377],
3	162	CD	NUMBER	162	num	4	SENT_196	[p14l574t302r764b377],
4	)	NN	O	)	dep	1	SENT_196	[p14l574t302r764b377],
5	in	IN	O	in	_	0	SENT_196	[p14l835t302r903b362],
6	those	DT	O	those	prep_in	4	SENT_196	[p14l966t302r1158b363],
7	with	IN	O	with	_	0	SENT_196	[p14l1222t302r1381b363],
8	the	DT	O	the	det	10	SENT_196	[p14l1444t302r1555b363],
9	CC	NN	O	cc	nn	10	SENT_196	[p14l1623t302r1746b363],
10	genotype	NN	O	genotype	prep_with	6	SENT_196	[p14l1814t316r2142b378],
11	(	NN	O	(	nn	12	SENT_196	[p14l16t396r314b471],
12	p	NN	O	p	dep	1	SENT_196	[p14l16t396r314b471],
13	=	JJ	O	=	amod	15	SENT_196	[p14l16t396r314b471],
14	0-6	CD	NUMBER	0-6	tmod	13	SENT_196	[p14l16t396r314b471],
15	)	NN	O	)	dep	12	SENT_196	[p14l16t396r314b471],
16	.	.	O	.	_	0	SENT_196	[p14l16t396r314b471],

1	Mean	NN	O	mean	nsubj	3	SENT_197	[p14l347t396r559b456],
2	(	CD	NUMBER	(	num	3	SENT_197	[p14l592t396r763b471],
3	SD	NN	O	sd	_	0	SENT_197	[p14l592t396r763b471],
4	)	CD	NUMBER	)	num	6	SENT_197	[p14l592t396r763b471],
5	viral	JJ	O	viral	amod	6	SENT_197	[p14l796t395r952b456],
6	load	NN	O	load	nsubj	20	SENT_197	[p14l981t395r1135b456],
7	at	IN	O	at	_	0	SENT_197	[p14l1165t410r1229b456],
8	baseline	NN	O	baseline	prep_at	6	SENT_197	[p14l1255t395r1548b456],
9	in	IN	O	in	_	0	SENT_197	[p14l1576t396r1645b455],
10	patients	NNS	O	patient	prep_in	8	SENT_197	[p14l1671t396r1956b471],
11	with	IN	O	with	_	0	SENT_197	[p14l1984t395r2143b456],
12	the	DT	O	the	det	16	SENT_197	[p14l10t489r121b549],
13	MDRI	NNP	O	MDRI	nn	16	SENT_197	[p14l157t490r405b548],
14	3435	CD	NUMBER	3435	num	16	SENT_197	[p14l449t491r626b549],
15	TT	NN	O	tt	nn	16	SENT_197	[p14l668t490r795b548],
16	genotype	NN	O	genotype	prep_with	10	SENT_197	[p14l833t503r1161b565],
17	was	VBD	O	be	cop	20	SENT_197	[p14l1198t509r1331b549],
18	5-37	CD	NUMBER	5-37	num	20	SENT_197	[p14l1373t491r1528b549],
19	log	NN	O	log	nn	20	SENT_197	[p14l1570t489r1724b566],
20	“	NN	O	“	rcmod	3	SENT_197	[p14l1570t489r1724b566],
21	,	,	O	,	_	0	SENT_197	[p14l1570t489r1724b566],
22	copies/mL	NN	O	copies/ml	conj_and	20	SENT_197	[p14l1764t489r2146b565],
23	(	CD	NUMBER	(	num	22	SENT_197	[p14l16t582r259b656],
24	0-54	CD	NUMBER	0-54	num	25	SENT_197	[p14l16t582r259b656],
25	)	NN	O	)	dep	22	SENT_197	[p14l16t582r259b656],
26	,	,	O	,	_	0	SENT_197	[p14l16t582r259b656],
27	5-01	CD	NUMBER	5-01	num	29	SENT_197	[p14l307t584r456b642],
28	log	NN	O	log	nn	29	SENT_197	[p14l507t581r661b658],
29	“	NN	O	“	conj_and	20	SENT_197	[p14l507t581r661b658],
30	,	,	O	,	_	0	SENT_197	[p14l507t581r661b658],
31	copies/mL	NN	O	copies/ml	conj_and	20	SENT_197	[p14l705t581r1087b657],
32	(	CD	NUMBER	(	num	31	SENT_197	[p14l1131t581r1346b656],
33	0-60	CD	NUMBER	0-60	num	34	SENT_197	[p14l1131t581r1346b656],
34	)	NN	O	)	dep	31	SENT_197	[p14l1131t581r1346b656],
35	in	IN	O	in	_	0	SENT_197	[p14l1394t581r1463b641],
36	patients	NNS	O	patient	prep_in	34	SENT_197	[p14l1503t581r1788b657],
37	with	IN	O	with	_	0	SENT_197	[p14l1831t581r1989b642],
38	the	DT	O	the	det	40	SENT_197	[p14l2030t581r2142b642],
39	CT	NNP	O	CT	nn	40	SENT_197	[p14l14t675r138b735],
40	genotype	NN	O	genotype	prep_with	36	SENT_197	[p14l179t688r530b750],
41	,	,	O	,	_	0	SENT_197	[p14l179t688r530b750],
42	and	CC	O	and	_	0	SENT_197	[p14l577t674r710b735],
43	5-04	CD	NUMBER	5-04	num	45	SENT_197	[p14l754t677r911b735],
44	log	NN	O	log	nn	45	SENT_197	[p14l955t674r1109b752],
45	“	NN	O	“	rcmod	3	SENT_197	[p14l955t674r1109b752],
46	,	,	O	,	_	0	SENT_197	[p14l955t674r1109b752],
47	copies/mL	NN	O	copies/ml	nn	61	SENT_197	[p14l1152t674r1535b751],
48	(	CD	NUMBER	(	num	47	SENT_197	[p14l1579t675r1794b750],
49	0-72	CD	NUMBER	0-72	num	50	SENT_197	[p14l1579t675r1794b750],
50	)	NN	O	)	dep	47	SENT_197	[p14l1579t675r1794b750],
51	in	IN	O	in	_	0	SENT_197	[p14l1841t675r1910b734],
52	those	DT	O	those	prep_in	50	SENT_197	[p14l1950t675r2142b735],
53	with	IN	O	with	_	0	SENT_197	[p14l9t768r168b828],
54	the	DT	O	the	det	58	SENT_197	[p14l244t768r355b828],
55	CC	NN	O	cc	nn	58	SENT_197	[p14l436t768r559b828],
56	genotype	NN	O	genotype	nn	58	SENT_197	[p14l639t782r968b844],
57	(	NN	O	(	nn	58	SENT_197	[p14l1051t768r1396b844],
58	p	NN	O	p	prep_with	52	SENT_197	[p14l1051t768r1396b844],
59	=	JJ	O	=	amod	61	SENT_197	[p14l1051t768r1396b844],
60	0-07	CD	NUMBER	0-07	tmod	59	SENT_197	[p14l1051t768r1396b844],
61	)	NN	O	)	dobj	3	SENT_197	[p14l1051t768r1396b844],
62	.	.	O	.	_	0	SENT_197	[p14l1051t768r1396b844],

1	On	IN	O	on	_	0	SENT_198	[p14l1480t768r1592b828],
2	initiation	NN	O	initiation	prep_on	11	SENT_198	[p14l1669t768r1998b828],
3	of	IN	O	of	_	0	SENT_198	[p14l2075t768r2153b828],
4	antiretroviral	JJ	O	antiretroviral	amod	5	SENT_198	[p14l12t860r483b921],
5	treatment	NN	O	treatment	prep_of	2	SENT_198	[p14l544t874r921b933],
6	,	,	O	,	_	0	SENT_198	[p14l544t874r921b933],
7	all	DT	O	all	det	8	SENT_198	[p14l987t860r1067b921],
8	groups	NNS	O	group	nsubj	11	SENT_198	[p14l1129t880r1373b936],
9	of	IN	O	of	_	0	SENT_198	[p14l1437t860r1515b921],
10	patients	NNS	O	patient	prep_of	8	SENT_198	[p14l1564t860r1849b936],
11	had	VBD	O	have	_	0	SENT_198	[p14l1911t860r2045b921],
12	a	DT	O	a	det	14	SENT_198	[p14l2108t880r2143b921],
13	similar	JJ	O	similar	amod	14	SENT_198	[p14l12t953r257b1014],
14	rate	NN	O	rate	dobj	11	SENT_198	[p14l322t968r459b1014],
15	of	IN	O	of	_	0	SENT_198	[p14l528t953r606b1014],
16	Viraemia	NNP	O	Viraemia	nn	19	SENT_198	[p14l661t954r972b1014],
17	decay	NN	O	decay	nn	19	SENT_198	[p14l1041t953r1247b1029],
18	(	NN	O	(	nn	19	SENT_198	[p14l1319t953r1553b1029],
19	ﬁgure	NN	O	ﬁgure	prep_of	14	SENT_198	[p14l1319t953r1553b1029],
20	2	CD	NUMBER	2	num	21	SENT_198	[p14l1623t954r1717b1028],
21	)	NN	O	)	dep	19	SENT_198	[p14l1623t954r1717b1028],
22	.	.	O	.	_	0	SENT_198	[p14l1623t954r1717b1028],

1	However	RB	O	however	advmod	24	SENT_199	[p14l1790t954r2140b1026],
2	,	,	O	,	_	0	SENT_199	[p14l1790t954r2140b1026],
3	patients	NNS	O	patient	dep	10	SENT_199	[p14l9t1047r295b1123],
4	with	IN	O	with	_	0	SENT_199	[p14l327t1047r486b1107],
5	the	DT	O	the	det	9	SENT_199	[p14l518t1047r630b1107],
6	MDRI	NNP	O	MDRI	nn	9	SENT_199	[p14l659t1048r907b1106],
7	3435	CD	NUMBER	3435	num	9	SENT_199	[p14l945t1049r1123b1107],
8	TT	NN	O	tt	nn	9	SENT_199	[p14l1159t1048r1286b1106],
9	genotype	NN	O	genotype	prep_with	3	SENT_199	[p14l1318t1061r1646b1123],
10	had	VBD	O	have	parataxis	24	SENT_199	[p14l1678t1047r1813b1107],
11	a	DT	O	a	det	13	SENT_199	[p14l1847t1067r1882b1107],
12	higher	JJR	O	higher	amod	13	SENT_199	[p14l1913t1047r2145b1123],
13	mean	NN	O	mean	dobj	10	SENT_199	[p14l10t1159r210b1200],
14	(	CD	NUMBER	(	num	17	SENT_199	[p14l262t1139r419b1214],
15	SE	NN	O	se	nn	17	SENT_199	[p14l262t1139r419b1214],
16	)	CD	NUMBER	)	num	17	SENT_199	[p14l262t1139r419b1214],
17	CD4	NN	O	cd4	nsubj	10	SENT_199	[p14l475t1139r809b1200],
18	—	NN	O	—	nn	20	SENT_199	[p14l475t1139r809b1200],
19	cell	NN	O	cell	nn	20	SENT_199	[p14l475t1139r809b1200],
20	count	NN	O	count	nsubj	24	SENT_199	[p14l858t1153r1065b1200],
21	at	IN	O	at	_	0	SENT_199	[p14l1112t1153r1177b1200],
22	6	CD	DURATION	6	num	23	SENT_199	[p14l1226t1142r1264b1200],
23	months	NNS	NUMBER	month	prep_at	20	SENT_199	[p14l1313t1139r1585b1200],
24	(	VBP	O	(	_	0	SENT_199	[p14l1639t1140r1799b1214],
25	257	CD	NUMBER	257	num	26	SENT_199	[p14l1639t1140r1799b1214],
26	cells/p	NNS	O	cells/p	dobj	24	SENT_199	[p14l1851t1139r2146b1216],
27	.	.	O	.	_	0	SENT_199	[p14l1851t1139r2146b1216],

1	L	NN	O	l	num	5	SENT_200	[p14l1851t1139r2146b1216],
2	[	CD	NUMBER	[	number	1	SENT_200	[p14l20t1232r190b1308],
3	37	CD	NUMBER	37	number	1	SENT_200	[p14l20t1232r190b1308],
4	]	CD	NUMBER	]	number	1	SENT_200	[p14l20t1232r190b1308],
5	)	NN	O	)	nsubj	14	SENT_200	[p14l20t1232r190b1308],
6	than	IN	O	than	_	0	SENT_200	[p14l256t1232r418b1293],
7	patients	NNS	O	patient	prep_than	5	SENT_200	[p14l476t1233r762b1308],
8	with	IN	O	with	_	0	SENT_200	[p14l821t1232r980b1293],
9	the	DT	O	the	det	13	SENT_200	[p14l1039t1232r1151b1293],
10	CT	NN	O	ct	nn	13	SENT_200	[p14l1214t1233r1339b1293],
11	and	CC	O	and	_	0	SENT_200	[p14l1399t1232r1532b1293],
12	CC	NN	O	cc	conj_and	10	SENT_200	[p14l1595t1233r1717b1293],
13	genotypes	NNS	O	genotype	prep_with	7	SENT_200	[p14l1780t1246r2141b1308],
14	(	VBP	O	(	_	0	SENT_200	[p14l16t1326r175b1401],
15	165	CD	NUMBER	165	num	16	SENT_200	[p14l16t1326r175b1401],
16	cells/p	NNS	O	cells/p	dobj	14	SENT_200	[p14l228t1326r523b1403],
17	.	.	O	.	_	0	SENT_200	[p14l228t1326r523b1403],

1	L	NN	O	l	_	0	SENT_201	[p14l228t1326r523b1403],
2	[	CD	NUMBER	[	num	1	SENT_201	[p14l575t1326r709b1401],
3	20	CD	NUMBER	20	num	4	SENT_201	[p14l575t1326r709b1401],
4	]	NN	O	]	dep	1	SENT_201	[p14l575t1326r709b1401],
5	and	CC	O	and	_	0	SENT_201	[p14l767t1326r900b1386],
6	121	CD	NUMBER	121	num	7	SENT_201	[p14l956t1328r1074b1385],
7	cells/p	NNS	O	cells/p	conj_and	4	SENT_201	[p14l1131t1326r1426b1403],
8	.	.	O	.	_	0	SENT_201	[p14l1131t1326r1426b1403],

1	L	NN	O	l	_	0	SENT_202	[p14l1131t1326r1426b1403],
2	[	CD	NUMBER	[	number	3	SENT_202	[p14l1479t1326r1645b1401],
3	21	CD	NUMBER	21	num	4	SENT_202	[p14l1479t1326r1645b1401],
4	]	NN	O	]	rcmod	1	SENT_202	[p14l1479t1326r1645b1401],
5	,	,	O	,	_	0	SENT_202	[p14l1479t1326r1645b1401],
6	respectively	RB	O	respectively	advmod	4	SENT_202	[p14l1694t1326r2140b1402],
7	,	,	O	,	_	0	SENT_202	[p14l1694t1326r2140b1402],
8	p	NN	O	p	appos	1	SENT_202	[p14l9t1421r367b1494],
9	=	JJ	O	=	amod	8	SENT_202	[p14l9t1421r367b1494],
10	0-0048	CD	NUMBER	0-0048	tmod	9	SENT_202	[p14l9t1421r367b1494],
11	for	IN	O	for	_	0	SENT_202	[p14l417t1418r520b1479],
12	the	DT	O	the	det	13	SENT_202	[p14l565t1418r677b1479],
13	difference	NN	O	difference	prep_for	9	SENT_202	[p14l727t1418r1085b1479],
14	in	IN	O	in	_	0	SENT_202	[p14l1133t1418r1202b1478],
15	CD4	NN	O	cd4	nn	18	SENT_202	[p14l1252t1418r1586b1479],
16	—	NN	O	—	nn	18	SENT_202	[p14l1252t1418r1586b1479],
17	cell	NN	O	cell	nn	18	SENT_202	[p14l1252t1418r1586b1479],
18	recovery	NN	O	recovery	prep_in	13	SENT_202	[p14l1634t1438r1942b1494],
19	over	IN	O	over	_	0	SENT_202	[p14l1990t1438r2145b1479],
20	6	CD	DURATION	6	num	21	SENT_202	[p14l14t1514r51b1572],
21	months	NNS	NUMBER	month	prep_over	18	SENT_202	[p14l80t1511r376b1584],
22	;	:	O	;	_	0	SENT_202	[p14l80t1511r376b1584],
23	ﬁgure	NN	O	ﬁgure	dep	1	SENT_202	[p14l406t1511r614b1587],
24	3	CD	NUMBER	3	num	25	SENT_202	[p14l643t1512r737b1587],
25	)	NN	O	)	dep	23	SENT_202	[p14l643t1512r737b1587],
26	.	.	O	.	_	0	SENT_202	[p14l643t1512r737b1587],

1	Although	IN	O	although	mark	3	SENT_203	[p14l93t1605r437b1681],
2	CYPZD6	NN	O	cypzd6	nsubj	3	SENT_203	[p14l502t1605r827b1665],
3	predicts	VBZ	O	predict	advcl	12	SENT_203	[p14l886t1605r1175b1681],
4	drug	NN	O	drug	nn	5	SENT_203	[p14l1241t1605r1410b1681],
5	concentrations	NNS	O	concentration	dobj	3	SENT_203	[p14l1474t1605r2009b1665],
6	in	IN	O	in	_	0	SENT_203	[p14l2075t1605r2143b1664],
7	plasma	NN	O	plasma	prep_in	5	SENT_203	[p14l9t1697r287b1773],
8	,	,	O	,	_	0	SENT_203	[p14l9t1697r287b1773],
9	it	PRP	O	it	nsubj	12	SENT_203	[p14l363t1697r411b1758],
10	does	VBZ	O	do	aux	12	SENT_203	[p14l484t1697r646b1758],
11	not	RB	O	not	neg	12	SENT_203	[p14l719t1711r839b1758],
12	affect	VB	O	affect	_	0	SENT_203	[p14l912t1697r1109b1758],
13	CD4	NN	O	cd4	nn	16	SENT_203	[p14l1183t1697r1518b1758],
14	—	NN	O	—	nn	16	SENT_203	[p14l1183t1697r1518b1758],
15	cell	NN	O	cell	nn	16	SENT_203	[p14l1183t1697r1518b1758],
16	response	NN	O	response	dobj	12	SENT_203	[p14l1590t1717r1907b1773],
17	after	IN	O	after	_	0	SENT_203	[p14l1981t1697r2145b1758],
18	initiation	NN	O	initiation	prep_after	12	SENT_203	[p14l10t1790r339b1850],
19	of	IN	O	of	_	0	SENT_203	[p14l389t1789r467b1850],
20	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_203	[p14l507t1789r979b1850],
21	treatment	NN	O	treatment	prep_of	18	SENT_203	[p14l1027t1803r1403b1850],
22	.	.	O	.	_	0	SENT_203	[p14l1027t1803r1403b1850],

1	At	IN	O	at	_	0	SENT_204	[p14l1454t1790r1543b1850],
2	6	CD	DURATION	6	num	3	SENT_204	[p14l1595t1792r1632b1850],
3	months	NNS	NUMBER	month	prep_at	23	SENT_204	[p14l1683t1789r1979b1861],
4	,	,	O	,	_	0	SENT_204	[p14l1683t1789r1979b1861],
5	the	DT	O	the	det	9	SENT_204	[p14l2030t1789r2142b1850],
6	CD4	NN	O	cd4	nn	9	SENT_204	[p14l14t1883r347b1943],
7	—	NN	O	—	nn	9	SENT_204	[p14l14t1883r347b1943],
8	cell	NN	O	cell	nn	9	SENT_204	[p14l14t1883r347b1943],
9	count	NN	O	count	nsubj	23	SENT_204	[p14l401t1897r608b1943],
10	in	IN	O	in	_	0	SENT_204	[p14l659t1883r727b1942],
11	patients	NNS	O	patient	prep_in	9	SENT_204	[p14l778t1883r1063b1959],
12	with	IN	O	with	_	0	SENT_204	[p14l1115t1883r1275b1943],
13	one	CD	NUMBER	one	nn	17	SENT_204	[p14l1327t1902r1456b1943],
14	or	CC	O	or	_	0	SENT_204	[p14l1510t1903r1585b1943],
15	two	CD	NUMBER	two	nn	17	SENT_204	[p14l1634t1897r1765b1943],
16	CYPZD6	NN	O	cypzd6	nn	17	SENT_204	[p14l1821t1883r2146b1943],
17	alleles	NNS	O	allele	prep_with	11	SENT_204	[p14l12t1975r228b2036],
18	associated	VBN	O	associate	partmod	17	SENT_204	[p14l263t1975r632b2036],
19	with	IN	O	with	_	0	SENT_204	[p14l663t1975r822b2036],
20	a	DT	O	a	det	22	SENT_204	[p14l856t1995r891b2036],
21	poor-metaboliser	NN	O	poor-metaboliser	nn	22	SENT_204	[p14l922t1975r1551b2051],
22	phenotype	NN	O	phenotype	prep_with	18	SENT_204	[p14l1580t1975r1962b2051],
23	rose	VBD	O	rise	_	0	SENT_204	[p14l1995t1995r2142b2036],
24	by	IN	O	by	_	0	SENT_204	[p14l9t2068r97b2144],
25	mean	NN	O	mean	nn	27	SENT_204	[p14l182t2088r382b2129],
26	151	CD	NUMBER	151	num	27	SENT_204	[p14l478t2071r597b2129],
27	cells/pLL	NN	O	cells/pll	prep_by	23	SENT_204	[p14l695t2068r990b2146],
28	(	CD	NUMBER	(	num	29	SENT_204	[p14l1080t2069r1212b2143],
29	SE	NN	O	se	tmod	23	SENT_204	[p14l1080t2069r1212b2143],
30	23	CD	NUMBER	23	num	31	SENT_204	[p14l1301t2069r1443b2143],
31	)	NN	O	)	dep	29	SENT_204	[p14l1301t2069r1443b2143],
32	,	,	O	,	_	0	SENT_204	[p14l1301t2069r1443b2143],
33	compared	VBN	O	compare	_	0	SENT_204	[p14l1536t2068r1898b2144],
34	with	IN	O	with	prepc_compared_with	23	SENT_204	[p14l1984t2068r2143b2129],
35	192	CD	NUMBER	192	num	36	SENT_204	[p14l19t2164r145b2222],
36	cells/p	NNS	O	cells/p	pobj	23	SENT_204	[p14l179t2162r473b2239],
37	.	.	O	.	_	0	SENT_204	[p14l179t2162r473b2239],

1	L	NN	O	l	_	0	SENT_205	[p14l179t2162r473b2239],
2	(	CD	NUMBER	(	number	3	SENT_205	[p14l505t2162r649b2237],
3	20	CD	NUMBER	20	num	4	SENT_205	[p14l505t2162r649b2237],
4	)	NN	O	)	dep	1	SENT_205	[p14l505t2162r649b2237],
5	in	IN	O	in	_	0	SENT_205	[p14l685t2162r753b2221],
6	patients	NNS	O	patient	prep_in	4	SENT_205	[p14l781t2162r1066b2238],
7	with	IN	O	with	_	0	SENT_205	[p14l1096t2162r1256b2222],
8	the	DT	O	the	det	10	SENT_205	[p14l1284t2162r1396b2222],
9	CYPZD6	NN	O	cypzd6	nn	10	SENT_205	[p14l1428t2162r1753b2222],
10	extensivemetaboliser	NN	O	extensivemetaboliser	prep_with	6	SENT_205	[p14l1781t2162r2142b2222, p14l10t2254r435b2315],
11	genotype	NN	O	genotype	nn	13	SENT_205	[p14l469t2268r798b2330],
12	(	NN	O	(	nn	13	SENT_205	[p14l840t2255r1185b2330],
13	p	NN	O	p	dep	1	SENT_205	[p14l840t2255r1185b2330],
14	=	JJ	O	=	amod	16	SENT_205	[p14l840t2255r1185b2330],
15	0-25	CD	NUMBER	0-25	tmod	14	SENT_205	[p14l840t2255r1185b2330],
16	)	NN	O	)	dep	13	SENT_205	[p14l840t2255r1185b2330],
17	.	.	O	.	_	0	SENT_205	[p14l840t2255r1185b2330],

1	None	NN	O	none	nsubjpass	8	SENT_206	[p14l1224t2255r1427b2315],
2	of	IN	O	of	_	0	SENT_206	[p14l1466t2254r1543b2315],
3	the	DT	O	the	det	5	SENT_206	[p14l1568t2254r1680b2315],
4	other	JJ	O	other	amod	5	SENT_206	[p14l1718t2254r1909b2315],
5	genes	NNS	O	gene	prep_of	1	SENT_206	[p14l1943t2274r2141b2330],
6	analysed	VBN	O	analyse	partmod	5	SENT_206	[p14l12t2347r322b2423],
7	were	VBD	O	be	auxpass	8	SENT_206	[p14l406t2367r577b2408],
8	associated	VBN	O	associate	_	0	SENT_206	[p14l664t2347r1033b2408],
9	with	IN	O	with	_	0	SENT_206	[p14l1117t2347r1276b2408],
10	treatment	NN	O	treatment	nn	11	SENT_206	[p14l1360t2362r1717b2408],
11	response	NN	O	response	prep_with	8	SENT_206	[p14l1801t2367r2137b2423],
12	.	.	O	.	_	0	SENT_206	[p14l1801t2367r2137b2423],

1	Furthermore	RB	O	furthermore	advmod	6	SENT_207	[p14l10t2441r502b2514],
2	,	,	O	,	_	0	SENT_207	[p14l10t2441r502b2514],
3	no	DT	O	no	det	4	SENT_207	[p14l562t2460r652b2501],
4	correlation	NN	O	correlation	nsubjpass	6	SENT_207	[p14l712t2441r1106b2501],
5	was	VBD	O	be	auxpass	6	SENT_207	[p14l1161t2461r1293b2501],
6	noted	VBN	O	note	_	0	SENT_207	[p14l1351t2441r1559b2501],
7	between	IN	O	between	_	0	SENT_207	[p14l1615t2441r1918b2501],
8	drug	NN	O	drug	nn	9	SENT_207	[p14l1976t2441r2144b2517],
9	concentrations	NNS	O	concentration	prep_between	6	SENT_207	[p14l12t2533r547b2594],
10	in	IN	O	in	_	0	SENT_207	[p14l581t2533r649b2593],
11	plasma	NN	O	plasma	nn	15	SENT_207	[p14l678t2533r935b2609],
12	and	CC	O	and	_	0	SENT_207	[p14l967t2533r1101b2594],
13	CD4	NN	O	cd4	nn	15	SENT_207	[p14l1135t2533r1469b2594],
14	—	NN	O	—	nn	15	SENT_207	[p14l1135t2533r1469b2594],
15	cell	NN	O	cell	prep_in	9	SENT_207	[p14l1135t2533r1469b2594],
16	recovery	NN	O	recovery	nn	18	SENT_207	[p14l1500t2553r1809b2609],
17	(	CD	NUMBER	(	num	18	SENT_207	[p14l1844t2534r2139b2608],
18	r	NN	O	r	dobj	6	SENT_207	[p14l1844t2534r2139b2608],
19	=	JJ	O	=	amod	18	SENT_207	[p14l1844t2534r2139b2608],
20	0-01	CD	NUMBER	0-01	tmod	19	SENT_207	[p14l1844t2534r2139b2608],
21	,	,	O	,	_	0	SENT_207	[p14l1844t2534r2139b2608],
22	p	NN	O	p	appos	18	SENT_207	[p14l9t2627r330b2702],
23	=	JJ	O	=	amod	25	SENT_207	[p14l9t2627r330b2702],
24	0-89	CD	NUMBER	0-89	tmod	23	SENT_207	[p14l9t2627r330b2702],
25	)	NN	O	)	dep	22	SENT_207	[p14l9t2627r330b2702],
26	,	,	O	,	_	0	SENT_207	[p14l9t2627r330b2702],
27	which	WDT	O	which	nsubj	28	SENT_207	[p14l368t2626r586b2687],
28	underscores	VBZ	O	underscore	rcmod	18	SENT_207	[p14l621t2626r1058b2687],
29	the	DT	O	the	det	31	SENT_207	[p14l1096t2626r1207b2687],
30	speciﬁc	NN	O	speciﬁc	nn	31	SENT_207	[p14l1245t2626r1513b2702],
31	relevance	NN	O	relevance	dobj	28	SENT_207	[p14l1549t2626r1889b2687],
32	of	IN	O	of	_	0	SENT_207	[p14l1927t2626r2005b2687],
33	the	DT	O	the	det	35	SENT_207	[p14l2030t2626r2142b2687],
34	MDRI	NNP	O	MDRI	nn	35	SENT_207	[p14l7t2721r255b2779],
35	genotype	NN	O	genotype	prep_of	31	SENT_207	[p14l286t2733r635b2796],
36	.	.	O	.	_	0	SENT_207	[p14l286t2733r635b2796],

1	THE	DT	O	the	det	2	SENT_208	[p14l92t2897r158b2917],
2	LANCET	NN	O	lancet	_	0	SENT_208	[p14l167t2897r297b2918],
3	-	:	O	-	_	0	SENT_208	[p14l306t2904r314b2911],
4	Vol	NN	O	vol	dep	2	SENT_208	[p14l323t2897r367b2918],
5	359	CD	NUMBER	359	num	4	SENT_208	[p14l377t2898r422b2918],
6	-	:	O	-	_	0	SENT_208	[p14l434t2904r441b2911],
7	January	NNP	DATE	January	dep	4	SENT_208	[p14l449t2897r547b2923],
8	5	CD	DATE	5	num	7	SENT_208	[p14l557t2897r578b2922],
9	,	,	DATE	,	_	0	SENT_208	[p14l557t2897r578b2922],
10	2002	CD	DATE	2002	num	7	SENT_208	[p14l589t2898r651b2918],
11	-	:	O	-	_	0	SENT_208	[p14l662t2904r669b2911],
12	wWw.thelancet.com	NNP	O	wWw.thelancet.com	nn	14	SENT_208	[p14l679t2897r930b2918],
13	33	CD	NUMBER	33	num	14	SENT_208	[p14l2025t2892r2062b2918],
14	ARTICLES	NNS	O	article	dep	2	SENT_208	[p14l91t2940r244b2961],

1	A	DT	O	a	det	3	SENT_209	[p14l529t3127r577b3174],
2	TT	NN	O	tt	nn	3	SENT_209	[p14l600t3127r666b3173],
3	genotype	NN	O	genotype	_	0	SENT_209	[p14l688t3130r951b3186],
4	(	CD	NUMBER	(	num	5	SENT_209	[p14l977t3126r1169b3184],
5	n	NN	O	n	dep	3	SENT_209	[p14l977t3126r1169b3184],
6	=	JJ	O	=	amod	8	SENT_209	[p14l977t3126r1169b3184],
7	22	CD	NUMBER	22	tmod	6	SENT_209	[p14l977t3126r1169b3184],
8	)	NN	O	)	dep	5	SENT_209	[p14l977t3126r1169b3184],

1	III	NNP	O	III	nn	2	SENT_210	[p15l529t13r577b62],
2	CT	NNP	O	CT	dep	12	SENT_210	[p15l602t14r675b61],
3	genotype	NN	O	genotype	nn	5	SENT_210	[p15l696t17r959b73],
4	(	NN	O	(	nn	5	SENT_210	[p15l985t14r1177b72],
5	n	NN	O	n	dep	2	SENT_210	[p15l985t14r1177b72],
6	=	JJ	O	=	amod	5	SENT_210	[p15l985t14r1177b72],
7	54	CD	NUMBER	54	tmod	6	SENT_210	[p15l985t14r1177b72],
8	)	NN	O	)	dep	12	SENT_210	[p15l985t14r1177b72],
9	400	CD	NUMBER	400	num	8	SENT_210	[p15l248t44r381b98],
10	o	NN	O	o	nn	12	SENT_210	[p15l529t86r577b135],
11	CC	NN	O	cc	nn	12	SENT_210	[p15l602t86r681b133],
12	genotype	NN	O	genotype	_	0	SENT_210	[p15l704t89r967b145],
13	(	CD	NUMBER	(	num	14	SENT_210	[p15l993t86r1185b144],
14	n	NN	O	n	dep	12	SENT_210	[p15l993t86r1185b144],
15	=	JJ	O	=	amod	17	SENT_210	[p15l993t86r1185b144],
16	20	CD	NUMBER	20	tmod	15	SENT_210	[p15l993t86r1185b144],
17	)	NN	O	)	dep	14	SENT_210	[p15l993t86r1185b144],

1	-	:	O	-	_	0	SENT_211	[p15l24t236r74b261],
2	I-1	NN	O	i-1	nn	3	SENT_211	[p15l24t236r74b261],
3	E	NN	O	e	dep	11	SENT_211	[p15l33t265r74b339],
4	,	,	O	,	_	0	SENT_211	[p15l33t265r74b339],
5	p	NN	O	p	appos	3	SENT_211	[p15l650t279r903b336],
6	=	JJ	O	=	amod	8	SENT_211	[p15l650t279r903b336],
7	O-O04	NN	O	o-o04	nn	8	SENT_211	[p15l650t279r903b336],
8	p	NN	O	p	dep	5	SENT_211	[p15l1192t279r1443b336],
9	=	JJ	O	=	amod	11	SENT_211	[p15l1192t279r1443b336],
10	O-O06	NN	O	o-o06	nn	11	SENT_211	[p15l1192t279r1443b336],
11	p	NN	O	p	dep	13	SENT_211	[p15l1868t279r2119b336],
12	=	JJ	O	=	amod	13	SENT_211	[p15l1868t279r2119b336],
13	O-O09	NN	O	o-o09	dep	25	SENT_211	[p15l1868t279r2119b336],
14	8	CD	NUMBER	8	number	15	SENT_211	[p15l33t347r74b420],
15	=	JJ	O	=	amod	13	SENT_211	[p15l21t452r73b477],
16	300	CD	NUMBER	300	dep	13	SENT_211	[p15l248t426r381b480],
17	as	IN	O	as	_	0	SENT_211	[p15l33t486r74b522],
18	A	DT	O	a	det	19	SENT_211	[p15l110t515r175b530],
19	93	CD	NUMBER	93	prep_as	13	SENT_211	[p15l33t527r74b579],
20	'	''	O	'	_	0	SENT_211	[p15l33t527r74b579],
21	.1	CD	NUMBER	.1	dep	25	SENT_211	[p15l110t535r163b567],
22	3	CD	NUMBER	3	num	25	SENT_211	[p15l21t581r73b670],
23	‘	NN	O	‘	nn	25	SENT_211	[p15l21t581r73b670],
24	E	NN	O	e	nn	25	SENT_211	[p15l110t575r178b666],
25	o	NN	O	o	dep	28	SENT_211	[p15l20t679r74b721],
26	2	CD	NUMBER	2	num	27	SENT_211	[p15l110t667r163b735],
27	E	NN	O	e	dep	25	SENT_211	[p15l21t752r73b801],
28	3	CD	NUMBER	3	_	0	SENT_211	[p15l123t745r163b818],

1	(	NN	O	(	_	0	SENT_212	[p15l33t875r74b908],
2	1	CD	NUMBER	1	number	3	SENT_212	[p15l33t875r74b908],
3	)	CD	NUMBER	)	num	4	SENT_212	[p15l33t875r74b908],
4	C6	NN	O	c6	dep	1	SENT_212	[p15l33t916r74b951],
5	2	CD	NUMBER	2	num	6	SENT_212	[p15l33t957r74b1015],
6	o	NN	O	o	dep	4	SENT_212	[p15l33t1022r74b1054],
7	I	PRP	O	I	dep	8	SENT_212	[p15l1267t1008r1304b1053],
8	E	NN	O	e	dep	1	SENT_212	[p15l21t1062r73b1112],

1	I	PRP	O	I	_	0	SENT_213	[p15l700t1130r737b1175],

1	O	NN	O	o	nn	2	SENT_214	[p15l341t1550r381b1604],
2	H	NN	O	h	_	0	SENT_214	[p15l420t1561r457b1595],

1	p	NN	O	p	_	0	SENT_215	[p15l650t1648r902b1705],
2	=	JJ	O	=	amod	4	SENT_215	[p15l650t1648r902b1705],
3	O-823	NN	O	o-823	nn	4	SENT_215	[p15l650t1648r902b1705],
4	p	NN	O	p	dep	1	SENT_215	[p15l1192t1648r1443b1705],
5	=	JJ	O	=	amod	7	SENT_215	[p15l1192t1648r1443b1705],
6	O-120	NN	O	o-120	nn	7	SENT_215	[p15l1192t1648r1443b1705],
7	p	NN	O	p	dep	4	SENT_215	[p15l1868t1648r2120b1705],
8	=	JJ	O	=	amod	9	SENT_215	[p15l1868t1648r2120b1705],
9	O-O98	NN	O	o-o98	dep	1	SENT_215	[p15l1868t1648r2120b1705],

1	E	NN	O	e	_	0	SENT_216	[p15l21t1997r74b2073],
2	O	NN	O	o	dep	1	SENT_216	[p15l33t2079r74b2114],
3	/	:	O	/	punct	1	SENT_216	[p15l110t2096r175b2112],
4	-	:	O	-	_	0	SENT_216	[p15l110t2096r175b2112],
5	\	NN	O	\	nn	6	SENT_216	[p15l110t2096r175b2112],
6	—	NN	O	—	dep	18	SENT_216	[p15l283t2059r381b2112],
7	1	CD	NUMBER	1	number	8	SENT_216	[p15l283t2059r381b2112],
8	—	CD	NUMBER	—	dep	6	SENT_216	[p15l21t2124r73b2130],
9	_	NN	O	_	nn	13	SENT_216	[p15l110t2116r163b2148],
10	l	NN	O	l	nn	13	SENT_216	[p15l110t2116r163b2148],
11	T5	NN	O	t5	nn	13	SENT_216	[p15l21t2165r74b2216],
12	E	NN	O	e	nn	13	SENT_216	[p15l123t2159r163b2212],
13	F	NN	O	f	dep	8	SENT_216	[p15l21t2219r73b2257],
14	;	:	O	;	_	0	SENT_216	[p15l21t2219r73b2257],
15	\	CD	NUMBER	\	num	16	SENT_216	[p15l110t2222r175b2259],
16	>	JJR	O	>	dep	8	SENT_216	[p15l34t2262r73b2296],
17	U	NNP	O	U	nn	18	SENT_216	[p15l123t2260r163b2294],
18	)	NNP	O	)	dep	1	SENT_216	[p15l123t2260r163b2294],
19	c	NN	O	c	dep	18	SENT_216	[p15l33t2324r73b2356],
20	.9	CD	NUMBER	.9	num	19	SENT_216	[p15l110t2301r163b2352],
21	--	:	O	--	_	0	SENT_216	[p15l21t2367r73b2374],
22	D.	NNP	O	D.	nn	25	SENT_216	[p15l123t2359r175b2393],
23	(	NN	O	(	nn	25	SENT_216	[p15l34t2406r74b2442],
24	D	NN	O	d	nn	25	SENT_216	[p15l34t2406r74b2442],
25	O	NN	O	o	dep	18	SENT_216	[p15l123t2402r163b2438],
26	3	CD	NUMBER	3	num	27	SENT_216	[p15l33t2447r74b2524],
27	o	NN	O	o	dep	25	SENT_216	[p15l123t2443r163b2475],
28	92	CD	NUMBER	92	dep	25	SENT_216	[p15l33t2529r74b2587],
29	:	:	O	:	_	0	SENT_216	[p15l110t2501r177b2594],
30	oo	NN	O	oo	nn	31	SENT_216	[p15l110t2501r177b2594],
31	_	NN	O	_	dep	25	SENT_216	[p15l283t2558r380b2611],
32	2	CD	NUMBER	2	number	33	SENT_216	[p15l283t2558r380b2611],
33	8	CD	NUMBER	8	num	31	SENT_216	[p15l33t2595r74b2669],
34	"	``	O	"	punct	31	SENT_216	[p15l110t2604r175b2620],
35	‘	NN	O	‘	nn	36	SENT_216	[p15l692t2591r732b2681],
36	I	NN	O	i	dep	31	SENT_216	[p15l692t2591r732b2681],
37	D	NN	O	d	nn	38	SENT_216	[p15l21t2674r73b2716],
38	k	NN	O	k	dep	36	SENT_216	[p15l730t2661r981b2772],

1	y	NN	O	y	_	0	SENT_217	[p15l981t2772r1007b2776],
2	+	CC	O	+	_	0	SENT_217	[p15l981t2772r1007b2776],
3	I	PRP	O	I	conj_+	1	SENT_217	[p15l1256t2762r1293b2806],
4	I	PRP	O	I	dep	1	SENT_217	[p15l2100t2765r2137b2810],

1	O	NN	O	o	_	0	SENT_218	[p15l415t3150r455b3203],
2	1	CD	NUMBER	1	number	3	SENT_218	[p15l697t3151r735b3203],
3	3	CD	NUMBER	3	dep	1	SENT_218	[p15l1257t3150r1297b3203],
4	6	CD	NUMBER	6	dep	3	SENT_218	[p15l2101t3150r2141b3203],

1	Antiretroviral	JJ	O	antiretroviral	amod	3	SENT_219	[p15l584t3229r999b3282],
2	treatment	NN	O	treatment	nn	3	SENT_219	[p15l1028t3232r1356b3282],
3	duration	NN	O	duration	_	0	SENT_219	[p15l1382t3229r1651b3282],
4	(	CD	NUMBER	(	num	5	SENT_219	[p15l1682t3229r1975b3294],
5	months	NNS	NUMBER	month	dep	3	SENT_219	[p15l1682t3229r1975b3294],
6	)	IN	O	)	amod	5	SENT_219	[p15l1682t3229r1975b3294],

1	Figure	NN	O	figure	_	0	SENT_220	[p15l17t3426r205b3493],
2	2	CD	NUMBER	2	num	1	SENT_220	[p15l234t3425r292b3478],
3	:	:	O	:	_	0	SENT_220	[p15l234t3425r292b3478],
4	Response	NN	O	response	dep	1	SENT_220	[p15l326t3426r646b3491],
5	to	TO	O	to	_	0	SENT_220	[p15l671t3427r738b3479],
6	antiretroviral	JJ	O	antiretroviral	amod	7	SENT_220	[p15l764t3425r1190b3479],
7	treatment	NN	O	treatment	prep_to	4	SENT_220	[p15l1216t3427r1549b3479],
8	according	VBG	O	accord	_	0	SENT_220	[p15l1575t3425r1904b3492],
9	to	TO	O	to	prepc_according_to	1	SENT_220	[p15l1926t3427r1994b3479],

1	MDR1	NN	O	mdr1	nn	4	SENT_221	[p15l13t3519r217b3571],
2	3435	CD	DATE	3435	num	4	SENT_221	[p15l242t3519r418b3572],
3	genotype	NN	O	genotype	nn	4	SENT_221	[p15l444t3521r751b3584],
4	CD4	NN	O	cd4	_	0	SENT_221	[p15l14t3607r243b3654],
5	—	CD	NUMBER	—	num	6	SENT_221	[p15l14t3607r243b3654],
6	ce	NN	O	ce	dep	4	SENT_221	[p15l14t3607r243b3654],
7	|	CD	NUMBER	|	num	10	SENT_221	[p15l14t3607r243b3654],
8	|	NN	O	|	nn	10	SENT_221	[p15l14t3607r243b3654],
9	count	NN	O	count	nn	10	SENT_221	[p15l270t3610r426b3654],
10	increase	NN	O	increase	dep	6	SENT_221	[p15l451t3608r689b3654],
11	(	CD	NUMBER	(	num	14	SENT_221	[p15l714t3608r894b3664],
12	upper	JJ	O	upper	amod	14	SENT_221	[p15l714t3608r894b3664],
13	panel	NN	O	panel	nn	14	SENT_221	[p15l918t3608r1088b3664],
14	)	NN	O	)	dep	4	SENT_221	[p15l918t3608r1088b3664],
15	and	CC	O	and	_	0	SENT_221	[p15l1112t3608r1213b3654],
16	suppression	NN	O	suppression	dep	4	SENT_221	[p15l1239t3608r1584b3664],
17	of	IN	O	of	_	0	SENT_221	[p15l1611t3607r1665b3654],
18	viraemia	NN	O	viraemia	prep_of	16	SENT_221	[p15l1683t3608r1921b3654],
19	(	CD	NUMBER	(	num	18	SENT_221	[p15l1948t3608r2116b3664],
20	lower	JJR	O	lower	amod	22	SENT_221	[p15l1948t3608r2116b3664],
21	panel	NN	O	panel	nn	22	SENT_221	[p15l16t3682r186b3738],
22	)	NN	O	)	dep	4	SENT_221	[p15l16t3682r186b3738],
23	after	IN	O	after	_	0	SENT_221	[p15l211t3681r342b3728],
24	initiation	NN	O	initiation	prep_after	22	SENT_221	[p15l366t3682r604b3728],
25	of	IN	O	of	_	0	SENT_221	[p15l630t3681r685b3728],
26	treatment	NN	O	treatment	prep_of	24	SENT_221	[p15l703t3684r997b3728],
27	.	.	O	.	_	0	SENT_221	[p15l703t3684r997b3728],

1	Data	NNS	O	datum	nsubj	5	SENT_222	[p15l1027t3682r1154b3728],
2	are	VBP	O	be	cop	5	SENT_222	[p15l1179t3692r1267b3728],
3	mean	JJ	O	mean	amod	5	SENT_222	[p15l1293t3692r1445b3728],
4	(	NN	O	(	nn	5	SENT_222	[p15l1472t3681r1600b3738],
5	SE	NN	O	se	_	0	SENT_222	[p15l1472t3681r1600b3738],
6	)	CD	NUMBER	)	attr	5	SENT_222	[p15l1472t3681r1600b3738],
7	.	.	O	.	_	0	SENT_222	[p15l1472t3681r1600b3738],

1	MDR1	NN	O	mdr1	nn	4	SENT_223	[p16l9t282r180b328],
2	3445	CD	NUMBER	3445	num	4	SENT_223	[p16l203t281r356b328],
3	TT	NN	O	tt	nn	4	SENT_223	[p16l380t282r444b328],
4	genotype	NN	O	genotype	dep	9	SENT_223	[p16l465t284r720b340],
5	3-O	NN	O	3-o	dep	4	SENT_223	[p16l796t281r890b328],
6	(	CD	NUMBER	(	num	5	SENT_223	[p16l916t281r1179b339],
7	1-3-7-1	CD	NUMBER	1-3-7-1	num	8	SENT_223	[p16l916t281r1179b339],
8	)	NN	O	)	dep	9	SENT_223	[p16l916t281r1179b339],
9	I	PRP	O	I	dep	12	SENT_223	[p16l1581t340r1586b359],
10	I	PRP	O	I	dep	9	SENT_223	[p16l1625t293r1924b325],
11	:	:	O	:	_	0	SENT_223	[p16l1625t293r1924b325],
12	-:1	CD	NUMBER	-:1	_	0	SENT_223	[p16l1625t293r1924b325],

1	CCR5	NN	O	ccr5	nn	2	SENT_224	[p16l9t475r160b521],
2	A32	NN	O	a32	nsubj	3	SENT_224	[p16l183t473r300b521],
3	heterozygosity	NN	O	heterozygosity	_	0	SENT_224	[p16l328t475r730b533],
4	1-2	CD	NUMBER	1-2	number	5	SENT_224	[p16l799t474r889b521],
5	(	CD	NUMBER	(	num	6	SENT_224	[p16l916t474r1179b532],
6	O-4-3-8	NN	O	o-4-3-8	dobj	3	SENT_224	[p16l916t474r1179b532],
7	)	NN	O	)	prep	3	SENT_224	[p16l916t474r1179b532],
8	1	CD	NUMBER	1	dep	7	SENT_224	[p16l1460t470r1819b536],
9	:	:	O	:	_	0	SENT_224	[p16l1460t470r1819b536],
10	:	:	O	:	_	0	SENT_224	[p16l1460t470r1819b536],
11	-	:	O	-	_	0	SENT_224	[p16l1460t470r1819b536],
12	.	.	O	.	_	0	SENT_224	[p16l1460t470r1819b536],

1	—	NN	O	—	_	0	SENT_225	[p16l1460t470r1819b536],
2	.	.	O	.	_	0	SENT_225	[p16l1460t470r1819b536],

1	|	SYM	O	|	_	0	SENT_226	[p16l1460t470r1819b536],

1	HIV-1	NN	O	hiv-1	_	0	SENT_227	[p16l11t649r155b695],
2	RNA	NN	O	rna	amod	1	SENT_227	[p16l182t649r298b695],
3	at	IN	O	at	_	0	SENT_227	[p16l320t652r374b695],
4	baseline	NN	O	baseline	prep_at	1	SENT_227	[p16l398t649r634b696],
5	7-1	CD	NUMBER	7-1	dep	4	SENT_227	[p16l799t649r890b695],
6	(	CD	NUMBER	(	rcmod	5	SENT_227	[p16l916t648r1218b706],
7	2-7-18-9	CD	DATE	2-7-18-9	number	9	SENT_227	[p16l916t648r1218b706],
8	)	NN	O	)	dep	9	SENT_227	[p16l916t648r1218b706],
9	I	NN	O	i	dep	6	SENT_227	[p16l1743t661r2091b693],
10	:	:	O	:	_	0	SENT_227	[p16l1743t661r2091b693],
11	-	:	O	-	_	0	SENT_227	[p16l1743t661r2091b693],
12	.	.	O	.	_	0	SENT_227	[p16l1743t661r2091b693],

1	—	NN	O	—	_	0	SENT_228	[p16l1743t661r2091b693],
2	.	.	O	.	_	0	SENT_228	[p16l1743t661r2091b693],

1	|	NN	O	|	_	0	SENT_229	[p16l1743t661r2091b693],
2	(	CD	NUMBER	(	dep	1	SENT_229	[p16l9t735r119b792],
3	per	IN	O	per	_	0	SENT_229	[p16l9t735r119b792],
4	log	NN	O	log	nn	5	SENT_229	[p16l143t735r222b793],
5	copies/mL	NN	O	copies/ml	prep_per	2	SENT_229	[p16l243t735r567b792],
6	)	CD	NUMBER	)	num	8	SENT_229	[p16l243t735r567b792],
7	E	NN	O	e	nn	8	SENT_229	[p16l1581t728r1586b814],
8	CD4	NN	O	cd4	dep	1	SENT_229	[p16l9t828r128b875],
9	at	IN	O	at	_	0	SENT_229	[p16l152t831r206b875],
10	baseline	NN	O	baseline	prep_at	8	SENT_229	[p16l230t829r466b875],
11	1-2	CD	NUMBER	1-2	num	10	SENT_229	[p16l799t828r889b874],
12	(	CD	NUMBER	(	num	13	SENT_229	[p16l916t828r1179b885],
13	1-O-1-1	NN	O	1-o-1-1	dep	1	SENT_229	[p16l916t828r1179b885],
14	)	CD	NUMBER	)	num	16	SENT_229	[p16l916t828r1179b885],
15	:	:	O	:	_	0	SENT_229	[p16l1581t841r1650b907],
16	|	CD	NUMBER	|	dep	13	SENT_229	[p16l1581t841r1650b907],
17	--	:	O	--	_	0	SENT_229	[p16l1581t841r1650b907],
18	n	NN	O	n	dep	13	SENT_229	[p16l1581t841r1650b907],
19	(	CD	NUMBER	(	num	18	SENT_229	[p16l9t908r119b965],
20	per	IN	O	per	_	0	SENT_229	[p16l9t908r119b965],
21	100	CD	NUMBER	100	num	23	SENT_229	[p16l142t907r254b955],
22	cells/pLL	NN	O	cells/pll	nn	23	SENT_229	[p16l278t908r536b967],
23	)	NN	O	)	prep_per	18	SENT_229	[p16l278t908r536b967],
24	.	.	O	.	_	0	SENT_229	[p16l1581t935r1586b954],

1	Hepatitis	NNP	O	Hepatitis	nn	2	SENT_230	[p16l11t1032r262b1088],
2	C	NNP	O	C	_	0	SENT_230	[p16l286t1031r321b1078],
3	0-4	CD	NUMBER	0-4	num	5	SENT_230	[p16l797t1032r891b1078],
4	(	CD	NUMBER	(	num	5	SENT_230	[p16l916t1031r1179b1089],
5	O-1-1-1	NN	O	o-1-1-1	dep	2	SENT_230	[p16l916t1031r1179b1089],
6	)	CD	NUMBER	)	num	7	SENT_230	[p16l916t1031r1179b1089],
7	|	NN	O	|	dep	5	SENT_230	[p16l1214t1048r1603b1081],
8	.	.	O	.	_	0	SENT_230	[p16l1214t1048r1603b1081],

1	—	NN	O	—	_	0	SENT_231	[p16l1214t1048r1603b1081],
2	.	.	O	.	_	0	SENT_231	[p16l1214t1048r1603b1081],

1	.	.	O	.	_	0	SENT_232	[p16l1214t1048r1603b1081],

1	j	NN	O	j	_	0	SENT_233	[p16l1214t1048r1603b1081],
2	|	SYM	O	|	dep	1	SENT_233	[p16l1214t1048r1603b1081],

1	Male	JJ	O	male	amod	2	SENT_234	[p16l11t1183r144b1229],
2	sex	NN	O	sex	_	0	SENT_234	[p16l169t1194r265b1229],
3	1-8	CD	NUMBER	1-8	dep	2	SENT_234	[p16l799t1183r890b1229],
4	(	CD	NUMBER	(	num	5	SENT_234	[p16l916t1183r1179b1240],
5	O-7-4-9	NN	O	o-7-4-9	rcmod	3	SENT_234	[p16l916t1183r1179b1240],
6	)	CD	NUMBER	)	number	7	SENT_234	[p16l916t1183r1179b1240],
7	Ii	NN	O	ii	dep	5	SENT_234	[p16l1526t1176r1863b1242],
8	:	:	O	:	_	0	SENT_234	[p16l1526t1176r1863b1242],
9	-	:	O	-	_	0	SENT_234	[p16l1526t1176r1863b1242],
10	in	IN	O	in	dep	3	SENT_234	[p16l1526t1176r1863b1242],

1	Age	NNP	O	Age	nn	2	SENT_235	[p16l7t1363r109b1422],
2	(	NNP	O	(	nsubj	6	SENT_235	[p16l134t1363r244b1420],
3	per	IN	O	per	_	0	SENT_235	[p16l134t1363r244b1420],
4	10	CD	DURATION	10	num	5	SENT_235	[p16l267t1362r339b1410],
5	years	NNS	NUMBER	year	prep_per	2	SENT_235	[p16l362t1363r533b1421],
6	)	VBP	O	)	_	0	SENT_235	[p16l362t1363r533b1421],
7	0-7	CD	NUMBER	0-7	num	8	SENT_235	[p16l797t1362r888b1410],
8	(	CD	NUMBER	(	nsubj	11	SENT_235	[p16l916t1362r1179b1420],
9	O-5-1-1	NN	O	o-5-1-1	dep	8	SENT_235	[p16l916t1362r1179b1420],
10	)	CD	NUMBER	)	num	9	SENT_235	[p16l916t1362r1179b1420],
11	I	PRP	O	I	xcomp	6	SENT_235	[p16l1455t1353r1612b1420],
12	-	:	O	-	_	0	SENT_235	[p16l1455t1353r1612b1420],
13	.	.	O	.	_	0	SENT_235	[p16l1455t1353r1612b1420],

1	—	NN	O	—	_	0	SENT_236	[p16l1455t1353r1612b1420],
2	.	.	O	.	_	0	SENT_236	[p16l1455t1353r1612b1420],

1	:	:	O	:	_	0	SENT_237	[p16l1455t1353r1612b1420],
2	I	PRP	O	I	nsubj	1	SENT_237	[p16l1455t1353r1612b1420],

1	|	NN	O	|	nsubj	15	SENT_238	[p16l1183t1482r2105b1563],
2	0-1	CD	NUMBER	0-1	num	1	SENT_238	[p16l1131t1580r1238b1634],
3	1	CD	NUMBER	1	number	4	SENT_238	[p16l1569t1581r1606b1633],
4	5	CD	NUMBER	5	amod	1	SENT_238	[p16l1843t1581r1881b1634],
5	20	CD	NUMBER	20	dep	4	SENT_238	[p16l2058t1580r2143b1634],
6	Because	IN	O	because	dep	5	SENT_238	[p16l94t1667r390b1727],
7	no	DT	O	no	det	8	SENT_238	[p16l448t1686r538b1727],
8	data	NNS	O	datum	pobj	6	SENT_238	[p16l599t1666r752b1727],
9	on	IN	O	on	_	0	SENT_238	[p16l813t1686r903b1727],
10	CD4	NN	O	cd4	nn	13	SENT_238	[p16l963t1666r1298b1727],
11	—	NN	O	—	nn	13	SENT_238	[p16l963t1666r1298b1727],
12	cell	NN	O	cell	nn	13	SENT_238	[p16l963t1666r1298b1727],
13	subpopulations	NNS	O	subpopulation	prep_on	8	SENT_238	[p16l1358t1666r1914b1742],
14	were	VBD	O	be	cop	15	SENT_238	[p16l1973t1686r2143b1727],
15	available	JJ	O	available	ccomp	22	SENT_238	[p16l10t1759r323b1820],
16	from	IN	O	from	_	0	SENT_238	[p16l356t1759r530b1820],
17	the	DT	O	the	det	19	SENT_238	[p16l562t1759r674b1820],
18	study	NN	O	study	nn	19	SENT_238	[p16l707t1759r904b1835],
19	participants	NNS	O	participant	prep_from	15	SENT_238	[p16l933t1760r1386b1835],
20	,	,	O	,	_	0	SENT_238	[p16l933t1760r1386b1835],
21	we	PRP	O	we	nsubj	22	SENT_238	[p16l1419t1779r1518b1820],
22	analysed	VBD	O	analyse	_	0	SENT_238	[p16l1552t1759r1863b1835],
23	MDR1	NN	O	mdr1	nn	24	SENT_238	[p16l1891t1760r2139b1819],
24	genotype	NN	O	genotype	nsubj	32	SENT_238	[p16l8t1867r338b1929],
25	for	IN	O	for	_	0	SENT_238	[p16l379t1853r483b1913],
26	80	CD	NUMBER	80	num	27	SENT_238	[p16l524t1855r609b1913],
27	patients	NNS	O	patient	prep_for	24	SENT_238	[p16l652t1853r938b1929],
28	in	IN	O	in	_	0	SENT_238	[p16l981t1853r1050b1912],
29	two	CD	NUMBER	two	num	31	SENT_238	[p16l1090t1867r1221b1913],
30	clinical	JJ	O	clinical	amod	31	SENT_238	[p16l1266t1853r1522b1913],
31	studies	NNS	O	study	prep_in	27	SENT_238	[p16l1564t1853r2034b1913],
32	—	VBP	O	—	ccomp	22	SENT_238	[p16l1564t1853r2034b1913],
33	one	CD	NUMBER	one	dobj	32	SENT_238	[p16l1564t1853r2034b1913],
34	in	IN	O	in	_	0	SENT_238	[p16l2076t1853r2144b1912],
35	which	WDT	O	which	rel	40	SENT_238	[p16l7t1945r226b2006],
36	47	CD	NUMBER	47	num	37	SENT_238	[p16l273t1948r359b2005],
37	patients	NNS	O	patient	nsubj	45	SENT_238	[p16l409t1945r694b2021],
38	were	VBD	O	be	cop	40	SENT_238	[p16l742t1965r913b2006],
39	given	VBN	O	give	amod	40	SENT_238	[p16l961t1945r1152b2021],
40	abacavir	NN	O	abacavir	rcmod	33	SENT_238	[p16l1201t1945r1502b2006],
41	and	CC	O	and	_	0	SENT_238	[p16l1549t1945r1682b2006],
42	amprenavir	NN	O	amprenavir	rcmod	33	SENT_238	[p16l1731t1945r2146b2021],
43	and	CC	O	and	_	0	SENT_238	[p16l10t2037r143b2098],
44	the	DT	O	the	det	45	SENT_238	[p16l184t2037r296b2098],
45	other	JJ	O	other	rcmod	33	SENT_238	[p16l340t2037r530b2098],
46	in	IN	O	in	_	0	SENT_238	[p16l569t2038r638b2097],
47	which	WDT	O	which	rel	49	SENT_238	[p16l677t2037r896b2098],
48	33	CD	NUMBER	33	nsubj	49	SENT_238	[p16l938t2040r1024b2098],
49	received	VBD	O	receive	rcmod	45	SENT_238	[p16l1068t2037r1369b2098],
50	abacavir	NN	O	abacavir	dobj	49	SENT_238	[p16l1411t2037r1733b2109],
51	,	,	O	,	_	0	SENT_238	[p16l1411t2037r1733b2109],
52	nelﬁnavir	NN	O	nelﬁnavir	conj_and	50	SENT_238	[p16l1776t2037r2141b2109],
53	,	,	O	,	_	0	SENT_238	[p16l1776t2037r2141b2109],
54	and	CC	O	and	_	0	SENT_238	[p16l10t2131r143b2191],
55	saquinavir	NN	O	saquinavir	conj_and	50	SENT_238	[p16l187t2131r562b2207],
56	or	CC	O	or	_	0	SENT_238	[p16l604t2150r679b2191],
57	amprenavir	NN	O	amprenavir	conj_or	50	SENT_238	[p16l720t2131r1153b2207],
58	.	.	O	.	_	0	SENT_238	[p16l720t2131r1153b2207],

1	The	DT	O	the	det	2	SENT_239	[p16l1200t2131r1348b2191],
2	pattern	NN	O	pattern	nsubj	7	SENT_239	[p16l1390t2145r1653b2207],
3	of	IN	O	of	_	0	SENT_239	[p16l1697t2131r1774b2191],
4	CD4-cell	JJ	O	cd4-cell	amod	5	SENT_239	[p16l1809t2131r2144b2191],
5	recovery	NN	O	recovery	prep_of	2	SENT_239	[p16l8t2243r317b2299],
6	was	VBD	O	be	cop	7	SENT_239	[p16l384t2243r517b2284],
7	available	JJ	O	available	_	0	SENT_239	[p16l591t2223r904b2284],
8	for	IN	O	for	_	0	SENT_239	[p16l975t2223r1078b2284],
9	all	DT	O	all	det	10	SENT_239	[p16l1148t2223r1229b2284],
10	patients	NNS	O	patient	prep_for	7	SENT_239	[p16l1298t2223r1605b2299],
11	.	.	O	.	_	0	SENT_239	[p16l1298t2223r1605b2299],

1	Despite	IN	O	despite	_	0	SENT_240	[p16l1682t2223r1961b2299],
2	the	DT	O	the	det	4	SENT_240	[p16l2031t2223r2143b2284],
3	negligible	JJ	O	negligible	amod	4	SENT_240	[p16l8t2316r357b2392],
4	degree	NN	O	degree	prep_despite	14	SENT_240	[p16l424t2316r661b2392],
5	of	IN	O	of	_	0	SENT_240	[p16l728t2316r806b2377],
6	immunosuppression	NN	O	immunosuppression	prep_of	4	SENT_240	[p16l861t2317r1605b2392],
7	that	WDT	O	that	nsubj	8	SENT_240	[p16l1669t2316r1812b2377],
8	characterised	VBD	O	characterise	rcmod	4	SENT_240	[p16l1878t2316r2144b2377, p16l8t2410r250b2470],
9	participants	NNS	O	participant	dobj	8	SENT_240	[p16l302t2410r731b2486],
10	in	IN	O	in	_	0	SENT_240	[p16l786t2410r854b2469],
11	these	DT	O	these	det	12	SENT_240	[p16l907t2410r1092b2470],
12	trials	NNS	O	trial	prep_in	8	SENT_240	[p16l1145t2410r1321b2470],
13	(	FW	O	(	nsubj	14	SENT_240	[p16l1382t2410r1608b2485],
14	mean	VB	O	mean	_	0	SENT_240	[p16l1382t2410r1608b2485],
15	710	CD	NUMBER	710	num	16	SENT_240	[p16l1663t2412r1795b2470],
16	cells/p	NNS	O	cells/p	dobj	14	SENT_240	[p16l1852t2410r2147b2487],
17	.	.	O	.	_	0	SENT_240	[p16l1852t2410r2147b2487],

1	L	NN	O	l	nn	3	SENT_241	[p16l1852t2410r2147b2487],
2	[	CD	NUMBER	[	num	3	SENT_241	[p16l18t2502r145b2578],
3	SE	NN	O	se	nsubj	22	SENT_241	[p16l18t2502r145b2578],
4	32	CD	NUMBER	32	number	5	SENT_241	[p16l194t2502r368b2578],
5	]	CD	NUMBER	]	num	6	SENT_241	[p16l194t2502r368b2578],
6	)	NN	O	)	dep	3	SENT_241	[p16l194t2502r368b2578],
7	,	,	O	,	_	0	SENT_241	[p16l194t2502r368b2578],
8	patients	NNS	O	patient	appos	3	SENT_241	[p16l417t2502r703b2578],
9	with	IN	O	with	_	0	SENT_241	[p16l750t2502r909b2563],
10	the	DT	O	the	det	14	SENT_241	[p16l955t2502r1067b2563],
11	MDR1	NN	O	mdr1	nn	14	SENT_241	[p16l1111t2503r1359b2562],
12	3435	CD	NUMBER	3435	num	14	SENT_241	[p16l1413t2505r1590b2563],
13	TT	NN	O	tt	nn	14	SENT_241	[p16l1641t2503r1768b2562],
14	genotype	NN	O	genotype	prep_with	8	SENT_241	[p16l1814t2516r2143b2578],
15	6	CD	DURATION	6	num	16	SENT_241	[p16l12t2598r49b2656],
16	months	NNS	NUMBER	month	tmod	14	SENT_241	[p16l94t2595r367b2656],
17	after	IN	O	after	_	0	SENT_241	[p16l412t2595r576b2656],
18	initiation	NN	O	initiation	prep_after	14	SENT_241	[p16l617t2596r946b2656],
19	of	IN	O	of	_	0	SENT_241	[p16l989t2595r1067b2656],
20	antiretroviral	JJ	O	antiretroviral	amod	21	SENT_241	[p16l1101t2595r1573b2656],
21	therapy	NN	O	therapy	prep_of	18	SENT_241	[p16l1615t2595r1891b2671],
22	had	VBD	O	have	_	0	SENT_241	[p16l1930t2595r2065b2656],
23	a	DT	O	a	det	25	SENT_241	[p16l2109t2615r2144b2656],
24	greater	JJR	O	greater	amod	25	SENT_241	[p16l8t2703r262b2765],
25	rise	NN	O	rise	dobj	22	SENT_241	[p16l305t2689r429b2749],
26	in	IN	O	in	_	0	SENT_241	[p16l475t2689r544b2748],
27	CD4-cell	JJ	O	cd4-cell	amod	29	SENT_241	[p16l591t2689r926b2749],
28	count	NN	O	count	nn	29	SENT_241	[p16l973t2703r1180b2749],
29	(	NN	O	(	prep_in	25	SENT_241	[p16l1230t2689r1391b2764],
30	196	CD	NUMBER	196	num	31	SENT_241	[p16l1230t2689r1391b2764],
31	cells/p	NNS	O	cells/p	dep	29	SENT_241	[p16l1441t2689r1736b2766],
32	.	.	O	.	_	0	SENT_241	[p16l1441t2689r1736b2766],

1	L	NN	O	l	num	5	SENT_242	[p16l1441t2689r1736b2766],
2	[	CD	NUMBER	[	number	1	SENT_242	[p16l1787t2689r1958b2764],
3	50	CD	NUMBER	50	number	1	SENT_242	[p16l1787t2689r1958b2764],
4	]	CD	NUMBER	]	number	1	SENT_242	[p16l1787t2689r1958b2764],
5	)	NN	O	)	nsubj	14	SENT_242	[p16l1787t2689r1958b2764],
6	and	CC	O	and	_	0	SENT_242	[p16l2011t2689r2144b2749],
7	more	JJR	O	more	amod	9	SENT_242	[p16l8t2801r195b2842],
8	effective	JJ	O	effective	amod	9	SENT_242	[p16l227t2781r525b2842],
9	recovery	NN	O	recovery	conj_and	5	SENT_242	[p16l555t2801r864b2857],
10	of	IN	O	of	_	0	SENT_242	[p16l892t2781r970b2842],
11	naive	JJ	O	naive	amod	13	SENT_242	[p16l988t2785r1178b2842],
12	T	NN	O	t	nn	13	SENT_242	[p16l1207t2782r1269b2841],
13	cells	NNS	O	cell	prep_of	9	SENT_242	[p16l1299t2781r1452b2842],
14	(	VBP	O	(	_	0	SENT_242	[p16l1488t2781r1602b2856],
15	89	CD	NUMBER	89	num	16	SENT_242	[p16l1488t2781r1602b2856],
16	cells	NNS	O	cell	dobj	14	SENT_242	[p16l1637t2781r1816b2842],
17	/	:	O	/	punct	18	SENT_242	[p16l1637t2781r1816b2842],
18	pl	NN	O	pl	dep	16	SENT_242	[p16l1822t2782r1932b2858],
19	.	.	O	.	_	0	SENT_242	[p16l1822t2782r1932b2858],

1	[	NN	O	[	_	0	SENT_243	[p16l1967t2781r2138b2856],
2	53	CD	NUMBER	53	num	1	SENT_243	[p16l1967t2781r2138b2856],
3	]	CD	NUMBER	]	num	4	SENT_243	[p16l1967t2781r2138b2856],
4	)	NN	O	)	dep	1	SENT_243	[p16l1967t2781r2138b2856],
5	than	IN	O	than	_	0	SENT_243	[p16l8t2874r171b2935],
6	patients	NNS	O	patient	prep_than	4	SENT_243	[p16l212t2875r498b2950],
7	with	IN	O	with	_	0	SENT_243	[p16l541t2874r700b2935],
8	the	DT	O	the	det	11	SENT_243	[p16l742t2874r855b2935],
9	CT	NNP	O	CT	nn	11	SENT_243	[p16l901t2875r1026b2935],
10	genotype	NN	O	genotype	nn	11	SENT_243	[p16l1069t2888r1397b2950],
11	(	NN	O	(	prep_with	6	SENT_243	[p16l1447t2875r1602b2950],
12	161	CD	NUMBER	161	num	13	SENT_243	[p16l1447t2875r1602b2950],
13	cells/pLL	NN	O	cells/pll	dep	1	SENT_243	[p16l1656t2874r1950b2952],
14	[	CD	NUMBER	[	number	15	SENT_243	[p16l2000t2874r2134b2950],
15	63	CD	NUMBER	63	dep	13	SENT_243	[p16l2000t2874r2134b2950],
16	]	NN	O	]	dep	1	SENT_243	[p16l2000t2874r2134b2950],
17	and	CC	O	and	_	0	SENT_243	[p16l10t2968r143b3028],
18	46	CD	NUMBER	46	num	19	SENT_243	[p16l186t2970r273b3028],
19	cells/p	NNS	O	cells/p	conj_and	16	SENT_243	[p16l319t2968r614b3045],
20	.	.	O	.	_	0	SENT_243	[p16l319t2968r614b3045],

1	L	NN	O	l	_	0	SENT_244	[p16l319t2968r614b3045],
2	[	CD	NUMBER	[	number	3	SENT_244	[p16l662t2968r828b3043],
3	55	CD	NUMBER	55	num	4	SENT_244	[p16l662t2968r828b3043],
4	]	NN	O	]	dep	1	SENT_244	[p16l662t2968r828b3043],
5	,	,	O	,	_	0	SENT_244	[p16l662t2968r828b3043],
6	respectively	RB	O	respectively	advmod	7	SENT_244	[p16l873t2968r1324b3044],
7	)	CD	NUMBER	)	dep	1	SENT_244	[p16l873t2968r1324b3044],
8	or	CC	O	or	_	0	SENT_244	[p16l1374t2987r1449b3028],
9	the	DT	O	the	det	12	SENT_244	[p16l1488t2968r1601b3028],
10	CC	NN	O	cc	nn	12	SENT_244	[p16l1646t2968r1769b3028],
11	genotype	NN	O	genotype	nn	12	SENT_244	[p16l1814t2982r2143b3044],
12	(	NN	O	(	conj_or	4	SENT_244	[p16l15t3061r176b3135],
13	142	CD	NUMBER	142	num	14	SENT_244	[p16l15t3061r176b3135],
14	cells/p	NNS	O	cells/p	dep	12	SENT_244	[p16l228t3060r524b3138],
15	.	.	O	.	_	0	SENT_244	[p16l228t3060r524b3138],

1	L	NN	O	l	_	0	SENT_245	[p16l228t3060r524b3138],
2	[	CD	NUMBER	[	num	1	SENT_245	[p16l578t3060r713b3135],
3	55	CD	NUMBER	55	num	4	SENT_245	[p16l578t3060r713b3135],
4	]	NN	O	]	dep	1	SENT_245	[p16l578t3060r713b3135],
5	and	CC	O	and	_	0	SENT_245	[p16l773t3060r906b3121],
6	50	CD	NUMBER	50	num	7	SENT_245	[p16l957t3063r1042b3121],
7	cells/p	NNS	O	cells/p	conj_and	4	SENT_245	[p16l1095t3060r1390b3137],
8	.	.	O	.	_	0	SENT_245	[p16l1095t3060r1390b3137],

1	L	NN	O	l	_	0	SENT_246	[p16l1095t3060r1390b3137],
2	[	CD	NUMBER	[	number	3	SENT_246	[p16l1444t3060r1611b3135],
3	50	CD	NUMBER	50	num	4	SENT_246	[p16l1444t3060r1611b3135],
4	]	NN	O	]	dep	1	SENT_246	[p16l1444t3060r1611b3135],
5	,	,	O	,	_	0	SENT_246	[p16l1444t3060r1611b3135],
6	respectively	RB	O	respectively	advmod	7	SENT_246	[p16l1662t3060r2138b3136],
7	)	CD	NUMBER	)	appos	4	SENT_246	[p16l1662t3060r2138b3136],
8	.	.	O	.	_	0	SENT_246	[p16l1662t3060r2138b3136],

1	Analysis	NN	O	analysis	nsubj	33	SENT_247	[p16l7t3153r307b3229],
2	of	IN	O	of	_	0	SENT_247	[p16l379t3153r457b3214],
3	trend	NN	O	trend	prep_of	1	SENT_247	[p16l515t3153r710b3214],
4	over	IN	O	over	_	0	SENT_247	[p16l780t3173r935b3214],
5	24	CD	DURATION	24	num	6	SENT_247	[p16l1004t3156r1090b3213],
6	weeks	NNS	NUMBER	week	prep_over	3	SENT_247	[p16l1159t3153r1374b3214],
7	after	IN	O	after	mark	12	SENT_247	[p16l1447t3153r1611b3214],
8	initiation	NN	O	initiation	nsubj	12	SENT_247	[p16l1677t3153r2007b3214],
9	of	IN	O	of	_	0	SENT_247	[p16l2077t3153r2154b3214],
10	antiretroviral	JJ	O	antiretroviral	amod	11	SENT_247	[p16l10t3247r482b3307],
11	treatment	NN	O	treatment	prep_of	8	SENT_247	[p16l555t3261r912b3307],
12	showed	VBD	O	show	dep	6	SENT_247	[p16l985t3247r1258b3307],
13	that	IN	O	that	complm	18	SENT_247	[p16l1330t3247r1473b3307],
14	naive	JJ	O	naive	amod	15	SENT_247	[p16l1544t3250r1733b3307],
15	CD4-cell	JJ	O	cd4-cell	amod	16	SENT_247	[p16l1809t3247r2144b3307],
16	recovery	NN	O	recovery	nsubj	18	SENT_247	[p17l8t43r317b99],
17	was	VBD	O	be	cop	18	SENT_247	[p17l360t43r492b84],
18	greater	JJR	O	greater	ccomp	12	SENT_247	[p17l540t37r793b99],
19	in	IN	O	in	_	0	SENT_247	[p17l836t23r905b83],
20	patients	NNS	O	patient	prep_in	18	SENT_247	[p17l949t23r1235b99],
21	with	IN	O	with	_	0	SENT_247	[p17l1280t23r1440b84],
22	the	DT	O	the	det	24	SENT_247	[p17l1485t23r1596b84],
23	TT	NN	O	tt	nn	24	SENT_247	[p17l1642t24r1769b83],
24	genotype	NN	O	genotype	prep_with	20	SENT_247	[p17l1814t37r2143b99],
25	than	IN	O	than	dep	18	SENT_247	[p17l8t116r171b177],
26	in	IN	O	in	_	0	SENT_247	[p17l197t117r266b176],
27	those	DT	O	those	prep_in	18	SENT_247	[p17l292t116r484b177],
28	with	IN	O	with	_	0	SENT_247	[p17l510t116r669b177],
29	CT	NN	O	ct	nn	32	SENT_247	[p17l699t117r824b177],
30	and	CC	O	and	_	0	SENT_247	[p17l852t116r985b177],
31	CC	NN	O	cc	nn	32	SENT_247	[p17l1015t117r1138b177],
32	genotypes	NNS	O	genotype	prep_with	27	SENT_247	[p17l1168t131r1529b192],
33	(	VBP	O	(	_	0	SENT_247	[p17l1564t117r1909b192],
34	p	NN	O	p	dobj	33	SENT_247	[p17l1564t117r1909b192],
35	=	JJ	O	=	amod	37	SENT_247	[p17l1564t117r1909b192],
36	0-O5	NN	O	0-o5	nn	37	SENT_247	[p17l1564t117r1909b192],
37	)	NN	O	)	dep	34	SENT_247	[p17l1564t117r1909b192],
38	.	.	O	.	_	0	SENT_247	[p17l1564t117r1909b192],

1	We	PRP	O	we	nsubj	2	SENT_248	[p17l91t211r214b270],
2	assessed	VBD	O	assess	_	0	SENT_248	[p17l281t210r579b270],
3	all	DT	O	all	iobj	2	SENT_248	[p17l645t210r726b270],
4	recognised	JJ	O	recognised	amod	5	SENT_248	[p17l790t210r1181b286],
5	factors	NNS	O	factor	dobj	2	SENT_248	[p17l1244t210r1486b270],
6	associated	VBN	O	associate	partmod	5	SENT_248	[p17l1554t210r1923b270],
7	with	IN	O	with	_	0	SENT_248	[p17l1985t210r2145b270],
8	differences	NNS	O	difference	prep_with	6	SENT_248	[p17l10t302r401b363],
9	in	IN	O	in	_	0	SENT_248	[p17l429t302r498b362],
10	rate	NN	O	rate	prep_in	8	SENT_248	[p17l524t316r660b363],
11	of	IN	O	of	_	0	SENT_248	[p17l689t302r767b363],
12	recovery	NN	O	recovery	prep_of	10	SENT_248	[p17l783t322r1092b378],
13	of	IN	O	of	_	0	SENT_248	[p17l1118t302r1196b363],
14	CD4-cell	JJ	O	cd4-cell	amod	15	SENT_248	[p17l1216t302r1550b363],
15	count	NN	O	count	prep_of	12	SENT_248	[p17l1579t316r1804b363],
16	:	:	O	:	_	0	SENT_248	[p17l1579t316r1804b363],
17	age	NN	O	age	conj_and	5	SENT_248	[p17l1838t322r1977b378],
18	,	,	O	,	_	0	SENT_248	[p17l1838t322r1977b378],
19	sex	NN	O	sex	conj_and	5	SENT_248	[p17l2008t322r2141b375],
20	,	,	O	,	_	0	SENT_248	[p17l2008t322r2141b375],
21	baseline	NN	O	baseline	nn	23	SENT_248	[p17l7t395r300b456],
22	CD4-cell	JJ	O	cd4-cell	amod	23	SENT_248	[p17l344t395r679b456],
23	count	NN	O	count	conj_and	5	SENT_248	[p17l721t410r928b456],
24	and	CC	O	and	_	0	SENT_248	[p17l969t395r1102b456],
25	viral	JJ	O	viral	amod	26	SENT_248	[p17l1140t395r1298b456],
26	load	NN	O	load	conj_and	5	SENT_248	[p17l1338t395r1515b468],
27	,	,	O	,	_	0	SENT_248	[p17l1338t395r1515b468],
28	and	CC	O	and	_	0	SENT_248	[p17l1560t395r1692b456],
29	hepatitis	NN	O	hepatitis	nn	31	SENT_248	[p17l1731t395r2040b471],
30	C	NN	O	c	nn	31	SENT_248	[p17l2085t396r2141b456],
31	serostatus	NN	O	serostatus	conj_and	5	SENT_248	[p17l10t490r440b549],
32	.	.	O	.	_	0	SENT_248	[p17l10t490r440b549],

1	”	NN	O	”	nsubj	18	SENT_249	[p17l10t490r440b549],
2	The	DT	O	the	det	5	SENT_249	[p17l505t489r653b549],
3	only	JJ	O	only	amod	5	SENT_249	[p17l720t489r875b565],
4	genetic	JJ	O	genetic	amod	5	SENT_249	[p17l938t489r1196b565],
5	marker	NN	O	marker	dep	1	SENT_249	[p17l1261t489r1520b549],
6	that	WDT	O	that	nsubjpass	9	SENT_249	[p17l1582t489r1725b549],
7	has	VBZ	O	have	aux	9	SENT_249	[p17l1787t489r1905b549],
8	been	VBN	O	be	auxpass	9	SENT_249	[p17l1970t489r2144b549],
9	reported	VBN	O	report	rcmod	1	SENT_249	[p17l8t581r319b657],
10	to	TO	O	to	aux	12	SENT_249	[p17l365t595r434b642],
11	be	VB	O	be	auxpass	12	SENT_249	[p17l481t581r565b642],
12	associated	VBN	O	associate	xcomp	9	SENT_249	[p17l615t581r983b642],
13	with	IN	O	with	_	0	SENT_249	[p17l1028t581r1188b642],
14	differences	NNS	O	difference	prep_with	12	SENT_249	[p17l1235t581r1626b642],
15	in	IN	O	in	_	0	SENT_249	[p17l1674t581r1742b641],
16	treatment	NN	O	treatment	nn	17	SENT_249	[p17l1788t595r2145b642],
17	response	NN	O	response	prep_in	14	SENT_249	[p17l8t694r325b750],
18	(	VBD	O	(	_	0	SENT_249	[p17l370t675r508b750],
19	the	DT	O	the	det	22	SENT_249	[p17l370t675r508b750],
20	chemokine	NN	O	chemokine	nn	22	SENT_249	[p17l549t675r944b735],
21	receptor	NN	O	receptor	nn	22	SENT_249	[p17l983t689r1287b750],
22	CCR5	NN	O	ccr5	dobj	18	SENT_249	[p17l1325t675r1545b735],
23	A32/wt	NN	O	a32/wt	nn	24	SENT_249	[p17l1581t672r1868b750],
24	)	NN	O	)	nsubj	25	SENT_249	[p17l1581t672r1868b750],
25	affects	VBZ	O	affect	rcmod	22	SENT_249	[p17l1914t674r2142b735],
26	viral	JJ	O	viral	amod	27	SENT_249	[p17l7t768r164b828],
27	decay	NN	O	decay	dobj	25	SENT_249	[p17l220t768r427b844],
28	after	IN	O	after	_	0	SENT_249	[p17l481t768r645b828],
29	initiation	NN	O	initiation	prep_after	25	SENT_249	[p17l697t768r1027b828],
30	of	IN	O	of	_	0	SENT_249	[p17l1083t768r1160b828],
31	treatment	NN	O	treatment	prep_of	29	SENT_249	[p17l1204t769r1631b828],
32	.	.	O	.	_	0	SENT_249	[p17l1204t769r1631b828],

1	”	NN	O	”	_	0	SENT_250	[p17l1204t769r1631b828],
2	When	WRB	O	when	advmod	11	SENT_250	[p17l1684t768r1904b828],
3	these	DT	O	these	det	4	SENT_250	[p17l1958t768r2143b828],
4	Variables	NNS	O	variable	nsubjpass	11	SENT_250	[p17l7t860r324b921],
5	and	CC	O	and	_	0	SENT_250	[p17l359t860r492b921],
6	the	DT	O	the	det	9	SENT_250	[p17l523t860r635b921],
7	MDRI	NNP	O	MDRI	nn	9	SENT_250	[p17l664t861r912b920],
8	3435	CD	DATE	3435	num	9	SENT_250	[p17l951t863r1128b921],
9	genotype	NN	O	genotype	conj_and	4	SENT_250	[p17l1164t874r1493b936],
10	were	VBD	O	be	auxpass	11	SENT_250	[p17l1524t880r1695b921],
11	included	VBN	O	include	advcl	23	SENT_250	[p17l1727t860r2044b921],
12	in	IN	O	in	_	0	SENT_250	[p17l2076t860r2144b920],
13	a	DT	O	a	det	15	SENT_250	[p17l10t973r45b1014],
14	logistic-regression	NN	O	logistic-regression	nn	15	SENT_250	[p17l94t953r752b1029],
15	model	NN	O	model	prep_in	11	SENT_250	[p17l799t953r1048b1026],
16	,	,	O	,	_	0	SENT_250	[p17l799t953r1048b1026],
17	TT	NN	O	tt	nn	18	SENT_250	[p17l1098t954r1226b1013],
18	genotype	NN	O	genotype	nsubj	23	SENT_250	[p17l1273t968r1602b1029],
19	was	VBD	O	be	cop	23	SENT_250	[p17l1649t973r1782b1014],
20	a	DT	O	a	det	23	SENT_250	[p17l1833t973r1868b1014],
21	strong	JJ	O	strong	amod	23	SENT_250	[p17l1918t968r2146b1029],
22	independent	JJ	O	independent	amod	23	SENT_250	[p17l8t1047r468b1123],
23	predictor	NN	O	predictor	rcmod	1	SENT_250	[p17l505t1047r841b1123],
24	of	IN	O	of	_	0	SENT_250	[p17l880t1047r958b1107],
25	rise	NN	O	rise	prep_of	23	SENT_250	[p17l986t1047r1111b1107],
26	in	IN	O	in	_	0	SENT_250	[p17l1151t1047r1219b1106],
27	CD4-cell	JJ	O	cd4-cell	amod	28	SENT_250	[p17l1261t1047r1596b1107],
28	count	NN	O	count	prep_in	25	SENT_250	[p17l1637t1061r1844b1107],
29	by	IN	O	by	_	0	SENT_250	[p17l1881t1047r1970b1123],
30	200	CD	NUMBER	200	num	32	SENT_250	[p17l2009t1049r2142b1107],
31	CD4	NN	O	cd4	nn	32	SENT_250	[p17l12t1139r188b1200],
32	cells/uL	NN	O	cells/ul	prep_by	23	SENT_250	[p17l251t1139r547b1216],
33	at	IN	O	at	_	0	SENT_250	[p17l604t1153r669b1200],
34	1	CD	DURATION	1	num	35	SENT_250	[p17l737t1142r762b1199],
35	month	NN	NUMBER	month	prep_at	32	SENT_250	[p17l831t1139r1072b1200],
36	(	CD	NUMBER	(	num	37	SENT_250	[p17l1137t1139r1336b1214],
37	odds	NNS	O	odds	amod	35	SENT_250	[p17l1137t1139r1336b1214],
38	ratio	NN	O	ratio	dep	37	SENT_250	[p17l1397t1139r1561b1200],
39	5-4	JJ	O	5-4	amod	43	SENT_250	[p17l1626t1142r1759b1212],
40	,	,	O	,	_	0	SENT_250	[p17l1626t1142r1759b1212],
41	95	CD	PERCENT	95	number	42	SENT_250	[p17l1825t1139r1985b1201],
42	%	NN	PERCENT	%	amod	43	SENT_250	[p17l1825t1139r1985b1201],
43	CI	NN	O	ci	dep	38	SENT_250	[p17l2053t1139r2144b1200],
44	1-6-18-8	CD	DATE	1-6-18-8	num	45	SENT_250	[p17l18t1233r386b1308],
45	)	NN	O	)	dep	38	SENT_250	[p17l18t1233r386b1308],
46	,	,	O	,	_	0	SENT_250	[p17l18t1233r386b1308],
47	3	CD	DURATION	3	num	48	SENT_250	[p17l429t1235r467b1293],
48	months	NNS	NUMBER	month	appos	38	SENT_250	[p17l509t1232r781b1293],
49	(	VBP	O	(	rcmod	48	SENT_250	[p17l827t1233r991b1308],
50	2-3	CD	NUMBER	2-3	nsubj	58	SENT_250	[p17l827t1233r991b1308],
51	,	,	O	,	_	0	SENT_250	[p17l827t1233r991b1308],
52	1-0-5-5	CD	NUMBER	1-0-5-5	num	53	SENT_250	[p17l1041t1233r1363b1308],
53	)	NN	O	)	nsubj	58	SENT_250	[p17l1041t1233r1363b1308],
54	,	,	O	,	_	0	SENT_250	[p17l1041t1233r1363b1308],
55	and	CC	O	and	_	0	SENT_250	[p17l1406t1232r1539b1293],
56	6	CD	DURATION	6	num	57	SENT_250	[p17l1580t1235r1618b1293],
57	months	NNS	NUMBER	month	nsubj	58	SENT_250	[p17l1659t1232r1932b1293],
58	(	VBP	O	(	ccomp	49	SENT_250	[p17l1978t1233r2141b1308],
59	3-0	CD	NUMBER	3-0	dobj	58	SENT_250	[p17l1978t1233r2141b1308],
60	,	,	O	,	_	0	SENT_250	[p17l1978t1233r2141b1308],
61	1-3	CD	NUMBER	1-3	num	62	SENT_250	[p17l17t1328r306b1399],
62	—	NN	O	—	appos	59	SENT_250	[p17l17t1328r306b1399],
63	7	CD	NUMBER	7	dep	62	SENT_250	[p17l17t1328r306b1399],
64	'	''	O	'	_	0	SENT_250	[p17l17t1328r306b1399],
65	1	CD	NUMBER	1	tmod	23	SENT_250	[p17l17t1328r306b1399],
66	;	:	O	;	_	0	SENT_250	[p17l17t1328r306b1399],
67	ﬁgure	NN	O	ﬁgure	dep	1	SENT_250	[p17l336t1326r544b1402],
68	3	CD	NUMBER	3	num	69	SENT_250	[p17l574t1326r667b1401],
69	)	NN	O	)	dep	67	SENT_250	[p17l574t1326r667b1401],
70	.	.	O	.	_	0	SENT_250	[p17l574t1326r667b1401],

1	Discussion	NN	O	discussion	_	0	SENT_251	[p17l11t1508r495b1575],

1	This	DT	O	this	det	2	SENT_252	[p17l8t1608r172b1668],
2	study	NN	O	study	nsubj	3	SENT_252	[p17l219t1608r416b1684],
3	addresses	VBZ	O	address	_	0	SENT_252	[p17l459t1608r803b1668],
4	the	DT	O	the	det	5	SENT_252	[p17l847t1608r959b1668],
5	contribution	NN	O	contribution	nsubj	9	SENT_252	[p17l1005t1608r1460b1668],
6	of	IN	O	of	_	0	SENT_252	[p17l1504t1608r1582b1668],
7	seven	CD	NUMBER	seven	prep_of	5	SENT_252	[p17l1617t1628r1815b1668],
8	geneswhich	JJ	O	geneswhich	amod	7	SENT_252	[p17l1858t1627r2146b1684, p17l7t1700r226b1761],
9	encode	VBP	O	encode	dep	3	SENT_252	[p17l297t1700r554b1761],
10	isoenzymes	NNS	O	isoenzyme	dobj	9	SENT_252	[p17l625t1700r1036b1776],
11	of	IN	O	of	_	0	SENT_252	[p17l1109t1700r1187b1761],
12	cytochrome	NN	O	cytochrome	nn	13	SENT_252	[p17l1249t1700r1677b1776],
13	P450	NN	O	p450	prep_of	10	SENT_252	[p17l1749t1701r1937b1761],
14	and	CC	O	and	_	0	SENT_252	[p17l2011t1700r2144b1761],
15	multidrug	JJ	O	multidrug	amod	16	SENT_252	[p17l8t1793r375b1869],
16	transporters	NNS	O	transporter	nsubj	17	SENT_252	[p17l455t1808r1052b1869],
17	—	VBP	O	—	conj_and	9	SENT_252	[p17l455t1808r1052b1869],
18	to	TO	O	to	_	0	SENT_252	[p17l455t1808r1052b1869],
19	drug	NN	O	drug	nn	20	SENT_252	[p17l1138t1793r1306b1869],
20	concentrations	NNS	O	concentration	prep_to	17	SENT_252	[p17l1389t1794r1925b1854],
21	and	CC	O	and	_	0	SENT_252	[p17l2011t1793r2144b1854],
22	treatment	NN	O	treatment	nn	23	SENT_252	[p17l8t1901r365b1947],
23	effectiveness	NN	O	effectiveness	nsubj	28	SENT_252	[p17l455t1887r908b1947],
24	of	IN	O	of	_	0	SENT_252	[p17l1000t1887r1078b1947],
25	two	CD	NUMBER	two	num	27	SENT_252	[p17l1157t1901r1288b1947],
26	antiretroviral	JJ	O	antiretroviral	amod	27	SENT_252	[p17l1381t1887r1853b1947],
27	drugs	NNS	O	drug	prep_of	23	SENT_252	[p17l1943t1887r2143b1963],
28	(	VBP	O	(	conj_and	3	SENT_252	[p17l15t1979r385b2054],
29	nelﬁnavir	NN	O	nelﬁnavir	nn	32	SENT_252	[p17l15t1979r385b2054],
30	and	CC	O	and	_	0	SENT_252	[p17l444t1979r577b2040],
31	efavirenz	NN	O	efavirenz	nn	32	SENT_252	[p17l637t1979r987b2054],
32	)	NN	O	)	dobj	28	SENT_252	[p17l637t1979r987b2054],
33	in	FW	O	in	prep	32	SENT_252	[p17l1052t1979r1121b2039],
34	vivo	FW	O	vivo	pobj	33	SENT_252	[p17l1177t1979r1346b2040],
35	.	.	O	.	_	0	SENT_252	[p17l1177t1979r1346b2040],

1	The	DT	O	the	det	4	SENT_253	[p17l1409t1979r1558b2040],
2	most	RBS	O	most	advmod	3	SENT_253	[p17l1617t1993r1797b2040],
3	relevant	JJ	O	relevant	amod	4	SENT_253	[p17l1854t1979r2145b2040],
4	ﬁndings	NNS	O	ﬁndings	nsubj	8	SENT_253	[p17l8t2072r298b2148],
5	of	IN	O	of	_	0	SENT_253	[p17l339t2072r416b2133],
6	our	PRP$	O	we	poss	7	SENT_253	[p17l446t2092r570b2133],
7	study	NN	O	study	prep_of	4	SENT_253	[p17l607t2072r804b2148],
8	relate	VBP	O	relate	_	0	SENT_253	[p17l839t2072r1039b2133],
9	to	TO	O	to	_	0	SENT_253	[p17l1077t2087r1147b2133],
10	the	DT	O	the	det	13	SENT_253	[p17l1186t2072r1298b2133],
11	multidrug	JJ	O	multidrug	amod	13	SENT_253	[p17l1337t2072r1703b2148],
12	transporter	NN	O	transporter	nn	13	SENT_253	[p17l1739t2087r2146b2148],
13	P-glycoprotein	NN	O	p-glycoprotein	prep_to	8	SENT_253	[p17l9t2166r566b2242],
14	.	.	O	.	_	0	SENT_253	[p17l9t2166r566b2242],

1	MDRI	NN	O	mdrus	nn	3	SENT_254	[p17l628t2167r876b2225],
2	allelic	JJ	O	allelic	amod	3	SENT_254	[p17l944t2166r1150b2226],
3	variants	NNS	O	variant	nsubj	8	SENT_254	[p17l1209t2166r1493b2226],
4	are	VBP	O	be	cop	8	SENT_254	[p17l1557t2185r1663b2226],
5	a	DT	O	a	det	8	SENT_254	[p17l1726t2186r1761b2226],
6	potential	JJ	O	potential	amod	8	SENT_254	[p17l1821t2166r2144b2242],
7	molecular	JJ	O	molecular	amod	8	SENT_254	[p17l8t2258r373b2319],
8	basis	NN	O	basis	_	0	SENT_254	[p17l408t2258r582b2319],
9	for	IN	O	for	_	0	SENT_254	[p17l622t2258r725b2319],
10	interindividual	JJ	O	interindividual	amod	11	SENT_254	[p17l761t2258r1296b2319],
11	differences	NNS	O	difference	prep_for	8	SENT_254	[p17l1336t2258r1727b2319],
12	in	IN	O	in	_	0	SENT_254	[p17l1767t2258r1835b2318],
13	pace	NN	O	pace	prep_in	11	SENT_254	[p17l1871t2278r2036b2334],
14	of	IN	O	of	_	0	SENT_254	[p17l2077t2258r2154b2319],
15	CD4-cell	JJ	O	cd4-cell	amod	16	SENT_254	[p17l12t2351r346b2412],
16	immune	JJ	O	immune	amod	17	SENT_254	[p17l380t2352r683b2412],
17	recovery	NN	O	recovery	prep_of	13	SENT_254	[p17l718t2371r1027b2427],
18	that	WDT	O	that	nsubjpass	20	SENT_254	[p17l1058t2351r1201b2412],
19	is	VBZ	O	be	auxpass	20	SENT_254	[p17l1235t2352r1286b2412],
20	seen	VBN	O	see	rcmod	8	SENT_254	[p17l1323t2371r1481b2412],
21	after	IN	O	after	_	0	SENT_254	[p17l1516t2351r1680b2412],
22	initiation	NN	O	initiation	prep_after	20	SENT_254	[p17l1712t2352r2041b2412],
23	of	IN	O	of	_	0	SENT_254	[p17l2077t2351r2154b2412],
24	treatment	NN	O	treatment	prep_of	22	SENT_254	[p17l8t2459r383b2505],
25	.	.	O	.	_	0	SENT_254	[p17l8t2459r383b2505],

1	Furthermore	RB	O	furthermore	advmod	16	SENT_255	[p17l417t2445r910b2518],
2	,	,	O	,	_	0	SENT_255	[p17l417t2445r910b2518],
3	genetic	JJ	O	genetic	amod	4	SENT_255	[p17l941t2445r1199b2521],
4	variation	NN	O	variation	nsubj	16	SENT_255	[p17l1226t2445r1548b2505],
5	in	IN	O	in	_	0	SENT_255	[p17l1575t2445r1644b2504],
6	MDRI	NN	O	mdrus	nn	7	SENT_255	[p17l1668t2445r2144b2505],
7	—	NN	O	—	prep_in	4	SENT_255	[p17l1668t2445r2144b2505],
8	and	CC	O	and	_	0	SENT_255	[p17l1668t2445r2144b2505],
9	to	TO	O	to	_	0	SENT_255	[p17l8t2551r78b2598],
10	a	DT	O	a	det	12	SENT_255	[p17l152t2557r187b2598],
11	lesser	JJR	O	lesser	amod	12	SENT_255	[p17l259t2537r460b2598],
12	degree	NN	O	degree	prep_to	4	SENT_255	[p17l530t2537r767b2613],
13	in	IN	O	in	_	0	SENT_255	[p17l840t2537r908b2597],
14	CYP2D6	NN	O	cyp2d6	prep_in	12	SENT_255	[p17l981t2537r1679b2613],
15	—	CD	NUMBER	—	num	14	SENT_255	[p17l981t2537r1679b2613],
16	predicts	VBZ	O	predict	_	0	SENT_255	[p17l981t2537r1679b2613],
17	the	DT	O	the	det	20	SENT_255	[p17l1752t2537r1863b2598],
18	noted	VBN	O	note	amod	20	SENT_255	[p17l1935t2537r2144b2598],
19	interindividual	JJ	O	interindividual	amod	20	SENT_255	[p17l8t2630r544b2691],
20	variation	NN	O	variation	dobj	16	SENT_255	[p17l582t2631r904b2691],
21	in	IN	O	in	_	0	SENT_255	[p17l943t2631r1011b2690],
22	plasma	NN	O	plasma	nn	23	SENT_255	[p17l1048t2630r1305b2706],
23	concentrations	NNS	O	concentration	prep_in	20	SENT_255	[p17l1347t2631r1883b2691],
24	of	IN	O	of	_	0	SENT_255	[p17l1925t2630r2003b2691],
25	the	DT	O	the	det	28	SENT_255	[p17l2031t2630r2144b2691],
26	two	CD	NUMBER	two	num	28	SENT_255	[p17l8t2738r140b2784],
27	study	NN	O	study	nn	28	SENT_255	[p17l219t2724r416b2800],
28	drugs	NNS	O	drug	prep_of	23	SENT_255	[p17l491t2724r711b2800],
29	.	.	O	.	_	0	SENT_255	[p17l491t2724r711b2800],

1	However	RB	O	however	advmod	7	SENT_256	[p17l793t2725r1144b2797],
2	,	,	O	,	_	0	SENT_256	[p17l793t2725r1144b2797],
3	this	DT	O	this	det	4	SENT_256	[p17l1222t2724r1351b2784],
4	work	NN	O	work	nsubj	7	SENT_256	[p17l1426t2724r1610b2784],
5	should	MD	O	should	aux	7	SENT_256	[p17l1685t2724r1928b2784],
6	also	RB	O	also	advmod	7	SENT_256	[p17l2006t2724r2142b2784],
7	emphasise	VB	O	emphasise	_	0	SENT_256	[p17l10t2816r383b2892],
8	the	DT	O	the	det	9	SENT_256	[p17l418t2816r529b2877],
9	complexity	NN	O	complexity	dobj	7	SENT_256	[p17l565t2816r966b2892],
10	of	IN	O	of	_	0	SENT_256	[p17l999t2816r1077b2877],
11	pharmacological	JJ	O	pharmacological	amod	12	SENT_256	[p17l1099t2816r1702b2892],
12	monitoring	NN	O	monitoring	prep_of	9	SENT_256	[p17l1736t2816r2146b2892],
13	of	IN	O	of	_	0	SENT_256	[p17l10t2909r88b2970],
14	antiretroviral	JJ	O	antiretroviral	amod	15	SENT_256	[p17l109t2909r581b2970],
15	treatment	NN	O	treatment	prep_of	12	SENT_256	[p17l611t2924r989b2982],
16	,	,	O	,	_	0	SENT_256	[p17l611t2924r989b2982],
17	at	IN	O	at	_	0	SENT_256	[p17l1023t2924r1088b2970],
18	the	DT	O	the	det	20	SENT_256	[p17l1117t2909r1229b2970],
19	same	JJ	O	same	amod	20	SENT_256	[p17l1261t2929r1443b2970],
20	time	NN	O	time	prep_at	7	SENT_256	[p17l1473t2910r1634b2970],
21	underscoring	VBG	O	underscore	partmod	20	SENT_256	[p17l1664t2909r2146b2985],
22	the	DT	O	the	det	23	SENT_256	[p17l8t3003r120b3063],
23	interest	NN	O	interest	dobj	21	SENT_256	[p17l180t3003r451b3063],
24	to	TO	O	to	aux	25	SENT_256	[p17l508t3017r578b3063],
25	explore	VB	O	explore	infmod	23	SENT_256	[p17l640t3003r905b3079],
26	P	NN	O	p	nn	28	SENT_256	[p17l965t3003r1504b3079],
27	—	JJ	O	—	amod	28	SENT_256	[p17l965t3003r1504b3079],
28	glycoprotein	NN	O	glycoprotein	nn	29	SENT_256	[p17l965t3003r1504b3079],
29	inhibition	NN	O	inhibition	dobj	25	SENT_256	[p17l1563t3003r1919b3063],
30	as	IN	O	as	_	0	SENT_256	[p17l1979t3023r2046b3063],
31	a	DT	O	a	det	32	SENT_256	[p17l2109t3023r2144b3063],
32	strategy	NN	O	strategy	prep_as	29	SENT_256	[p17l10t3109r293b3171],
33	in	IN	O	in	_	0	SENT_256	[p17l318t3095r386b3155],
34	management	NN	O	management	prep_in	32	SENT_256	[p17l412t3109r886b3171],
35	of	IN	O	of	_	0	SENT_256	[p17l914t3095r991b3156],
36	HIV-1-infected	JJ	O	hiv-1-infected	amod	37	SENT_256	[p17l1009t3095r1572b3156],
37	individuals	NNS	O	individual	prep_of	29	SENT_256	[p17l1599t3095r2068b3156],
38	.	.	O	.	_	0	SENT_256	[p17l1599t3095r2068b3156],

1	”	NN	O	”	_	0	SENT_257	[p17l1599t3095r2068b3156],

1	How	WRB	O	how	advmod	2	SENT_258	[p17l94t3190r271b3249],
2	could	MD	O	could	_	0	SENT_258	[p17l319t3189r521b3249],
3	levels	NNS	O	level	dep	2	SENT_258	[p17l568t3189r763b3249],
4	of	IN	O	of	_	0	SENT_258	[p17l814t3188r892b3249],
5	P	NN	O	p	nn	8	SENT_258	[p17l930t3189r1468b3265],
6	—	CD	NUMBER	—	num	8	SENT_258	[p17l930t3189r1468b3265],
7	glycoprotein	NN	O	glycoprotein	nn	8	SENT_258	[p17l930t3189r1468b3265],
8	expression	NN	O	expression	prep_of	2	SENT_258	[p17l1517t3189r1899b3265],
9	affect	VBP	O	affect	rcmod	8	SENT_258	[p17l1948t3188r2145b3249],
10	recovery	NN	O	recovery	dobj	9	SENT_258	[p17l8t3301r317b3358],
11	of	IN	O	of	_	0	SENT_258	[p17l366t3282r443b3342],
12	CD4	NN	O	cd4	nn	13	SENT_258	[p17l485t3282r661b3342],
13	cells	NNS	O	cell	prep_of	10	SENT_258	[p17l713t3282r866b3342],
14	and	CC	O	and	_	0	SENT_258	[p17l918t3282r1051b3342],
15	the	DT	O	the	det	18	SENT_258	[p17l1099t3282r1211b3342],
16	naive	JJ	O	naive	amod	18	SENT_258	[p17l1260t3285r1449b3342],
17	cell	NN	O	cell	nn	18	SENT_258	[p17l1500t3282r1620b3342],
18	subset	NN	O	subset	conj_and	13	SENT_258	[p17l1671t3282r1929b3342],
19	?	.	O	?	_	0	SENT_258	[p17l1671t3282r1929b3342],

1	This	DT	O	this	det	2	SENT_259	[p17l1978t3282r2143b3342],
2	protein	NN	O	protein	nsubjpass	4	SENT_259	[p17l7t3374r271b3450],
3	is	VBZ	O	be	auxpass	4	SENT_259	[p17l297t3374r349b3435],
4	expressed	VBN	O	express	_	0	SENT_259	[p17l378t3374r730b3450],
5	in	IN	O	in	_	0	SENT_259	[p17l757t3374r826b3434],
6	haemopoietic	JJ	O	haemopoietic	amod	8	SENT_259	[p17l851t3374r1343b3450],
7	progenitor	NN	O	progenitor	nn	8	SENT_259	[p17l1370t3374r1755b3450],
8	cells	NNS	O	cell	prep_in	4	SENT_259	[p17l1781t3374r1957b3447],
9	,	,	O	,	_	0	SENT_259	[p17l1781t3374r1957b3447],
10	with	IN	O	with	_	0	SENT_259	[p17l1985t3374r2145b3435],
11	the	DT	O	the	det	13	SENT_259	[p17l8t3467r120b3528],
12	highest	JJS	O	highest	amod	13	SENT_259	[p17l156t3467r417b3543],
13	levels	NNS	O	level	prep_with	4	SENT_259	[p17l453t3467r648b3528],
14	of	IN	O	of	_	0	SENT_259	[p17l687t3467r765b3528],
15	expression	NN	O	expression	prep_of	13	SENT_259	[p17l793t3468r1174b3543],
16	being	VBG	O	be	auxpass	17	SENT_259	[p17l1209t3467r1411b3543],
17	noted	VBN	O	note	partmod	15	SENT_259	[p17l1444t3467r1653b3528],
18	in	IN	O	in	_	0	SENT_259	[p17l1690t3468r1758b3527],
19	cells	NNS	O	cell	prep_in	17	SENT_259	[p17l1796t3467r1948b3528],
20	with	IN	O	with	_	0	SENT_259	[p17l1985t3467r2145b3528],
21	characteristics	NNS	O	characteristic	prep_with	19	SENT_259	[p17l10t3561r525b3621],
22	of	IN	O	of	_	0	SENT_259	[p17l573t3561r651b3621],
23	pluripotent	JJ	O	pluripotent	amod	25	SENT_259	[p17l685t3561r1096b3637],
24	stem	NN	O	stem	nn	25	SENT_259	[p17l1141t3575r1312b3621],
25	cells	NNS	O	cell	prep_of	21	SENT_259	[p17l1358t3561r1557b3621],
26	.	.	O	.	_	0	SENT_259	[p17l1358t3561r1557b3621],

1	‘	NN	O	‘	nn	2	SENT_260	[p17l1358t3561r1557b3621],
2	P	NN	O	p	nsubj	6	SENT_260	[p17l1606t3561r2144b3637],
3	—	CD	NUMBER	—	num	4	SENT_260	[p17l1606t3561r2144b3637],
4	glycoprotein	NN	O	glycoprotein	dep	2	SENT_260	[p17l1606t3561r2144b3637],
5	could	MD	O	could	aux	6	SENT_260	[p17l10t3653r211b3714],
6	have	VB	O	have	_	0	SENT_260	[p17l249t3653r414b3714],
7	a	DT	O	a	det	8	SENT_260	[p17l456t3673r491b3714],
8	role	NN	O	role	dobj	6	SENT_260	[p17l530t3653r666b3714],
9	in	IN	O	in	_	0	SENT_260	[p17l706t3653r775b3713],
10	protection	NN	O	protection	prep_in	8	SENT_260	[p17l812t3653r1190b3729],
11	of	IN	O	of	_	0	SENT_260	[p17l1229t3653r1307b3714],
12	these	DT	O	these	det	13	SENT_260	[p17l1335t3653r1520b3714],
13	cells	NNS	O	cell	prep_of	10	SENT_260	[p17l1562t3653r1715b3714],
14	from	IN	O	from	_	0	SENT_260	[p17l1755t3653r1929b3714],
15	toxic	JJ	O	toxic	amod	16	SENT_260	[p17l1967t3653r2143b3714],
16	substances	NNS	O	substance	prep_from	6	SENT_260	[p17l10t3746r421b3819],
17	,	,	O	,	_	0	SENT_260	[p17l10t3746r421b3819],
18	and	CC	O	and	_	0	SENT_260	[p17l457t3746r590b3807],
19	potentially	RB	O	potentially	advmod	6	SENT_260	[p17l620t3746r1029b3822],
20	,	,	O	,	_	0	SENT_260	[p17l620t3746r1029b3822],
21	in	IN	O	in	conj_and	6	SENT_260	[p17l1064t3747r1132b3806],
22	reduction	NN	O	reduction	pobj	21	SENT_260	[p17l1163t3746r1515b3807],
23	of	IN	O	of	_	0	SENT_260	[p17l1548t3746r1626b3807],
24	accumulation	NN	O	accumulation	prep_of	22	SENT_260	[p17l1649t3746r2144b3807],
25	of	IN	O	of	_	0	SENT_260	[p18l10t19r88b79],
26	regulatory	JJ	O	regulatory	amod	27	SENT_260	[p18l118t19r490b95],
27	substances	NNS	O	substance	prep_of	24	SENT_260	[p18l530t19r918b79],
28	that	WDT	O	that	nsubj	30	SENT_260	[p18l960t19r1103b79],
29	could	MD	O	could	aux	30	SENT_260	[p18l1144t19r1346b79],
30	affect	VB	O	affect	rcmod	22	SENT_260	[p18l1388t19r1585b79],
31	differentiation	NN	O	differentiation	dobj	30	SENT_260	[p18l1626t19r2145b79],
32	or	CC	O	or	_	0	SENT_260	[p18l10t131r85b172],
33	proliferation	NN	O	proliferation	conj_or	31	SENT_260	[p18l200t111r698b187],
34	.	.	O	.	_	0	SENT_260	[p18l200t111r698b187],

1	‘	NN	O	‘	ccomp	7	SENT_261	[p18l200t111r698b187],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_261	[p18l820t111r1313b184],
3	,	,	O	,	_	0	SENT_261	[p18l820t111r1313b184],
4	lymphocytes	NNS	O	lymphocyte	nsubj	7	SENT_261	[p18l1434t111r1890b187],
5	and	CC	O	and	_	0	SENT_261	[p18l2011t111r2144b172],
6	macrophages	NNS	O	macrophage	conj_and	4	SENT_261	[p18l8t204r487b280],
7	express	VBP	O	express	_	0	SENT_261	[p18l542t224r804b280],
8	MDR1	NN	O	mdr1	dobj	7	SENT_261	[p18l854t205r1102b264],
9	in	IN	O	in	_	0	SENT_261	[p18l1159t205r1227b264],
10	a	DT	O	a	det	14	SENT_261	[p18l1280t224r1315b265],
11	development-speciﬁc	JJ	O	development-speciﬁc	amod	14	SENT_261	[p18l1369t204r2143b280],
12	and	CC	O	and	_	0	SENT_261	[p18l10t298r143b358],
13	differentiation-speciﬁc	JJ	O	differentiation-speciﬁc	amod	14	SENT_261	[p18l199t298r1020b374],
14	manner	NN	O	manner	prep_in	8	SENT_261	[p18l1076t299r1404b358],
15	?	.	O	?	_	0	SENT_261	[p18l1076t299r1404b358],

1	In	IN	O	in	_	0	SENT_262	[p18l1459t299r1537b357],
2	thymus	NN	O	thymus	nn	3	SENT_262	[p18l1591t298r1859b374],
3	tissue	NN	O	tissue	pobj	1	SENT_262	[p18l1915t298r2141b371],
4	,	,	O	,	_	0	SENT_262	[p18l1915t298r2141b371],

1	30	CD	PERCENT	30	num	2	SENT_263	[p18l1128t382r1199b410],
2	%	NN	PERCENT	%	nsubjpass	6	SENT_263	[p18l1128t382r1199b410],
3	of	IN	O	of	_	0	SENT_263	[p18l1220t382r1255b409],
4	cells	NNS	O	cell	prep_of	2	SENT_263	[p18l1269t382r1337b409],
5	are	VBP	O	be	auxpass	6	SENT_263	[p18l1357t391r1404b409],
6	reported	VBN	O	report	_	0	SENT_263	[p18l1422t382r1560b416],
7	to	TO	O	to	aux	9	SENT_263	[p18l1578t388r1609b409],
8	be	VB	O	be	cop	9	SENT_263	[p18l1627t382r1665b409],
9	P-glycoprotein-positive	JJ	O	p-glycoprotein-positive	xcomp	6	SENT_263	[p18l1684t382r2070b416],
10	,	,	O	,	_	0	SENT_263	[p18l1684t382r2070b416],
11	:	:	O	:	_	0	SENT_263	[p18l89t447r355b512],
12	\	CD	NUMBER	\	num	13	SENT_263	[p18l89t447r355b512],
13	rf	NN	O	rf	dep	9	SENT_263	[p18l89t447r355b512],
14	:	:	O	:	_	0	SENT_263	[p18l89t447r355b512],
15	:	:	O	:	_	0	SENT_263	[p18l89t447r355b512],
16	‘	CD	NUMBER	‘	number	17	SENT_263	[p18l89t447r355b512],
17	¢	CD	NUMBER	¢	num	18	SENT_263	[p18l89t447r355b512],
18	t	NN	O	t	dep	13	SENT_263	[p18l89t447r355b512],
19	:	:	O	:	_	0	SENT_263	[p18l89t447r355b512],
20	$	$	O	$	dep	18	SENT_263	[p18l89t447r355b512],
21	r	NN	O	r	dep	37	SENT_263	[p18l89t447r355b512],
22	‘	CD	NUMBER	‘	dep	21	SENT_263	[p18l89t447r355b512],
23	I	PRP	O	I	dep	22	SENT_263	[p18l89t447r355b512],
24	:	:	O	:	_	0	SENT_263	[p18l89t447r355b512],
25	|	CD	NUMBER	|	num	27	SENT_263	[p18l89t447r355b512],
26	tcD4-cell	NN	O	tcd4-cell	nn	27	SENT_263	[p18l89t447r355b512],
27	recovery	NN	O	recovery	dep	23	SENT_263	[p18l368t453r493b476],
28	after	IN	O	after	_	0	SENT_263	[p18l504t447r573b471],
29	initiation	NN	O	initiation	prep_after	21	SENT_263	[p18l585t447r714b471],
30	of	IN	O	of	_	0	SENT_263	[p18l726t447r754b471],
31	antiretroviral	JJ	O	antiretroviral	amod	34	SENT_263	[p18l764t447r953b471],
32	4D	NN	O	4d	nn	34	SENT_263	[p18l1127t424r1516b492],
33	:	:	O	:	_	0	SENT_263	[p18l1127t424r1516b492],
34	r	NN	O	r	prep_of	21	SENT_263	[p18l1127t424r1516b492],
35	’	CD	NUMBER	’	num	36	SENT_263	[p18l1127t424r1516b492],
36	ldCCDD4	NN	O	ldccdd4	dep	21	SENT_263	[p18l1127t424r1516b492],
37	’	CD	NUMBER	’	num	20	SENT_263	[p18l1127t424r1516b492],
38	8	CD	NUMBER	8	num	40	SENT_263	[p18l1127t424r1516b492],
39	(	NN	O	(	nn	40	SENT_263	[p18l1536t424r1894b499],
40	ffgﬁfer	NN	O	ffgﬁfer	dep	20	SENT_263	[p18l1536t424r1894b499],
41	,	,	O	,	_	0	SENT_263	[p18l1907t424r2071b492],
42	f.	NN	O	f.	nn	43	SENT_263	[p18l1907t424r2071b492],
43	e1Cl	NN	O	e1cl	appos	18	SENT_263	[p18l1907t424r2071b492],
44	:	:	O	:	_	0	SENT_263	[p18l1907t424r2071b492],
45	ll	NN	O	ll	dep	43	SENT_263	[p18l1907t424r2071b492],
46	:	:	O	:	_	0	SENT_263	[p18l1907t424r2071b492],
47	IE	NN	O	ie	dep	45	SENT_263	[p18l1907t424r2071b492],
48	.	.	O	.	_	0	SENT_263	[p18l1238t507r1243b511],

1	.	.	O	.	_	0	SENT_264	[p18l1624t507r1628b511],

1	_	NN	O	_	_	0	SENT_265	[p18l1744t523r1763b525],
2	o	NN	O	o	dep	1	SENT_265	[p18l1807t507r1818b521],
3	.	.	O	.	_	0	SENT_265	[p18l2031t507r2036b511],

1	Odds	NNS	O	odds	nn	2	SENT_266	[p18l90t529r153b550],
2	ratio	NN	O	ratio	nsubj	16	SENT_266	[p18l164t529r217b550],
3	and	CC	O	and	_	0	SENT_266	[p18l227t529r271b550],
4	95	CD	PERCENT	95	number	5	SENT_266	[p18l281t529r335b550],
5	%	NN	PERCENT	%	amod	6	SENT_266	[p18l281t529r335b550],
6	CI	NN	O	ci	nsubj	16	SENT_266	[p18l344t529r366b550],
7	of	IN	O	of	_	0	SENT_266	[p18l377t529r402b550],
8	CD4cel	JJ	O	cd4cel	amod	11	SENT_266	[p18l410t529r509b550],
9	|	NN	O	|	nn	11	SENT_266	[p18l410t529r509b550],
10	count	NN	O	count	nn	11	SENT_266	[p18l520t530r588b550],
11	ampliﬁcation	NN	O	ampliﬁcation	prep_of	6	SENT_266	[p18l597t529r753b554],
12	by	IN	O	by	_	0	SENT_266	[p18l765t529r791b555],
13	at	IN	O	at	num	15	SENT_266	[p18l800t530r823b550],
14	least	JJS	O	least	quantmod	13	SENT_266	[p18l834t529r893b550],
15	blood	NN	O	blood	prep_by	11	SENT_266	[p18l1127t507r1219b534],
16	Include	VB	O	include	_	0	SENT_266	[p18l1236t507r1354b534],
17	a	DT	O	a	det	20	SENT_266	[p18l1372t516r1388b534],
18	large	JJ	O	large	amod	20	SENT_266	[p18l1405t507r1481b541],
19	proporuon	NN	O	proporuon	nn	20	SENT_266	[p18l1498t513r1673b541],
20	(	NN	O	(	dobj	16	SENT_266	[p18l1692t507r1742b540],
21	50	CD	NUMBER	50	number	22	SENT_266	[p18l1692t507r1742b540],
22	60	CD	NUMBER	60	num	25	SENT_266	[p18l1765t508r1803b534],
23	A	DT	O	a	det	25	SENT_266	[p18l1811t507r1849b540],
24	’	NN	O	’	nn	25	SENT_266	[p18l1811t507r1849b540],
25	)	NN	O	)	nsubj	28	SENT_266	[p18l1811t507r1849b540],
26	of	IN	O	of	_	0	SENT_266	[p18l1869t507r1904b534],
27	Cells	NNS	MISC	cell	prep_of	25	SENT_266	[p18l1917t507r1984b534],
28	Wlth	VBP	MISC	wlth	dep	16	SENT_266	[p18l2001t507r2072b534],
29	200	CD	NUMBER	200	num	30	SENT_266	[p18l90t562r140b583],
30	cells/p	NNS	O	cells/p	dobj	28	SENT_266	[p18l150t562r255b589],
31	.	.	O	.	_	0	SENT_266	[p18l150t562r255b589],

1	L	NN	O	l	_	0	SENT_267	[p18l150t562r255b589],
2	6	CD	DURATION	6	num	3	SENT_267	[p18l264t562r279b583],
3	months	NNS	NUMBER	month	tmod	1	SENT_267	[p18l290t562r381b583],
4	after	IN	O	after	_	0	SENT_267	[p18l391t562r448b583],
5	initiation	NN	O	initiation	prep_after	1	SENT_267	[p18l458t562r560b583],
6	of	IN	O	of	_	0	SENT_267	[p18l571t562r595b583],
7	treatment	NN	O	treatment	prep_of	5	SENT_267	[p18l602t564r730b583],
8	.	.	O	.	_	0	SENT_267	[p18l602t564r730b583],

1	Analysis	NN	O	analysis	nsubjpass	3	SENT_268	[p18l741t562r841b588],
2	was	VBD	O	be	auxpass	3	SENT_268	[p18l850t567r899b583],
3	based	VBN	O	base	_	0	SENT_268	[p18l909t562r983b583],
4	on	IN	O	on	_	0	SENT_268	[p18l994t567r1022b583],
5	P	NN	O	p	nn	7	SENT_268	[p18l1128t549r1366b582],
6	'	''	O	'	_	0	SENT_268	[p18l1128t549r1366b582],
7	g1YC0P1	NN	O	g1yc0p1	prep_on	3	SENT_268	[p18l1128t549r1366b582],
8	'	''	O	'	_	0	SENT_268	[p18l1128t549r1366b582],
9	0tein	NN	O	0tein	prep	7	SENT_268	[p18l1128t549r1366b582],
10	3CtiVit	NN	O	3ctivit	nn	12	SENT_268	[p18l1381t549r1505b594],
11	§	CD	NUMBER	§	num	12	SENT_268	[p18l1381t549r1505b594],
12	_	NN	O	_	dep	9	SENT_268	[p18l1381t549r1505b594],
13	’	CD	NUMBER	’	num	12	SENT_268	[p18l1381t549r1505b594],
14	>	JJR	O	>	amod	18	SENT_268	[p18l1381t549r1505b594],
15	Pa1TiCu1a1	NN	O	pa1ticu1a1	nn	18	SENT_268	[p18l1520t549r1705b594],
16	‘	CD	NUMBER	‘	num	18	SENT_268	[p18l1520t549r1705b594],
17	_	NN	O	_	nn	18	SENT_268	[p18l1520t549r1705b594],
18	1Y	NN	O	1y	dobj	3	SENT_268	[p18l1520t549r1705b594],
19	in	IN	O	in	_	0	SENT_268	[p18l1719t549r1749b575],
20	the	DT	O	the	prep_in	3	SENT_268	[p18l1763t549r1812b576],
21	Subset	NNP	MISC	Subset	dep	20	SENT_268	[p18l1828t549r1929b576],
22	Of	IN	MISC	of	_	0	SENT_268	[p18l1943t549r1978b575],
23	n3	NN	MISC	n3	prep_of	21	SENT_268	[p18l1987t550r2071b594],
24	'	''	O	'	_	0	SENT_268	[p18l1987t550r2071b594],
25	1	LS	NUMBER	1	dep	20	SENT_268	[p18l1987t550r2071b594],
26	.	.	O	.	_	0	SENT_268	[p18l1987t550r2071b594],

1	‘	NN	O	‘	dep	16	SENT_269	[p18l1987t550r2071b594],
2	.7	CD	NUMBER	.7	num	1	SENT_269	[p18l1987t550r2071b594],
3	e	SYM	O	e	dep	5	SENT_269	[p18l1987t550r2071b594],
4	134	CD	NUMBER	134	num	5	SENT_269	[p18l91t595r140b616],
5	patients	NNS	O	patient	dep	16	SENT_269	[p18l151t595r249b621],
6	for	IN	O	for	_	0	SENT_269	[p18l258t595r292b616],
7	whom	WP	O	whom	prep_for	5	SENT_269	[p18l300t595r371b616],
8	data	NNS	O	datum	nsubj	16	SENT_269	[p18l382t595r435b616],
9	for	IN	O	for	_	0	SENT_269	[p18l445t595r478b616],
10	all	DT	O	all	det	11	SENT_269	[p18l487t595r513b616],
11	variables	NNS	O	variable	prep_for	8	SENT_269	[p18l523t595r633b617],
12	in	IN	O	in	_	0	SENT_269	[p18l644t595r663b616],
13	the	DT	O	the	det	14	SENT_269	[p18l673t595r712b616],
14	model	NN	O	model	prep_in	11	SENT_269	[p18l723t595r796b617],
15	were	VBD	O	be	cop	16	SENT_269	[p18l806t600r864b616],
16	available	JJ	O	available	_	0	SENT_269	[p18l874t595r989b616],
17	.	.	O	.	_	0	SENT_269	[p18l874t595r989b616],

1	CCllS	NN	O	ccll	nn	3	SENT_270	[p18l1128t590r1228b617],
2	.2	NN	NUMBER	.2	nn	3	SENT_270	[p18l1128t590r1228b617],
3	°	NN	O	°	_	0	SENT_270	[p18l1128t590r1228b617],
4	Thus	RB	O	thus	advmod	9	SENT_270	[p18l1265t590r1359b622],
5	,	,	O	,	_	0	SENT_270	[p18l1265t590r1359b622],
6	the	DT	O	the	det	8	SENT_270	[p18l1397t590r1447b617],
7	Immunological	JJ	O	immunological	amod	8	SENT_270	[p18l1485t590r1727b624],
8	beneﬁt	NN	O	beneﬁt	nsubj	9	SENT_270	[p18l1763t590r1875b617],
9	noted	VBD	O	note	rcmod	3	SENT_270	[p18l1911t590r2004b617],
10	In	IN	O	in	_	0	SENT_270	[p18l2041t599r2071b617],
11	Figure	NNP	O	Figure	prep_in	9	SENT_270	[p18l91t405r175b435],
12	3	CD	NUMBER	3	num	11	SENT_270	[p18l187t405r214b429],
13	:	:	O	:	_	0	SENT_270	[p18l187t405r214b429],
14	Logistic	JJ	O	logistic	amod	16	SENT_270	[p18l228t405r343b435],
15	regression	NN	O	regression	nn	16	SENT_270	[p18l356t405r508b435],
16	analysis	NN	O	analysis	dobj	9	SENT_270	[p18l521t405r640b435],
17	of	IN	O	of	_	0	SENT_270	[p18l651t405r679b429],
18	recognised	JJ	O	recognised	amod	19	SENT_270	[p18l690t405r850b435],
19	factors	NNS	O	factor	prep_of	16	SENT_270	[p18l862t405r966b429],

1	34	CD	NUMBER	34	_	0	SENT_271	[p18l93t693r131b719],
2	THE	DT	O	the	det	3	SENT_271	[p18l1226t698r1292b718],
3	LANCET	NN	O	lancet	dep	1	SENT_271	[p18l1302t698r1431b719],
4	-	:	O	-	_	0	SENT_271	[p18l1441t705r1448b712],
5	Vol	NN	O	vol	dep	1	SENT_271	[p18l1458t698r1502b719],
6	359	CD	NUMBER	359	num	5	SENT_271	[p18l1512t699r1557b719],
7	-	:	O	-	_	0	SENT_271	[p18l1568t705r1576b712],
8	January	NNP	DATE	January	dep	5	SENT_271	[p18l1584t698r1682b724],
9	5	CD	DATE	5	num	8	SENT_271	[p18l1691t699r1713b723],
10	,	,	DATE	,	_	0	SENT_271	[p18l1691t699r1713b723],
11	2002	CD	DATE	2002	num	8	SENT_271	[p18l1724t699r1786b719],
12	-	:	O	-	_	0	SENT_271	[p18l1796t705r1804b712],
13	www.the1ancet.com	CD	NUMBER	www.the1ancet.com	num	14	SENT_271	[p18l1813t698r2064b719],
14	ARTICLES	NNS	O	article	dep	8	SENT_271	[p18l1913t741r2067b762],

1	individuals	NNS	O	individual	nsubj	13	SENT_272	[p18l10t933r406b994],
2	with	IN	O	with	_	0	SENT_272	[p18l468t933r627b994],
3	MDR1	NN	O	mdr1	nn	6	SENT_272	[p18l684t934r932b993],
4	3435	CD	NUMBER	3435	num	6	SENT_272	[p18l1000t936r1177b994],
5	TT	NN	O	tt	nn	6	SENT_272	[p18l1242t934r1369b993],
6	genotype	NN	O	genotype	prep_with	1	SENT_272	[p18l1430t947r1758b1009],
7	and	CC	O	and	_	0	SENT_272	[p18l1822t933r1954b994],
8	low	JJ	O	low	amod	9	SENT_272	[p18l2016t933r2144b994],
9	expression	NN	O	expression	conj_and	1	SENT_272	[p18l12t1027r394b1102],
10	of	IN	O	of	_	0	SENT_272	[p18l460t1026r537b1087],
11	P-glycoprotein	NN	O	p-glycoprotein	prep_of	9	SENT_272	[p18l593t1026r1131b1102],
12	could	MD	O	could	aux	13	SENT_272	[p18l1197t1026r1398b1087],
13	suggest	VB	O	suggest	_	0	SENT_272	[p18l1465t1041r1729b1102],
14	enhanced	VBN	O	enhance	amod	15	SENT_272	[p18l1795t1026r2143b1087],
15	penetration	NN	O	penetration	dobj	13	SENT_272	[p18l9t1120r430b1196],
16	of	IN	O	of	_	0	SENT_272	[p18l489t1120r567b1180],
17	antiretroviral	JJ	O	antiretroviral	amod	18	SENT_272	[p18l617t1120r1088b1180],
18	drugs	NNS	O	drug	prep_of	15	SENT_272	[p18l1148t1120r1346b1196],
19	in	IN	O	in	_	0	SENT_272	[p18l1407t1120r1475b1179],
20	cell	NN	O	cell	nn	21	SENT_272	[p18l1535t1120r1655b1180],
21	populations	NNS	O	population	prep_in	18	SENT_272	[p18l1713t1120r2142b1196],
22	susceptible	JJ	O	susceptible	amod	18	SENT_272	[p18l12t1212r411b1288],
23	to	TO	O	to	_	0	SENT_272	[p18l451t1226r520b1273],
24	HIV-1	NN	O	hiv-1	nn	25	SENT_272	[p18l562t1213r790b1273],
25	infection	NN	O	infection	prep_to	22	SENT_272	[p18l840t1212r1181b1285],
26	,	,	O	,	_	0	SENT_272	[p18l840t1212r1181b1285],
27	in	IN	O	in	_	0	SENT_272	[p18l1224t1212r1292b1272],
28	infected	JJ	O	infected	amod	29	SENT_272	[p18l1331t1212r1622b1273],
29	lymphocytes	NNS	O	lymphocyte	prep_in	22	SENT_272	[p18l1662t1212r2140b1288],
30	,	,	O	,	_	0	SENT_272	[p18l1662t1212r2140b1288],
31	and	CC	O	and	_	0	SENT_272	[p18l12t1305r145b1366],
32	in	IN	O	in	conj_and	22	SENT_272	[p18l184t1306r253b1365],
33	pharmacological	JJ	O	pharmacological	amod	34	SENT_272	[p18l291t1305r893b1381],
34	sanctuaries	NNS	O	sanctuary	pobj	32	SENT_272	[p18l935t1306r1468b1366],
35	?	.	O	?	_	0	SENT_272	[p18l935t1306r1468b1366],

1	”	NN	O	”	dep	6	SENT_273	[p18l935t1306r1468b1366],
2	Although	IN	O	although	dep	6	SENT_273	[p18l1506t1306r1849b1382],
3	we	PRP	O	we	nsubj	6	SENT_273	[p18l1887t1325r1986b1366],
4	did	VBD	O	do	aux	6	SENT_273	[p18l2027t1306r2143b1366],
5	not	RB	O	not	neg	6	SENT_273	[p18l10t1413r131b1459],
6	note	VB	O	note	advcl	27	SENT_273	[p18l166t1413r326b1459],
7	differences	NNS	O	difference	dobj	6	SENT_273	[p18l365t1399r756b1459],
8	in	IN	O	in	_	0	SENT_273	[p18l795t1399r864b1458],
9	rate	NN	O	rate	prep_in	6	SENT_273	[p18l900t1413r1037b1459],
10	of	IN	O	of	_	0	SENT_273	[p18l1076t1399r1154b1459],
11	Viral	JJ	O	viral	amod	12	SENT_273	[p18l1179t1399r1336b1459],
12	suppression	NN	O	suppression	prep_of	9	SENT_273	[p18l1375t1399r1804b1475],
13	between	IN	O	between	_	0	SENT_273	[p18l1840t1399r2143b1459],
14	the	DT	O	the	det	16	SENT_273	[p18l10t1491r122b1552],
15	different	JJ	O	different	amod	16	SENT_273	[p18l168t1491r477b1552],
16	MDR1	NN	O	mdr1	prep_between	12	SENT_273	[p18l517t1492r764b1551],
17	3435	CD	DATE	3435	num	18	SENT_273	[p18l816t1494r993b1552],
18	genotypes	NNS	O	genotype	dep	16	SENT_273	[p18l1042t1505r1426b1567],
19	,	,	O	,	_	0	SENT_273	[p18l1042t1505r1426b1567],
20	the	DT	O	the	det	21	SENT_273	[p18l1473t1491r1585b1552],
21	design	NN	O	design	nsubj	27	SENT_273	[p18l1632t1491r1863b1567],
22	of	IN	O	of	_	0	SENT_273	[p18l1909t1491r1986b1552],
23	our	PRP$	O	we	poss	24	SENT_273	[p18l2022t1511r2145b1552],
24	study	NN	O	study	prep_of	21	SENT_273	[p18l12t1584r208b1660],
25	did	VBD	O	do	aux	27	SENT_273	[p18l239t1584r354b1645],
26	not	RB	O	not	neg	27	SENT_273	[p18l384t1599r504b1645],
27	allow	VB	O	allow	_	0	SENT_273	[p18l536t1584r726b1645],
28	precise	JJ	O	precise	amod	29	SENT_273	[p18l755t1585r1007b1660],
29	analysis	NN	O	analysis	dobj	27	SENT_273	[p18l1040t1584r1317b1660],
30	of	IN	O	of	_	0	SENT_273	[p18l1350t1584r1428b1645],
31	decay	NN	O	decay	nn	32	SENT_273	[p18l1449t1584r1656b1660],
32	rates	NNS	O	rate	prep_of	29	SENT_273	[p18l1684t1599r1853b1645],
33	and	CC	O	and	_	0	SENT_273	[p18l1887t1584r2041b1657],
34	,	,	O	,	_	0	SENT_273	[p18l1887t1584r2041b1657],
35	in	IN	O	in	dep	32	SENT_273	[p18l2075t1585r2143b1644],
36	particular	JJ	O	particular	pobj	35	SENT_273	[p18l9t1678r384b1754],
37	,	,	O	,	_	0	SENT_273	[p18l9t1678r384b1754],
38	effect	NN	O	effect	prep_of	29	SENT_273	[p18l466t1678r662b1738],
39	of	IN	O	of	_	0	SENT_273	[p18l740t1678r817b1738],
40	P-glycoprotein	NN	O	p-glycoprotein	nn	41	SENT_273	[p18l886t1678r1423b1754],
41	expression	NN	O	expression	prep_of	38	SENT_273	[p18l1502t1678r1883b1754],
42	in	IN	O	in	_	0	SENT_273	[p18l1960t1678r2029b1737],
43	a	DT	O	a	det	47	SENT_273	[p18l2108t1698r2143b1738],
44	multiple	JJ	O	multiple	amod	47	SENT_273	[p18l10t1770r842b1846],
45	—	NN	O	—	nn	47	SENT_273	[p18l10t1770r842b1846],
46	compartment	NN	O	compartment	nn	47	SENT_273	[p18l10t1770r842b1846],
47	model	NN	O	model	prep_in	27	SENT_273	[p18l868t1770r1095b1831],
48	of	IN	O	of	_	0	SENT_273	[p18l1124t1770r1202b1831],
49	Viral	JJ	O	viral	amod	51	SENT_273	[p18l1216t1770r1373b1831],
50	decay	NN	O	decay	nn	51	SENT_273	[p18l1402t1770r1608b1846],
51	kinetics	NNS	O	kinetics	prep_of	47	SENT_273	[p18l1634t1770r1979b1831],
52	.	.	O	.	_	0	SENT_273	[p18l1634t1770r1979b1831],

1	”	NN	O	”	_	0	SENT_274	[p18l1634t1770r1979b1831],

1	Controversy	NN	O	controversy	nsubj	2	SENT_275	[p18l98t1864r546b1939],
2	remains	VBZ	O	remain	_	0	SENT_275	[p18l602t1864r889b1924],
3	about	IN	O	about	_	0	SENT_275	[p18l950t1864r1156b1924],
4	the	DT	O	the	det	5	SENT_275	[p18l1213t1864r1325b1924],
5	association	NN	O	association	prep_about	2	SENT_275	[p18l1386t1864r1784b1924],
6	between	IN	O	between	_	0	SENT_275	[p18l1840t1864r2143b1924],
7	MDR1	NN	O	mdr1	nn	9	SENT_275	[p18l7t1958r255b2016],
8	genetic	JJ	O	genetic	amod	9	SENT_275	[p18l305t1957r562b2033],
9	Variation	NN	O	variation	prep_between	5	SENT_275	[p18l607t1957r949b2030],
10	,	,	O	,	_	0	SENT_275	[p18l607t1957r949b2030],
11	P-glycoprotein	NN	O	p-glycoprotein	nn	12	SENT_275	[p18l998t1957r1536b2033],
12	expression	NN	O	expression	prep_between	5	SENT_275	[p18l1582t1957r1964b2033],
13	and	CC	O	and	_	0	SENT_275	[p18l2010t1957r2143b2017],
14	function	NN	O	function	conj_and	12	SENT_275	[p18l10t2049r338b2122],
15	,	,	O	,	_	0	SENT_275	[p18l10t2049r338b2122],
16	and	CC	O	and	_	0	SENT_275	[p18l422t2049r555b2110],
17	concentrations	NNS	O	concentration	conj_and	9	SENT_275	[p18l635t2049r1171b2110],
18	in	IN	O	in	_	0	SENT_275	[p18l1252t2049r1321b2109],
19	plasma	NN	O	plasma	prep_in	2	SENT_275	[p18l1398t2049r1655b2125],
20	of	IN	O	of	_	0	SENT_275	[p18l1736t2049r1813b2110],
21	Various	JJ	O	various	amod	22	SENT_275	[p18l1880t2049r2142b2110],
22	substrates	NNS	O	substrate	prep_of	19	SENT_275	[p18l12t2142r371b2203],
23	of	IN	O	of	_	0	SENT_275	[p18l442t2142r519b2203],
24	P-glycoprotein	NN	O	p-glycoprotein	prep_of	22	SENT_275	[p18l578t2142r1134b2218],
25	.	.	O	.	_	0	SENT_275	[p18l578t2142r1134b2218],

1	The	DT	O	the	det	2	SENT_276	[p18l1207t2142r1355b2203],
2	MDR	NN	ORGANIZATION	mdr	tmod	8	SENT_276	[p18l1420t2143r1668b2202],
3	]	CD	NUMBER	]	dep	2	SENT_276	[p18l1420t2143r1668b2202],
4	3435	CD	NUMBER	3435	num	6	SENT_276	[p18l1742t2145r1920b2203],
5	C/T	NNP	O	C/T	nn	6	SENT_276	[p18l1995t2142r2144b2203],
6	polymorphism	NN	O	polymorphism	nsubj	8	SENT_276	[p18l9t2236r540b2312],
7	is	VBZ	O	be	cop	8	SENT_276	[p18l579t2236r631b2296],
8	non-coding	JJ	O	non-coding	_	0	SENT_276	[p18l671t2236r1112b2312],
9	,	,	O	,	_	0	SENT_276	[p18l671t2236r1112b2312],
10	and	CC	O	and	_	0	SENT_276	[p18l1156t2236r1289b2296],
11	it	PRP	O	it	nsubj	13	SENT_276	[p18l1328t2236r1376b2296],
12	could	MD	O	could	aux	13	SENT_276	[p18l1416t2236r1617b2296],
13	be	VB	O	be	conj_and	8	SENT_276	[p18l1654t2236r1739b2296],
14	in	IN	O	in	_	0	SENT_276	[p18l1779t2236r1847b2295],
15	linkage	NN	O	linkage	nn	16	SENT_276	[p18l1886t2236r2142b2312],
16	disequilibrium	NN	O	disequilibrium	prep_in	13	SENT_276	[p18l12t2328r541b2404],
17	with	IN	O	with	_	0	SENT_276	[p18l597t2328r756b2389],
18	a	DT	O	a	det	19	SENT_276	[p18l815t2348r850b2389],
19	polymorphism	NN	O	polymorphism	prep_with	16	SENT_276	[p18l906t2328r1438b2404],
20	elsewhere	RB	O	elsewhere	advmod	13	SENT_276	[p18l1496t2328r1847b2389],
21	in	IN	O	in	_	0	SENT_276	[p18l1905t2328r1974b2388],
22	the	DT	O	the	det	23	SENT_276	[p18l2031t2328r2142b2389],
23	genome	NN	O	genome	prep_in	13	SENT_276	[p18l10t2441r296b2497],
24	that	WDT	O	that	nsubj	25	SENT_276	[p18l329t2421r471b2482],
25	modiﬁes	VBZ	O	modiﬁes	rcmod	23	SENT_276	[p18l502t2421r811b2482],
26	MDR1	NN	O	mdr1	nn	27	SENT_276	[p18l841t2422r1089b2481],
27	expression	NN	O	expression	dobj	25	SENT_276	[p18l1128t2422r1509b2497],
28	or	CC	O	or	_	0	SENT_276	[p18l1543t2441r1617b2482],
29	function	NN	O	function	conj_or	27	SENT_276	[p18l1648t2421r2142b2482],
30	.	.	O	.	_	0	SENT_276	[p18l1648t2421r2142b2482],

1	‘“	NN	O	‘“	nsubjpass	19	SENT_277	[p18l1648t2421r2142b2482],
2	‘’	CD	NUMBER	‘’	number	3	SENT_277	[p18l1648t2421r2142b2482],
3	’25	CD	NUMBER	’25	amod	1	SENT_277	[p18l1648t2421r2142b2482],
4	In	IN	O	in	dep	3	SENT_277	[p18l11t2516r88b2574],
5	the	DT	O	the	det	6	SENT_277	[p18l128t2515r240b2575],
6	study	NN	O	study	pobj	4	SENT_277	[p18l284t2515r480b2591],
7	by	IN	O	by	_	0	SENT_277	[p18l518t2515r606b2591],
8	Hoffmeyer	NNP	PERSON	Hoffmeyer	prep_by	6	SENT_277	[p18l646t2515r1040b2591],
9	and	CC	O	and	_	0	SENT_277	[p18l1081t2515r1214b2575],
10	colleagues	NNS	O	colleague	prep_by	6	SENT_277	[p18l1257t2515r1699b2591],
11	,	,	O	,	_	0	SENT_277	[p18l1257t2515r1699b2591],
12	”	IN	O	”	_	0	SENT_277	[p18l1257t2515r1699b2591],
13	the	DT	O	the	det	17	SENT_277	[p18l1740t2515r1852b2575],
14	MDRI	NNP	O	MDRI	nn	17	SENT_277	[p18l1890t2516r2138b2574],
15	3435	CD	NUMBER	3435	num	17	SENT_277	[p18l13t2610r190b2668],
16	TT	NN	O	tt	nn	17	SENT_277	[p18l311t2608r438b2667],
17	genotype	NN	O	genotype	prep_”	19	SENT_277	[p18l555t2621r884b2683],
18	was	VBD	O	be	auxpass	19	SENT_277	[p18l1001t2627r1134b2668],
19	associated	VBN	O	associate	_	0	SENT_277	[p18l1255t2607r1623b2668],
20	with	IN	O	with	_	0	SENT_277	[p18l1739t2607r1899b2668],
21	low	JJ	O	low	amod	23	SENT_277	[p18l2016t2607r2144b2668],
22	P-glycoprotein	NN	O	p-glycoprotein	nn	23	SENT_277	[p18l11t2700r549b2776],
23	expression	NN	O	expression	prep_with	19	SENT_277	[p18l638t2701r1019b2776],
24	in	IN	O	in	_	0	SENT_277	[p18l1107t2701r1176b2760],
25	enterocytes	NNS	O	enterocyte	prep_in	23	SENT_277	[p18l1265t2715r1674b2776],
26	and	CC	O	and	_	0	SENT_277	[p18l1765t2700r1898b2761],
27	high	JJ	O	high	amod	28	SENT_277	[p18l1985t2700r2144b2776],
28	concentrations	NNS	O	concentration	prep_in	23	SENT_277	[p18l12t2794r548b2854],
29	in	IN	O	in	_	0	SENT_277	[p18l581t2794r649b2853],
30	plasma	NN	O	plasma	prep_in	19	SENT_277	[p18l679t2794r935b2870],
31	of	IN	O	of	_	0	SENT_277	[p18l969t2794r1046b2854],
32	digoxin	NN	O	digoxin	prep_of	30	SENT_277	[p18l1069t2794r1357b2870],
33	.	.	O	.	_	0	SENT_277	[p18l1069t2794r1357b2870],

1	However	RB	O	however	advmod	29	SENT_278	[p18l1395t2795r1744b2867],
2	,	,	O	,	_	0	SENT_278	[p18l1395t2795r1744b2867],
3	in	IN	O	in	_	0	SENT_278	[p18l1779t2794r1847b2853],
4	a	DT	O	a	det	5	SENT_278	[p18l1880t2814r1915b2854],
5	study	NN	O	study	prep_in	29	SENT_278	[p18l1948t2794r2145b2870],
6	by	IN	O	by	_	0	SENT_278	[p18l9t2886r97b2962],
7	Kim	NNP	PERSON	Kim	prep_by	5	SENT_278	[p18l134t2886r295b2946],
8	and	CC	O	and	_	0	SENT_278	[p18l335t2886r468b2947],
9	colleagues	NNS	O	colleague	conj_and	7	SENT_278	[p18l508t2886r949b2962],
10	,	,	O	,	_	0	SENT_278	[p18l508t2886r949b2962],
11	”	IN	O	”	_	0	SENT_278	[p18l508t2886r949b2962],
12	the	DT	O	the	det	17	SENT_278	[p18l989t2886r1100b2947],
13	MDR1	NN	O	mdr1	nn	17	SENT_278	[p18l1136t2887r1384b2946],
14	3435	CD	NUMBER	3435	num	17	SENT_278	[p18l1429t2889r1606b2947],
15	TT	NN	O	tt	nn	17	SENT_278	[p18l1649t2887r1776b2946],
16	genotype	NN	O	genotype	nn	17	SENT_278	[p18l1814t2900r2142b2962],
17	(	NN	O	(	prep_”	29	SENT_278	[p18l17t2980r112b3055],
18	in	IN	O	in	_	0	SENT_278	[p18l17t2980r112b3055],
19	the	DT	O	the	det	20	SENT_278	[p18l156t2979r268b3040],
20	context	NN	O	context	prep_in	17	SENT_278	[p18l316t2994r585b3040],
21	of	IN	O	of	_	0	SENT_278	[p18l631t2979r708b3040],
22	a	DT	O	a	det	23	SENT_278	[p18l746t2999r780b3040],
23	C1236T	NN	O	c1236t	prep_of	20	SENT_278	[p18l830t2980r1162b3052],
24	,	,	O	,	_	0	SENT_278	[p18l830t2980r1162b3052],
25	G2677T	NN	O	g2677t	nn	27	SENT_278	[p18l1213t2980r1531b3040],
26	haplotype	NN	O	haplotype	nn	27	SENT_278	[p18l1574t2979r1959b3055],
27	)	NN	O	)	nsubjpass	29	SENT_278	[p18l1574t2979r1959b3055],
28	was	VBD	O	be	auxpass	29	SENT_278	[p18l2009t2999r2142b3040],
29	associated	VBN	O	associate	_	0	SENT_278	[p18l12t3073r381b3133],
30	with	IN	O	with	_	0	SENT_278	[p18l428t3073r587b3133],
31	high	JJ	O	high	amod	33	SENT_278	[p18l634t3073r794b3149],
32	P-glycoprotein	NN	MISC	p-glycoprotein	nn	33	SENT_278	[p18l842t3073r1380b3149],
33	expression	NN	O	expression	prep_with	29	SENT_278	[p18l1430t3073r1812b3149],
34	in	FW	O	in	nn	35	SENT_278	[p18l1860t3073r1928b3132],
35	vitro	FW	O	vitro	dep	33	SENT_278	[p18l1975t3073r2141b3133],
36	and	CC	O	and	_	0	SENT_278	[p18l12t3165r145b3226],
37	low	JJ	O	low	amod	38	SENT_278	[p18l239t3165r368b3226],
38	concentrations	NNS	O	concentration	dep	33	SENT_278	[p18l462t3165r998b3226],
39	in	IN	O	in	_	0	SENT_278	[p18l1094t3165r1162b3225],
40	plasma	NN	O	plasma	prep_in	38	SENT_278	[p18l1255t3165r1511b3241],
41	of	IN	O	of	_	0	SENT_278	[p18l1607t3165r1684b3226],
42	the	DT	O	the	det	44	SENT_278	[p18l1768t3165r1880b3226],
43	drug	NN	O	drug	nn	44	SENT_278	[p18l1976t3165r2144b3241],
44	fexofenadine	NN	O	fexofenadine	prep_of	40	SENT_278	[p18l10t3258r496b3319],
45	.	.	O	.	_	0	SENT_278	[p18l10t3258r496b3319],

1	In	IN	O	in	_	0	SENT_279	[p18l529t3259r606b3318],
2	our	PRP$	O	we	poss	3	SENT_279	[p18l635t3278r759b3319],
3	study	NN	O	study	prep_in	11	SENT_279	[p18l786t3258r1002b3334],
4	,	,	O	,	_	0	SENT_279	[p18l786t3258r1002b3334],
5	the	DT	O	the	det	9	SENT_279	[p18l1032t3258r1144b3319],
6	MDR1	NN	O	mdr1	nn	9	SENT_279	[p18l1169t3259r1416b3318],
7	3435	CD	NUMBER	3435	num	9	SENT_279	[p18l1451t3261r1629b3319],
8	TT	NN	O	tt	nn	9	SENT_279	[p18l1660t3259r1787b3318],
9	genotype	NN	O	genotype	nsubjpass	11	SENT_279	[p18l1814t3273r2142b3334],
10	was	VBD	O	be	auxpass	11	SENT_279	[p18l9t3372r142b3412],
11	associated	VBN	O	associate	_	0	SENT_279	[p18l275t3352r644b3412],
12	with	IN	O	with	_	0	SENT_279	[p18l772t3352r932b3412],
13	low	JJ	O	low	amod	14	SENT_279	[p18l1061t3352r1190b3412],
14	expression	NN	O	expression	prep_with	11	SENT_279	[p18l1320t3352r1702b3428],
15	of	IN	O	of	_	0	SENT_279	[p18l1833t3352r1911b3412],
16	the	DT	O	the	det	18	SENT_279	[p18l2031t3352r2142b3412],
17	MDR1	NN	O	mdr1	nn	18	SENT_279	[p18l7t3445r255b3504],
18	transcript	NN	O	transcript	prep_of	14	SENT_279	[p18l295t3444r646b3520],
19	and	CC	O	and	_	0	SENT_279	[p18l684t3444r816b3505],
20	P-glycoprotein	NN	O	p-glycoprotein	prep_with	11	SENT_279	[p18l853t3444r1390b3520],
21	in	IN	O	in	_	0	SENT_279	[p18l1426t3444r1495b3504],
22	peripheral	JJ	O	peripheral	amod	23	SENT_279	[p18l1529t3444r1899b3520],
23	blood	NN	O	blood	prep_in	20	SENT_279	[p18l1934t3444r2143b3505],
24	mononuclear	JJ	O	mononuclear	amod	25	SENT_279	[p18l10t3537r495b3598],
25	cells	NNS	O	cell	dep	20	SENT_279	[p18l525t3537r677b3598],
26	and	CC	O	and	_	0	SENT_279	[p18l711t3537r844b3598],
27	with	IN	O	with	_	0	SENT_279	[p18l873t3537r1032b3598],
28	low	JJ	O	low	amod	29	SENT_279	[p18l1062t3537r1190b3598],
29	concentrations	NNS	O	concentration	conj_and	14	SENT_279	[p18l1222t3538r1757b3598],
30	in	IN	O	in	_	0	SENT_279	[p18l1789t3538r1858b3597],
31	plasma	NN	O	plasma	prep_in	29	SENT_279	[p18l1886t3537r2143b3613],
32	of	IN	O	of	_	0	SENT_279	[p18l12t3631r90b3691],
33	nelﬁnavir	NN	O	nelﬁnavir	prep_of	31	SENT_279	[p18l106t3631r450b3691],
34	and	CC	O	and	_	0	SENT_279	[p18l477t3631r610b3691],
35	efavirenz	NN	O	efavirenz	prep_of	31	SENT_279	[p18l638t3631r980b3691],
36	.	.	O	.	_	0	SENT_279	[p18l638t3631r980b3691],

1	The	DT	O	the	det	5	SENT_280	[p19l94t23r243b84],
2	MDR1	NN	O	mdr1	nn	5	SENT_280	[p19l269t24r517b83],
3	3435	CD	NUMBER	3435	num	5	SENT_280	[p19l553t26r730b84],
4	TT	NN	O	tt	nn	5	SENT_280	[p19l763t24r890b83],
5	genotype	NN	O	genotype	nsubjpass	9	SENT_280	[p19l919t37r1247b99],
6	has	VBZ	O	have	aux	9	SENT_280	[p19l1276t23r1394b84],
7	also	RB	O	also	advmod	9	SENT_280	[p19l1426t23r1562b84],
8	been	VBN	O	be	auxpass	9	SENT_280	[p19l1591t23r1766b84],
9	described	VBN	O	describe	conj_and	9	SENT_280	[p19l1796t23r2143b84],
10	in	IN	O	in	_	0	SENT_280	[p19l10t117r79b176],
11	association	NN	O	association	prep_in	9	SENT_280	[p19l146t117r544b177],
12	with	IN	O	with	_	0	SENT_280	[p19l607t116r767b177],
13	low	JJ	O	low	amod	15	SENT_280	[p19l832t116r960b177],
14	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_280	[p19l1025t116r1562b192],
15	expression	NN	O	expression	prep_with	9	SENT_280	[p19l1629t117r2010b192],
16	in	IN	O	in	_	0	SENT_280	[p19l2075t117r2143b176],
17	CD56	NN	O	cd56	nn	20	SENT_280	[p19l14t210r236b270],
18	natural-killer	NN	O	natural-killer	nn	20	SENT_280	[p19l312t210r787b270],
19	cells2	NN	O	cells2	nn	20	SENT_280	[p19l861t210r1061b270],
20	°	NN	O	°	prep_in	15	SENT_280	[p19l861t210r1061b270],
21	and	CC	O	and	_	0	SENT_280	[p19l1137t210r1270b270],
22	in	IN	O	in	_	0	SENT_280	[p19l1344t210r1413b269],
23	human	JJ	O	human	amod	25	SENT_280	[p19l1485t210r1742b270],
24	placental	JJ	O	placental	amod	25	SENT_280	[p19l1814t210r2143b286],
25	tissue	NN	O	tissue	prep_in	9	SENT_280	[p19l10t302r285b363],
26	.	.	O	.	_	0	SENT_280	[p19l10t302r285b363],

1	“	NN	O	“	nn	2	SENT_281	[p19l10t302r285b363],
2	Blockage	NN	O	blockage	nsubj	25	SENT_281	[p19l351t302r679b378],
3	of	IN	O	of	_	0	SENT_281	[p19l747t302r824b363],
4	transport	NN	O	transport	prep_of	2	SENT_281	[p19l879t316r1213b378],
5	by	IN	O	by	_	0	SENT_281	[p19l1276t302r1364b378],
6	the	DT	O	the	det	9	SENT_281	[p19l1427t302r1539b363],
7	P-glycoprotein	NN	MISC	p-glycoprotein	nn	9	SENT_281	[p19l1606t302r2143b378],
8	inhibitor	NN	O	inhibitor	nn	9	SENT_281	[p19l10t395r328b456],
9	LY	NN	O	ly	prep_by	4	SENT_281	[p19l361t396r809b468],
10	—	CD	NUMBER	—	number	11	SENT_281	[p19l361t396r809b468],
11	335979	CD	NUMBER	335979	num	9	SENT_281	[p19l361t396r809b468],
12	,	,	O	,	_	0	SENT_281	[p19l361t396r809b468],
13	leading	VBG	O	lead	partmod	25	SENT_281	[p19l848t395r1111b471],
14	to	TO	O	to	_	0	SENT_281	[p19l1145t410r1214b456],
15	raised	VBN	O	raise	amod	16	SENT_281	[p19l1251t395r1465b456],
16	concentrations	NNS	O	concentration	prep_to	13	SENT_281	[p19l1502t396r2038b456],
17	of	IN	O	of	_	0	SENT_281	[p19l2076t395r2153b456],
18	nelﬁnavir	NN	O	nelﬁnavir	prep_of	16	SENT_281	[p19l10t489r354b549],
19	in	IN	O	in	_	0	SENT_281	[p19l389t489r457b548],
20	brain	NN	O	brain	nn	23	SENT_281	[p19l492t489r682b549],
21	and	CC	O	and	_	0	SENT_281	[p19l720t489r852b549],
22	testicular	JJ	O	testicular	nn	23	SENT_281	[p19l888t489r1223b549],
23	tissue	NN	O	tissue	prep_in	18	SENT_281	[p19l1258t489r1483b561],
24	,	,	O	,	_	0	SENT_281	[p19l1258t489r1483b561],
25	resulted	VBD	O	result	_	0	SENT_281	[p19l1522t489r1812b549],
26	in	IN	O	in	_	0	SENT_281	[p19l1849t489r1917b548],
27	small	JJ	O	small	amod	28	SENT_281	[p19l1954t489r2143b549],
28	changes	NNS	O	change	prep_in	25	SENT_281	[p19l12t580r298b656],
29	in	IN	O	in	_	0	SENT_281	[p19l354t580r423b640],
30	plasma	NN	O	plasma	nn	32	SENT_281	[p19l476t580r732b656],
31	nelfinavir	NN	O	nelfinavir	nn	32	SENT_281	[p19l786t580r1130b641],
32	concentrations	NNS	O	concentration	prep_in	28	SENT_281	[p19l1184t580r1720b641],
33	in	IN	O	in	_	0	SENT_281	[p19l1776t580r1845b640],
34	mice	NNS	O	mouse	prep_in	25	SENT_281	[p19l1899t580r2142b641],
35	.	.	O	.	_	0	SENT_281	[p19l1899t580r2142b641],

1	”	NN	O	”	nn	2	SENT_282	[p19l1899t580r2142b641],
2	Differences	NNS	O	difference	nsubj	9	SENT_282	[p19l11t673r425b734],
3	in	IN	O	in	_	0	SENT_282	[p19l457t674r526b733],
4	study	NN	O	study	nn	5	SENT_282	[p19l557t674r753b749],
5	strategy	NN	O	strategy	prep_in	2	SENT_282	[p19l783t688r1065b750],
6	and	CC	O	and	_	0	SENT_282	[p19l1095t674r1228b734],
7	substrates	NNS	O	substrate	prep_in	2	SENT_282	[p19l1259t674r1618b734],
8	could	MD	O	could	aux	9	SENT_282	[p19l1651t674r1852b734],
9	explain	VB	O	explain	_	0	SENT_282	[p19l1883t674r2143b750],
10	the	DT	O	the	det	11	SENT_282	[p19l10t767r122b827],
11	discrepancies	NNS	O	discrepancy	dobj	9	SENT_282	[p19l186t767r692b843],
12	;	:	O	;	_	0	SENT_282	[p19l186t767r692b843],
13	however	RB	O	however	advmod	16	SENT_282	[p19l756t767r1083b840],
14	,	,	O	,	_	0	SENT_282	[p19l756t767r1083b840],
15	there	EX	O	there	expl	16	SENT_282	[p19l1148t767r1331b827],
16	is	VBZ	O	be	parataxis	9	SENT_282	[p19l1394t767r1446b827],
17	urgent	JJ	O	urgent	amod	18	SENT_282	[p19l1509t781r1746b843],
18	need	NN	O	need	nsubj	16	SENT_282	[p19l1806t767r1980b827],
19	for	IN	O	for	_	0	SENT_282	[p19l2042t767r2145b827],
20	additional	JJ	O	additional	amod	21	SENT_282	[p19l12t859r377b920],
21	work	NN	O	work	prep_for	18	SENT_282	[p19l402t859r586b920],
22	to	TO	O	to	aux	23	SENT_282	[p19l610t873r680b920],
23	reconcile	VB	O	reconcile	infmod	18	SENT_282	[p19l708t859r1035b920],
24	these	DT	O	these	det	26	SENT_282	[p19l1062t859r1248b920],
25	opposing	VBG	O	oppose	amod	26	SENT_282	[p19l1277t859r1608b935],
26	results	NNS	O	result	dobj	23	SENT_282	[p19l1633t859r1888b920],
27	.	.	O	.	_	0	SENT_282	[p19l1633t859r1888b920],

1	The	DT	O	the	det	2	SENT_283	[p19l95t952r243b1013],
2	fact	NN	O	fact	nsubj	20	SENT_283	[p19l275t952r407b1013],
3	that	IN	O	that	complm	12	SENT_283	[p19l437t952r580b1013],
4	concentrations	NNS	O	concentration	nsubj	12	SENT_283	[p19l612t953r1147b1013],
5	of	IN	O	of	_	0	SENT_283	[p19l1182t952r1259b1013],
6	nelfinavir	NN	O	nelfinavir	prep_of	4	SENT_283	[p19l1280t952r1624b1013],
7	and	CC	O	and	_	0	SENT_283	[p19l1656t952r1788b1013],
8	efavirenz	NN	O	efavirenz	prep_of	4	SENT_283	[p19l1821t952r2144b1013],
9	in	IN	O	in	_	0	SENT_283	[p19l10t1046r79b1105],
10	plasma	NN	O	plasma	prep_in	6	SENT_283	[p19l111t1046r367b1122],
11	are	VBP	O	be	cop	12	SENT_283	[p19l402t1066r508b1106],
12	low	JJ	O	low	dep	2	SENT_283	[p19l542t1046r671b1106],
13	when	WRB	O	when	advmod	18	SENT_283	[p19l702t1046r898b1106],
14	P-glycoprotein	NN	O	p-glycoprotein	nn	15	SENT_283	[p19l931t1046r1468b1122],
15	expression	NN	O	expression	nsubj	18	SENT_283	[p19l1503t1046r1884b1122],
16	is	VBZ	O	be	cop	18	SENT_283	[p19l1917t1046r1969b1106],
17	also	RB	O	also	advmod	18	SENT_283	[p19l2005t1046r2141b1106],
18	low	JJ	O	low	ccomp	12	SENT_283	[p19l11t1138r139b1199],
19	could	MD	O	could	aux	20	SENT_283	[p19l180t1138r381b1199],
20	suggest	VB	O	suggest	_	0	SENT_283	[p19l422t1152r687b1214],
21	an	DT	O	a	det	23	SENT_283	[p19l728t1158r812b1199],
22	indirect	JJ	O	indirect	amod	23	SENT_283	[p19l852t1138r1132b1199],
23	effect	NN	O	effect	dobj	20	SENT_283	[p19l1173t1138r1369b1199],
24	of	IN	O	of	_	0	SENT_283	[p19l1410t1138r1488b1199],
25	the	DT	O	the	det	28	SENT_283	[p19l1517t1138r1629b1199],
26	MDR1	NN	O	mdr1	nn	28	SENT_283	[p19l1666t1139r1914b1198],
27	3435	CD	NUMBER	3435	num	28	SENT_283	[p19l1961t1141r2138b1199],
28	genotype	NN	O	genotype	prep_of	23	SENT_283	[p19l10t1246r359b1307],
29	.	.	O	.	_	0	SENT_283	[p19l10t1246r359b1307],

1	We	PRP	O	we	nsubj	2	SENT_284	[p19l401t1232r523b1292],
2	explored	VBD	O	explore	_	0	SENT_284	[p19l563t1231r877b1307],
3	two	CD	NUMBER	two	num	4	SENT_284	[p19l914t1246r1046b1292],
4	hypotheses	NNS	O	hypothesis	dobj	2	SENT_284	[p19l1084t1231r1484b1307],
5	that	WDT	O	that	nsubj	6	SENT_284	[p19l1524t1231r1666b1292],
6	address	VBP	O	address	rcmod	4	SENT_284	[p19l1705t1231r1975b1292],
7	this	DT	O	this	det	8	SENT_284	[p19l2014t1231r2142b1292],
8	paradox	NN	O	paradox	dobj	6	SENT_284	[p19l9t1325r324b1401],
9	.	.	O	.	_	0	SENT_284	[p19l9t1325r324b1401],

1	First	RB	ORDINAL	first	advmod	9	SENT_285	[p19l399t1325r589b1398],
2	,	,	O	,	_	0	SENT_285	[p19l399t1325r589b1398],
3	low	JJ	O	low	amod	4	SENT_285	[p19l662t1325r790b1385],
4	concentrations	NNS	O	concentration	nsubjpass	9	SENT_285	[p19l860t1325r1396b1385],
5	of	IN	O	of	_	0	SENT_285	[p19l1468t1325r1546b1385],
6	P-glycoprotein	NN	O	p-glycoprotein	prep_of	4	SENT_285	[p19l1606t1325r2143b1401],
7	might	MD	O	might	aux	9	SENT_285	[p19l10t1417r223b1493],
8	be	VB	O	be	auxpass	9	SENT_285	[p19l273t1417r358b1478],
9	compensated	VBN	O	compensate	_	0	SENT_285	[p19l413t1417r894b1493],
10	for	IN	O	for	dep	9	SENT_285	[p19l946t1417r1049b1478],
11	by	IN	O	by	_	0	SENT_285	[p19l1099t1417r1187b1493],
12	overexpression	NN	O	overexpression	agent	9	SENT_285	[p19l1240t1417r1779b1493],
13	of	IN	O	of	_	0	SENT_285	[p19l1833t1417r1910b1478],
14	other	JJ	O	other	amod	15	SENT_285	[p19l1955t1417r2145b1478],
15	transporters	NNS	O	transporter	prep_of	12	SENT_285	[p19l10t1524r447b1586],
16	with	IN	O	with	_	0	SENT_285	[p19l522t1510r682b1571],
17	affinity	NN	O	affinity	prep_with	9	SENT_285	[p19l758t1510r1012b1586],
18	for	IN	O	for	_	0	SENT_285	[p19l1086t1510r1188b1571],
19	antiretroviral	JJ	O	antiretroviral	amod	20	SENT_285	[p19l1264t1510r1735b1571],
20	drugs	NNS	O	drug	prep_for	17	SENT_285	[p19l1813t1510r2142b1586],
21	,	,	O	,	_	0	SENT_285	[p19l1813t1510r2142b1586],
22	”’	CD	NUMBER	”’	num	23	SENT_285	[p19l1813t1510r2142b1586],
23	28	CD	NUMBER	28	appos	20	SENT_285	[p19l1813t1510r2142b1586],
24	potentially	RB	O	potentially	advmod	25	SENT_285	[p19l9t1604r397b1680],
25	leading	VBG	O	lead	partmod	23	SENT_285	[p19l472t1604r736b1680],
26	to	TO	O	to	_	0	SENT_285	[p19l810t1618r880b1664],
27	a	DT	O	a	det	28	SENT_285	[p19l959t1624r995b1664],
28	reduction	NN	O	reduction	prep_to	25	SENT_285	[p19l1071t1604r1422b1664],
29	of	IN	O	of	_	0	SENT_285	[p19l1500t1604r1577b1664],
30	plasma	NN	O	plasma	nn	32	SENT_285	[p19l1642t1604r1899b1680],
31	drug	NN	O	drug	nn	32	SENT_285	[p19l1977t1604r2145b1680],
32	concentrations	NNS	O	concentration	prep_of	28	SENT_285	[p19l12t1696r569b1757],
33	.	.	O	.	_	0	SENT_285	[p19l12t1696r569b1757],

1	For	IN	O	for	_	0	SENT_286	[p19l605t1697r737b1757],
2	example	NN	O	example	prep_for	22	SENT_286	[p19l766t1696r1090b1772],
3	,	,	O	,	_	0	SENT_286	[p19l766t1696r1090b1772],
4	in	IN	O	in	_	0	SENT_286	[p19l1122t1696r1191b1756],
5	mdrl-knockout	JJ	O	mdrl-knockout	amod	6	SENT_286	[p19l1222t1696r1774b1757],
6	mice	NNS	O	mouse	prep_in	22	SENT_286	[p19l1803t1696r1997b1769],
7	,	,	O	,	_	0	SENT_286	[p19l1803t1696r1997b1769],
8	the	DT	O	the	det	11	SENT_286	[p19l2030t1696r2142b1757],
9	cumulative	JJ	O	cumulative	amod	11	SENT_286	[p19l12t1789r412b1850],
10	renal	JJ	O	renal	amod	11	SENT_286	[p19l439t1789r619b1850],
11	output	NN	O	output	nsubjpass	22	SENT_286	[p19l648t1804r890b1865],
12	of	IN	O	of	_	0	SENT_286	[p19l918t1789r995b1850],
13	Vecuronium	NNP	O	Vecuronium	prep_of	11	SENT_286	[p19l1010t1790r1470b1862],
14	,	,	O	,	_	0	SENT_286	[p19l1010t1790r1470b1862],
15	a	DT	O	a	det	16	SENT_286	[p19l1501t1809r1536b1850],
16	substrate	NN	O	substrate	appos	11	SENT_286	[p19l1565t1789r1891b1850],
17	of	IN	O	of	_	0	SENT_286	[p19l1920t1789r1997b1850],
18	this	DT	O	this	det	19	SENT_286	[p19l2014t1789r2142b1850],
19	protein	NN	O	protein	prep_of	16	SENT_286	[p19l9t1883r293b1959],
20	,	,	O	,	_	0	SENT_286	[p19l9t1883r293b1959],
21	was	VBD	O	be	auxpass	22	SENT_286	[p19l327t1903r459b1943],
22	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_286	[p19l494t1883r834b1959],
23	several-fold	RB	O	several-fold	advmod	22	SENT_286	[p19l867t1883r1286b1943],
24	compared	VBN	O	compare	_	0	SENT_286	[p19l1320t1883r1682b1959],
25	with	IN	O	with	prepc_compared_with	22	SENT_286	[p19l1712t1883r1871b1943],
26	that	DT	O	that	pobj	22	SENT_286	[p19l1902t1883r2044b1943],
27	in	IN	O	in	_	0	SENT_286	[p19l2075t1883r2144b1942],
28	wild	JJ	O	wild	amod	31	SENT_286	[p19l9t1975r350b2051],
29	—	NN	O	—	nn	31	SENT_286	[p19l9t1975r350b2051],
30	type	NN	O	type	nn	31	SENT_286	[p19l9t1975r350b2051],
31	mice	NNS	O	mouse	prep_in	26	SENT_286	[p19l390t1975r585b2048],
32	,	,	O	,	_	0	SENT_286	[p19l390t1975r585b2048],
33	which	WDT	O	which	nsubjpass	35	SENT_286	[p19l626t1975r845b2036],
34	was	VBD	O	be	auxpass	35	SENT_286	[p19l883t1995r1015b2036],
35	attributed	VBN	O	attribute	rcmod	26	SENT_286	[p19l1059t1975r1419b2036],
36	to	TO	O	to	_	0	SENT_286	[p19l1458t1989r1528b2036],
37	upregulation	NN	O	upregulation	prep_to	35	SENT_286	[p19l1569t1975r2035b2051],
38	of	IN	O	of	_	0	SENT_286	[p19l2076t1975r2153b2036],
39	other	JJ	O	other	amod	41	SENT_286	[p19l12t2068r203b2129],
40	renal	JJ	O	renal	amod	41	SENT_286	[p19l227t2068r407b2129],
41	transporters	NNS	O	transporter	prep_of	37	SENT_286	[p19l434t2070r943b2144],
42	.	.	O	.	_	0	SENT_286	[p19l434t2070r943b2144],

1	”	NN	O	”	_	0	SENT_287	[p19l434t2070r943b2144],

1	Second	RB	ORDINAL	second	advmod	7	SENT_288	[p19l98t2162r387b2235],
2	,	,	O	,	_	0	SENT_288	[p19l98t2162r387b2235],
3	intestinal	JJ	O	intestinal	amod	4	SENT_288	[p19l461t2162r794b2222],
4	CYP3A	NN	O	cyp3a	nsubj	7	SENT_288	[p19l869t2162r1153b2222],
5	and	CC	O	and	_	0	SENT_288	[p19l1224t2162r1357b2222],
6	P-glycoprotein	NN	O	p-glycoprotein	conj_and	4	SENT_288	[p19l1429t2162r1967b2238],
7	act	VBP	O	act	_	0	SENT_288	[p19l2040t2176r2144b2222],
8	together	RB	O	together	advmod	7	SENT_288	[p19l10t2254r313b2330],
9	to	TO	O	to	aux	10	SENT_288	[p19l401t2268r470b2315],
10	limit	VB	O	limit	xcomp	7	SENT_288	[p19l563t2254r730b2315],
11	drug	NN	O	drug	nn	12	SENT_288	[p19l822t2254r990b2330],
12	absorption	NN	O	absorption	dobj	10	SENT_288	[p19l1081t2254r1539b2330],
13	.	.	O	.	_	0	SENT_288	[p19l1081t2254r1539b2330],

1	”	NNP	O	”	nn	2	SENT_289	[p19l1081t2254r1539b2330],
2	Schuetz	NNP	PERSON	Schuetz	nsubj	6	SENT_289	[p19l1633t2254r1918b2315],
3	and	CC	O	and	_	0	SENT_289	[p19l2010t2254r2143b2315],
4	colleagues	NNS	O	colleague	conj_and	2	SENT_289	[p19l12t2347r426b2423],
5	“	RB	O	“	advmod	6	SENT_289	[p19l12t2347r426b2423],
6	reported	VBD	O	report	_	0	SENT_289	[p19l492t2348r802b2424],
7	that	IN	O	that	complm	17	SENT_289	[p19l864t2348r1006b2408],
8	mdrl-knockout	JJ	O	mdrl-knockout	amod	9	SENT_289	[p19l1069t2348r1620b2408],
9	mice	NNS	O	mouse	nsubj	17	SENT_289	[p19l1681t2348r1853b2408],
10	could	MD	O	could	aux	17	SENT_289	[p19l1917t2348r2140b2420],
11	,	,	O	,	_	0	SENT_289	[p19l1917t2348r2140b2420],
12	by	IN	O	by	_	0	SENT_289	[p19l9t2441r97b2517],
13	induction	NN	O	induction	prep_by	17	SENT_289	[p19l179t2441r530b2501],
14	of	IN	O	of	_	0	SENT_289	[p19l614t2441r691b2501],
15	CYP3A	NN	O	cyp3a	prep_of	13	SENT_289	[p19l768t2441r1072b2514],
16	,	,	O	,	_	0	SENT_289	[p19l768t2441r1072b2514],
17	compensate	VB	O	compensate	ccomp	6	SENT_289	[p19l1159t2455r1590b2517],
18	for	IN	O	for	_	0	SENT_289	[p19l1674t2441r1777b2501],
19	loss	NN	O	loss	prep_for	17	SENT_289	[p19l1858t2441r1989b2501],
20	of	IN	O	of	_	0	SENT_289	[p19l2076t2441r2153b2501],
21	P-glycoprotein	NN	O	p-glycoprotein	nn	22	SENT_289	[p19l11t2533r549b2609],
22	function	NN	O	function	prep_of	19	SENT_289	[p19l623t2533r950b2606],
23	,	,	O	,	_	0	SENT_289	[p19l623t2533r950b2606],
24	thus	RB	O	thus	advmod	25	SENT_289	[p19l1027t2533r1180b2594],
25	leading	VBG	O	lead	partmod	19	SENT_289	[p19l1256t2533r1520b2609],
26	to	TO	O	to	aux	27	SENT_289	[p19l1592t2547r1662b2594],
27	diminished	VBN	O	diminish	xcomp	25	SENT_289	[p19l1739t2533r2143b2594],
28	concentrations	NNS	O	concentration	dobj	27	SENT_289	[p19l12t2627r548b2687],
29	of	IN	O	of	_	0	SENT_289	[p19l582t2626r659b2687],
30	common	JJ	O	common	amod	31	SENT_289	[p19l683t2646r1005b2687],
31	substrates	NNS	O	substrate	prep_of	28	SENT_289	[p19l1037t2626r1396b2687],
32	in	IN	O	in	_	0	SENT_289	[p19l1428t2627r1497b2686],
33	plasma	NN	O	plasma	prep_in	27	SENT_289	[p19l1527t2626r1803b2702],
34	.	.	O	.	_	0	SENT_289	[p19l1527t2626r1803b2702],

1	There	EX	O	there	expl	2	SENT_290	[p19l1838t2626r2058b2687],
2	is	VBZ	O	be	_	0	SENT_290	[p19l2090t2627r2142b2687],
3	additional	JJ	O	additional	amod	4	SENT_290	[p19l12t2720r377b2780],
4	complexity	NN	O	complexity	nsubj	2	SENT_290	[p19l433t2720r852b2796],
5	,	,	O	,	_	0	SENT_290	[p19l433t2720r852b2796],
6	since	IN	O	since	mark	12	SENT_290	[p19l911t2720r1090b2780],
7	some	DT	O	some	det	9	SENT_290	[p19l1145t2739r1332b2780],
8	antiretroviral	JJ	O	antiretroviral	amod	9	SENT_290	[p19l1388t2720r1859b2780],
9	agents	NNS	O	agent	nsubj	12	SENT_290	[p19l1915t2734r2142b2796],
10	are	VBP	O	be	cop	12	SENT_290	[p19l12t2832r118b2873],
11	both	DT	O	both	preconj	12	SENT_290	[p19l148t2812r316b2873],
12	inhibitors	NNS	O	inhibitor	advcl	2	SENT_290	[p19l346t2812r693b2873],
13	and	CC	O	and	_	0	SENT_290	[p19l726t2812r859b2873],
14	inducers	NNS	O	inducer	advcl	2	SENT_290	[p19l889t2812r1197b2873],
15	of	IN	O	of	_	0	SENT_290	[p19l1231t2812r1308b2873],
16	cytochrome	NN	O	cytochrome	nn	17	SENT_290	[p19l1330t2812r1757b2888],
17	P450	NN	O	p450	prep_of	12	SENT_290	[p19l1788t2813r1977b2873],
18	and	CC	O	and	_	0	SENT_290	[p19l2010t2812r2143b2873],
19	P-glycoprotein	NN	O	p-glycoprotein	prep_of	12	SENT_290	[p19l11t2905r620b2981],
20	.	.	O	.	_	0	SENT_290	[p19l11t2905r620b2981],

1	”	NN	O	”	ccomp	7	SENT_291	[p19l11t2905r620b2981],
2	However	RB	O	however	advmod	1	SENT_291	[p19l671t2907r1022b2978],
3	,	,	O	,	_	0	SENT_291	[p19l671t2907r1022b2978],
4	we	PRP	O	we	nsubj	7	SENT_291	[p19l1075t2925r1173b2966],
5	could	MD	O	could	aux	7	SENT_291	[p19l1227t2906r1429b2966],
6	not	RB	O	not	neg	7	SENT_291	[p19l1479t2920r1600b2966],
7	identify	VB	O	identify	_	0	SENT_291	[p19l1651t2905r1927b2981],
8	such	JJ	O	such	amod	10	SENT_291	[p19l1978t2906r2144b2966],
9	compensatory	JJ	O	compensatory	amod	10	SENT_291	[p19l12t3013r525b3075],
10	mechanisms	NNS	O	mechanism	dobj	7	SENT_291	[p19l554t2999r1025b3072],
11	,	,	O	,	_	0	SENT_291	[p19l554t2999r1025b3072],
12	as	IN	O	as	advmod	13	SENT_291	[p19l1062t3019r1129b3059],
13	suggested	VBN	O	suggest	partmod	10	SENT_291	[p19l1164t2999r1516b3075],
14	by	IN	O	by	_	0	SENT_291	[p19l1546t2999r1634b3075],
15	the	DT	O	the	det	16	SENT_291	[p19l1663t2999r1775b3059],
16	results	NNS	O	result	agent	13	SENT_291	[p19l1807t2999r2041b3059],
17	of	IN	O	of	_	0	SENT_291	[p19l2076t2999r2153b3059],
18	analysis	NN	O	analysis	prep_of	16	SENT_291	[p19l12t3091r289b3167],
19	of	IN	O	of	_	0	SENT_291	[p19l339t3091r416b3152],
20	transcription	NN	O	transcription	nn	21	SENT_291	[p19l453t3091r921b3167],
21	levels	NNS	O	level	prep_of	18	SENT_291	[p19l968t3091r1162b3152],
22	of	IN	O	of	_	0	SENT_291	[p19l1212t3091r1290b3152],
23	ABCC1	NN	O	abcc1	prep_of	21	SENT_291	[p19l1320t3091r1603b3152],
24	and	CC	O	and	_	0	SENT_291	[p19l1657t3091r1789b3152],
25	ABCC2	NN	O	abcc2	prep_of	21	SENT_291	[p19l1830t3091r2140b3164],
26	,	,	O	,	_	0	SENT_291	[p19l1830t3091r2140b3164],
27	which	WDT	O	which	nsubj	28	SENT_291	[p19l9t3184r227b3245],
28	encode	VBP	O	encode	conj_or	28	SENT_291	[p19l253t3184r510b3245],
29	for	IN	O	for	_	0	SENT_291	[p19l535t3184r638b3245],
30	multidrug-resistant	JJ	O	multidrug-resistant	amod	31	SENT_291	[p19l661t3184r1364b3260],
31	proteins	NNS	O	protein	prep_for	28	SENT_291	[p19l1387t3185r1682b3260],
32	with	IN	O	with	_	0	SENT_291	[p19l1706t3184r1866b3245],
33	afﬁnity	NN	O	afﬁnity	prep_with	28	SENT_291	[p19l1892t3184r2145b3260],
34	for	IN	O	for	_	0	SENT_291	[p19l10t3278r113b3338],
35	antiretroviral	JJ	O	antiretroviral	amod	36	SENT_291	[p19l154t3278r625b3338],
36	agents	NNS	O	agent	prep_for	33	SENT_291	[p19l668t3279r1025b3354],
37	,	,	O	,	_	0	SENT_291	[p19l668t3279r1025b3354],
38	‘	NN	O	‘	appos	36	SENT_291	[p19l668t3279r1025b3354],
39	3	CD	NUMBER	3	number	40	SENT_291	[p19l668t3279r1025b3354],
40	’28	CD	NUMBER	’28	dep	38	SENT_291	[p19l668t3279r1025b3354],
41	or	CC	O	or	_	0	SENT_291	[p19l1068t3297r1143b3338],
42	by	IN	O	by	_	0	SENT_291	[p19l1180t3278r1268b3354],
43	assessment	NN	O	assessment	prep_by	28	SENT_291	[p19l1308t3292r1709b3338],
44	of	IN	O	of	_	0	SENT_291	[p19l1750t3278r1827b3338],
45	CYP3A	NN	O	cyp3a	nn	46	SENT_291	[p19l1861t3278r2145b3338],
46	activity	NN	O	activity	prep_of	43	SENT_291	[p19l12t3370r291b3446],
47	.	.	O	.	_	0	SENT_291	[p19l12t3370r291b3446],

1	Further	RB	O	further	advmod	18	SENT_292	[p19l95t3463r378b3524],
2	to	TO	O	to	_	0	SENT_292	[p19l423t3478r492b3524],
3	the	DT	O	the	det	4	SENT_292	[p19l542t3463r654b3524],
4	role	NN	O	role	prep_to	18	SENT_292	[p19l702t3463r839b3524],
5	of	IN	O	of	_	0	SENT_292	[p19l889t3463r967b3524],
6	P-glycoprotein	NN	O	p-glycoprotein	prep_of	4	SENT_292	[p19l1006t3463r1543b3539],
7	in	IN	O	in	_	0	SENT_292	[p19l1591t3464r1659b3523],
8	response	NN	O	response	prep_in	6	SENT_292	[p19l1707t3483r2023b3539],
9	to	TO	O	to	_	0	SENT_292	[p19l2072t3478r2141b3524],
10	treatment	NN	O	treatment	prep_to	18	SENT_292	[p19l10t3571r367b3617],
11	through	IN	O	through	_	0	SENT_292	[p19l441t3557r731b3633],
12	pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_292	[p19l805t3557r1414b3633],
13	modulation	NN	O	modulation	prep_through	10	SENT_292	[p19l1491t3557r1935b3630],
14	,	,	O	,	_	0	SENT_292	[p19l1491t3557r1935b3630],
15	this	DT	O	this	det	16	SENT_292	[p19l2014t3557r2142b3617],
16	protein	NN	O	protein	nsubj	18	SENT_292	[p19l9t3649r272b3725],
17	could	MD	O	could	aux	18	SENT_292	[p19l306t3649r508b3710],
18	affect	VB	O	affect	_	0	SENT_292	[p19l543t3649r739b3710],
19	the	DT	O	the	det	21	SENT_292	[p19l771t3649r883b3710],
20	natural	JJ	O	natural	amod	21	SENT_292	[p19l916t3649r1175b3710],
21	history	NN	O	history	dobj	18	SENT_292	[p19l1207t3649r1457b3725],
22	of	IN	O	of	_	0	SENT_292	[p19l1490t3649r1568b3710],
23	HIV-1	NN	O	hiv-1	nn	24	SENT_292	[p19l1591t3650r1820b3710],
24	disease	NN	O	disease	prep_of	21	SENT_292	[p19l1864t3649r2137b3710],
25	.	.	O	.	_	0	SENT_292	[p19l1864t3649r2137b3710],

1	Reports	NNS	O	report	nsubj	2	SENT_293	[p19l11t3743r293b3818],
2	suggest	VBP	O	suggest	_	0	SENT_293	[p19l355t3757r620b3818],
3	that	IN	O	that	complm	7	SENT_293	[p19l677t3742r820b3803],
4	overexpression	NN	O	overexpression	nsubj	7	SENT_293	[p19l879t3743r1419b3818],
5	of	IN	O	of	_	0	SENT_293	[p19l1479t3742r1556b3803],
6	P-glycoprotein	NN	O	p-glycoprotein	prep_of	4	SENT_293	[p19l1606t3742r2143b3818],
7	leads	VBZ	O	lead	ccomp	2	SENT_293	[p20l11t17r191b77],
8	to	TO	O	to	_	0	SENT_293	[p20l272t30r342b77],
9	a	DT	O	a	det	10	SENT_293	[p20l425t37r461b77],
10	reduction	NN	O	reduction	prep_to	7	SENT_293	[p20l541t17r892b77],
11	in	IN	O	in	_	0	SENT_293	[p20l972t17r1041b76],
12	infectiveness	NN	O	infectiveness	prep_in	10	SENT_293	[p20l1121t17r1580b77],
13	and	CC	O	and	_	0	SENT_293	[p20l1664t17r1797b77],
14	cellular	JJ	O	cellular	amod	15	SENT_293	[p20l1878t17r2145b77],
15	permissiveness	NN	O	permissiveness	prep_to	7	SENT_293	[p20l9t109r546b185],
16	in	FW	O	in	nn	17	SENT_293	[p20l592t109r661b169],
17	vitro	FW	O	vitro	rcmod	15	SENT_293	[p20l702t109r868b170],
18	by	IN	O	by	dep	17	SENT_293	[p20l912t109r1001b185],
19	interference	NN	O	interference	pobj	18	SENT_293	[p20l1043t109r1475b170],
20	with	IN	O	with	_	0	SENT_293	[p20l1519t109r1678b170],
21	viral	JJ	O	viral	amod	22	SENT_293	[p20l1719t109r1876b170],
22	fusion	NN	O	fusion	prep_with	7	SENT_293	[p20l1920t109r2143b170],
23	and	CC	O	and	_	0	SENT_293	[p20l12t202r167b275],
24	,	,	O	,	_	0	SENT_293	[p20l12t202r167b275],
25	possibly	RB	O	possibly	dep	22	SENT_293	[p20l228t202r542b278],
26	,	,	O	,	_	0	SENT_293	[p20l228t202r542b278],
27	viral	JJ	O	viral	amod	28	SENT_293	[p20l602t202r760b263],
28	release	NN	O	release	prep_with	7	SENT_293	[p20l819t202r1132b263],
29	.	.	O	.	_	0	SENT_293	[p20l819t202r1132b263],

1	“	NN	O	“	nsubjpass	6	SENT_294	[p20l819t202r1132b263],
2	These	DT	O	these	det	3	SENT_294	[p20l1194t203r1416b263],
3	effects	NNS	O	effect	dep	1	SENT_294	[p20l1478t202r1705b263],
4	are	VBP	O	be	auxpass	6	SENT_294	[p20l1768t222r1874b263],
5	partly	RB	O	partly	advmod	6	SENT_294	[p20l1933t203r2144b279],
6	reversed	VBN	O	reverse	_	0	SENT_294	[p20l10t296r313b356],
7	by	IN	O	by	_	0	SENT_294	[p20l337t296r425b372],
8	selective	JJ	O	selective	amod	9	SENT_294	[p20l450t296r752b356],
9	inhibition	NN	O	inhibition	agent	6	SENT_294	[p20l778t296r1134b356],
10	of	IN	O	of	_	0	SENT_294	[p20l1161t296r1238b356],
11	the	DT	O	the	det	12	SENT_294	[p20l1253t296r1365b356],
12	transporter	NN	O	transporter	prep_of	9	SENT_294	[p20l1391t310r1815b372],
13	.	.	O	.	_	0	SENT_294	[p20l1391t310r1815b372],

1	Because	IN	O	because	mark	6	SENT_295	[p20l1847t297r2142b356],
2	this	DT	O	this	det	3	SENT_295	[p20l10t388r138b449],
3	protein	NN	O	protein	nsubjpass	6	SENT_295	[p20l173t388r437b464],
4	has	VBZ	O	have	aux	6	SENT_295	[p20l470t388r588b449],
5	been	VBN	O	be	auxpass	6	SENT_295	[p20l624t388r798b449],
6	proposed	VBN	O	propose	advcl	27	SENT_295	[p20l832t388r1171b464],
7	to	TO	O	to	aux	8	SENT_295	[p20l1206t402r1275b449],
8	localise	VB	O	localise	xcomp	6	SENT_295	[p20l1313t388r1577b449],
9	in	IN	O	in	_	0	SENT_295	[p20l1614t388r1682b448],
10	lipid	NN	O	lipid	nn	11	SENT_295	[p20l1717t388r1879b464],
11	rafts	NNS	O	raft	prep_in	8	SENT_295	[p20l1914t388r2142b461],
12	,	,	O	,	_	0	SENT_295	[p20l1914t388r2142b461],
13	”	NN	O	”	appos	11	SENT_295	[p20l1914t388r2142b461],
14	which	WDT	O	which	nsubj	17	SENT_295	[p20l9t482r228b542],
15	are	VBP	O	be	cop	17	SENT_295	[p20l269t501r375b542],
16	important	JJ	O	important	amod	17	SENT_295	[p20l416t482r780b558],
17	sites	NNS	O	site	rcmod	13	SENT_295	[p20l822t482r973b542],
18	for	IN	O	for	_	0	SENT_295	[p20l1015t481r1118b542],
19	viral	JJ	O	viral	amod	20	SENT_295	[p20l1154t482r1311b542],
20	fusion	NN	O	fusion	prep_for	17	SENT_295	[p20l1352t481r1575b542],
21	and	CC	O	and	_	0	SENT_295	[p20l1616t482r1750b542],
22	assembly	NN	O	assembly	prep_for	17	SENT_295	[p20l1791t482r2140b557],
23	,	,	O	,	_	0	SENT_295	[p20l1791t482r2140b557],
24	these	DT	O	these	det	25	SENT_295	[p20l10t575r195b635],
25	ﬁndings	NNS	O	ﬁndings	nsubj	27	SENT_295	[p20l238t575r527b651],
26	are	VBP	O	be	cop	27	SENT_295	[p20l572t594r679b635],
27	useful	JJ	O	useful	_	0	SENT_295	[p20l721t575r937b635],
28	for	IN	O	for	_	0	SENT_295	[p20l980t575r1083b635],
29	the	DT	O	the	det	30	SENT_295	[p20l1122t575r1234b635],
30	understanding	NN	O	understanding	prep_for	27	SENT_295	[p20l1276t575r1806b651],
31	of	IN	O	of	_	0	SENT_295	[p20l1848t575r1925b635],
32	these	DT	O	these	det	33	SENT_295	[p20l1957t575r2142b635],
33	stages	NNS	O	stage	prep_of	30	SENT_295	[p20l12t681r223b743],
34	in	IN	O	in	_	0	SENT_295	[p20l252t667r320b727],
35	the	DT	O	the	det	37	SENT_295	[p20l347t667r458b728],
36	viral	JJ	O	viral	amod	37	SENT_295	[p20l484t667r641b728],
37	lifecycle	NN	O	lifecycle	prep_in	33	SENT_295	[p20l669t667r979b743],
38	.	.	O	.	_	0	SENT_295	[p20l669t667r979b743],

1	The	DT	O	the	det	3	SENT_296	[p20l94t760r243b821],
2	potential	JJ	O	potential	amod	3	SENT_296	[p20l293t760r614b836],
3	effect	NN	O	effect	nsubjpass	19	SENT_296	[p20l667t760r863b821],
4	of	IN	O	of	_	0	SENT_296	[p20l914t760r991b821],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	6	SENT_296	[p20l1032t760r1569b836],
6	expression	NN	O	expression	prep_of	3	SENT_296	[p20l1621t761r2002b836],
7	on	IN	O	on	_	0	SENT_296	[p20l2053t780r2143b821],
8	progression	NN	O	progression	prep_on	6	SENT_296	[p20l9t854r431b930],
9	of	IN	O	of	_	0	SENT_296	[p20l520t854r597b914],
10	HIV-1	NN	O	hiv-1	nn	11	SENT_296	[p20l675t855r903b914],
11	disease	NN	O	disease	prep_of	8	SENT_296	[p20l1001t854r1255b914],
12	before	IN	O	before	_	0	SENT_296	[p20l1341t854r1570b914],
13	initiation	NN	O	initiation	prep_before	11	SENT_296	[p20l1658t854r1987b914],
14	of	IN	O	of	_	0	SENT_296	[p20l2075t854r2153b914],
15	antiretroviral	JJ	O	antiretroviral	amod	16	SENT_296	[p20l12t946r483b1007],
16	treatment	NN	O	treatment	prep_of	13	SENT_296	[p20l575t960r932b1007],
17	should	MD	O	should	aux	19	SENT_296	[p20l1024t946r1266b1007],
18	be	VB	O	be	auxpass	19	SENT_296	[p20l1356t946r1441b1007],
19	investigated	VBN	O	investigate	_	0	SENT_296	[p20l1534t946r1967b1022],
20	by	IN	O	by	_	0	SENT_296	[p20l2057t946r2144b1022],
21	longitudinal	JJ	O	longitudinal	amod	22	SENT_296	[p20l11t1039r450b1115],
22	analysis	NN	O	analysis	agent	19	SENT_296	[p20l481t1039r758b1115],
23	of	IN	O	of	_	0	SENT_296	[p20l790t1039r867b1100],
24	large	JJ	O	large	amod	25	SENT_296	[p20l887t1039r1060b1115],
25	cohorts	NNS	O	cohort	prep_of	22	SENT_296	[p20l1091t1039r1358b1100],
26	of	IN	O	of	_	0	SENT_296	[p20l1389t1039r1467b1100],
27	patients	NNS	O	patient	prep_of	25	SENT_296	[p20l1485t1040r1791b1115],
28	.	.	O	.	_	0	SENT_296	[p20l1485t1040r1791b1115],

1	Analyses	NNS	O	analysis	nsubj	3	SENT_297	[p20l1824t1039r2142b1115],
2	should	MD	O	should	aux	3	SENT_297	[p20l12t1133r254b1193],
3	pay	VB	O	pay	dep	15	SENT_297	[p20l281t1152r410b1209],
4	particular	JJ	O	particular	amod	5	SENT_297	[p20l435t1133r790b1209],
5	attention	NN	O	attention	dobj	3	SENT_297	[p20l818t1133r1144b1193],
6	to	TO	O	to	_	0	SENT_297	[p20l1172t1147r1241b1193],
7	ethnic	JJ	O	ethnic	amod	8	SENT_297	[p20l1273t1133r1494b1193],
8	origin	NN	O	origin	prep_to	3	SENT_297	[p20l1525t1133r1756b1209],
9	,	,	O	,	_	0	SENT_297	[p20l1525t1133r1756b1209],
10	in	IN	O	in	_	0	SENT_297	[p20l1788t1133r1856b1192],
11	View	NNP	O	View	prep_in	3	SENT_297	[p20l1882t1133r2047b1193],
12	of	IN	O	of	_	0	SENT_297	[p20l2075t1133r2153b1193],
13	the	DT	O	the	det	14	SENT_297	[p20l10t1225r122b1286],
14	differences	NNS	O	difference	prep_of	11	SENT_297	[p20l222t1225r613b1286],
15	noted	VBD	O	note	_	0	SENT_297	[p20l712t1225r920b1286],
16	in	IN	O	in	_	0	SENT_297	[p20l1018t1225r1087b1285],
17	MDRI	NNP	O	MDRI	prep_in	15	SENT_297	[p20l1181t1226r1429b1285],
18	3435	CD	NUMBER	3435	num	17	SENT_297	[p20l1534t1228r1710b1286],
19	genotype	NN	O	genotype	nn	20	SENT_297	[p20l1814t1239r2142b1301],
20	distribution	NN	O	distribution	nsubj	15	SENT_297	[p20l12t1318r438b1379],
21	in	IN	O	in	_	0	SENT_297	[p20l495t1319r563b1378],
22	different	JJ	O	different	amod	24	SENT_297	[p20l622t1318r930b1379],
23	human	JJ	O	human	amod	24	SENT_297	[p20l986t1318r1242b1379],
24	populations	NNS	O	population	prep_in	20	SENT_297	[p20l1299t1318r1748b1394],
25	.	.	O	.	_	0	SENT_297	[p20l1299t1318r1748b1394],

1	In	IN	O	in	dep	15	SENT_298	[p20l1812t1319r1889b1378],
2	white	JJ	O	white	amod	3	SENT_298	[p20l1945t1318r2142b1379],
3	people	NNS	O	people	pobj	1	SENT_298	[p20l9t1412r272b1488],
4	,	,	O	,	_	0	SENT_298	[p20l9t1412r272b1488],
5	and	CC	O	and	_	0	SENT_298	[p20l305t1412r438b1472],
6	also	RB	O	also	dep	15	SENT_298	[p20l467t1412r604b1472],
7	in	IN	O	in	dep	15	SENT_298	[p20l633t1412r701b1471],
8	participants	NNS	O	participant	pobj	7	SENT_298	[p20l728t1412r1156b1488],
9	of	IN	O	of	_	0	SENT_298	[p20l1188t1412r1265b1472],
10	our	PRP$	O	we	poss	11	SENT_298	[p20l1284t1431r1407b1472],
11	study	NN	O	study	prep_of	8	SENT_298	[p20l1435t1412r1651b1488],
12	,	,	O	,	_	0	SENT_298	[p20l1435t1412r1651b1488],
13	MDRI	NNP	O	MDRI	appos	11	SENT_298	[p20l1678t1413r1926b1471],
14	3435	CD	NUMBER	3435	num	13	SENT_298	[p20l1961t1414r2138b1472],
15	polymorphism	NN	O	polymorphism	nsubj	16	SENT_298	[p20l9t1504r540b1580],
16	shows	VBZ	O	show	_	0	SENT_298	[p20l573t1504r788b1565],
17	a	DT	O	a	det	24	SENT_298	[p20l823t1524r858b1565],
18	25	CD	PERCENT	25	number	19	SENT_298	[p20l892t1504r1052b1567],
19	%	NN	PERCENT	%	amod	24	SENT_298	[p20l892t1504r1052b1567],
20	TT	NN	O	tt	nn	24	SENT_298	[p20l1087t1505r1235b1577],
21	,	,	O	,	_	0	SENT_298	[p20l1087t1505r1235b1577],
22	50	CD	PERCENT	50	number	23	SENT_298	[p20l1272t1504r1431b1567],
23	%	NN	PERCENT	%	amod	24	SENT_298	[p20l1272t1504r1431b1567],
24	CT	NN	O	ct	dobj	16	SENT_298	[p20l1470t1504r1616b1577],
25	,	,	O	,	_	0	SENT_298	[p20l1470t1504r1616b1577],
26	and	CC	O	and	_	0	SENT_298	[p20l1652t1504r1785b1565],
27	25	CD	PERCENT	25	number	28	SENT_298	[p20l1818t1504r1978b1567],
28	%	NN	PERCENT	%	amod	30	SENT_298	[p20l1818t1504r1978b1567],
29	CC	NN	O	cc	nn	30	SENT_298	[p20l2017t1504r2140b1565],
30	distribution	NN	O	distribution	dobj	16	SENT_298	[p20l12t1597r456b1658],
31	.	.	O	.	_	0	SENT_298	[p20l12t1597r456b1658],

1	By	IN	O	by	_	0	SENT_299	[p20l507t1598r604b1673],
2	contrast	NN	O	contrast	prep_by	14	SENT_299	[p20l648t1612r961b1670],
3	,	,	O	,	_	0	SENT_299	[p20l648t1612r961b1670],
4	frequency	NN	O	frequency	nsubj	14	SENT_299	[p20l1009t1597r1370b1673],
5	of	IN	O	of	_	0	SENT_299	[p20l1415t1597r1492b1658],
6	CC	NN	O	cc	nn	7	SENT_299	[p20l1530t1598r1653b1658],
7	genotype	NN	O	genotype	prep_of	4	SENT_299	[p20l1701t1612r2029b1673],
8	in	IN	O	in	_	0	SENT_299	[p20l2075t1598r2143b1657],
9	African	JJ	MISC	african	amod	11	SENT_299	[p20l8t1691r279b1751],
10	black	JJ	O	black	amod	11	SENT_299	[p20l322t1691r517b1751],
11	people	NNS	O	people	prep_in	7	SENT_299	[p20l559t1691r799b1767],
12	is	VBZ	O	be	cop	14	SENT_299	[p20l846t1691r898b1751],
13	67-83	CD	PERCENT	67-83	num	14	SENT_299	[p20l948t1691r1269b1764],
14	%	NN	PERCENT	%	_	0	SENT_299	[p20l948t1691r1269b1764],
15	,	,	O	,	_	0	SENT_299	[p20l948t1691r1269b1764],
16	and	CC	O	and	_	0	SENT_299	[p20l1320t1691r1452b1751],
17	frequency	NN	O	frequency	nsubj	21	SENT_299	[p20l1497t1691r1859b1767],
18	of	IN	O	of	_	0	SENT_299	[p20l1904t1691r1982b1751],
19	TT	NN	O	tt	nn	20	SENT_299	[p20l2016t1692r2144b1750],
20	genotype	NN	O	genotype	prep_of	17	SENT_299	[p20l10t1797r339b1859],
21	is	VBZ	O	be	conj_and	14	SENT_299	[p20l395t1783r446b1844],
22	very	RB	O	very	advmod	23	SENT_299	[p20l500t1803r654b1859],
23	low	JJ	O	low	advmod	21	SENT_299	[p20l706t1783r964b1844],
24	.22	CD	NUMBER	.22	dep	23	SENT_299	[p20l706t1783r964b1844],
25	’	CD	NUMBER	’	num	26	SENT_299	[p20l706t1783r964b1844],
26	3	CD	NUMBER	3	dep	23	SENT_299	[p20l706t1783r964b1844],
27	"	``	O	"	punct	21	SENT_299	[p20l706t1783r964b1844],
28	This	DT	O	this	det	29	SENT_299	[p20l1017t1783r1182b1844],
29	variation	NN	O	variation	nsubj	31	SENT_299	[p20l1236t1783r1558b1844],
30	could	MD	O	could	aux	31	SENT_299	[p20l1614t1783r1814b1844],
31	lead	VB	O	lead	ccomp	21	SENT_299	[p20l1869t1783r2018b1844],
32	to	TO	O	to	_	0	SENT_299	[p20l2071t1797r2141b1844],
33	different	JJ	O	different	amod	34	SENT_299	[p20l12t1876r320b1937],
34	patterns	NNS	O	pattern	prep_to	31	SENT_299	[p20l400t1891r694b1952],
35	of	IN	O	of	_	0	SENT_299	[p20l780t1876r857b1937],
36	HIV-1	NN	O	hiv-1	nn	38	SENT_299	[p20l929t1877r1158b1937],
37	disease	NN	O	disease	nn	38	SENT_299	[p20l1250t1876r1504b1937],
38	evolution	NN	O	evolution	prep_of	34	SENT_299	[p20l1588t1876r1927b1937],
39	and	CC	O	and	_	0	SENT_299	[p20l2010t1876r2143b1937],
40	responses	NNS	O	response	prep_of	34	SENT_299	[p20l10t1989r360b2046],
41	to	TO	O	to	_	0	SENT_299	[p20l472t1984r542b2030],
42	antiretroviral	JJ	O	antiretroviral	amod	43	SENT_299	[p20l657t1970r1128b2030],
43	treatment	NN	O	treatment	prep_to	31	SENT_299	[p20l1240t1984r1596b2030],
44	in	IN	O	in	_	0	SENT_299	[p20l1708t1970r1776b2029],
45	human	JJ	O	human	amod	46	SENT_299	[p20l1886t1970r2143b2030],
46	populations	NNS	O	population	prep_in	43	SENT_299	[p20l9t2062r459b2138],
47	.	.	O	.	_	0	SENT_299	[p20l9t2062r459b2138],

1	Contributors	NNS	O	contributor	nn	3	SENT_300	[p20l13t2257r399b2310],
2	J	NNP	O	J	nn	3	SENT_300	[p20l6t2339r32b2396],
3	Fellay	NNP	PERSON	Fellay	nsubj	12	SENT_300	[p20l52t2338r239b2397],
4	,	,	O	,	_	0	SENT_300	[p20l52t2338r239b2397],
5	C	NN	O	c	nn	7	SENT_300	[p20l265t2338r309b2386],
6	B	NN	O	b	nn	7	SENT_300	[p20l332t2339r373b2385],
7	Eap	NN	O	eap	conj_and	3	SENT_300	[p20l396t2339r523b2397],
8	,	,	O	,	_	0	SENT_300	[p20l396t2339r523b2397],
9	and	CC	O	and	_	0	SENT_300	[p20l548t2338r651b2386],
10	A	DT	O	a	det	11	SENT_300	[p20l670t2339r718b2385],
11	Telenti	JJ	MISC	telenti	nsubj	12	SENT_300	[p20l737t2338r943b2386],
12	designed	VBN	O	design	_	0	SENT_300	[p20l964t2338r1213b2397],
13	the	DT	O	the	det	14	SENT_300	[p20l1233t2338r1320b2386],
14	study	NN	O	study	dobj	12	SENT_300	[p20l1343t2338r1510b2397],
15	.	.	O	.	_	0	SENT_300	[p20l1343t2338r1510b2397],

1	C	NN	O	c	nn	2	SENT_301	[p20l1537t2338r1581b2386],
2	Marzolini	NNS	PERSON	marzolinus	nsubj	7	SENT_301	[p20l1604t2338r1881b2386],
3	and	CC	O	and	_	0	SENT_301	[p20l1903t2338r2006b2386],
4	L	NN	O	l	nsubj	7	SENT_301	[p20l10t2414r55b2460],
5	A	DT	O	a	det	6	SENT_301	[p20l71t2414r119b2460],
6	Decosterd	NN	MISC	decosterd	dep	4	SENT_301	[p20l139t2413r431b2460],
7	measured	VBN	O	measure	_	0	SENT_301	[p20l451t2413r726b2460],
8	drug	NN	O	drug	nn	9	SENT_301	[p20l748t2413r879b2472],
9	concentrations	NNS	O	concentration	dobj	7	SENT_301	[p20l900t2413r1316b2460],
10	in	IN	O	in	_	0	SENT_301	[p20l1338t2413r1392b2460],
11	plasma	NN	O	plasma	prep_in	9	SENT_301	[p20l1411t2413r1626b2472],
12	.	.	O	.	_	0	SENT_301	[p20l1411t2413r1626b2472],

1	J	NNP	O	J	nn	2	SENT_302	[p20l1647t2414r1673b2471],
2	Fellay	NNP	PERSON	Fellay	npadvmod	10	SENT_302	[p20l1693t2413r1880b2472],
3	,	,	O	,	_	0	SENT_302	[p20l1693t2413r1880b2472],
4	E	NNP	O	E	nn	6	SENT_302	[p20l10t2489r52b2535],
5	R	NNP	O	R	nn	6	SENT_302	[p20l74t2489r121b2535],
6	Meaden	NNP	PERSON	Meaden	appos	2	SENT_302	[p20l138t2488r388b2545],
7	,	,	O	,	_	0	SENT_302	[p20l138t2488r388b2545],
8	D	NNP	O	D	nn	9	SENT_302	[p20l412t2489r463b2535],
9	J	NNP	O	J	appos	6	SENT_302	[p20l482t2489r508b2546],
10	Back	RB	O	back	advmod	19	SENT_302	[p20l528t2488r683b2545],
11	,	,	O	,	_	0	SENT_302	[p20l528t2488r683b2545],
12	D	NN	O	d	nn	13	SENT_302	[p20l706t2489r758b2535],
13	Retelska	NN	O	retelska	nsubj	19	SENT_302	[p20l781t2488r1035b2545],
14	,	,	O	,	_	0	SENT_302	[p20l781t2488r1035b2545],
15	and	CC	O	and	_	0	SENT_302	[p20l1059t2488r1163b2536],
16	C	NN	O	c	nn	18	SENT_302	[p20l1186t2489r1230b2536],
17	B	NN	O	b	nn	18	SENT_302	[p20l1254t2489r1295b2535],
18	Eap	NN	O	eap	nsubj	19	SENT_302	[p20l1317t2489r1426b2548],
19	did	VBD	O	do	_	0	SENT_302	[p20l1450t2488r1540b2536],
20	the	DT	O	the	det	24	SENT_302	[p20l1560t2488r1647b2536],
21	genetic	JJ	O	genetic	amod	24	SENT_302	[p20l1669t2489r1869b2548],
22	and	CC	O	and	_	0	SENT_302	[p20l1892t2488r1995b2536],
23	expression	NN	O	expression	conj_and	21	SENT_302	[p20l11t2563r308b2622],
24	analyses	NNS	O	analysis	dobj	19	SENT_302	[p20l330t2563r574b2622],
25	.	.	O	.	_	0	SENT_302	[p20l330t2563r574b2622],

1	G	NN	O	g	nn	2	SENT_303	[p20l601t2563r653b2611],
2	Pantaleo	NN	PERSON	pantaleo	nsubj	3	SENT_303	[p20l673t2563r918b2611],
3	did	VBD	O	do	_	0	SENT_303	[p20l941t2563r1031b2611],
4	the	DT	O	the	det	6	SENT_303	[p20l1051t2563r1138b2611],
5	immunological	JJ	O	immunological	amod	6	SENT_303	[p20l1160t2563r1585b2622],
6	analyses	NNS	O	analysis	dobj	3	SENT_303	[p20l1608t2563r1852b2622],
7	.	.	O	.	_	0	SENT_303	[p20l1608t2563r1852b2622],

1	T	NN	O	t	nn	2	SENT_304	[p20l1877t2564r1926b2610],
2	Buclin	NN	O	buclin	nsubj	7	SENT_304	[p20l1946t2563r2131b2611],
3	and	CC	O	and	_	0	SENT_304	[p20l11t2638r115b2685],
4	A	NN	O	a	nn	6	SENT_304	[p20l134t2639r181b2685],
5	H	NN	O	h	nn	6	SENT_304	[p20l201t2639r254b2685],
6	Schinkel	NNP	PERSON	Schinkel	nsubj	7	SENT_304	[p20l278t2638r518b2685],
7	had	VBD	O	have	_	0	SENT_304	[p20l538t2638r643b2685],
8	a	DT	O	a	det	11	SENT_304	[p20l665t2653r693b2685],
9	major	JJ	O	major	amod	11	SENT_304	[p20l713t2638r879b2697],
10	intellectual	JJ	O	intellectual	amod	11	SENT_304	[p20l898t2638r1211b2685],
11	input	NN	O	input	dobj	7	SENT_304	[p20l1232t2638r1397b2697],
12	.	.	O	.	_	0	SENT_304	[p20l1232t2638r1397b2697],

1	J-P	NNP	O	J-P	nn	2	SENT_305	[p20l1418t2639r1508b2696],
2	Chave	NNP	O	Chave	nsubj	17	SENT_305	[p20l1531t2638r1726b2695],
3	,	,	O	,	_	0	SENT_305	[p20l1531t2638r1726b2695],
4	H	NNP	PERSON	H	nn	5	SENT_305	[p20l1749t2639r1803b2685],
5	Furrer	NNP	PERSON	Furrer	nsubj	17	SENT_305	[p20l1824t2639r2024b2695],
6	,	,	O	,	_	0	SENT_305	[p20l1824t2639r2024b2695],
7	M	NN	O	m	nn	8	SENT_305	[p20l10t2714r75b2760],
8	Opravil	NN	O	opravil	nsubj	17	SENT_305	[p20l96t2713r324b2773],
9	,	,	O	,	_	0	SENT_305	[p20l96t2713r324b2773],
10	L	NN	PERSON	l	nn	11	SENT_305	[p20l346t2714r391b2760],
11	Ruiz	NN	PERSON	ruiz	nsubj	17	SENT_305	[p20l410t2713r556b2770],
12	,	,	O	,	_	0	SENT_305	[p20l410t2713r556b2770],
13	and	CC	O	and	_	0	SENT_305	[p20l580t2713r684b2761],
14	P	NN	O	p	nn	15	SENT_305	[p20l705t2714r743b2760],
15	Vernazza	NNP	LOCATION	Vernazza	conj_and	2	SENT_305	[p20l763t2714r1022b2761],
16	were	VBD	O	be	cop	17	SENT_305	[p20l1042t2729r1175b2761],
17	responsible	JJ	O	responsible	_	0	SENT_305	[p20l1196t2713r1515b2773],
18	for	IN	O	for	_	0	SENT_305	[p20l1536t2713r1617b2761],
19	recruitment	NN	O	recruitment	prep_for	17	SENT_305	[p20l1636t2714r1971b2761],
20	of	IN	O	of	_	0	SENT_305	[p20l1992t2713r2053b2761],
21	patients	NNS	O	patient	prep_of	19	SENT_305	[p20l9t2788r231b2847],
22	and	CC	O	and	_	0	SENT_305	[p20l255t2788r358b2836],
23	clinical	JJ	O	clinical	amod	24	SENT_305	[p20l380t2788r579b2836],
24	assessment	NN	O	assessment	prep_of	19	SENT_305	[p20l601t2799r927b2836],
25	.	.	O	.	_	0	SENT_305	[p20l601t2799r927b2836],

1	The	DT	O	the	det	2	SENT_306	[p20l952t2788r1067b2836],
2	report	NN	O	report	nsubjpass	4	SENT_306	[p20l1088t2799r1262b2847],
3	was	VBD	O	be	auxpass	4	SENT_306	[p20l1280t2804r1384b2836],
4	written	VBN	O	write	_	0	SENT_306	[p20l1405t2788r1606b2836],
5	byJ	NNP	O	byJ	nn	6	SENT_306	[p20l1626t2788r1736b2847],
6	Fellay	NNP	PERSON	Fellay	dobj	4	SENT_306	[p20l1756t2788r1928b2847],
7	and	CC	O	and	_	0	SENT_306	[p20l1948t2788r2052b2836],
8	A	NNP	O	A	nn	9	SENT_306	[p20l8t2863r56b2908],
9	Telenti	NNP	O	Telenti	dobj	4	SENT_306	[p20l75t2862r298b2918],
10	,	,	O	,	_	0	SENT_306	[p20l75t2862r298b2918],
11	with	IN	O	with	_	0	SENT_306	[p20l319t2862r443b2908],
12	contributions	NNS	O	contribution	prep_with	4	SENT_306	[p20l465t2862r843b2908],
13	from	IN	O	from	_	0	SENT_306	[p20l865t2862r1001b2908],
14	all	DT	O	all	det	15	SENT_306	[p20l1023t2862r1086b2908],
15	co-authors	NNS	O	co-author	prep_from	12	SENT_306	[p20l1108t2862r1425b2908],
16	.	.	O	.	_	0	SENT_306	[p20l1108t2862r1425b2908],

1	Swiss	JJ	MISC	swiss	dep	139	SENT_307	[p20l9t3006r186b3060],
2	HIV	NN	O	hiv	dep	139	SENT_307	[p20l214t3007r324b3058],
3	Cohort	NN	O	cohort	dep	139	SENT_307	[p20l345t3006r553b3060],
4	Study	NN	O	study	dep	139	SENT_307	[p20l575t3006r757b3072],
5	group	NN	O	group	dep	139	SENT_307	[p20l774t3013r958b3073],
6	M	NN	O	m	dep	139	SENT_307	[p20l10t3088r75b3134],
7	Battegay	NN	O	battegay	dep	139	SENT_307	[p20l95t3088r342b3146],
8	(	CD	NUMBER	(	dep	139	SENT_307	[p20l365t3087r673b3145],
9	Chairman	NNP	O	Chairman	dep	139	SENT_307	[p20l365t3087r673b3145],
10	of	IN	O	of	dep	139	SENT_307	[p20l695t3087r755b3134],
11	the	DT	O	the	dep	139	SENT_307	[p20l768t3087r855b3134],
12	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	dep	139	SENT_307	[p20l879t3087r1139b3134],
13	Board	NNP	ORGANIZATION	Board	dep	139	SENT_307	[p20l1161t3087r1376b3145],
14	)	NN	O	)	dep	139	SENT_307	[p20l1161t3087r1376b3145],
15	,	,	O	,	_	0	SENT_307	[p20l1161t3087r1376b3145],
16	M-C	NN	O	m-c	dep	139	SENT_307	[p20l1398t3087r1536b3134],
17	Bernard	NNP	PERSON	Bernard	dep	139	SENT_307	[p20l1560t3087r1806b3144],
18	,	,	O	,	_	0	SENT_307	[p20l1560t3087r1806b3144],
19	E	NNP	O	E	dep	139	SENT_307	[p20l10t3163r52b3209],
20	Bernasconi	NNP	PERSON	Bernasconi	dep	139	SENT_307	[p20l74t3162r406b3219],
21	,	,	O	,	_	0	SENT_307	[p20l74t3162r406b3219],
22	H	NNP	O	H	dep	139	SENT_307	[p20l430t3163r483b3209],
23	Bucher	NNP	PERSON	Bucher	dep	139	SENT_307	[p20l504t3162r725b3219],
24	,	,	O	,	_	0	SENT_307	[p20l504t3162r725b3219],
25	Ph	NN	O	ph	dep	139	SENT_307	[p20l748t3162r825b3209],
26	Biirgisser	NNP	O	Biirgisser	dep	139	SENT_307	[p20l845t3163r1126b3222],
27	,	,	O	,	_	0	SENT_307	[p20l845t3163r1126b3222],
28	M	NNP	O	M	dep	139	SENT_307	[p20l1149t3163r1214b3209],
29	Egger	NNP	PERSON	Egger	dep	139	SENT_307	[p20l1234t3163r1415b3222],
30	,	,	O	,	_	0	SENT_307	[p20l1234t3163r1415b3222],
31	P	NN	O	p	dep	139	SENT_307	[p20l1439t3163r1477b3209],
32	Erb	NN	PERSON	erb	dep	139	SENT_307	[p20l1498t3162r1619b3219],
33	,	,	O	,	_	0	SENT_307	[p20l1498t3162r1619b3219],
34	W	NNP	O	W	dep	139	SENT_307	[p20l1640t3163r1707b3210],
35	Fierz	NNP	PERSON	Fierz	dep	139	SENT_307	[p20l1727t3162r1886b3219],
36	,	,	O	,	_	0	SENT_307	[p20l1727t3162r1886b3219],
37	M	NNP	O	M	dep	139	SENT_307	[p20l10t3238r75b3284],
38	Flepp	NNP	O	Flepp	dep	139	SENT_307	[p20l95t3237r257b3296],
39	(	NNP	O	(	dep	139	SENT_307	[p20l284t3237r592b3296],
40	Chairman	NNP	O	Chairman	dep	139	SENT_307	[p20l284t3237r592b3296],
41	of	IN	O	of	dep	139	SENT_307	[p20l613t3237r673b3285],
42	the	DT	O	the	dep	139	SENT_307	[p20l686t3237r773b3285],
43	Clinical	JJ	O	clinical	dep	139	SENT_307	[p20l797t3237r1015b3285],
44	and	CC	O	and	dep	139	SENT_307	[p20l1037t3237r1141b3285],
45	Laboratory	NNP	ORGANIZATION	Laboratory	dep	139	SENT_307	[p20l1161t3237r1480b3296],
46	Committee	NNP	ORGANIZATION	Committee	dep	139	SENT_307	[p20l1501t3237r1864b3296],
47	)	NN	O	)	dep	139	SENT_307	[p20l1501t3237r1864b3296],
48	,	,	O	,	_	0	SENT_307	[p20l1501t3237r1864b3296],
49	P	NN	PERSON	p	dep	139	SENT_307	[p20l10t3313r49b3359],
50	Francioli	JJ	PERSON	francioli	dep	139	SENT_307	[p20l70t3312r325b3359],
51	(	CD	NUMBER	(	dep	139	SENT_307	[p20l351t3312r639b3370],
52	President	NN	O	president	dep	139	SENT_307	[p20l351t3312r639b3370],
53	of	IN	O	of	dep	139	SENT_307	[p20l661t3312r721b3359],
54	the	DT	O	the	dep	139	SENT_307	[p20l734t3312r821b3359],
55	Swiss	JJ	MISC	swiss	dep	139	SENT_307	[p20l844t3312r996b3359],
56	HIV	NN	O	hiv	dep	139	SENT_307	[p20l1018t3313r1144b3359],
57	Cohort	NN	O	cohort	dep	139	SENT_307	[p20l1166t3312r1369b3359],
58	Study	NN	O	study	dep	139	SENT_307	[p20l1391t3312r1597b3371],
59	)	NN	O	)	dep	139	SENT_307	[p20l1391t3312r1597b3371],
60	,	,	O	,	_	0	SENT_307	[p20l1391t3312r1597b3371],
61	H	NN	PERSON	h	dep	139	SENT_307	[p20l1621t3313r1673b3359],
62	J	NN	PERSON	j	dep	139	SENT_307	[p20l1691t3313r1717b3370],
63	Furrer	NNP	PERSON	Furrer	dep	139	SENT_307	[p20l1736t3313r1937b3369],
64	,	,	O	,	_	0	SENT_307	[p20l1736t3313r1937b3369],
65	M	NNP	O	M	dep	139	SENT_307	[p20l10t3388r75b3434],
66	Gorgievski	NNP	O	Gorgievski	dep	139	SENT_307	[p20l96t3387r415b3447],
67	,	,	O	,	_	0	SENT_307	[p20l96t3387r415b3447],
68	H	NNP	PERSON	H	dep	139	SENT_307	[p20l439t3388r492b3434],
69	Giinthard	NNP	PERSON	Giinthard	dep	139	SENT_307	[p20l514t3387r811b3444],
70	,	,	O	,	_	0	SENT_307	[p20l514t3387r811b3444],
71	P	NN	O	p	dep	139	SENT_307	[p20l835t3388r873b3434],
72	Grob	NN	PERSON	grob	dep	139	SENT_307	[p20l896t3387r1061b3444],
73	,	,	O	,	_	0	SENT_307	[p20l896t3387r1061b3444],
74	B	NN	O	b	dep	139	SENT_307	[p20l1085t3388r1126b3434],
75	Hirschel	NNP	PERSON	Hirschel	dep	139	SENT_307	[p20l1148t3387r1404b3444],
76	,	,	O	,	_	0	SENT_307	[p20l1148t3387r1404b3444],
77	C	NNP	O	C	dep	139	SENT_307	[p20l1430t3388r1474b3435],
78	Kind	NNP	O	Kind	dep	139	SENT_307	[p20l1497t3387r1658b3444],
79	,	,	O	,	_	0	SENT_307	[p20l1497t3387r1658b3444],
80	Th	NN	O	th	dep	139	SENT_307	[p20l1680t3387r1766b3434],
81	Klimkait	NN	O	klimkait	dep	139	SENT_307	[p20l1787t3387r2051b3444],
82	,	,	O	,	_	0	SENT_307	[p20l1787t3387r2051b3444],
83	B	NN	O	b	dep	139	SENT_307	[p20l10t3463r51b3509],
84	Ledergerber	NN	O	ledergerber	dep	139	SENT_307	[p20l73t3462r438b3521],
85	,	,	O	,	_	0	SENT_307	[p20l73t3462r438b3521],
86	U	NNP	O	U	dep	139	SENT_307	[p20l461t3463r514b3510],
87	Lauper	NNP	PERSON	Lauper	dep	139	SENT_307	[p20l535t3463r755b3521],
88	,	,	O	,	_	0	SENT_307	[p20l535t3463r755b3521],
89	M	NN	O	m	dep	139	SENT_307	[p20l779t3463r844b3509],
90	Opravil	NN	O	opravil	dep	139	SENT_307	[p20l866t3462r1092b3521],
91	,	,	O	,	_	0	SENT_307	[p20l866t3462r1092b3521],
92	F	NN	O	f	dep	139	SENT_307	[p20l1116t3463r1156b3509],
93	Paccaud	NN	O	paccaud	dep	139	SENT_307	[p20l1178t3462r1434b3519],
94	,	,	O	,	_	0	SENT_307	[p20l1178t3462r1434b3519],
95	G	NN	PERSON	g	dep	139	SENT_307	[p20l1458t3462r1510b3510],
96	Pantaleo	NN	PERSON	pantaleo	dep	139	SENT_307	[p20l1530t3462r1794b3519],
97	,	,	O	,	_	0	SENT_307	[p20l1530t3462r1794b3519],
98	L	NN	PERSON	l	dep	139	SENT_307	[p20l1817t3463r1862b3509],
99	Perrin	NNP	PERSON	Perrin	dep	139	SENT_307	[p20l1880t3462r2072b3519],
100	,	,	O	,	_	0	SENT_307	[p20l1880t3462r2072b3519],
101	J-C	JJ	O	j-c	dep	139	SENT_307	[p20l6t3537r104b3595],
102	Piffaretti	NNP	PERSON	Piffaretti	dep	139	SENT_307	[p20l128t3537r391b3594],
103	,	,	O	,	_	0	SENT_307	[p20l128t3537r391b3594],
104	M	NN	O	m	dep	139	SENT_307	[p20l414t3538r479b3584],
105	Rickenbach	NN	PERSON	rickenbach	dep	139	SENT_307	[p20l500t3537r832b3584],
106	(	CD	NUMBER	(	dep	139	SENT_307	[p20l857t3537r1032b3595],
107	Head	NNP	O	Head	dep	139	SENT_307	[p20l857t3537r1032b3595],
108	of	IN	O	of	dep	139	SENT_307	[p20l1054t3537r1115b3584],
109	Data	NNP	O	Data	dep	139	SENT_307	[p20l1128t3538r1265b3584],
110	Centre	NNP	O	Centre	dep	139	SENT_307	[p20l1289t3537r1524b3595],
111	)	NNP	O	)	dep	139	SENT_307	[p20l1289t3537r1524b3595],
112	,	,	O	,	_	0	SENT_307	[p20l1289t3537r1524b3595],
113	C	NNP	O	C	dep	139	SENT_307	[p20l1549t3537r1594b3584],
114	Rudin	NNP	PERSON	Rudin	dep	139	SENT_307	[p20l1617t3537r1793b3584],
115	(	NNP	O	(	dep	139	SENT_307	[p20l1818t3537r2126b3595],
116	Chairman	NNP	O	Chairman	dep	139	SENT_307	[p20l1818t3537r2126b3595],
117	of	IN	O	of	dep	139	SENT_307	[p20l11t3612r72b3660],
118	the	DT	O	the	dep	139	SENT_307	[p20l84t3612r171b3660],
119	Mother	NN	O	mother	dep	139	SENT_307	[p20l192t3612r408b3660],
120	and	CC	O	and	dep	139	SENT_307	[p20l429t3612r533b3660],
121	Child	NN	O	child	dep	139	SENT_307	[p20l556t3612r713b3660],
122	Substudy	JJ	O	substudy	dep	139	SENT_307	[p20l736t3612r1042b3671],
123	)	NN	O	)	dep	139	SENT_307	[p20l736t3612r1042b3671],
124	,	,	O	,	_	0	SENT_307	[p20l736t3612r1042b3671],
125	J	NNP	PERSON	J	dep	139	SENT_307	[p20l1062t3613r1088b3670],
126	Schupbach	NNP	PERSON	Schupbach	dep	139	SENT_307	[p20l1110t3612r1440b3672],
127	,	,	O	,	_	0	SENT_307	[p20l1110t3612r1440b3672],
128	A	NNP	O	A	dep	139	SENT_307	[p20l1461t3613r1509b3659],
129	Telenti	NNP	O	Telenti	dep	139	SENT_307	[p20l1528t3612r1751b3669],
130	,	,	O	,	_	0	SENT_307	[p20l1528t3612r1751b3669],
131	P	NN	O	p	dep	139	SENT_307	[p20l1774t3613r1813b3659],
132	Vernazza	NNP	LOCATION	Vernazza	dep	139	SENT_307	[p20l1832t3613r2109b3669],
133	,	,	O	,	_	0	SENT_307	[p20l1832t3613r2109b3669],
134	Th	NN	O	th	dep	139	SENT_307	[p20l9t3687r95b3734],
135	Wagels	NNS	O	wagel	dep	139	SENT_307	[p20l114t3687r335b3746],
136	,	,	O	,	_	0	SENT_307	[p20l114t3687r335b3746],
137	and	CC	O	and	dep	139	SENT_307	[p20l360t3687r463b3735],
138	R	NN	PERSON	r	dep	139	SENT_307	[p20l485t3688r532b3734],
139	Weber	NNP	PERSON	Weber	_	0	SENT_307	[p20l548t3687r752b3735],
140	.	.	O	.	_	0	SENT_307	[p20l548t3687r752b3735],

1	Conflict	NN	O	conflict	nsubj	6	SENT_308	[p21l13t68r249b121],
2	of	IN	O	of	_	0	SENT_308	[p21l273t68r338b121],
3	interest	NN	O	interest	nn	5	SENT_308	[p21l356t69r598b121],
4	statement	NN	O	statement	nn	5	SENT_308	[p21l619t73r945b121],
5	None	NN	O	none	prep_of	1	SENT_308	[p21l9t149r167b194],
6	declared	VBD	O	declare	_	0	SENT_308	[p21l189t148r443b194],
7	.	.	O	.	_	0	SENT_308	[p21l189t148r443b194],

1	Acknowledgments	NNP	O	Acknowledgments	nn	2	SENT_309	[p21l7t349r586b415],
2	Support	NN	O	support	nsubjpass	7	SENT_309	[p21l12t429r241b488],
3	for	IN	O	for	_	0	SENT_309	[p21l261t429r342b476],
4	this	DT	O	this	det	5	SENT_309	[p21l361t429r460b476],
5	Work	NN	O	work	prep_for	2	SENT_309	[p21l481t429r623b476],
6	was	VBD	O	be	auxpass	7	SENT_309	[p21l641t444r744b476],
7	provided	VBN	O	provide	_	0	SENT_309	[p21l765t429r1017b488],
8	by	IN	O	by	_	0	SENT_309	[p21l1037t429r1106b488],
9	the	DT	O	the	det	15	SENT_309	[p21l1125t429r1212b476],
10	Swiss	NNP	ORGANIZATION	Swiss	nn	15	SENT_309	[p21l1235t429r1387b476],
11	National	NNP	ORGANIZATION	National	nn	15	SENT_309	[p21l1407t429r1656b476],
12	Science	NNP	ORGANIZATION	Science	nn	15	SENT_309	[p21l1679t429r1892b476],
13	Foundation	NNP	ORGANIZATION	Foundation	nn	15	SENT_309	[p21l10t504r345b552],
14	(	NNP	O	(	nn	15	SENT_309	[p21l370t505r560b563],
15	Grant	NNP	PERSON	Grant	agent	7	SENT_309	[p21l370t505r560b563],
16	3346-62092	CD	NUMBER	3346-62092	num	18	SENT_309	[p21l582t505r1042b563],
17	.99	CD	NUMBER	.99	num	18	SENT_309	[p21l582t505r1042b563],
18	)	NN	O	)	dep	15	SENT_309	[p21l582t505r1042b563],
19	and	CC	O	and	_	0	SENT_309	[p21l1069t504r1172b552],
20	by	IN	O	by	_	0	SENT_309	[p21l1191t504r1260b563],
21	the	DT	O	the	det	25	SENT_309	[p21l1279t504r1367b552],
22	Swiss	JJ	MISC	swiss	amod	25	SENT_309	[p21l1390t505r1542b552],
23	HIV	NN	O	hiv	nn	25	SENT_309	[p21l1564t505r1690b552],
24	Cohort	NN	O	cohort	nn	25	SENT_309	[p21l1712t504r1914b552],
25	Study	NN	O	study	conj_and	15	SENT_309	[p21l1937t504r2101b563],
26	(	CD	NUMBER	(	dep	25	SENT_309	[p21l15t579r189b638],
27	Swiss	NNP	ORGANIZATION	Swiss	nn	32	SENT_309	[p21l15t579r189b638],
28	National	NNP	ORGANIZATION	National	nn	32	SENT_309	[p21l210t579r458b627],
29	Science	NNP	ORGANIZATION	Science	nn	32	SENT_309	[p21l481t579r694b627],
30	Foundation	NNP	ORGANIZATION	Foundation	nn	32	SENT_309	[p21l716t579r1067b636],
31	,	,	O	,	_	0	SENT_309	[p21l716t579r1067b636],
32	Grant	NNP	PERSON	Grant	dep	26	SENT_309	[p21l1092t579r1260b627],
33	3345-062041	CD	NUMBER	3345-062041	num	34	SENT_309	[p21l1282t580r1706b638],
34	)	CD	NUMBER	)	dep	7	SENT_309	[p21l1282t580r1706b638],
35	.	.	O	.	_	0	SENT_309	[p21l1282t580r1706b638],

1	We	PRP	O	we	nsubj	2	SENT_310	[p21l1729t580r1824b627],
2	thank	VBP	O	thank	_	0	SENT_310	[p21l1846t579r2007b627],
3	P	NN	PERSON	p	nn	4	SENT_310	[p21l10t655r49b701],
4	Taffé	NN	PERSON	taffé	dobj	2	SENT_310	[p21l69t654r221b701],
5	for	IN	O	for	_	0	SENT_310	[p21l242t654r322b701],
6	statistical	JJ	O	statistical	amod	7	SENT_310	[p21l343t654r604b701],
7	input	NN	O	input	prep_for	4	SENT_310	[p21l625t654r790b713],
8	.	.	O	.	_	0	SENT_310	[p21l625t654r790b713],

1	References	NNS	O	reference	_	0	SENT_311	[p21l13t910r362b960],
2	1	CD	NUMBER	1	dep	1	SENT_311	[p21l17t999r37b1044],

1	Chaudhary	NNP	O	Chaudhary	nn	2	SENT_312	[p21l116t997r433b1056],
2	PM	NNP	O	PM	_	0	SENT_312	[p21l453t998r575b1054],
3	,	,	O	,	_	0	SENT_312	[p21l453t998r575b1054],
4	Roninson	NNP	O	Roninson	nn	5	SENT_312	[p21l599t997r872b1044],
5	IB	NNP	O	IB	appos	2	SENT_312	[p21l893t998r976b1044],
6	.	.	O	.	_	0	SENT_312	[p21l893t998r976b1044],

1	Expression	NN	O	expression	_	0	SENT_313	[p21l1000t997r1312b1056],
2	and	CC	O	and	_	0	SENT_313	[p21l1334t997r1437b1045],
3	activity	NN	O	activity	conj_and	1	SENT_313	[p21l1459t997r1662b1056],
4	of	IN	O	of	_	0	SENT_313	[p21l1683t997r1743b1044],
5	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_313	[p21l114t1074r549b1133],
6	,	,	O	,	_	0	SENT_313	[p21l114t1074r549b1133],
7	a	DT	O	a	det	10	SENT_313	[p21l573t1089r601b1121],
8	multidrug	JJ	O	multidrug	amod	10	SENT_313	[p21l622t1074r907b1133],
9	efﬂux	NN	O	efﬂux	nn	10	SENT_313	[p21l927t1074r1085b1121],
10	pump	NN	O	pump	appos	5	SENT_313	[p21l1104t1089r1288b1133],
11	,	,	O	,	_	0	SENT_313	[p21l1104t1089r1288b1133],
12	in	IN	O	in	_	0	SENT_313	[p21l1311t1074r1364b1121],
13	human	JJ	O	human	amod	16	SENT_313	[p21l1384t1074r1584b1121],
14	hematopoietic	JJ	O	hematopoietic	amod	16	SENT_313	[p21l1604t1074r2007b1133],
15	stem	NN	O	stem	nn	16	SENT_313	[p21l114t1161r247b1197],
16	cells	NNS	O	cell	prep_in	1	SENT_313	[p21l269t1150r404b1197],
17	.	.	O	.	_	0	SENT_313	[p21l269t1150r404b1197],

1	Cell	NN	O	cell	_	0	SENT_314	[p21l431t1151r535b1197],
2	1991	CD	DATE	1991	num	1	SENT_314	[p21l558t1152r711b1206],
3	;	:	O	;	_	0	SENT_314	[p21l558t1152r711b1206],
4	66	CD	NUMBER	66	num	6	SENT_314	[p21l735t1153r819b1197],
5	:	:	O	:	_	0	SENT_314	[p21l735t1153r819b1197],
6	85-94	CD	NUMBER	85-94	dep	1	SENT_314	[p21l846t1152r1035b1197],
7	.	.	O	.	_	0	SENT_314	[p21l846t1152r1035b1197],

1	MacDonald	NNP	ORGANIZATION	MacDonald	nn	2	SENT_315	[p21l113t1227r457b1275],
2	HR	NNP	ORGANIZATION	HR	_	0	SENT_315	[p21l477t1228r595b1284],
3	,	,	O	,	_	0	SENT_315	[p21l477t1228r595b1284],
4	Bommhardt	NNP	PERSON	Bommhardt	nn	5	SENT_315	[p21l619t1227r965b1275],
5	U	NNP	PERSON	U	appos	2	SENT_315	[p21l984t1228r1054b1284],
6	,	,	O	,	_	0	SENT_315	[p21l984t1228r1054b1284],
7	Cerottini	NNP	O	Cerottini	nn	8	SENT_315	[p21l1080t1227r1335b1275],
8	JC	NNP	O	JC	appos	5	SENT_315	[p21l1352t1228r1444b1285],
9	.	.	O	.	_	0	SENT_315	[p21l1352t1228r1444b1285],

1	Developmentally	RB	O	developmentally	advmod	2	SENT_316	[p21l1469t1227r1953b1287],
2	regulated	VBN	O	regulate	_	0	SENT_316	[p21l113t1304r378b1363],
3	expression	NN	O	expression	dobj	2	SENT_316	[p21l399t1304r696b1363],
4	of	IN	O	of	_	0	SENT_316	[p21l718t1304r778b1351],
5	P-glycoprotein	NN	O	p-glycoprotein	nn	10	SENT_316	[p21l792t1304r1210b1363],
6	(	CD	NUMBER	(	num	10	SENT_316	[p21l1235t1304r1541b1363],
7	multidrug	JJ	O	multidrug	amod	10	SENT_316	[p21l1235t1304r1541b1363],
8	resistance	NN	O	resistance	nn	10	SENT_316	[p21l1560t1304r1857b1363],
9	)	NN	O	)	nn	10	SENT_316	[p21l1560t1304r1857b1363],
10	activity	NN	O	activity	prep_of	3	SENT_316	[p21l1884t1304r2087b1363],
11	in	IN	O	in	_	0	SENT_316	[p21l113t1381r167b1428],
12	mouse	NN	O	mouse	nn	13	SENT_316	[p21l187t1396r372b1428],
13	thymocytes	NNS	O	thymocyte	prep_in	2	SENT_316	[p21l393t1381r731b1440],
14	.	.	O	.	_	0	SENT_316	[p21l393t1381r731b1440],

1	Eur	NNP	O	Eur	nn	3	SENT_317	[p21l754t1381r909b1440],
2	}	NNP	O	}	nn	3	SENT_317	[p21l754t1381r909b1440],
3	Immunol	NNP	O	Immunol	_	0	SENT_317	[p21l923t1381r1169b1428],
4	1995	CD	DATE	1995	num	3	SENT_317	[p21l1192t1383r1344b1438],
5	;	:	O	;	_	0	SENT_317	[p21l1192t1383r1344b1438],
6	25	CD	NUMBER	25	num	8	SENT_317	[p21l1368t1382r1453b1428],
7	:	:	O	:	_	0	SENT_317	[p21l1368t1382r1453b1428],
8	1457-60	CD	NUMBER	1457-60	dep	3	SENT_317	[p21l1484t1383r1741b1428],
9	.	.	O	.	_	0	SENT_317	[p21l1484t1383r1741b1428],

1	Kim	NNP	PERSON	Kim	nn	2	SENT_318	[p21l114t1458r239b1505],
2	RB	NN	O	rb	_	0	SENT_318	[p21l260t1459r367b1515],
3	,	,	O	,	_	0	SENT_318	[p21l260t1459r367b1515],
4	Fromm	NNP	ORGANIZATION	Fromm	nn	5	SENT_318	[p21l390t1459r605b1505],
5	MF	NN	ORGANIZATION	mf	appos	2	SENT_318	[p21l626t1459r750b1515],
6	,	,	O	,	_	0	SENT_318	[p21l626t1459r750b1515],
7	Wandel	NNP	ORGANIZATION	Wandel	nn	8	SENT_318	[p21l772t1458r992b1505],
8	C	NNP	ORGANIZATION	C	appos	2	SENT_318	[p21l1016t1458r1080b1515],
9	,	,	O	,	_	0	SENT_318	[p21l1016t1458r1080b1515],
10	et	FW	O	et	nn	11	SENT_318	[p21l1104t1468r1153b1505],
11	al.	FW	O	al.	appos	2	SENT_318	[p21l1175t1458r1236b1505],
12	.	.	O	.	_	0	SENT_318	[p21l1175t1458r1236b1505],

1	The	DT	O	the	det	5	SENT_319	[p21l1260t1458r1376b1505],
2	drug	NN	O	drug	nn	5	SENT_319	[p21l1398t1458r1529b1517],
3	transporter	NN	O	transporter	nn	5	SENT_319	[p21l1548t1469r1865b1517],
4	P-glycoprotein	NN	MISC	p-glycoprotein	nn	5	SENT_319	[p21l114t1535r532b1595],
5	limits	NNS	O	limit	_	0	SENT_319	[p21l553t1535r708b1583],
6	oral	JJ	O	oral	amod	7	SENT_319	[p21l731t1535r837b1583],
7	absorption	NN	O	absorption	dep	5	SENT_319	[p21l859t1535r1161b1595],
8	and	CC	O	and	_	0	SENT_319	[p21l1183t1535r1286b1583],
9	brain	NN	O	brain	nn	10	SENT_319	[p21l1306t1535r1454b1583],
10	entry	NN	O	entry	dep	5	SENT_319	[p21l1476t1546r1620b1595],
11	of	IN	O	of	_	0	SENT_319	[p21l1641t1535r1701b1583],
12	HIV-1	NN	MISC	hiv-1	nn	14	SENT_319	[p21l1714t1536r1892b1583],
13	protease	NN	O	protease	nn	14	SENT_319	[p21l112t1623r349b1671],
14	inhibitors	NNS	O	inhibitor	prep_of	7	SENT_319	[p21l371t1612r657b1659],
15	.	.	O	.	_	0	SENT_319	[p21l371t1612r657b1659],

1	3	CD	NUMBER	3	num	3	SENT_320	[p21l675t1612r717b1671],
2	’	NN	O	’	nn	3	SENT_320	[p21l675t1612r717b1671],
3	Clin	NNP	O	Clin	_	0	SENT_320	[p21l734t1612r845b1659],
4	Invest	NNP	O	Invest	dep	3	SENT_320	[p21l865t1613r1028b1659],
5	1998	CD	DATE	1998	num	4	SENT_320	[p21l1051t1614r1204b1669],
6	;	:	O	;	_	0	SENT_320	[p21l1051t1614r1204b1669],
7	101	CD	NUMBER	101	num	9	SENT_320	[p21l1232t1614r1347b1660],
8	:	:	O	:	_	0	SENT_320	[p21l1232t1614r1347b1660],
9	289-94	CD	NUMBER	289-94	dep	3	SENT_320	[p21l1373t1614r1599b1660],
10	.	.	O	.	_	0	SENT_320	[p21l1373t1614r1599b1660],

1	Jones	NNP	PERSON	Jones	nn	2	SENT_321	[p21l110t1690r264b1747],
2	K	NNP	PERSON	K	_	0	SENT_321	[p21l286t1690r353b1746],
3	,	,	O	,	_	0	SENT_321	[p21l286t1690r353b1746],
4	Hoggard	NNP	PERSON	Hoggard	nn	5	SENT_321	[p21l376t1689r626b1748],
5	PG	NNP	O	PG	appos	2	SENT_321	[p21l647t1689r758b1746],
6	,	,	O	,	_	0	SENT_321	[p21l647t1689r758b1746],
7	Sales	NNS	O	sale	nn	8	SENT_321	[p21l783t1689r923b1737],
8	SD	NN	O	sd	appos	2	SENT_321	[p21l947t1689r1054b1746],
9	,	,	O	,	_	0	SENT_321	[p21l947t1689r1054b1746],
10	et	FW	O	et	nn	11	SENT_321	[p21l1078t1700r1128b1736],
11	al.	FW	O	al.	appos	2	SENT_321	[p21l1150t1689r1210b1736],
12	.	.	O	.	_	0	SENT_321	[p21l1150t1689r1210b1736],

1	Differences	NNS	O	difference	_	0	SENT_322	[p21l1235t1689r1559b1736],
2	in	IN	O	in	_	0	SENT_322	[p21l1581t1689r1634b1736],
3	the	DT	O	the	det	5	SENT_322	[p21l1654t1689r1741b1737],
4	intracellular	JJ	O	intracellular	amod	5	SENT_322	[p21l1763t1689r2105b1736],
5	accumulation	NN	O	accumulation	prep_in	1	SENT_322	[p21l115t1766r500b1813],
6	of	IN	O	of	_	0	SENT_322	[p21l522t1766r582b1813],
7	HIV	NN	MISC	hiv	nn	9	SENT_322	[p21l596t1767r722b1813],
8	protease	NN	O	protease	nn	9	SENT_322	[p21l740t1776r977b1825],
9	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_322	[p21l998t1766r1268b1813],
10	in	FW	O	in	nn	11	SENT_322	[p21l1291t1766r1344b1813],
11	vitro	FW	O	vitro	dep	5	SENT_322	[p21l1363t1766r1492b1813],
12	and	CC	O	and	_	0	SENT_322	[p21l1516t1766r1619b1813],
13	the	DT	O	the	det	14	SENT_322	[p21l1640t1766r1727b1813],
14	effect	NN	O	effect	conj_and	11	SENT_322	[p21l1749t1766r1902b1813],
15	of	IN	O	of	_	0	SENT_322	[p21l1923t1766r1984b1813],
16	active	JJ	O	active	amod	17	SENT_322	[p21l115t1844r275b1891],
17	transport	NN	O	transport	prep_of	14	SENT_322	[p21l296t1854r571b1903],
18	.	.	O	.	_	0	SENT_322	[p21l296t1854r571b1903],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_323	[p21l591t1844r761b1891],
2	2001	CD	DATE	2001	num	1	SENT_323	[p21l780t1845r938b1900],
3	;	:	O	;	_	0	SENT_323	[p21l780t1845r938b1900],
4	15	CD	NUMBER	15	num	6	SENT_323	[p21l965t1845r1046b1891],
5	:	:	O	:	_	0	SENT_323	[p21l965t1845r1046b1891],
6	675-81	CD	NUMBER	675-81	dep	1	SENT_323	[p21l1073t1845r1298b1891],
7	.	.	O	.	_	0	SENT_323	[p21l1073t1845r1298b1891],

1	Li	NNP	PERSON	Li	nn	2	SENT_324	[p21l113t1921r174b1967],
2	X	NNP	PERSON	X	_	0	SENT_324	[p21l193t1921r260b1977],
3	,	,	O	,	_	0	SENT_324	[p21l193t1921r260b1977],
4	Chan	NNP	O	Chan	nn	5	SENT_324	[p21l286t1920r439b1968],
5	WK	NNP	DURATION	WK	appos	2	SENT_324	[p21l458t1921r591b1968],
6	.	.	O	.	_	0	SENT_324	[p21l458t1921r591b1968],

1	Transport	NN	O	transport	nn	6	SENT_325	[p21l615t1921r920b1980],
2	,	,	O	,	_	0	SENT_325	[p21l615t1921r920b1980],
3	metabolism	NN	O	metabolism	nn	6	SENT_325	[p21l943t1920r1274b1968],
4	and	CC	O	and	_	0	SENT_325	[p21l1296t1920r1399b1968],
5	elimination	NN	O	elimination	nn	6	SENT_325	[p21l1421t1920r1742b1968],
6	mechanisms	NNS	O	mechanism	_	0	SENT_325	[p21l1762t1920r2111b1968],
7	of	IN	O	of	_	0	SENT_325	[p21l115t1997r175b2044],
8	anti-HIV	JJ	O	anti-hiv	amod	9	SENT_325	[p21l189t1997r448b2045],
9	agents	NNS	O	agent	prep_of	6	SENT_325	[p21l469t2008r661b2056],
10	.	.	O	.	_	0	SENT_325	[p21l469t2008r661b2056],

1	Adv	NNP	MISC	Adv	nn	4	SENT_326	[p21l681t1997r799b2044],
2	Drug	NNP	MISC	Drug	nn	4	SENT_326	[p21l819t1998r960b2056],
3	Deliv	NNP	MISC	Deliv	nn	4	SENT_326	[p21l976t1997r1120b2044],
4	Rev	NN	O	rev	_	0	SENT_326	[p21l1139t1998r1244b2044],
5	1999	CD	DATE	1999	num	4	SENT_326	[p21l1271t1999r1424b2054],
6	,	,	O	,	_	0	SENT_326	[p21l1271t1999r1424b2054],
7	39	CD	NUMBER	39	num	9	SENT_326	[p21l1448t1999r1532b2045],
8	:	:	O	:	_	0	SENT_326	[p21l1448t1999r1532b2045],
9	81-103	CD	NUMBER	81-103	appos	4	SENT_326	[p21l1559t1999r1784b2045],
10	.	.	O	.	_	0	SENT_326	[p21l1559t1999r1784b2045],

1	de	IN	O	de	dep	6	SENT_327	[p21l114t2074r179b2122],
2	Morais	NNP	O	Morais	nn	3	SENT_327	[p21l200t2074r399b2121],
3	SM	NNP	O	SM	pobj	1	SENT_327	[p21l424t2074r542b2131],
4	,	,	O	,	_	0	SENT_327	[p21l424t2074r542b2131],
5	Wilkinson	NNP	PERSON	Wilkinson	nn	6	SENT_327	[p21l563t2074r853b2122],
6	GR	NN	O	gr	_	0	SENT_327	[p21l875t2074r990b2131],
7	,	,	O	,	_	0	SENT_327	[p21l875t2074r990b2131],
8	Blaisdell	NNP	PERSON	Blaisdell	nn	9	SENT_327	[p21l1014t2074r1254b2122],
9	J	NNP	PERSON	J	appos	6	SENT_327	[p21l1271t2075r1312b2132],
10	,	,	O	,	_	0	SENT_327	[p21l1271t2075r1312b2132],
11	et	FW	O	et	nn	12	SENT_327	[p21l1337t2085r1387b2121],
12	al.	FW	O	al.	appos	6	SENT_327	[p21l1408t2074r1469b2121],
13	.	.	O	.	_	0	SENT_327	[p21l1408t2074r1469b2121],

1	The	DT	O	the	det	4	SENT_328	[p21l1493t2074r1609b2121],
2	major	JJ	O	major	amod	4	SENT_328	[p21l1630t2074r1796b2133],
3	genetic	JJ	O	genetic	amod	4	SENT_328	[p21l1815t2074r2015b2133],
4	defect	NN	O	defect	_	0	SENT_328	[p21l114t2151r284b2198],
5	responsible	JJ	O	responsible	amod	11	SENT_328	[p21l304t2151r623b2210],
6	for	IN	O	for	_	0	SENT_328	[p21l645t2151r725b2198],
7	the	DT	O	the	det	8	SENT_328	[p21l744t2151r831b2198],
8	polymorphism	NN	O	polymorphism	prep_for	5	SENT_328	[p21l851t2151r1265b2210],
9	of	IN	O	of	_	0	SENT_328	[p21l1286t2151r1347b2198],
10	S-mephenytoin	NN	MISC	s-mephenytoin	prep_of	8	SENT_328	[p21l1362t2151r1796b2210],
11	metabolism	NN	O	metabolism	dep	4	SENT_328	[p21l113t2228r444b2276],
12	in	IN	O	in	_	0	SENT_328	[p21l465t2229r518b2275],
13	humans	NNS	O	human	prep_in	11	SENT_328	[p21l538t2228r779b2276],
14	.	.	O	.	_	0	SENT_328	[p21l538t2228r779b2276],

1	3	CD	NUMBER	3	num	3	SENT_329	[p21l797t2229r838b2288],
2	’	NN	O	’	nn	3	SENT_329	[p21l797t2229r838b2288],
3	Biol	NNP	O	Biol	_	0	SENT_329	[p21l852t2229r965b2276],
4	Chem	NNP	O	Chem	dep	3	SENT_329	[p21l983t2229r1135b2276],
5	1994	CD	DATE	1994	num	4	SENT_329	[p21l1164t2230r1317b2285],
6	;	:	O	;	_	0	SENT_329	[p21l1164t2230r1317b2285],
7	269	CD	NUMBER	269	num	9	SENT_329	[p21l1340t2230r1459b2276],
8	:	:	O	:	_	0	SENT_329	[p21l1340t2230r1459b2276],
9	15419-22	CD	NUMBER	15419-22	dep	3	SENT_329	[p21l1491t2230r1784b2276],
10	.	.	O	.	_	0	SENT_329	[p21l1491t2230r1784b2276],

1	Heim	NNP	PERSON	Heim	nn	2	SENT_330	[p21l114t2306r273b2353],
2	M	NNP	O	M	_	0	SENT_330	[p21l294t2306r375b2362],
3	,	,	O	,	_	0	SENT_330	[p21l294t2306r375b2362],
4	Meyer	NNP	PERSON	Meyer	nn	5	SENT_330	[p21l398t2306r582b2365],
5	UA	NNP	O	UA	appos	2	SENT_330	[p21l601t2306r716b2353],
6	.	.	O	.	_	0	SENT_330	[p21l601t2306r716b2353],

1	Genotyping	NN	O	genotyping	_	0	SENT_331	[p21l742t2305r1078b2365],
2	of	IN	O	of	_	0	SENT_331	[p21l1099t2305r1159b2353],
3	poor	JJ	O	poor	amod	4	SENT_331	[p21l1171t2321r1305b2365],
4	metabolisers	NNS	O	metaboliser	prep_of	1	SENT_331	[p21l1323t2305r1678b2353],
5	of	IN	O	of	_	0	SENT_331	[p21l1701t2305r1761b2353],
6	debrisoquine	NN	O	debrisoquine	prep_of	1	SENT_331	[p21l1775t2305r2143b2365],
7	by	IN	O	by	_	0	SENT_331	[p21l112t2382r181b2441],
8	allele-speciﬁc	JJ	O	allele-speciﬁc	amod	10	SENT_331	[p21l202t2382r580b2441],
9	PCR	NN	O	pcr	nn	10	SENT_331	[p21l602t2382r743b2430],
10	ampliﬁcation	NN	O	ampliﬁcation	prep_by	1	SENT_331	[p21l762t2382r1149b2441],
11	.	.	O	.	_	0	SENT_331	[p21l762t2382r1149b2441],

1	Lancet	NNP	O	Lancet	_	0	SENT_332	[p21l1173t2383r1357b2429],
2	1990	CD	DATE	1990	num	1	SENT_332	[p21l1381t2384r1534b2439],
3	;	:	O	;	_	0	SENT_332	[p21l1381t2384r1534b2439],
4	336	CD	NUMBER	336	num	6	SENT_332	[p21l1558t2384r1676b2430],
5	:	:	O	:	_	0	SENT_332	[p21l1558t2384r1676b2430],
6	529-32	CD	NUMBER	529-32	dep	1	SENT_332	[p21l1703t2384r1928b2430],
7	.	.	O	.	_	0	SENT_332	[p21l1703t2384r1928b2430],

1	THE	DT	O	the	det	2	SENT_333	[p21l92t2543r158b2563],
2	LANCET	NN	O	lancet	_	0	SENT_333	[p21l167t2543r297b2564],
3	-	:	O	-	_	0	SENT_333	[p21l306t2550r314b2557],
4	Vo1359	NN	O	vo1359	dep	2	SENT_333	[p21l323t2543r422b2564],
5	-	:	O	-	_	0	SENT_333	[p21l434t2550r441b2557],
6	January	NNP	DATE	January	dep	4	SENT_333	[p21l449t2543r547b2569],
7	5	CD	DATE	5	num	6	SENT_333	[p21l557t2543r578b2568],
8	,	,	DATE	,	_	0	SENT_333	[p21l557t2543r578b2568],
9	2002	CD	DATE	2002	num	6	SENT_333	[p21l589t2544r651b2564],
10	-	:	O	-	_	0	SENT_333	[p21l662t2550r669b2557],
11	wWW.thelancet.com	NNP	O	wWW.thelancet.com	nn	13	SENT_333	[p21l679t2543r930b2564],
12	35	CD	NUMBER	35	num	13	SENT_333	[p21l2025t2538r2062b2564],
13	ARTICLES	NNS	O	article	dep	2	SENT_333	[p21l91t2586r244b2607],

1	Johansson	NNP	PERSON	Johansson	nn	2	SENT_334	[p21l105t2792r400b2850],
2	I	NNP	O	I	_	0	SENT_334	[p21l421t2793r460b2849],
3	,	,	O	,	_	0	SENT_334	[p21l421t2793r460b2849],
4	Lundqvist	NNP	PERSON	Lundqvist	nn	5	SENT_334	[p21l483t2792r777b2851],
5	E	NNP	O	E	appos	2	SENT_334	[p21l797t2793r856b2849],
6	,	,	O	,	_	0	SENT_334	[p21l797t2793r856b2849],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_334	[p21l880t2792r1020b2839],
8	ML	NNP	O	ML	appos	2	SENT_334	[p21l1041t2793r1167b2849],
9	,	,	O	,	_	0	SENT_334	[p21l1041t2793r1167b2849],
10	Ingelman-Sundberg	NNP	O	Ingelman-Sundberg	nn	13	SENT_334	[p21l1191t2792r1767b2851],
11	M.	NNP	MISC	M.	nn	13	SENT_334	[p21l1786t2793r1866b2839],
12	PCR-based	JJ	MISC	pcr-based	amod	13	SENT_334	[p21l110t2868r438b2916],
13	genotyping	NN	O	genotyping	appos	2	SENT_334	[p21l459t2869r776b2928],
14	for	IN	O	for	_	0	SENT_334	[p21l795t2868r876b2916],
15	duplicated	JJ	O	duplicated	amod	19	SENT_334	[p21l896t2868r1197b2928],
16	and	CC	O	and	_	0	SENT_334	[p21l1219t2868r1323b2916],
17	deleted	JJ	O	deleted	conj_and	15	SENT_334	[p21l1345t2868r1551b2916],
18	CYP2D6	NN	O	cyp2d6	nn	19	SENT_334	[p21l1575t2868r1839b2916],
19	genes	NNS	O	gene	prep_for	13	SENT_334	[p21l1862t2884r2034b2928],
20	.	.	O	.	_	0	SENT_334	[p21l1862t2884r2034b2928],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_335	[p21l108t2944r583b3003],
2	19965	CD	NUMBER	19965	number	3	SENT_335	[p21l610t2946r764b3001],
3	6	CD	NUMBER	6	dep	1	SENT_335	[p21l788t2946r838b2992],
4	:	:	O	:	_	0	SENT_335	[p21l788t2946r838b2992],
5	351-55	CD	NUMBER	351-55	dep	1	SENT_335	[p21l865t2946r1092b2992],
6	.	.	O	.	_	0	SENT_335	[p21l865t2946r1092b2992],

1	Marzolini	NNP	PERSON	Marzolini	nn	2	SENT_336	[p21l109t3026r388b3074],
2	C	NNP	O	C	_	0	SENT_336	[p21l411t3026r475b3083],
3	,	,	O	,	_	0	SENT_336	[p21l411t3026r475b3083],
4	Telenti	NNP	O	Telenti	nn	5	SENT_336	[p21l498t3026r704b3074],
5	A	NNP	O	A	appos	2	SENT_336	[p21l724t3027r788b3083],
6	,	,	O	,	_	0	SENT_336	[p21l724t3027r788b3083],
7	Buclin	NNP	O	Buclin	nn	8	SENT_336	[p21l812t3026r998b3074],
8	T	NN	O	t	appos	2	SENT_336	[p21l1018t3027r1083b3083],
9	,	,	O	,	_	0	SENT_336	[p21l1018t3027r1083b3083],
10	et	FW	O	et	nn	11	SENT_336	[p21l1108t3037r1158b3074],
11	al.	FW	O	al.	appos	2	SENT_336	[p21l1180t3026r1241b3074],
12	.	.	O	.	_	0	SENT_336	[p21l1180t3026r1241b3074],

1	Simultaneous	JJ	O	simultaneous	amod	2	SENT_337	[p21l1268t3026r1657b3074],
2	determination	NN	O	determination	nsubj	7	SENT_337	[p21l1680t3026r2084b3074],
3	of	IN	O	of	_	0	SENT_337	[p21l111t3102r171b3150],
4	the	DT	O	the	det	5	SENT_337	[p21l184t3103r271b3150],
5	HIV	NN	MISC	hiv	prep_of	2	SENT_337	[p21l294t3103r421b3150],
6	protease	NN	O	protease	nn	7	SENT_337	[p21l440t3113r678b3162],
7	inhibitors	NNS	O	inhibitor	_	0	SENT_337	[p21l699t3103r972b3150],
8	indinavir	NN	O	indinavir	dobj	7	SENT_337	[p21l994t3103r1265b3159],
9	,	,	O	,	_	0	SENT_337	[p21l994t3103r1265b3159],
10	amprenavir	NN	O	amprenavir	dobj	7	SENT_337	[p21l1290t3103r1630b3162],
11	,	,	O	,	_	0	SENT_337	[p21l1290t3103r1630b3162],
12	saquinavir	NN	O	saquinavir	dobj	7	SENT_337	[p21l1654t3103r1964b3162],
13	,	,	O	,	_	0	SENT_337	[p21l1654t3103r1964b3162],
14	ritonavir	NN	O	ritonavir	dobj	7	SENT_337	[p21l109t3180r369b3236],
15	,	,	O	,	_	0	SENT_337	[p21l109t3180r369b3236],
16	nelﬁnavir	NN	O	nelﬁnavir	dobj	7	SENT_337	[p21l392t3179r662b3227],
17	and	CC	O	and	_	0	SENT_337	[p21l683t3179r787b3227],
18	the	DT	O	the	det	21	SENT_337	[p21l807t3179r895b3227],
19	non	JJ	O	non	amod	21	SENT_337	[p21l916t3179r1356b3227],
20	—	NN	O	—	nn	21	SENT_337	[p21l916t3179r1356b3227],
21	nucleoside	NN	O	nucleoside	conj_and	8	SENT_337	[p21l916t3179r1356b3227],
22	reverse	JJ	O	reverse	amod	25	SENT_337	[p21l1377t3195r1576b3227],
23	transcriptase	NN	O	transcriptase	nn	25	SENT_337	[p21l1597t3180r1960b3239],
24	inhibitor	NN	O	inhibitor	nn	25	SENT_337	[p21l109t3255r358b3302],
25	efavirenz	NN	O	efavirenz	dep	21	SENT_337	[p21l378t3255r631b3303],
26	by	IN	O	by	_	0	SENT_337	[p21l651t3255r720b3314],
27	high-performance	JJ	O	high-performance	amod	29	SENT_337	[p21l739t3255r1251b3314],
28	liquid	JJ	O	liquid	amod	29	SENT_337	[p21l1273t3255r1437b3314],
29	chromatography	NN	O	chromatography	prep_by	7	SENT_337	[p21l1460t3255r1930b3314],
30	after	IN	O	after	_	0	SENT_337	[p21l1951t3255r2079b3303],
31	solid	JJ	O	solid	amod	34	SENT_337	[p21l111t3331r431b3390],
32	—	NN	O	—	nn	34	SENT_337	[p21l111t3331r431b3390],
33	phase	NN	O	phase	nn	34	SENT_337	[p21l111t3331r431b3390],
34	extraction	NN	O	extraction	prep_after	29	SENT_337	[p21l453t3331r753b3378],
35	.	.	O	.	_	0	SENT_337	[p21l453t3331r753b3378],

1	3	CD	NUMBER	3	num	2	SENT_338	[p21l771t3331r813b3390],
2	‘	NN	O	‘	_	0	SENT_338	[p21l771t3331r813b3390],
3	Chromatogr	NN	O	chromatogr	nn	6	SENT_338	[p21l830t3331r1152b3390],
4	B	NN	O	b	nn	6	SENT_338	[p21l1167t3331r1214b3377],
5	Biomed	NNP	O	Biomed	nn	6	SENT_338	[p21l1232t3331r1440b3378],
6	Appl	NNP	O	Appl	dep	2	SENT_338	[p21l1451t3331r1588b3390],
7	2000	CD	DATE	2000	num	6	SENT_338	[p21l1605t3333r1765b3387],
8	;	:	O	;	_	0	SENT_338	[p21l1605t3333r1765b3387],
9	740	CD	NUMBER	740	num	11	SENT_338	[p21l1791t3333r1908b3378],
10	:	:	O	:	_	0	SENT_338	[p21l1791t3333r1908b3378],
11	43-58	CD	NUMBER	43-58	dep	2	SENT_338	[p21l1934t3332r2126b3378],
12	.	.	O	.	_	0	SENT_338	[p21l1934t3332r2126b3378],

1	10	CD	NUMBER	10	num	3	SENT_339	[p21l12t3416r74b3462],
2	Schinkel	NNP	ORGANIZATION	Schinkel	nn	3	SENT_339	[p21l112t3414r353b3462],
3	AH	NNP	ORGANIZATION	AH	nsubj	24	SENT_339	[p21l373t3415r493b3471],
4	,	,	O	,	_	0	SENT_339	[p21l373t3415r493b3471],
5	Wagenaar	NNP	PERSON	Wagenaar	nn	6	SENT_339	[p21l515t3415r805b3474],
6	E	NNP	PERSON	E	appos	3	SENT_339	[p21l824t3415r884b3471],
7	,	,	O	,	_	0	SENT_339	[p21l824t3415r884b3471],
8	van	NNP	PERSON	van	nn	10	SENT_339	[p21l906t3430r1007b3462],
9	Deemter	NNP	PERSON	Deemter	nn	10	SENT_339	[p21l1028t3415r1280b3462],
10	L	NNP	PERSON	L	appos	3	SENT_339	[p21l1300t3415r1359b3471],
11	,	,	O	,	_	0	SENT_339	[p21l1300t3415r1359b3471],
12	Mol	NNP	ORGANIZATION	Mol	nn	13	SENT_339	[p21l1382t3414r1501b3462],
13	CA	NNP	O	CA	appos	3	SENT_339	[p21l1525t3414r1636b3471],
14	,	,	O	,	_	0	SENT_339	[p21l1525t3414r1636b3471],
15	Borst	NNP	PERSON	Borst	nn	17	SENT_339	[p21l1660t3415r1813b3462],
16	P.	NNP	PERSON	P.	nn	17	SENT_339	[p21l1834t3415r1888b3462],
17	Absence	NN	PERSON	absence	appos	3	SENT_339	[p21l1912t3414r2153b3462],
18	of	IN	O	of	_	0	SENT_339	[p21l111t3490r171b3538],
19	the	DT	O	the	det	21	SENT_339	[p21l184t3490r271b3538],
20	mdrla	NN	O	mdrlum	nn	21	SENT_339	[p21l293t3490r480b3538],
21	P-glycoprotein	NN	O	p-glycoprotein	prep_of	17	SENT_339	[p21l501t3490r923b3549],
22	in	IN	O	in	_	0	SENT_339	[p21l943t3490r997b3537],
23	mice	NNS	O	mouse	prep_in	21	SENT_339	[p21l1017t3490r1152b3538],
24	affects	VBZ	O	affect	_	0	SENT_339	[p21l1175t3490r1354b3538],
25	tissue	NN	O	tissue	dobj	24	SENT_339	[p21l1376t3490r1535b3538],
26	distribution	NN	O	distribution	dep	39	SENT_339	[p21l1557t3490r1891b3538],
27	and	CC	O	and	_	0	SENT_339	[p21l1913t3490r2017b3538],
28	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	26	SENT_339	[p21l108t3566r612b3625],
29	of	IN	O	of	_	0	SENT_339	[p21l635t3566r696b3613],
30	dexamethasone	NN	O	dexamethasone	nn	32	SENT_339	[p21l710t3566r1169b3623],
31	,	,	O	,	_	0	SENT_339	[p21l710t3566r1169b3623],
32	digoxin	NN	O	digoxin	prep_of	26	SENT_339	[p21l1193t3566r1421b3625],
33	,	,	O	,	_	0	SENT_339	[p21l1193t3566r1421b3625],
34	and	CC	O	and	_	0	SENT_339	[p21l1446t3566r1550b3613],
35	cyclosporin	NN	O	cyclosporin	nn	36	SENT_339	[p21l1572t3566r1897b3625],
36	A.	NN	O	a.	conj_and	32	SENT_339	[p21l1916t3567r1979b3613],
37	3	CD	NUMBER	3	num	38	SENT_339	[p21l102t3643r144b3702],
38	’	NN	O	’	dep	39	SENT_339	[p21l102t3643r144b3702],
39	Clin	NNP	O	Clin	dep	45	SENT_339	[p21l161t3643r273b3690],
40	Invest	NNP	O	Invest	dep	39	SENT_339	[p21l293t3643r457b3690],
41	1995	CD	DATE	1995	num	40	SENT_339	[p21l482t3644r636b3699],
42	,	,	O	,	_	0	SENT_339	[p21l482t3644r636b3699],
43	96	CD	NUMBER	96	num	40	SENT_339	[p21l659t3644r744b3690],
44	:	:	O	:	_	0	SENT_339	[p21l659t3644r744b3690],
45	1698-705	CD	NUMBER	1698-705	dep	24	SENT_339	[p21l776t3644r1072b3690],
46	.	.	O	.	_	0	SENT_339	[p21l776t3644r1072b3690],

1	Carrillo	NNP	ORGANIZATION	Carrillo	nn	2	SENT_340	[p22l112t18r329b66],
2	IA	NNP	ORGANIZATION	IA	_	0	SENT_340	[p22l347t19r437b76],
3	,	,	O	,	_	0	SENT_340	[p22l347t19r437b76],
4	Ramos	NNP	PERSON	Ramos	nn	5	SENT_340	[p22l461t19r656b66],
5	SI	NNP	O	SI	conj_and	2	SENT_340	[p22l680t18r757b75],
6	,	,	O	,	_	0	SENT_340	[p22l680t18r757b75],
7	Agundez	NNP	ORGANIZATION	Agundez	nn	8	SENT_340	[p22l779t18r1033b77],
8	IA	NNP	ORGANIZATION	IA	conj_and	2	SENT_340	[p22l1050t19r1140b76],
9	,	,	O	,	_	0	SENT_340	[p22l1050t19r1140b76],
10	Martinez	NNP	PERSON	Martinez	nn	11	SENT_340	[p22l1163t18r1423b66],
11	C	NNP	O	C	conj_and	2	SENT_340	[p22l1446t18r1510b75],
12	,	,	O	,	_	0	SENT_340	[p22l1446t18r1510b75],
13	Benitez	NNP	PERSON	Benitez	nn	15	SENT_340	[p22l1534t18r1746b66],
14	J.	NNP	O	J.	nn	15	SENT_340	[p22l1763t19r1803b76],
15	Analysis	NN	O	analysis	conj_and	2	SENT_340	[p22l1826t18r2062b77],
16	of	IN	O	of	_	0	SENT_340	[p22l2086t18r2146b66],
17	midazolam	NN	O	midazolam	prep_of	15	SENT_340	[p22l109t94r424b142],
18	and	CC	O	and	_	0	SENT_340	[p22l446t94r550b142],
19	metabolites	NNS	O	metabolite	conj_and	2	SENT_340	[p22l571t94r899b141],
20	in	IN	O	in	_	0	SENT_340	[p22l921t94r975b141],
21	plasma	NN	O	plasma	prep_in	19	SENT_340	[p22l995t94r1196b153],
22	by	IN	O	by	_	0	SENT_340	[p22l1216t94r1285b153],
23	high	JJ	O	high	amod	25	SENT_340	[p22l1304t94r1815b153],
24	—	NN	O	—	nn	25	SENT_340	[p22l1304t94r1815b153],
25	performance	NN	O	performance	prep_by	21	SENT_340	[p22l1304t94r1815b153],
26	liquid	JJ	O	liquid	amod	27	SENT_340	[p22l1837t94r2002b153],
27	chromatography	NN	O	chromatography	dep	19	SENT_340	[p22l111t170r595b229],
28	:	:	O	:	_	0	SENT_340	[p22l111t170r595b229],
29	probe	NN	O	probe	dep	2	SENT_340	[p22l619t170r784b229],
30	of	IN	O	of	_	0	SENT_340	[p22l806t169r867b217],
31	CYP3A	NN	O	cyp3a	prep_of	29	SENT_340	[p22l882t170r1119b217],
32	.	.	O	.	_	0	SENT_340	[p22l882t170r1119b217],

1	Ther	NNP	O	Ther	nn	3	SENT_341	[p22l1150t170r1273b217],
2	Drug	NNP	O	Drug	nn	3	SENT_341	[p22l1289t170r1431b229],
3	Monit	NNP	O	Monit	_	0	SENT_341	[p22l1445t170r1616b217],
4	1998	CD	DATE	1998	num	6	SENT_341	[p22l1641t172r1795b226],
5	;	:	O	;	_	0	SENT_341	[p22l1641t172r1795b226],
6	20	CD	NUMBER	20	dep	3	SENT_341	[p22l1818t172r1904b217],
7	:	:	O	:	_	0	SENT_341	[p22l1818t172r1904b217],
8	3	CD	NUMBER	3	number	9	SENT_341	[p22l111t248r141b294],
9	1	CD	NUMBER	1	dep	3	SENT_341	[p22l153t248r173b293],
10	9-24	CD	NUMBER	9-24	dep	9	SENT_341	[p22l185t248r338b294],
11	.	.	O	.	_	0	SENT_341	[p22l185t248r338b294],

1	Hoffmeyer	NNP	PERSON	Hoffmeyer	nn	2	SENT_342	[p22l110t330r419b389],
2	S	NNP	O	S	_	0	SENT_342	[p22l440t330r492b387],
3	,	,	O	,	_	0	SENT_342	[p22l440t330r492b387],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_342	[p22l516t330r657b378],
5	o	NN	O	o	appos	2	SENT_342	[p22l679t330r745b387],
6	,	,	O	,	_	0	SENT_342	[p22l679t330r745b387],
7	Von	NNP	PERSON	Von	nn	9	SENT_342	[p22l766t346r872b378],
8	Richter	NNP	PERSON	Richter	nn	9	SENT_342	[p22l893t330r1104b378],
9	O	NNP	PERSON	O	appos	2	SENT_342	[p22l1125t330r1192b387],
10	,	,	O	,	_	0	SENT_342	[p22l1125t330r1192b387],
11	et	FW	O	et	nn	12	SENT_342	[p22l1216t341r1266b378],
12	al.	FW	O	al.	appos	2	SENT_342	[p22l1288t330r1349b378],
13	.	.	O	.	_	0	SENT_342	[p22l1288t330r1349b378],

1	Functional	JJ	O	functional	amod	2	SENT_343	[p22l1375t330r1686b378],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_343	[p22l1707t330r2148b389],
3	of	IN	O	of	_	0	SENT_343	[p22l111t406r171b453],
4	the	DT	O	the	det	7	SENT_343	[p22l184t406r271b453],
5	human	JJ	O	human	amod	7	SENT_343	[p22l292t406r494b453],
6	multidrug-resistance	JJ	O	multidrug-resistance	amod	7	SENT_343	[p22l514t406r1104b465],
7	gene	NN	O	gene	prep_of	2	SENT_343	[p22l1126t421r1272b465],
8	:	:	O	:	_	0	SENT_343	[p22l1126t421r1272b465],
9	multiple	JJ	O	multiple	amod	11	SENT_343	[p22l1297t406r1534b465],
10	sequence	NN	O	sequence	nn	11	SENT_343	[p22l1556t421r1816b465],
11	Variations	NNS	O	variation	dep	2	SENT_343	[p22l1837t406r2113b453],
12	and	CC	O	and	_	0	SENT_343	[p22l111t482r215b530],
13	correlation	NN	O	correlation	conj_and	11	SENT_343	[p22l237t482r546b530],
14	of	IN	O	of	_	0	SENT_343	[p22l567t482r628b530],
15	one	CD	NUMBER	one	num	16	SENT_343	[p22l642t498r743b530],
16	allele	NN	O	allele	prep_of	13	SENT_343	[p22l766t482r910b530],
17	with	IN	O	with	_	0	SENT_343	[p22l930t482r1055b530],
18	P	NN	O	p	nn	21	SENT_343	[p22l1076t483r1139b529],
19	—	CD	NUMBER	—	num	21	SENT_343	[p22l1076t483r1139b529],
20	glycoprotein	NN	O	glycoprotein	nn	21	SENT_343	[p22l1160t482r1516b542],
21	expression	NN	O	expression	prep_with	16	SENT_343	[p22l1538t483r1837b542],
22	and	CC	O	and	_	0	SENT_343	[p22l1859t482r1963b530],
23	activity	NN	O	activity	prep_of	13	SENT_343	[p22l111t558r315b617],
24	in	IN	O	in	_	0	SENT_343	[p22l335t558r389b605],
25	Vivo	NNP	O	Vivo	prep_in	23	SENT_343	[p22l408t558r539b606],
26	.	.	O	.	_	0	SENT_343	[p22l408t558r539b606],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_344	[p22l563t559r682b605],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_344	[p22l700t558r828b605],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_344	[p22l839t558r988b605],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_344	[p22l1004t558r1090b605],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_344	[p22l1113t558r1241b605],
6	2000	CD	DATE	2000	num	5	SENT_344	[p22l1266t560r1426b615],
7	;	:	O	;	_	0	SENT_344	[p22l1266t560r1426b615],
8	97	CD	NUMBER	97	num	10	SENT_344	[p22l1449t560r1535b606],
9	:	:	O	:	_	0	SENT_344	[p22l1449t560r1535b606],
10	3473-78	CD	NUMBER	3473-78	dep	5	SENT_344	[p22l1561t560r1825b606],
11	.	.	O	.	_	0	SENT_344	[p22l1561t560r1825b606],

1	Srinivas	NNP	PERSON	Srinivas	nn	2	SENT_345	[p22l112t641r334b689],
2	RV	NN	PERSON	rv	nsubj	17	SENT_345	[p22l357t642r465b698],
3	,	,	O	,	_	0	SENT_345	[p22l357t642r465b698],
4	Middlemas	NN	ORGANIZATION	middlema	nn	5	SENT_345	[p22l489t641r811b689],
5	D	NN	ORGANIZATION	d	appos	2	SENT_345	[p22l833t642r903b698],
6	,	,	O	,	_	0	SENT_345	[p22l833t642r903b698],
7	Flynn	NNP	PERSON	Flynn	nn	8	SENT_345	[p22l927t641r1094b700],
8	P	NN	PERSON	p	appos	2	SENT_345	[p22l1115t642r1171b698],
9	,	,	O	,	_	0	SENT_345	[p22l1115t642r1171b698],
10	Fridland	NNP	O	Fridland	nn	12	SENT_345	[p22l1195t641r1443b689],
11	A.	NNP	O	A.	nn	12	SENT_345	[p22l1462t642r1524b688],
12	Human	NNP	O	Human	appos	2	SENT_345	[p22l1550t642r1769b688],
13	immunodeﬁciency	NN	O	immunodeﬁciency	nn	16	SENT_345	[p22l109t716r642b776],
14	virus	NN	O	virus	nn	16	SENT_345	[p22l660t717r797b764],
15	protease	NN	O	protease	nn	16	SENT_345	[p22l818t727r1057b776],
16	inhibitors	NNS	O	inhibitor	dep	12	SENT_345	[p22l1079t717r1351b764],
17	serve	VBP	O	serve	_	0	SENT_345	[p22l1374t732r1515b764],
18	as	IN	O	as	_	0	SENT_345	[p22l1538t732r1591b764],
19	substrates	NNS	O	substrate	prep_as	17	SENT_345	[p22l1614t717r1896b764],
20	for	IN	O	for	_	0	SENT_345	[p22l1917t716r1998b764],
21	multidrug	JJ	O	multidrug	amod	24	SENT_345	[p22l109t793r396b852],
22	transporter	NN	O	transporter	nn	24	SENT_345	[p22l415t804r734b852],
23	proteins	NNS	O	protein	nn	24	SENT_345	[p22l753t793r983b852],
24	MDR1	NN	O	mdr1	prep_for	19	SENT_345	[p22l1005t794r1203b840],
25	and	CC	O	and	_	0	SENT_345	[p22l1233t793r1337b841],
26	MRP1	NN	O	mrp1	prep_for	19	SENT_345	[p22l1358t794r1542b840],
27	but	CC	O	but	_	0	SENT_345	[p22l1569t793r1666b841],
28	retain	VBP	O	retain	conj_but	17	SENT_345	[p22l1686t793r1850b841],
29	antiviral	JJ	O	antiviral	amod	30	SENT_345	[p22l1872t793r2102b841],
30	efficacy	NN	O	efficacy	dobj	28	SENT_345	[p22l111t869r325b928],
31	in	IN	O	in	_	0	SENT_345	[p22l344t869r398b916],
32	cell	NN	O	cell	nn	33	SENT_345	[p22l420t869r514b916],
33	lines	NNS	O	line	prep_in	28	SENT_345	[p22l535t869r663b916],
34	expressing	VBG	O	express	partmod	33	SENT_345	[p22l687t869r984b928],
35	these	DT	O	these	det	36	SENT_345	[p22l1003t869r1148b916],
36	transporters	NNS	O	transporter	dobj	34	SENT_345	[p22l1169t880r1528b928],
37	.	.	O	.	_	0	SENT_345	[p22l1169t880r1528b928],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_346	[p22l1548t869r1850b916],
2	Agents	NNPS	O	Agents	nn	3	SENT_346	[p22l1866t869r2050b928],
3	Chemother	NNP	O	Chemother	_	0	SENT_346	[p22l111t946r402b993],
4	1998	CD	DATE	1998	dep	3	SENT_346	[p22l426t947r579b1002],
5	;	:	O	;	_	0	SENT_346	[p22l426t947r579b1002],
6	42	CD	NUMBER	42	num	8	SENT_346	[p22l603t947r688b993],
7	:	:	O	:	_	0	SENT_346	[p22l603t947r688b993],
8	3157-62	CD	NUMBER	3157-62	dep	3	SENT_346	[p22l715t947r979b993],
9	.	.	O	.	_	0	SENT_346	[p22l715t947r979b993],

1	Bardsley-Elliot	NNP	O	Bardsley-Elliot	nn	2	SENT_347	[p22l110t1029r537b1088],
2	A	NNP	O	A	_	0	SENT_347	[p22l555t1030r619b1086],
3	,	,	O	,	_	0	SENT_347	[p22l555t1030r619b1086],
4	Plosker	NNP	O	Plosker	nn	5	SENT_347	[p22l643t1029r853b1077],
5	GL	NNP	O	GL	appos	2	SENT_347	[p22l874t1030r986b1077],
6	.	.	O	.	_	0	SENT_347	[p22l874t1030r986b1077],

1	Nelﬁnavir	NNP	O	Nelﬁnavir	_	0	SENT_348	[p22l1010t1029r1312b1077],
2	:	:	O	:	_	0	SENT_348	[p22l1010t1029r1312b1077],
3	an	DT	O	a	nsubj	4	SENT_348	[p22l1339t1045r1405b1077],
4	update	VBP	O	update	dep	1	SENT_348	[p22l1425t1029r1621b1089],
5	on	IN	O	on	_	0	SENT_348	[p22l1644t1045r1715b1077],
6	its	PRP$	O	its	poss	7	SENT_348	[p22l1735t1030r1798b1077],
7	use	NN	O	use	prep_on	4	SENT_348	[p22l1819t1045r1913b1077],
8	in	IN	O	in	_	0	SENT_348	[p22l1934t1030r1988b1076],
9	HIV	NN	MISC	hiv	nn	10	SENT_348	[p22l2009t1030r2136b1077],
10	infection	NN	O	infection	prep_in	7	SENT_348	[p22l109t1105r375b1152],
11	.	.	O	.	_	0	SENT_348	[p22l109t1105r375b1152],

1	Drugs	NNS	O	drug	_	0	SENT_349	[p22l400t1106r560b1164],
2	2000	CD	DATE	2000	num	1	SENT_349	[p22l582t1107r742b1162],
3	,	,	O	,	_	0	SENT_349	[p22l582t1107r742b1162],
4	59	CD	NUMBER	59	num	6	SENT_349	[p22l767t1106r851b1153],
5	:	:	O	:	_	0	SENT_349	[p22l767t1106r851b1153],
6	581-620	CD	NUMBER	581-620	appos	1	SENT_349	[p22l878t1107r1141b1153],
7	.	.	O	.	_	0	SENT_349	[p22l878t1107r1141b1153],

1	Sata	NNP	PERSON	Sata	nn	2	SENT_350	[p22l112t1188r232b1236],
2	F	NN	O	f	_	0	SENT_350	[p22l253t1189r311b1245],
3	,	,	O	,	_	0	SENT_350	[p22l253t1189r311b1245],
4	Sapone	NNP	O	Sapone	nn	5	SENT_350	[p22l336t1188r545b1247],
5	A	NNP	O	A	appos	2	SENT_350	[p22l565t1189r629b1245],
6	,	,	O	,	_	0	SENT_350	[p22l565t1189r629b1245],
7	Elizondo	NNP	PERSON	Elizondo	nn	8	SENT_350	[p22l652t1188r906b1236],
8	G	NNP	O	G	appos	2	SENT_350	[p22l930t1188r998b1245],
9	,	,	O	,	_	0	SENT_350	[p22l930t1188r998b1245],
10	et	FW	O	et	nn	11	SENT_350	[p22l1023t1199r1073b1235],
11	al.	FW	O	al.	appos	2	SENT_350	[p22l1095t1188r1156b1235],
12	.	.	O	.	_	0	SENT_350	[p22l1095t1188r1156b1235],

1	CYP3A4	NN	O	cyp3a4	nn	3	SENT_351	[p22l1183t1188r1440b1236],
2	allelic	JJ	O	allelic	amod	3	SENT_351	[p22l1464t1188r1625b1235],
3	Variants	NNS	O	variant	_	0	SENT_351	[p22l1645t1188r1868b1236],
4	with	IN	O	with	_	0	SENT_351	[p22l1889t1188r2014b1236],
5	amino	NN	O	amino	nn	7	SENT_351	[p22l111t1264r286b1311],
6	acid	NN	O	acid	nn	7	SENT_351	[p22l310t1264r426b1311],
7	substitutions	NNS	O	substitution	prep_with	3	SENT_351	[p22l448t1264r811b1311],
8	in	IN	O	in	_	0	SENT_351	[p22l834t1264r887b1311],
9	exons	NNS	O	exon	prep_in	7	SENT_351	[p22l909t1279r1069b1311],
10	7	CD	NUMBER	7	num	9	SENT_351	[p22l1093t1266r1123b1311],
11	and	CC	O	and	_	0	SENT_351	[p22l1148t1264r1252b1311],
12	12	CD	NUMBER	12	prep_in	7	SENT_351	[p22l1280t1266r1359b1311],
13	:	:	O	:	_	0	SENT_351	[p22l1280t1266r1359b1311],
14	evidence	NN	O	evidence	dep	3	SENT_351	[p22l1385t1264r1631b1311],
15	for	IN	O	for	_	0	SENT_351	[p22l1653t1263r1733b1311],
16	an	DT	O	a	det	18	SENT_351	[p22l1754t1279r1821b1311],
17	allelic	JJ	O	allelic	amod	18	SENT_351	[p22l1842t1264r2004b1311],
18	variant	NN	O	variant	prep_for	14	SENT_351	[p22l108t1341r306b1389],
19	with	IN	O	with	_	0	SENT_351	[p22l325t1341r450b1389],
20	altered	JJ	O	altered	amod	22	SENT_351	[p22l472t1341r665b1389],
21	catalytic	JJ	O	catalytic	amod	22	SENT_351	[p22l687t1341r921b1400],
22	activity	NN	O	activity	prep_with	18	SENT_351	[p22l944t1341r1162b1400],
23	.	.	O	.	_	0	SENT_351	[p22l944t1341r1162b1400],

1	Clin	NNP	O	Clin	nn	2	SENT_352	[p22l1189t1341r1301b1389],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_352	[p22l1320t1341r1614b1389],
3	Ther	NNP	O	Ther	dep	2	SENT_352	[p22l1636t1341r1759b1389],
4	2000	CD	DATE	2000	num	3	SENT_352	[p22l1777t1343r1937b1398],
5	,	,	O	,	_	0	SENT_352	[p22l1777t1343r1937b1398],
6	67	CD	NUMBER	67	num	3	SENT_352	[p22l1960t1343r2045b1389],
7	:	:	O	:	_	0	SENT_352	[p22l1960t1343r2045b1389],
8	48-56	CD	NUMBER	48-56	dep	2	SENT_352	[p22l110t1419r302b1465],
9	.	.	O	.	_	0	SENT_352	[p22l110t1419r302b1465],

1	Kuehl	NNP	PERSON	Kuehl	nn	2	SENT_353	[p22l110t1501r284b1548],
2	P	NN	O	p	_	0	SENT_353	[p22l306t1502r362b1558],
3	,	,	O	,	_	0	SENT_353	[p22l306t1502r362b1558],
4	Zhang	NNP	PERSON	Zhang	nn	5	SENT_353	[p22l386t1501r570b1560],
5	J	NNP	PERSON	J	appos	2	SENT_353	[p22l585t1502r627b1559],
6	,	,	O	,	_	0	SENT_353	[p22l585t1502r627b1559],
7	Lin	NNP	O	Lin	nn	8	SENT_353	[p22l650t1501r749b1548],
8	Y	NN	O	y	appos	2	SENT_353	[p22l769t1502r832b1558],
9	,	,	O	,	_	0	SENT_353	[p22l769t1502r832b1558],
10	et	FW	O	et	nn	11	SENT_353	[p22l857t1512r907b1548],
11	al.	FW	O	al.	appos	2	SENT_353	[p22l929t1501r990b1548],
12	.	.	O	.	_	0	SENT_353	[p22l929t1501r990b1548],

1	Sequence	NN	O	sequence	nn	2	SENT_354	[p22l1017t1501r1289b1560],
2	diversity	NN	O	diversity	_	0	SENT_354	[p22l1312t1501r1552b1560],
3	in	IN	O	in	_	0	SENT_354	[p22l1571t1501r1625b1548],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_354	[p22l1648t1501r1871b1548],
5	promoters	NNS	O	promoter	prep_in	2	SENT_354	[p22l108t1588r401b1637],
6	and	CC	O	and	_	0	SENT_354	[p22l425t1577r529b1625],
7	characterization	NN	O	characterization	prep_in	2	SENT_354	[p22l551t1577r1007b1625],
8	of	IN	O	of	_	0	SENT_354	[p22l1029t1577r1090b1625],
9	the	DT	O	the	det	11	SENT_354	[p22l1102t1577r1190b1625],
10	genetic	JJ	O	genetic	amod	11	SENT_354	[p22l1212t1578r1413b1637],
11	basis	NN	O	basis	prep_of	2	SENT_354	[p22l1434t1577r1571b1625],
12	of	IN	O	of	_	0	SENT_354	[p22l1594t1577r1655b1625],
13	polymorphic	JJ	O	polymorphic	amod	15	SENT_354	[p22l1667t1577r2030b1637],
14	CYP3A5	NN	O	cyp3a5	nn	15	SENT_354	[p22l112t1653r366b1701],
15	expression	NN	O	expression	prep_of	11	SENT_354	[p22l392t1653r705b1712],
16	.	.	O	.	_	0	SENT_354	[p22l392t1653r705b1712],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_355	[p22l729t1654r840b1700],
2	Genet	NNP	PERSON	Genet	_	0	SENT_355	[p22l861t1653r1017b1700],
3	2001	CD	DATE	2001	num	2	SENT_355	[p22l1035t1655r1195b1710],
4	;	:	O	;	_	0	SENT_355	[p22l1035t1655r1195b1710],
5	27	CD	NUMBER	27	num	7	SENT_355	[p22l1218t1655r1304b1701],
6	:	:	O	:	_	0	SENT_355	[p22l1218t1655r1304b1701],
7	383-91	CD	NUMBER	383-91	dep	2	SENT_355	[p22l1330t1655r1558b1701],
8	.	.	O	.	_	0	SENT_355	[p22l1330t1655r1558b1701],

1	Greub	NNP	PERSON	Greub	nn	2	SENT_356	[p22l111t1736r292b1783],
2	G	NNP	PERSON	G	_	0	SENT_356	[p22l316t1736r384b1793],
3	,	,	O	,	_	0	SENT_356	[p22l316t1736r384b1793],
4	Ledergerber	NNP	O	Ledergerber	nn	5	SENT_356	[p22l408t1736r760b1795],
5	B	NNP	O	B	appos	2	SENT_356	[p22l779t1737r839b1793],
6	,	,	O	,	_	0	SENT_356	[p22l779t1737r839b1793],
7	Battegay	NNP	O	Battegay	nn	8	SENT_356	[p22l863t1737r1111b1795],
8	M	NNP	O	M	appos	2	SENT_356	[p22l1130t1737r1212b1793],
9	,	,	O	,	_	0	SENT_356	[p22l1130t1737r1212b1793],
10	et	FW	O	et	nn	11	SENT_356	[p22l1237t1747r1287b1783],
11	al.	FW	O	al.	appos	2	SENT_356	[p22l1308t1736r1370b1783],
12	.	.	O	.	_	0	SENT_356	[p22l1308t1736r1370b1783],

1	Clinical	JJ	O	clinical	amod	2	SENT_357	[p22l1397t1736r1617b1783],
2	progression	NN	O	progression	_	0	SENT_357	[p22l1637t1736r1985b1795],
3	,	,	O	,	_	0	SENT_357	[p22l1637t1736r1985b1795],
4	survival	NN	O	survival	conj_and	2	SENT_357	[p22l111t1812r344b1868],
5	,	,	O	,	_	0	SENT_357	[p22l111t1812r344b1868],
6	and	CC	O	and	_	0	SENT_357	[p22l369t1812r473b1859],
7	immune	JJ	O	immune	amod	8	SENT_357	[p22l494t1812r731b1859],
8	recovery	NN	O	recovery	conj_and	2	SENT_357	[p22l753t1827r994b1871],
9	during	IN	O	during	_	0	SENT_357	[p22l1015t1812r1203b1871],
10	antiretroviral	JJ	O	antiretroviral	amod	11	SENT_357	[p22l1224t1812r1593b1859],
11	therapy	NN	O	therapy	prep_during	8	SENT_357	[p22l1614t1812r1830b1871],
12	in	IN	O	in	_	0	SENT_357	[p22l1850t1812r1903b1858],
13	patients	NNS	O	patient	prep_in	11	SENT_357	[p22l1923t1812r2147b1871],
14	with	IN	O	with	_	0	SENT_357	[p22l108t1888r233b1936],
15	HIV-1	NN	O	hiv-1	prep_with	13	SENT_357	[p22l254t1889r433b1936],
16	and	CC	O	and	_	0	SENT_357	[p22l463t1888r567b1936],
17	hepatitis	NN	O	hepatitis	prep_with	13	SENT_357	[p22l587t1888r828b1947],
18	C	NN	O	c	nn	20	SENT_357	[p22l853t1888r897b1936],
19	virus	NN	O	virus	nn	20	SENT_357	[p22l919t1888r1056b1936],
20	coinfection	NN	O	coinfection	dep	2	SENT_357	[p22l1079t1888r1411b1936],
21	:	:	O	:	_	0	SENT_357	[p22l1079t1888r1411b1936],
22	the	DT	O	the	det	26	SENT_357	[p22l1436t1888r1524b1936],
23	Swiss	JJ	MISC	swiss	amod	26	SENT_357	[p22l1547t1888r1700b1936],
24	HIV	NN	O	hiv	nn	26	SENT_357	[p22l1723t1889r1849b1936],
25	Cohort	NN	O	cohort	nn	26	SENT_357	[p22l1872t1888r2076b1936],
26	Study	NN	O	study	dep	20	SENT_357	[p22l112t1964r292b2023],
27	.	.	O	.	_	0	SENT_357	[p22l112t1964r292b2023],

1	Lancet	NNP	O	Lancet	_	0	SENT_358	[p22l316t1965r501b2011],
2	2000	CD	DATE	2000	num	1	SENT_358	[p22l520t1966r679b2021],
3	;	:	O	;	_	0	SENT_358	[p22l520t1966r679b2021],
4	356	CD	NUMBER	356	num	6	SENT_358	[p22l704t1965r823b2011],
5	:	:	O	:	_	0	SENT_358	[p22l704t1965r823b2011],
6	1800-05	CD	DATE	1800-05	dep	1	SENT_358	[p22l855t1966r1114b2011],
7	.	.	O	.	_	0	SENT_358	[p22l855t1966r1114b2011],

1	Yamashita	NNP	PERSON	Yamashita	nn	2	SENT_359	[p22l108t2047r411b2094],
2	TE	NNP	O	TE	_	0	SENT_359	[p22l431t2048r542b2104],
3	,	,	O	,	_	0	SENT_359	[p22l431t2048r542b2104],
4	Phair	NNP	PERSON	Phair	nn	5	SENT_359	[p22l566t2047r719b2094],
5	JP	NNP	O	JP	appos	2	SENT_359	[p22l734t2048r818b2105],
6	,	,	O	,	_	0	SENT_359	[p22l734t2048r818b2105],
7	Munoz	NNP	PERSON	Munoz	nn	8	SENT_359	[p22l841t2048r1047b2094],
8	A	NNP	O	A	appos	2	SENT_359	[p22l1067t2048r1130b2104],
9	,	,	O	,	_	0	SENT_359	[p22l1067t2048r1130b2104],
10	et	FW	O	et	nn	11	SENT_359	[p22l1155t2058r1205b2094],
11	al.	FW	O	al.	appos	2	SENT_359	[p22l1227t2047r1288b2094],
12	.	.	O	.	_	0	SENT_359	[p22l1227t2047r1288b2094],

1	Immunologic	JJ	MISC	immunologic	amod	4	SENT_360	[p22l1313t2047r1698b2106],
2	and	CC	O	and	_	0	SENT_360	[p22l1721t2047r1825b2094],
3	virologic	JJ	O	virologic	conj_and	1	SENT_360	[p22l1844t2047r2090b2106],
4	response	NN	O	response	_	0	SENT_360	[p22l109t2139r357b2183],
5	to	TO	O	to	_	0	SENT_360	[p22l378t2134r433b2171],
6	highly	RB	O	highly	advmod	7	SENT_360	[p22l454t2123r630b2183],
7	active	JJ	O	active	amod	9	SENT_360	[p22l651t2124r812b2171],
8	antiretroviral	JJ	O	antiretroviral	amod	9	SENT_360	[p22l835t2123r1205b2171],
9	therapy	NN	O	therapy	prep_to	4	SENT_360	[p22l1225t2123r1441b2183],
10	in	IN	O	in	_	0	SENT_360	[p22l1461t2124r1515b2170],
11	the	DT	O	the	det	15	SENT_360	[p22l1535t2123r1623b2171],
12	multicenter	JJ	O	multicenter	amod	15	SENT_360	[p22l1644t2123r1975b2171],
13	AIDS	NN	MISC	aid	nn	15	SENT_360	[p22l108t2199r273b2247],
14	cohort	NN	O	cohort	nn	15	SENT_360	[p22l297t2199r481b2247],
15	study	NN	O	study	prep_in	4	SENT_360	[p22l503t2199r671b2258],
16	.	.	O	.	_	0	SENT_360	[p22l503t2199r671b2258],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_361	[p22l691t2199r862b2246],
2	2001	CD	DATE	2001	num	1	SENT_361	[p22l881t2201r1041b2256],
3	;	:	O	;	_	0	SENT_361	[p22l881t2201r1041b2256],
4	15	CD	NUMBER	15	num	6	SENT_361	[p22l1069t2200r1149b2247],
5	:	:	O	:	_	0	SENT_361	[p22l1069t2200r1149b2247],
6	735-46	CD	NUMBER	735-46	dep	1	SENT_361	[p22l1176t2201r1404b2247],
7	.	.	O	.	_	0	SENT_361	[p22l1176t2201r1404b2247],

1	Huisman	NNP	PERSON	Huisman	nn	2	SENT_362	[p22l110t2282r374b2329],
2	MT	NNP	O	MT	_	0	SENT_362	[p22l394t2283r526b2339],
3	,	,	O	,	_	0	SENT_362	[p22l394t2283r526b2339],
4	Smit	NNP	PERSON	Smit	nn	5	SENT_362	[p22l551t2282r685b2329],
5	JW	NNP	O	JW	appos	2	SENT_362	[p22l701t2283r809b2340],
6	,	,	O	,	_	0	SENT_362	[p22l701t2283r809b2340],
7	Schinkel	NNP	PERSON	Schinkel	nn	8	SENT_362	[p22l835t2282r1077b2329],
8	AH	NNP	O	AH	appos	5	SENT_362	[p22l1097t2283r1215b2329],
9	.	.	O	.	_	0	SENT_362	[p22l1097t2283r1215b2329],

1	Signiﬁcance	NN	O	signiﬁcance	_	0	SENT_363	[p22l1242t2282r1586b2341],
2	of	IN	O	of	_	0	SENT_363	[p22l1609t2282r1669b2329],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_363	[p22l1683t2282r2104b2341],
4	for	IN	O	for	_	0	SENT_363	[p22l109t2357r190b2405],
5	the	DT	O	the	det	6	SENT_363	[p22l209t2358r297b2405],
6	pharmacology	NN	O	pharmacology	prep_for	1	SENT_363	[p22l318t2358r724b2417],
7	and	CC	O	and	_	0	SENT_363	[p22l745t2358r849b2405],
8	clinical	JJ	O	clinical	amod	9	SENT_363	[p22l871t2358r1071b2405],
9	use	NN	O	use	prep_for	1	SENT_363	[p22l1092t2373r1184b2405],
10	of	IN	O	of	_	0	SENT_363	[p22l1208t2357r1268b2405],
11	HIV	NN	MISC	hiv	nn	13	SENT_363	[p22l1282t2358r1409b2405],
12	protease	NN	O	protease	nn	13	SENT_363	[p22l1428t2368r1666b2417],
13	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_363	[p22l1688t2358r1976b2405],
14	.	.	O	.	_	0	SENT_363	[p22l1688t2358r1976b2405],

1	AIDS	NNP	MISC	AIDS	_	0	SENT_364	[p22l105t2434r276b2482],
2	2000	CD	DATE	2000	num	1	SENT_364	[p22l295t2436r454b2491],
3	;	:	O	;	_	0	SENT_364	[p22l295t2436r454b2491],
4	14	CD	NUMBER	14	num	6	SENT_364	[p22l482t2436r563b2482],
5	:	:	O	:	_	0	SENT_364	[p22l482t2436r563b2482],
6	237-42	CD	NUMBER	237-42	dep	1	SENT_364	[p22l590t2436r817b2482],
7	.	.	O	.	_	0	SENT_364	[p22l590t2436r817b2482],

1	Pilarski	NNP	PERSON	Pilarski	nn	2	SENT_365	[p22l110t2518r317b2565],
2	LM	NNP	O	LM	_	0	SENT_365	[p22l337t2519r463b2575],
3	,	,	O	,	_	0	SENT_365	[p22l337t2519r463b2575],
4	Paine	NNP	PERSON	Paine	nn	5	SENT_365	[p22l486t2518r642b2565],
5	D	NNP	PERSON	D	appos	2	SENT_365	[p22l664t2519r733b2575],
6	,	,	O	,	_	0	SENT_365	[p22l664t2519r733b2575],
7	McElhaney	NNP	PERSON	McElhaney	nn	8	SENT_365	[p22l756t2518r1083b2577],
8	JE	NNP	O	JE	appos	2	SENT_365	[p22l1098t2519r1184b2576],
9	,	,	O	,	_	0	SENT_365	[p22l1098t2519r1184b2576],
10	Cass	NNP	PERSON	Cass	nn	11	SENT_365	[p22l1209t2518r1338b2566],
11	CE	NNP	O	CE	appos	2	SENT_365	[p22l1362t2518r1470b2575],
12	,	,	O	,	_	0	SENT_365	[p22l1362t2518r1470b2575],
13	Belch	NNP	O	Belch	nn	14	SENT_365	[p22l1494t2518r1652b2565],
14	AR	NNS	O	ar	appos	2	SENT_365	[p22l1671t2519r1780b2565],
15	.	.	O	.	_	0	SENT_365	[p22l1671t2519r1780b2565],

1	Multidrug	JJ	O	multidrug	amod	3	SENT_366	[p22l109t2594r402b2653],
2	transporter	NN	O	transporter	nn	3	SENT_366	[p22l421t2605r736b2653],
3	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_366	[p22l755t2594r1172b2653],
4	170	CD	NUMBER	170	dep	3	SENT_366	[p22l1199t2596r1297b2641],
5	as	IN	O	as	_	0	SENT_366	[p22l1320t2609r1373b2641],
6	a	DT	O	a	det	8	SENT_366	[p22l1396t2609r1423b2641],
7	differentiation	NN	O	differentiation	nn	8	SENT_366	[p22l1445t2594r1845b2641],
8	antigen	NN	O	antigen	prep_as	4	SENT_366	[p22l1866t2594r2073b2653],
9	on	IN	O	on	_	0	SENT_366	[p22l111t2686r181b2718],
10	normal	JJ	O	normal	amod	12	SENT_366	[p22l200t2670r402b2718],
11	human	JJ	O	human	amod	12	SENT_366	[p22l421t2670r622b2718],
12	lymphocytes	NNS	O	lymphocyte	prep_on	8	SENT_366	[p22l642t2670r994b2730],
13	and	CC	O	and	_	0	SENT_366	[p22l1017t2670r1121b2718],
14	thymocytes	NNS	O	thymocyte	prep_on	8	SENT_366	[p22l1141t2670r1477b2729],
15	:	:	O	:	_	0	SENT_366	[p22l1141t2670r1477b2729],
16	modulation	NN	O	modulation	dep	3	SENT_366	[p22l1501t2670r1829b2718],
17	with	IN	O	with	_	0	SENT_366	[p22l1848t2670r1972b2718],
18	differentiation	NN	O	differentiation	nn	19	SENT_366	[p22l110t2746r510b2794],
19	stage	NN	O	stage	prep_with	16	SENT_366	[p22l532t2757r670b2805],
20	and	CC	O	and	_	0	SENT_366	[p22l692t2746r796b2794],
21	during	IN	O	during	_	0	SENT_366	[p22l817t2746r1003b2805],
22	aging	NN	O	aging	prep_during	16	SENT_366	[p22l1024t2746r1188b2805],
23	.	.	O	.	_	0	SENT_366	[p22l1024t2746r1188b2805],

1	Am	VBP	O	be	cop	2	SENT_367	[p22l1207t2746r1308b2793],
2	_	NN	O	_	_	0	SENT_367	[p22l1322t2746r1364b2805],
3	7	CD	NUMBER	7	num	2	SENT_367	[p22l1322t2746r1364b2805],
4	Hematol	NNP	O	Hematol	dep	2	SENT_367	[p22l1377t2746r1609b2793],
5	1995	CD	DATE	1995	num	4	SENT_367	[p22l1632t2748r1784b2803],
6	,	,	O	,	_	0	SENT_367	[p22l1632t2748r1784b2803],
7	49	CD	NUMBER	49	num	4	SENT_367	[p22l1808t2748r1892b2794],
8	:	:	O	:	_	0	SENT_367	[p22l1808t2748r1892b2794],
9	323-35	CD	NUMBER	323-35	dep	2	SENT_367	[p22l1918t2748r2143b2794],
10	.	.	O	.	_	0	SENT_367	[p22l1918t2748r2143b2794],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_368	[p22l110t2823r214b2869],
2	CG	NNP	PERSON	CG	_	0	SENT_368	[p22l238t2822r357b2879],
3	,	,	O	,	_	0	SENT_368	[p22l238t2822r357b2879],
4	Ramachandra	NNP	PERSON	Ramachandra	nn	5	SENT_368	[p22l381t2822r780b2869],
5	M	NNP	PERSON	M	appos	2	SENT_368	[p22l801t2823r883b2879],
6	,	,	O	,	_	0	SENT_368	[p22l801t2823r883b2879],
7	Jeang	NNP	O	Jeang	nn	8	SENT_368	[p22l902t2823r1062b2881],
8	KT	NNP	O	KT	appos	2	SENT_368	[p22l1083t2823r1200b2879],
9	,	,	O	,	_	0	SENT_368	[p22l1083t2823r1200b2879],
10	et	FW	O	et	nn	11	SENT_368	[p22l1225t2833r1275b2869],
11	al.	FW	O	al.	appos	2	SENT_368	[p22l1297t2822r1358b2869],
12	.	.	O	.	_	0	SENT_368	[p22l1297t2822r1358b2869],

1	Effect	NN	O	effect	_	0	SENT_369	[p22l1383t2822r1552b2869],
2	of	IN	O	of	_	0	SENT_369	[p22l1573t2822r1634b2869],
3	ABC	NNP	ORGANIZATION	ABC	nn	4	SENT_369	[p22l1646t2822r1788b2869],
4	transporters	NNS	O	transporter	prep_of	1	SENT_369	[p22l1811t2832r2153b2881],
5	on	IN	O	on	_	0	SENT_369	[p22l111t2914r182b2946],
6	HIV-1	NN	O	hiv-1	nn	7	SENT_369	[p22l203t2899r382b2946],
7	infection	NN	O	infection	prep_on	4	SENT_369	[p22l411t2898r676b2946],
8	:	:	O	:	_	0	SENT_369	[p22l411t2898r676b2946],
9	inhibition	NN	O	inhibition	dep	1	SENT_369	[p22l701t2898r980b2946],
10	of	IN	O	of	_	0	SENT_369	[p22l1002t2898r1063b2946],
11	virus	NN	O	virus	nn	12	SENT_369	[p22l1074t2898r1211b2946],
12	production	NN	O	production	prep_of	9	SENT_369	[p22l1232t2898r1551b2958],
13	by	IN	O	by	_	0	SENT_369	[p22l1570t2898r1640b2957],
14	the	DT	O	the	det	16	SENT_369	[p22l1659t2898r1747b2946],
15	MDR1	NN	O	mdr1	nn	16	SENT_369	[p22l1768t2899r1965b2945],
16	transporter	NN	O	transporter	prep_by	12	SENT_369	[p22l109t2985r442b3033],
17	.	.	O	.	_	0	SENT_369	[p22l109t2985r442b3033],

1	FASEB	NNP	ORGANIZATION	FASEB	_	0	SENT_370	[p22l466t2974r687b3021],
2	:7	CD	NUMBER	:7	num	1	SENT_370	[p22l699t2974r741b3033],
3	2000	CD	DATE	2000	dep	1	SENT_370	[p22l758t2976r918b3031],
4	;	:	O	;	_	0	SENT_370	[p22l758t2976r918b3031],
5	14	CD	NUMBER	14	num	7	SENT_370	[p22l946t2976r1026b3021],
6	:	:	O	:	_	0	SENT_370	[p22l946t2976r1026b3021],
7	516-22	CD	NUMBER	516-22	dep	1	SENT_370	[p22l1054t2976r1281b3021],
8	.	.	O	.	_	0	SENT_370	[p22l1054t2976r1281b3021],

1	Schaeffeler	NN	O	schaeffeler	nn	2	SENT_371	[p22l113t3056r426b3104],
2	E	NN	O	e	_	0	SENT_371	[p22l446t3057r505b3113],
3	,	,	O	,	_	0	SENT_371	[p22l446t3057r505b3113],
4	Eichelbaum	NNP	PERSON	Eichelbaum	nn	5	SENT_371	[p22l528t3057r871b3104],
5	M	NNP	O	M	appos	2	SENT_371	[p22l892t3057r974b3113],
6	,	,	O	,	_	0	SENT_371	[p22l892t3057r974b3113],
7	Brinkmann	NNP	PERSON	Brinkmann	nn	8	SENT_371	[p22l997t3057r1321b3104],
8	U	NNP	PERSON	U	appos	2	SENT_371	[p22l1341t3057r1411b3113],
9	,	,	O	,	_	0	SENT_371	[p22l1341t3057r1411b3113],
10	et	FW	O	et	nn	11	SENT_371	[p22l1436t3067r1486b3104],
11	al.	FW	O	al.	appos	2	SENT_371	[p22l1507t3057r1569b3104],
12	.	.	O	.	_	0	SENT_371	[p22l1507t3057r1569b3104],

1	Frequency	NN	O	frequency	_	0	SENT_372	[p22l1594t3057r1900b3116],
2	of	IN	O	of	_	0	SENT_372	[p22l1921t3056r1981b3104],
3	C3435T	NN	O	c3435t	nn	4	SENT_372	[p22l113t3133r357b3181],
4	polymorphism	NN	O	polymorphism	prep_of	1	SENT_372	[p22l377t3133r793b3192],
5	of	IN	O	of	_	0	SENT_372	[p22l815t3133r876b3180],
6	MDR1	NN	O	mdr1	nn	7	SENT_372	[p22l886t3134r1080b3180],
7	gene	NN	O	gene	prep_of	1	SENT_372	[p22l1105t3149r1235b3192],
8	in	IN	O	in	_	0	SENT_372	[p22l1257t3133r1311b3180],
9	African	JJ	MISC	african	amod	10	SENT_372	[p22l1330t3133r1541b3180],
10	people	NNS	O	people	prep_in	1	SENT_372	[p22l1561t3133r1765b3192],
11	.	.	O	.	_	0	SENT_372	[p22l1561t3133r1765b3192],

1	Lancet	NNP	O	Lancet	_	0	SENT_373	[p22l1790t3134r1975b3180],
2	2001	CD	DATE	2001	num	1	SENT_373	[p22l112t3211r271b3266],
3	;	:	O	;	_	0	SENT_373	[p22l112t3211r271b3266],
4	358	CD	NUMBER	358	num	6	SENT_373	[p22l296t3211r415b3257],
5	:	:	O	:	_	0	SENT_373	[p22l296t3211r415b3257],
6	383-84	CD	NUMBER	383-84	dep	1	SENT_373	[p22l441t3211r669b3257],
7	.	.	O	.	_	0	SENT_373	[p22l441t3211r669b3257],

1	Ramratnam	NN	MISC	ramratnam	nn	2	SENT_374	[p22l111t3294r451b3341],
2	B	NN	O	b	_	0	SENT_374	[p22l472t3294r532b3350],
3	,	,	O	,	_	0	SENT_374	[p22l472t3294r532b3350],
4	Mittler	NNP	PERSON	Mittler	nn	5	SENT_374	[p22l555t3293r757b3341],
5	JE	NNP	O	JE	appos	2	SENT_374	[p22l773t3294r860b3351],
6	,	,	O	,	_	0	SENT_374	[p22l773t3294r860b3351],
7	Zhang	NNP	PERSON	Zhang	nn	8	SENT_374	[p22l883t3293r1067b3352],
8	L	NNP	PERSON	L	appos	2	SENT_374	[p22l1087t3294r1147b3350],
9	,	,	O	,	_	0	SENT_374	[p22l1087t3294r1147b3350],
10	et	FW	O	et	nn	11	SENT_374	[p22l1171t3304r1221b3341],
11	al.	FW	O	al.	appos	2	SENT_374	[p22l1243t3293r1304b3341],
12	.	.	O	.	_	0	SENT_374	[p22l1243t3293r1304b3341],

1	The	DT	O	the	det	2	SENT_375	[p22l1329t3293r1445b3341],
2	decay	NN	O	decay	nsubjpass	12	SENT_375	[p22l1467t3293r1630b3352],
3	of	IN	O	of	_	0	SENT_375	[p22l1651t3293r1711b3341],
4	the	DT	O	the	det	6	SENT_375	[p22l1724t3293r1812b3341],
5	latent	JJ	O	latent	amod	6	SENT_375	[p22l1833t3293r1995b3341],
6	reservoir	NN	O	reservoir	prep_of	2	SENT_375	[p22l109t3369r358b3416],
7	of	IN	O	of	_	0	SENT_375	[p22l379t3368r440b3416],
8	replication-competent	JJ	O	replication-competent	amod	9	SENT_375	[p22l452t3369r1088b3428],
9	HIV-1	NN	O	hiv-1	prep_of	6	SENT_375	[p22l1109t3369r1288b3416],
10	is	VBZ	O	be	auxpass	12	SENT_375	[p22l1316t3369r1356b3416],
11	inversely	RB	O	inversely	advmod	12	SENT_375	[p22l1379t3369r1629b3428],
12	correlated	VBN	O	correlate	_	0	SENT_375	[p22l1650t3369r1936b3416],
13	with	IN	O	with	_	0	SENT_375	[p22l1955t3369r2080b3416],
14	the	DT	O	the	det	15	SENT_375	[p22l109t3445r197b3492],
15	extent	NN	O	extent	prep_with	12	SENT_375	[p22l220t3456r395b3492],
16	of	IN	O	of	_	0	SENT_375	[p22l417t3445r477b3492],
17	residual	JJ	O	residual	amod	19	SENT_375	[p22l490t3445r714b3493],
18	Viral	JJ	O	viral	amod	19	SENT_375	[p22l733t3445r856b3493],
19	replication	NN	O	replication	prep_of	15	SENT_375	[p22l878t3445r1182b3504],
20	during	IN	O	during	_	0	SENT_375	[p22l1204t3445r1392b3504],
21	prolonged	JJ	O	prolonged	amod	23	SENT_375	[p22l1411t3445r1702b3504],
22	anti-retroviral	JJ	O	anti-retroviral	amod	23	SENT_375	[p22l1724t3445r2118b3493],
23	therapy	NN	O	therapy	prep_during	12	SENT_375	[p22l109t3521r339b3581],
24	.	.	O	.	_	0	SENT_375	[p22l109t3521r339b3581],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_376	[p22l362t3522r473b3569],
2	Med	NNP	O	Med	_	0	SENT_376	[p22l488t3522r616b3569],
3	2000	CD	DATE	2000	num	2	SENT_376	[p22l634t3523r794b3578],
4	;	:	O	;	_	0	SENT_376	[p22l634t3523r794b3578],
5	6	CD	NUMBER	6	num	7	SENT_376	[p22l817t3524r868b3569],
6	:	:	O	:	_	0	SENT_376	[p22l817t3524r868b3569],
7	82-85	CD	DATE	82-85	dep	2	SENT_376	[p22l895t3523r1085b3569],
8	.	.	O	.	_	0	SENT_376	[p22l895t3523r1085b3569],

1	24	CD	NUMBER	24	num	3	SENT_377	[p23l7t20r75b65],
2	Tanabe	NN	ORGANIZATION	tanabe	nn	3	SENT_377	[p23l109t18r327b66],
3	M	NN	ORGANIZATION	m	_	0	SENT_377	[p23l349t19r431b75],
4	,	,	O	,	_	0	SENT_377	[p23l349t19r431b75],
5	Ieiri	NNP	O	Ieiri	nn	9	SENT_377	[p23l454t18r568b66],
6	I	PRP	O	I	dep	9	SENT_377	[p23l590t19r629b75],
7	,	,	O	,	_	0	SENT_377	[p23l590t19r629b75],
8	Nagata	NNP	PERSON	Nagata	dep	9	SENT_377	[p23l651t19r856b77],
9	N	NNP	O	N	appos	3	SENT_377	[p23l876t19r948b75],
10	,	,	O	,	_	0	SENT_377	[p23l876t19r948b75],
11	et	FW	O	et	nn	12	SENT_377	[p23l972t29r1023b66],
12	al.	FW	O	al.	appos	9	SENT_377	[p23l1044t18r1106b66],
13	.	.	O	.	_	0	SENT_377	[p23l1044t18r1106b66],

1	Expression	NN	O	expression	_	0	SENT_378	[p23l1131t18r1445b77],
2	of	IN	O	of	_	0	SENT_378	[p23l1466t18r1527b66],
3	P-glycoprotein	NN	O	p-glycoprotein	prep_of	1	SENT_378	[p23l1541t18r1962b77],
4	in	IN	O	in	_	0	SENT_378	[p23l1983t18r2037b65],
5	human	JJ	O	human	amod	6	SENT_378	[p23l109t94r310b141],
6	placenta	NN	O	placenta	prep_in	3	SENT_378	[p23l330t94r585b153],
7	:	:	O	:	_	0	SENT_378	[p23l330t94r585b153],
8	relation	NN	O	relation	dep	1	SENT_378	[p23l610t94r828b141],
9	to	TO	O	to	_	0	SENT_378	[p23l848t105r903b141],
10	genetic	JJ	O	genetic	amod	11	SENT_378	[p23l925t94r1127b153],
11	polymorphism	NN	O	polymorphism	prep_to	8	SENT_378	[p23l1148t94r1564b153],
12	of	IN	O	of	_	0	SENT_378	[p23l1586t94r1647b141],
13	the	DT	O	the	det	17	SENT_378	[p23l1660t94r1747b141],
14	multidrug	JJ	O	multidrug	amod	17	SENT_378	[p23l1769t94r2055b153],
15	resistance	NN	O	resistance	nn	17	SENT_378	[p23l109t170r387b218],
16	(	CD	NUMBER	(	num	17	SENT_378	[p23l414t170r682b229],
17	MDR	NN	ORGANIZATION	mdr	prep_of	11	SENT_378	[p23l414t170r682b229],
18	)	CD	NUMBER	)	num	20	SENT_378	[p23l414t170r682b229],
19	-1	CD	NUMBER	-1	num	20	SENT_378	[p23l414t170r682b229],
20	gene	NN	O	gene	dep	8	SENT_378	[p23l711t186r857b229],
21	.	.	O	.	_	0	SENT_378	[p23l711t186r857b229],

1	j	NN	O	j	nn	5	SENT_379	[p23l875t170r1224b229],
2	‘	CD	NUMBER	‘	num	5	SENT_379	[p23l875t170r1224b229],
3	Pharmacol	NNP	O	Pharmacol	nn	5	SENT_379	[p23l875t170r1224b229],
4	Exp	NNP	O	Exp	nn	5	SENT_379	[p23l1239t171r1348b229],
5	Ther	NNP	O	Ther	_	0	SENT_379	[p23l1374t170r1497b218],
6	2001	CD	DATE	2001	dep	5	SENT_379	[p23l1515t172r1675b227],
7	;	:	O	;	_	0	SENT_379	[p23l1515t172r1675b227],
8	297	CD	NUMBER	297	dep	5	SENT_379	[p23l1698t172r1818b218],
9	:	:	O	:	_	0	SENT_379	[p23l1698t172r1818b218],
10	1	CD	NUMBER	1	number	11	SENT_379	[p23l117t247r137b293],
11	137-43	CD	NUMBER	137-43	dep	8	SENT_379	[p23l154t247r376b293],
12	.	.	O	.	_	0	SENT_379	[p23l154t247r376b293],

1	25	CD	NUMBER	25	num	3	SENT_380	[p23l7t332r73b378],
2	Kim	NNP	O	Kim	nn	3	SENT_380	[p23l110t330r236b377],
3	RB	NN	O	rb	_	0	SENT_380	[p23l258t331r365b387],
4	,	,	O	,	_	0	SENT_380	[p23l258t331r365b387],
5	Leake	NNP	PERSON	Leake	nn	6	SENT_380	[p23l388t330r558b378],
6	BF	NNP	O	BF	appos	3	SENT_380	[p23l580t331r683b387],
7	,	,	O	,	_	0	SENT_380	[p23l580t331r683b387],
8	Choo	NNP	ORGANIZATION	Choo	nn	9	SENT_380	[p23l709t330r864b378],
9	EF	NNP	ORGANIZATION	EF	appos	3	SENT_380	[p23l887t331r990b387],
10	,	,	O	,	_	0	SENT_380	[p23l887t331r990b387],
11	et	FW	O	et	nn	12	SENT_380	[p23l1014t341r1065b378],
12	al.	FW	O	al.	appos	3	SENT_380	[p23l1086t330r1147b378],
13	.	.	O	.	_	0	SENT_380	[p23l1086t330r1147b378],

1	Identiﬁcation	NN	O	identiﬁcation	_	0	SENT_381	[p23l1173t330r1558b378],
2	of	IN	O	of	prep	1	SENT_381	[p23l1580t330r1641b378],
3	functionally	RB	O	functionally	pcomp	2	SENT_381	[p23l1654t330r1995b389],

1	Variant	JJ	O	variant	amod	3	SENT_382	[p23l108t406r307b453],
2	MDR1	NN	O	mdr1	nn	3	SENT_382	[p23l327t407r525b453],
3	alleles	NNS	O	allele	_	0	SENT_382	[p23l554t406r723b453],
4	among	IN	O	among	_	0	SENT_382	[p23l747t421r941b465],
5	European	JJ	MISC	european	amod	6	SENT_382	[p23l961t407r1241b465],
6	Americans	NNPS	MISC	Americans	prep_among	3	SENT_382	[p23l1260t406r1564b453],
7	and	CC	O	and	_	0	SENT_382	[p23l1588t406r1692b453],
8	African	NNP	MISC	African	nn	9	SENT_382	[p23l1711t406r1923b453],
9	Americans	NNPS	MISC	Americans	prep_among	3	SENT_382	[p23l108t482r429b530],
10	.	.	O	.	_	0	SENT_382	[p23l108t482r429b530],

1	Clin	NNP	O	Clin	nn	3	SENT_383	[p23l456t482r568b530],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_383	[p23l588t482r881b530],
3	Ther	NNP	O	Ther	_	0	SENT_383	[p23l904t482r1027b530],
4	2001	CD	DATE	2001	num	3	SENT_383	[p23l1045t484r1204b539],
5	;	:	O	;	_	0	SENT_383	[p23l1045t484r1204b539],
6	70	CD	NUMBER	70	num	8	SENT_383	[p23l1230t484r1313b530],
7	:	:	O	:	_	0	SENT_383	[p23l1230t484r1313b530],
8	189-99	CD	NUMBER	189-99	dep	3	SENT_383	[p23l1345t484r1567b530],
9	.	.	O	.	_	0	SENT_383	[p23l1345t484r1567b530],

1	26	CD	NUMBER	26	num	3	SENT_384	[p23l7t567r74b613],
2	Hitzl	NN	O	hitzl	nn	3	SENT_384	[p23l110t565r251b613],
3	M	NN	O	m	_	0	SENT_384	[p23l272t566r354b622],
4	,	,	O	,	_	0	SENT_384	[p23l272t566r354b622],
5	Drescher	NNP	PERSON	Drescher	nn	6	SENT_384	[p23l377t565r639b613],
6	S	NNP	O	S	appos	3	SENT_384	[p23l661t565r713b622],
7	,	,	O	,	_	0	SENT_384	[p23l661t565r713b622],
8	Van	NNP	PERSON	Van	nn	10	SENT_384	[p23l734t581r835b613],
9	der	FW	PERSON	der	nn	10	SENT_384	[p23l857t565r949b613],
10	KH	NNP	PERSON	KH	appos	3	SENT_384	[p23l969t566r1093b622],
11	,	,	O	,	_	0	SENT_384	[p23l969t566r1093b622],
12	et	FW	O	et	nn	13	SENT_384	[p23l1118t576r1168b613],
13	al.	FW	O	al.	appos	3	SENT_384	[p23l1190t565r1250b613],
14	.	.	O	.	_	0	SENT_384	[p23l1190t565r1250b613],

1	The	DT	O	the	det	3	SENT_385	[p23l1275t565r1391b613],
2	C3435T	NN	O	c3435t	nn	3	SENT_385	[p23l1415t565r1660b613],
3	mutation	NN	O	mutation	nsubjpass	10	SENT_385	[p23l1680t565r1942b613],
4	in	IN	O	in	_	0	SENT_385	[p23l1963t565r2017b612],
5	the	DT	O	the	det	8	SENT_385	[p23l110t642r197b690],
6	human	JJ	O	human	amod	8	SENT_385	[p23l218t642r419b690],
7	MDR1	NN	O	mdr1	nn	8	SENT_385	[p23l440t643r638b689],
8	gene	NN	O	gene	prep_in	3	SENT_385	[p23l666t658r796b702],
9	is	VBZ	O	be	auxpass	10	SENT_385	[p23l818t643r859b690],
10	associated	VBN	O	associate	_	0	SENT_385	[p23l882t642r1171b690],
11	with	IN	O	with	_	0	SENT_385	[p23l1191t642r1315b690],
12	altered	JJ	O	altered	amod	13	SENT_385	[p23l1338t642r1531b690],
13	efﬂux	NN	O	efﬂux	prep_with	10	SENT_385	[p23l1553t642r1712b690],
14	of	IN	O	of	_	0	SENT_385	[p23l1733t642r1794b690],
15	the	DT	O	the	det	18	SENT_385	[p23l1807t642r1895b690],
16	P-glycoprotein	NN	MISC	p-glycoprotein	nn	18	SENT_385	[p23l110t718r532b777],
17	substrate	NN	O	substrate	nn	18	SENT_385	[p23l553t718r809b765],
18	rhodamine	NN	O	rhodamine	prep_of	13	SENT_385	[p23l831t718r1140b766],
19	123	CD	NUMBER	123	tmod	10	SENT_385	[p23l1169t720r1267b766],
20	from	IN	O	from	_	0	SENT_385	[p23l1290t718r1427b765],
21	CD56	NN	O	cd56	prep_from	10	SENT_385	[p23l1450t718r1668b766],
22	+	CC	O	+	_	0	SENT_385	[p23l1450t718r1668b766],
23	natural	JJ	O	natural	amod	25	SENT_385	[p23l1692t718r1894b765],
24	killer	NN	O	killer	nn	25	SENT_385	[p23l1916t718r2058b765],
25	cells	NNS	O	cell	prep_from	10	SENT_385	[p23l112t794r247b842],
26	.	.	O	.	_	0	SENT_385	[p23l112t794r247b842],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_386	[p23l271t795r746b854],
2	20015	CD	NUMBER	20015	number	3	SENT_386	[p23l767t796r927b851],
3	11	CD	NUMBER	11	dep	1	SENT_386	[p23l955t796r1036b842],
4	:	:	O	:	_	0	SENT_386	[p23l955t796r1036b842],
5	293-98	CD	NUMBER	293-98	dep	1	SENT_386	[p23l1062t796r1290b842],
6	.	.	O	.	_	0	SENT_386	[p23l1062t796r1290b842],

1	27	CD	NUMBER	27	num	3	SENT_387	[p23l7t879r73b924],
2	Choo	NNP	ORGANIZATION	Choo	nn	3	SENT_387	[p23l113t877r267b925],
3	EF	NNP	ORGANIZATION	EF	_	0	SENT_387	[p23l289t878r393b934],
4	,	,	O	,	_	0	SENT_387	[p23l289t878r393b934],
5	Leake	NNP	PERSON	Leake	nn	6	SENT_387	[p23l416t877r586b925],
6	B	NNP	O	B	appos	3	SENT_387	[p23l608t878r668b934],
7	,	,	O	,	_	0	SENT_387	[p23l608t878r668b934],
8	Wandel	NNP	ORGANIZATION	Wandel	nn	9	SENT_387	[p23l689t877r911b925],
9	C	NNP	ORGANIZATION	C	appos	3	SENT_387	[p23l935t877r999b934],
10	,	,	O	,	_	0	SENT_387	[p23l935t877r999b934],
11	et	FW	O	et	nn	12	SENT_387	[p23l1024t888r1074b925],
12	al.	FW	O	al.	appos	3	SENT_387	[p23l1095t877r1157b925],
13	.	.	O	.	_	0	SENT_387	[p23l1095t877r1157b925],

1	Pharmacological	JJ	O	pharmacological	amod	2	SENT_388	[p23l1183t877r1658b936],
2	inhibition	NN	O	inhibition	_	0	SENT_388	[p23l1679t877r1958b925],
3	of	IN	O	of	prep	2	SENT_388	[p23l1980t877r2040b925],

1	P-glycoprotein	NN	O	p-glycoprotein	nn	2	SENT_389	[p23l110t953r532b1012],
2	transport	NN	O	transport	nsubj	3	SENT_389	[p23l552t963r814b1012],
3	enhances	VBZ	O	enhance	_	0	SENT_389	[p23l836t953r1096b1000],
4	the	DT	O	the	det	5	SENT_389	[p23l1118t953r1205b1000],
5	distribution	NN	O	distribution	dobj	3	SENT_389	[p23l1228t953r1561b1000],
6	of	IN	O	of	_	0	SENT_389	[p23l1584t952r1644b1000],
7	HIV-1	NN	MISC	hiv-1	nn	9	SENT_389	[p23l1658t953r1837b1000],
8	protease	NN	O	protease	nn	9	SENT_389	[p23l109t1040r348b1088],
9	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_389	[p23l369t1029r641b1076],
10	into	IN	O	into	_	0	SENT_389	[p23l664t1029r774b1076],
11	brain	NN	O	brain	prep_into	3	SENT_389	[p23l795t1029r944b1076],
12	and	CC	O	and	_	0	SENT_389	[p23l966t1029r1070b1077],
13	testes	NNS	O	testis	prep_into	3	SENT_389	[p23l1091t1040r1263b1077],
14	.	.	O	.	_	0	SENT_389	[p23l1091t1040r1263b1077],

1	Drug	NN	O	drug	nn	3	SENT_390	[p23l1287t1030r1429b1088],
2	Metab	NNP	O	Metab	nn	3	SENT_390	[p23l1443t1029r1619b1076],
3	Dispos	NNP	O	Dispos	_	0	SENT_390	[p23l1639t1029r1815b1088],
4	2000	CD	DATE	2000	num	3	SENT_390	[p23l1836t1031r1996b1086],
5	;	:	O	;	_	0	SENT_390	[p23l1836t1031r1996b1086],
6	28	CD	NUMBER	28	num	8	SENT_390	[p23l110t1107r196b1153],
7	:	:	O	:	_	0	SENT_390	[p23l110t1107r196b1153],
8	655-60	CD	NUMBER	655-60	dep	3	SENT_390	[p23l223t1107r450b1153],
9	.	.	O	.	_	0	SENT_390	[p23l223t1107r450b1153],

1	28	CD	NUMBER	28	num	3	SENT_391	[p23l7t1191r74b1237],
2	Gutmann	NN	ORGANIZATION	gutmann	nn	3	SENT_391	[p23l112t1189r389b1237],
3	H	NN	ORGANIZATION	h	_	0	SENT_391	[p23l410t1190r481b1246],
4	,	,	O	,	_	0	SENT_391	[p23l410t1190r481b1246],
5	Fricker	NNP	PERSON	Fricker	nn	6	SENT_391	[p23l504t1189r711b1237],
6	G	NNP	PERSON	G	appos	3	SENT_391	[p23l731t1189r800b1246],
7	,	,	O	,	_	0	SENT_391	[p23l731t1189r800b1246],
8	Drewe	NNP	PERSON	Drewe	nn	9	SENT_391	[p23l823t1190r1011b1237],
9	J	NNP	PERSON	J	appos	3	SENT_391	[p23l1029t1190r1071b1247],
10	,	,	O	,	_	0	SENT_391	[p23l1029t1190r1071b1247],
11	Toeroek	NNP	PERSON	Toeroek	nn	12	SENT_391	[p23l1094t1189r1337b1237],
12	M	NNP	O	M	appos	3	SENT_391	[p23l1356t1190r1438b1246],
13	,	,	O	,	_	0	SENT_391	[p23l1356t1190r1438b1246],
14	Miller	NNP	PERSON	Miller	nn	15	SENT_391	[p23l1461t1189r1638b1237],
15	DS	NN	O	d	appos	3	SENT_391	[p23l1657t1189r1765b1237],
16	.	.	O	.	_	0	SENT_391	[p23l1657t1189r1765b1237],

1	Interactions	NNS	O	interaction	_	0	SENT_392	[p23l1791t1189r2131b1237],
2	of	IN	O	of	_	0	SENT_392	[p23l111t1264r172b1312],
3	HIV	NN	O	hiv	nn	5	SENT_392	[p23l186t1265r313b1312],
4	protease	NN	O	protease	nn	5	SENT_392	[p23l331t1275r570b1324],
5	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_392	[p23l591t1265r863b1312],
6	with	IN	O	with	_	0	SENT_392	[p23l885t1265r1009b1312],
7	ATP-dependent	JJ	O	atp-dependent	amod	10	SENT_392	[p23l1028t1265r1498b1324],
8	drug	NN	O	drug	nn	10	SENT_392	[p23l1519t1265r1651b1324],
9	export	NN	O	export	nn	10	SENT_392	[p23l1672t1275r1854b1324],
10	proteins	NNS	O	protein	prep_with	1	SENT_392	[p23l1873t1265r2120b1324],
11	.	.	O	.	_	0	SENT_392	[p23l1873t1265r2120b1324],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_393	[p23l107t1341r223b1389],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_393	[p23l238t1341r531b1389],
3	1999	CD	DATE	1999	num	2	SENT_393	[p23l555t1343r708b1398],
4	,	,	O	,	_	0	SENT_393	[p23l555t1343r708b1398],
5	56	CD	NUMBER	56	num	2	SENT_393	[p23l734t1342r818b1389],
6	:	:	O	:	_	0	SENT_393	[p23l734t1342r818b1389],
7	383-89	CD	NUMBER	383-89	dep	2	SENT_393	[p23l844t1343r1072b1389],
8	.	.	O	.	_	0	SENT_393	[p23l844t1343r1072b1389],

1	29	CD	NUMBER	29	num	3	SENT_394	[p23l7t1427r73b1472],
2	Smit	NNP	ORGANIZATION	Smit	nn	3	SENT_394	[p23l113t1425r245b1472],
3	JW	NNP	ORGANIZATION	JW	_	0	SENT_394	[p23l262t1426r370b1483],
4	,	,	O	,	_	0	SENT_394	[p23l262t1426r370b1483],
5	Schinkel	NNP	PERSON	Schinkel	nn	6	SENT_394	[p23l395t1425r637b1472],
6	AH	NNP	O	AH	appos	3	SENT_394	[p23l657t1426r778b1482],
7	,	,	O	,	_	0	SENT_394	[p23l657t1426r778b1482],
8	Weert	NNP	O	Weert	nn	9	SENT_394	[p23l799t1426r975b1472],
9	B	NNP	O	B	appos	3	SENT_394	[p23l996t1426r1056b1482],
10	,	,	O	,	_	0	SENT_394	[p23l996t1426r1056b1482],
11	Meijer	NNP	ORGANIZATION	Meijer	nn	12	SENT_394	[p23l1078t1425r1267b1484],
12	DK	NNP	ORGANIZATION	DK	appos	3	SENT_394	[p23l1287t1426r1409b1472],
13	.	.	O	.	_	0	SENT_394	[p23l1287t1426r1409b1472],

1	Hepatobiliary	JJ	O	hepatobiliary	amod	4	SENT_395	[p23l1434t1425r1828b1484],
2	and	CC	O	and	_	0	SENT_395	[p23l1849t1425r1953b1472],
3	intestinal	JJ	O	intestinal	conj_and	1	SENT_395	[p23l110t1501r371b1549],
4	clearance	NN	O	clearance	_	0	SENT_395	[p23l393t1501r658b1549],
5	of	IN	O	of	_	0	SENT_395	[p23l681t1501r741b1549],
6	amphiphilic	JJ	O	amphiphilic	amod	8	SENT_395	[p23l756t1501r1093b1560],
7	cationic	JJ	O	cationic	amod	8	SENT_395	[p23l1116t1501r1338b1549],
8	drugs	NNS	O	drug	prep_of	4	SENT_395	[p23l1360t1501r1516b1560],
9	in	IN	O	in	_	0	SENT_395	[p23l1538t1501r1592b1548],
10	mice	NNS	O	mouse	prep_in	8	SENT_395	[p23l1613t1501r1748b1549],
11	in	IN	O	in	_	0	SENT_395	[p23l1769t1501r1823b1548],
12	which	WDT	O	which	rel	20	SENT_395	[p23l1842t1501r2013b1549],
13	both	CC	O	both	preconj	14	SENT_395	[p23l109t1577r241b1624],
14	mdrla	NN	O	mdrlum	nsubjpass	20	SENT_395	[p23l261t1577r447b1624],
15	and	CC	O	and	_	0	SENT_395	[p23l470t1577r574b1624],
16	mdrlb	NN	O	mdrlb	nn	17	SENT_395	[p23l594t1577r785b1624],
17	genes	NNS	O	gene	nsubjpass	20	SENT_395	[p23l807t1592r964b1636],
18	have	VBP	O	have	aux	20	SENT_395	[p23l985t1577r1115b1624],
19	been	VBN	O	be	auxpass	20	SENT_395	[p23l1135t1577r1272b1624],
20	disrupted	VBN	O	disrupt	rcmod	10	SENT_395	[p23l1293t1577r1579b1636],
21	.	.	O	.	_	0	SENT_395	[p23l1293t1577r1579b1636],

1	Brj	NN	O	brj	_	0	SENT_396	[p23l1602t1577r1726b1636],
2	‘	CD	NUMBER	‘	num	1	SENT_396	[p23l1602t1577r1726b1636],
3	Pharmacol	NNP	O	Pharmacol	dep	1	SENT_396	[p23l1741t1577r2034b1624],
4	1998	CD	DATE	1998	num	3	SENT_396	[p23l117t1655r271b1710],
5	,	,	O	,	_	0	SENT_396	[p23l117t1655r271b1710],
6	124	CD	NUMBER	124	num	3	SENT_396	[p23l299t1655r415b1701],
7	:	:	O	:	_	0	SENT_396	[p23l299t1655r415b1701],
8	416-24	CD	NUMBER	416-24	dep	1	SENT_396	[p23l441t1655r669b1701],
9	.	.	O	.	_	0	SENT_396	[p23l441t1655r669b1701],

1	30	CD	NUMBER	30	num	3	SENT_397	[p23l7t1739r74b1785],
2	Schuetz	NNP	ORGANIZATION	Schuetz	nn	3	SENT_397	[p23l113t1737r336b1785],
3	EG	NNP	ORGANIZATION	EG	_	0	SENT_397	[p23l357t1737r472b1794],
4	,	,	O	,	_	0	SENT_397	[p23l357t1737r472b1794],
5	Schinkel	NNP	PERSON	Schinkel	nn	6	SENT_397	[p23l497t1737r739b1785],
6	AH	NNP	O	AH	appos	3	SENT_397	[p23l759t1738r879b1794],
7	,	,	O	,	_	0	SENT_397	[p23l759t1738r879b1794],
8	Relling	NNP	ORGANIZATION	Relling	nn	9	SENT_397	[p23l903t1737r1106b1796],
9	MV	NNP	ORGANIZATION	MV	appos	3	SENT_397	[p23l1125t1738r1254b1794],
10	,	,	O	,	_	0	SENT_397	[p23l1125t1738r1254b1794],
11	Schuetz	NNP	PERSON	Schuetz	nn	12	SENT_397	[p23l1279t1737r1503b1785],
12	JD	NNP	O	JD	appos	3	SENT_397	[p23l1520t1738r1616b1795],
13	.	.	O	.	_	0	SENT_397	[p23l1520t1738r1616b1795],

1	P-glycoprotein	NN	O	p-glycoprotein	_	0	SENT_398	[p23l1642t1737r2078b1796],
2	:	:	O	:	_	0	SENT_398	[p23l1642t1737r2078b1796],
3	a	DT	O	a	det	5	SENT_398	[p23l2104t1753r2132b1784],
4	major	JJ	O	major	amod	5	SENT_398	[p23l109t1814r276b1872],
5	determinant	NN	O	determinant	dep	1	SENT_398	[p23l297t1813r647b1861],
6	of	IN	O	of	_	0	SENT_398	[p23l668t1813r729b1861],
7	rifampicin	NN	O	rifampicin	nn	10	SENT_398	[p23l742t1813r1327b1873],
8	—	CD	NUMBER	—	num	10	SENT_398	[p23l742t1813r1327b1873],
9	inducib1e	NN	O	inducib1e	nn	10	SENT_398	[p23l742t1813r1327b1873],
10	expression	NN	O	expression	prep_of	5	SENT_398	[p23l1349t1814r1648b1873],
11	of	IN	O	of	_	0	SENT_398	[p23l1670t1813r1731b1861],
12	cytochrome	NN	O	cytochrome	nn	13	SENT_398	[p23l1745t1813r2079b1872],
13	P4503A	NN	O	p4503a	prep_of	5	SENT_398	[p23l110t1890r345b1936],
14	in	IN	O	in	_	0	SENT_398	[p23l365t1889r419b1936],
15	mice	NNS	O	mouse	prep_in	13	SENT_398	[p23l439t1889r574b1936],
16	and	CC	O	and	_	0	SENT_398	[p23l597t1889r701b1936],
17	humans	NNS	O	human	conj_and	15	SENT_398	[p23l721t1889r964b1936],
18	.	.	O	.	_	0	SENT_398	[p23l721t1889r964b1936],

1	Proc	NNP	ORGANIZATION	Proc	nn	5	SENT_399	[p23l988t1890r1106b1936],
2	Natl	NNP	ORGANIZATION	Natl	nn	5	SENT_399	[p23l1125t1889r1253b1936],
3	Acad	NNP	ORGANIZATION	Acad	nn	5	SENT_399	[p23l1264t1889r1413b1936],
4	Sci	NNP	ORGANIZATION	Sci	nn	5	SENT_399	[p23l1429t1889r1514b1936],
5	USA	NNP	ORGANIZATION	USA	_	0	SENT_399	[p23l1538t1889r1666b1936],
6	1996	CD	DATE	1996	num	5	SENT_399	[p23l1696t1891r1850b1946],
7	;	:	O	;	_	0	SENT_399	[p23l1696t1891r1850b1946],
8	93	CD	NUMBER	93	num	10	SENT_399	[p23l1874t1891r1959b1936],
9	:	:	O	:	_	0	SENT_399	[p23l1874t1891r1959b1936],
10	4001-05	CD	DATE	4001-05	dep	5	SENT_399	[p23l111t1968r376b2014],
11	.	.	O	.	_	0	SENT_399	[p23l111t1968r376b2014],

1	31	CD	NUMBER	31	num	3	SENT_400	[p23l7t2052r69b2098],
2	Schuetz	NNP	ORGANIZATION	Schuetz	nn	3	SENT_400	[p23l112t2050r336b2098],
3	EG	NNP	ORGANIZATION	EG	_	0	SENT_400	[p23l357t2050r472b2107],
4	,	,	O	,	_	0	SENT_400	[p23l357t2050r472b2107],
5	Umbenhauer	NNP	O	Umbenhauer	nn	6	SENT_400	[p23l494t2050r876b2098],
6	DR	NN	O	dr	appos	3	SENT_400	[p23l896t2051r1014b2107],
7	,	,	O	,	_	0	SENT_400	[p23l896t2051r1014b2107],
8	Yasuda	NNP	ORGANIZATION	Yasuda	nn	9	SENT_400	[p23l1036t2050r1248b2098],
9	K	NNP	ORGANIZATION	K	appos	3	SENT_400	[p23l1270t2051r1337b2107],
10	,	,	O	,	_	0	SENT_400	[p23l1270t2051r1337b2107],
11	et	FW	O	et	nn	12	SENT_400	[p23l1362t2061r1412b2097],
12	al.	FW	O	al.	appos	3	SENT_400	[p23l1433t2050r1495b2097],
13	.	.	O	.	_	0	SENT_400	[p23l1433t2050r1495b2097],

1	Altered	JJ	O	altered	amod	2	SENT_401	[p23l1519t2050r1731b2097],
2	expression	NN	O	expression	_	0	SENT_401	[p23l1753t2050r2052b2109],
3	of	IN	O	of	_	0	SENT_401	[p23l2073t2050r2134b2097],
4	hepatic	JJ	O	hepatic	amod	6	SENT_401	[p23l109t2126r316b2186],
5	cytochromes	NNS	O	cytochrome	nn	6	SENT_401	[p23l338t2126r698b2185],
6	P-450	NN	O	p-450	prep_of	2	SENT_401	[p23l722t2127r893b2174],
7	in	IN	O	in	_	0	SENT_401	[p23l916t2127r969b2173],
8	mice	NNS	O	mouse	prep_in	6	SENT_401	[p23l990t2127r1125b2174],
9	deﬁcient	JJ	O	deﬁcient	amod	2	SENT_401	[p23l1148t2126r1393b2174],
10	in	IN	O	in	_	0	SENT_401	[p23l1413t2126r1467b2173],
11	one	CD	NUMBER	one	num	15	SENT_401	[p23l1489t2142r1590b2174],
12	or	CC	O	or	_	0	SENT_401	[p23l1612t2142r1672b2174],
13	more	JJR	O	more	num	15	SENT_401	[p23l1691t2142r1837b2174],
14	mdrl	NN	O	mdrl	nn	15	SENT_401	[p23l1858t2126r2006b2174],
15	genes	NNS	O	gene	prep_in	9	SENT_401	[p23l110t2217r283b2261],
16	.	.	O	.	_	0	SENT_401	[p23l110t2217r283b2261],

1	Mol	NNP	ORGANIZATION	Mol	nn	2	SENT_402	[p23l305t2202r421b2249],
2	Pharmacol	NNP	O	Pharmacol	_	0	SENT_402	[p23l436t2202r729b2249],
3	2000	CD	DATE	2000	num	2	SENT_402	[p23l747t2204r906b2259],
4	,	,	O	,	_	0	SENT_402	[p23l747t2204r906b2259],
5	57	CD	NUMBER	57	num	2	SENT_402	[p23l932t2203r1015b2249],
6	:	:	O	:	_	0	SENT_402	[p23l932t2203r1015b2249],
7	188-97	CD	NUMBER	188-97	dep	2	SENT_402	[p23l1047t2204r1260b2249],
8	.	.	O	.	_	0	SENT_402	[p23l1047t2204r1260b2249],

1	32	CD	NUMBER	32	num	3	SENT_403	[p23l7t2287r74b2332],
2	Huang	NNP	ORGANIZATION	Huang	nn	3	SENT_403	[p23l110t2285r307b2344],
3	L	NNP	ORGANIZATION	L	_	0	SENT_403	[p23l326t2285r386b2341],
4	,	,	O	,	_	0	SENT_403	[p23l326t2285r386b2341],
5	Wring	NNP	O	Wring	nn	6	SENT_403	[p23l408t2285r589b2344],
6	SA	NNP	O	SA	appos	3	SENT_403	[p23l610t2285r710b2341],
7	,	,	O	,	_	0	SENT_403	[p23l610t2285r710b2341],
8	Woolley	NNP	PERSON	Woolley	nn	9	SENT_403	[p23l732t2285r969b2344],
9	JL	NNP	O	JL	appos	3	SENT_403	[p23l985t2285r1072b2342],
10	,	,	O	,	_	0	SENT_403	[p23l985t2285r1072b2342],
11	et	FW	O	et	nn	12	SENT_403	[p23l1096t2295r1147b2332],
12	al.	FW	O	al.	appos	3	SENT_403	[p23l1168t2285r1230b2332],
13	.	.	O	.	_	0	SENT_403	[p23l1168t2285r1230b2332],

1	Induction	NN	O	induction	_	0	SENT_404	[p23l1255t2285r1537b2332],
2	of	IN	O	of	_	0	SENT_404	[p23l1559t2284r1619b2332],
3	P-glycoprotein	NN	O	p-glycoprotein	nn	7	SENT_404	[p23l1633t2285r2054b2344],
4	and	CC	O	and	_	0	SENT_404	[p23l112t2361r215b2409],
5	cytochrome	NN	O	cytochrome	nn	7	SENT_404	[p23l238t2361r572b2420],
6	P450	NN	O	p450	nn	7	SENT_404	[p23l594t2362r742b2409],
7	3A	NN	O	3a	prep_of	1	SENT_404	[p23l766t2362r848b2409],
8	by	IN	O	by	_	0	SENT_404	[p23l866t2361r935b2420],
9	HIV	NN	MISC	hiv	nn	11	SENT_404	[p23l955t2362r1082b2409],
10	protease	NN	O	protease	nn	11	SENT_404	[p23l1101t2372r1339b2420],
11	inhibitors	NNS	O	inhibitor	prep_by	1	SENT_404	[p23l1361t2361r1650b2409],
12	.	.	O	.	_	0	SENT_404	[p23l1361t2361r1650b2409],

1	Drug	NN	O	drug	nn	3	SENT_405	[p23l1674t2362r1816b2420],
2	Metab	NNP	O	Metab	nn	3	SENT_405	[p23l1830t2361r2006b2409],
3	Dispos	NNP	O	Dispos	_	0	SENT_405	[p23l109t2437r285b2496],
4	2001	CD	DATE	2001	num	3	SENT_405	[p23l306t2438r466b2493],
5	;	:	O	;	_	0	SENT_405	[p23l306t2438r466b2493],
6	29	CD	NUMBER	29	num	8	SENT_405	[p23l490t2439r575b2484],
7	:	:	O	:	_	0	SENT_405	[p23l490t2439r575b2484],
8	754-60	CD	NUMBER	754-60	dep	3	SENT_405	[p23l601t2438r829b2484],
9	.	.	O	.	_	0	SENT_405	[p23l601t2438r829b2484],

1	33	CD	NUMBER	33	num	3	SENT_406	[p23l7t2522r73b2568],
2	Lavie	NNP	O	Lavie	nn	3	SENT_406	[p23l110t2521r265b2568],
3	Y	NN	O	y	_	0	SENT_406	[p23l285t2521r349b2577],
4	,	,	O	,	_	0	SENT_406	[p23l285t2521r349b2577],
5	Liscovitch	NNP	O	Liscovitch	nn	7	SENT_406	[p23l371t2520r666b2568],
6	M.	NNP	O	M.	nn	7	SENT_406	[p23l687t2521r767b2568],
7	Changes	NNS	O	change	appos	3	SENT_406	[p23l794t2520r1038b2580],
8	in	IN	O	in	_	0	SENT_406	[p23l1060t2521r1114b2567],
9	lipid	NN	O	lipid	nn	12	SENT_406	[p23l1135t2520r1262b2580],
10	and	CC	O	and	_	0	SENT_406	[p23l1283t2520r1388b2568],
11	protein	NN	O	protein	nn	12	SENT_406	[p23l1408t2521r1614b2580],
12	constituents	NNS	O	constituent	prep_in	7	SENT_406	[p23l1636t2521r1980b2568],
13	of	IN	O	of	_	0	SENT_406	[p23l2004t2520r2064b2568],
14	rafts	NNS	O	raft	prep_of	12	SENT_406	[p23l110t2596r232b2643],
15	and	CC	O	and	_	0	SENT_406	[p23l256t2596r360b2643],
16	caveolae	NNS	O	caveola	prep_of	12	SENT_406	[p23l382t2596r620b2643],
17	in	IN	O	in	_	0	SENT_406	[p23l642t2596r696b2643],
18	multidrug	JJ	O	multidrug	amod	19	SENT_406	[p23l716t2596r1003b2655],
19	resistant	JJ	O	resistant	amod	21	SENT_406	[p23l1022t2596r1262b2643],
20	cancer	NN	O	cancer	nn	21	SENT_406	[p23l1283t2611r1469b2643],
21	cells	NNS	O	cell	prep_in	14	SENT_406	[p23l1490t2596r1609b2643],
22	and	CC	O	and	_	0	SENT_406	[p23l1633t2596r1737b2643],
23	their	PRP$	O	they	poss	25	SENT_406	[p23l1758t2596r1890b2643],
24	functional	JJ	O	functional	amod	25	SENT_406	[p23l110t2672r399b2720],
25	consequences	NNS	O	consequence	prep_in	14	SENT_406	[p23l421t2688r829b2731],
26	.	.	O	.	_	0	SENT_406	[p23l421t2688r829b2731],

1	Glycoconjj	NNP	O	Glycoconjj	_	0	SENT_407	[p23l858t2672r1169b2731],
2	‘	CD	NUMBER	‘	num	1	SENT_407	[p23l858t2672r1169b2731],
3	2000	CD	DATE	2000	dep	1	SENT_407	[p23l1186t2674r1346b2729],
4	;	:	O	;	_	0	SENT_407	[p23l1186t2674r1346b2729],
5	17	CD	NUMBER	17	num	7	SENT_407	[p23l1374t2674r1454b2720],
6	:	:	O	:	_	0	SENT_407	[p23l1374t2674r1454b2720],
7	253-59	CD	NUMBER	253-59	dep	1	SENT_407	[p23l1481t2674r1709b2720],
8	.	.	O	.	_	0	SENT_407	[p23l1481t2674r1709b2720],

1	34	CD	NUMBER	34	num	3	SENT_408	[p23l7t2757r75b2803],
2	Ameyaw	NNP	O	Ameyaw	nn	3	SENT_408	[p23l108t2756r357b2814],
3	MM	NN	O	mm	_	0	SENT_408	[p23l377t2756r525b2812],
4	,	,	O	,	_	0	SENT_408	[p23l377t2756r525b2812],
5	Regateiro	NN	O	regateiro	nn	6	SENT_408	[p23l550t2755r821b2814],
6	F	NN	O	f	appos	3	SENT_408	[p23l844t2756r902b2812],
7	,	,	O	,	_	0	SENT_408	[p23l844t2756r902b2812],
8	Li	NNP	PERSON	Li	nn	9	SENT_408	[p23l924t2755r985b2802],
9	T	NN	PERSON	t	appos	3	SENT_408	[p23l1005t2756r1071b2812],
10	,	,	O	,	_	0	SENT_408	[p23l1005t2756r1071b2812],
11	et	FW	O	et	nn	12	SENT_408	[p23l1096t2766r1146b2802],
12	al.	FW	O	al.	appos	3	SENT_408	[p23l1168t2755r1229b2803],
13	.	.	O	.	_	0	SENT_408	[p23l1168t2755r1229b2803],

1	MDR1	NN	O	mdr1	nn	2	SENT_409	[p23l1254t2756r1452b2802],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_409	[p23l1479t2755r2011b2814],
3	:	:	O	:	_	0	SENT_409	[p23l1479t2755r2011b2814],

1	frequency	NN	O	frequency	nsubjpass	11	SENT_410	[p23l110t2831r393b2891],
2	of	IN	O	of	_	0	SENT_410	[p23l414t2831r475b2879],
3	the	DT	O	the	det	5	SENT_410	[p23l487t2831r575b2879],
4	C3435T	NN	O	c3435t	nn	5	SENT_410	[p23l599t2832r844b2879],
5	mutation	NN	O	mutation	prep_of	1	SENT_410	[p23l864t2831r1125b2879],
6	in	IN	O	in	_	0	SENT_410	[p23l1146t2832r1200b2878],
7	exon	NN	O	exon	prep_in	5	SENT_410	[p23l1222t2847r1357b2879],
8	26	CD	NUMBER	26	num	7	SENT_410	[p23l1379t2833r1446b2879],
9	is	VBZ	O	be	auxpass	11	SENT_410	[p23l1470t2831r1510b2879],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_410	[p23l1533t2831r1876b2891],
11	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_410	[p23l110t2907r410b2954],
12	by	IN	O	by	_	0	SENT_410	[p23l429t2907r499b2966],
13	ethnicity	NN	O	ethnicity	agent	11	SENT_410	[p23l519t2907r780b2966],
14	.	.	O	.	_	0	SENT_410	[p23l519t2907r780b2966],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_411	[p23l805t2907r1279b2966],
2	2001	CD	DATE	2001	num	1	SENT_411	[p23l1301t2909r1461b2964],
3	;	:	O	;	_	0	SENT_411	[p23l1301t2909r1461b2964],
4	11	CD	NUMBER	11	num	6	SENT_411	[p23l1488t2909r1569b2954],
5	:	:	O	:	_	0	SENT_411	[p23l1488t2909r1569b2954],
6	217-21	CD	NUMBER	217-21	dep	1	SENT_411	[p23l1596t2909r1823b2954],
7	.	.	O	.	_	0	SENT_411	[p23l1596t2909r1823b2954],

1	36	CD	NUMBER	36	_	0	SENT_412	[p23l93t3088r131b3114],
2	THE	DT	O	the	det	3	SENT_412	[p23l1226t3093r1292b3113],
3	LANCET	NN	O	lancet	dep	1	SENT_412	[p23l1302t3093r1431b3114],
4	-	:	O	-	_	0	SENT_412	[p23l1441t3100r1448b3107],
5	Vol	NN	O	vol	dep	1	SENT_412	[p23l1458t3093r1502b3114],
6	359	CD	NUMBER	359	num	5	SENT_412	[p23l1512t3094r1557b3114],
7	-	:	O	-	_	0	SENT_412	[p23l1568t3100r1576b3107],
8	January	NNP	DATE	January	dep	5	SENT_412	[p23l1584t3093r1682b3119],
9	5	CD	DATE	5	num	8	SENT_412	[p23l1691t3094r1713b3118],
10	,	,	DATE	,	_	0	SENT_412	[p23l1691t3094r1713b3118],
11	2002	CD	DATE	2002	num	8	SENT_412	[p23l1724t3094r1786b3114],
12	-	:	O	-	_	0	SENT_412	[p23l1796t3100r1804b3107],
13	www.the1ancet.com	NN	O	www.the1ancet.com	dep	8	SENT_412	[p23l1813t3093r2064b3114],

